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Neuronal diversity in the nervous system is ge-
nerated through the activation of multiple uni-
que batteries of terminal differentiation genes, 
which determine the functional properties of the 
distinct mature neurons. It is generally accepted 
that transcription factors (TFs) bind in a combina-
torial and cooperative manner to DNA sequences 
of the genome called enhancers, placing TFs as 
the main regulators of gene expression. However, 
how these combinations of TFs identify and acti-
vate their target sequences is poorly understood. 
In this work we use as a paradigm the serotonergic 
neurons to unravel the regulatory rules that select 
a cell type-specific transcriptome during terminal 
differentiation. 
Serotonergic neurons are present in all eumetazoan 
groups and are universally defined by their ability 
to synthesise and release serotonin (5-HT), which 
is achieved by the expression of the ‘5-HT pathway 
genes’. Taking advantage of this phylogenetic 
conservation, we use the simple model organism 
Caenorhabditis elegans to dissect the transcrip-
tional regulatory logic of serotonergic neurons. 
C. elegans hermaphrodites have three functiona-
lly different serotonergic subclasses: the HSN mo-
torneuron, the ADF sensory neuron and the NSM 
neurosecretory motorneuron. All three neuron sub-
types express the 5-HT pathway genes. Through 
an in vivo cis-regulatory analysis of these genes we 
have identified independent cis-regulatory modu-
les (CRM) responsible for their expression in each 
serotonergic neuron subtype. This modular organi-
sation suggests that different regulatory logics are 
employed in each neuron subclass to activate its 
terminal transcriptome. To deepen in our unders-
tanding of how cell type-specific transcriptional 
programmes are implemented we decided to focus 
the rest of our work on the best characterised sero-
tonergic neuron subtype, the HSN neuron, and ca-
rried out an extensive dissection of HSN terminal 
differentiation transcriptional rules. 
Loss of function mutant and cis-regulatory analy-
ses reveal that direct activation of the HSN trans-
criptome is orchestrated by a code of six TFs, that 
we have termed HSN TF collective. This TF code is 
composed by AST-1 (ETS TF family), UNC-86 (POU 
TF family), SEM-4 (SPALT TF family), HLH-3 (bHLH 
TF family), EGL-46 (INSM TF family) and EGL-18 
(GATA TF family). The expression of the HSN TF co-
llective is sufficient to induce serotonergic fate in 
some specific contexts and is required throughout 
the life of the animal in order to maintain the identi-
ty of the HSN neuron.
Bioinformatically identified binding site clusters for 
the six TFs of the HSN TF collective are enriched in 
known HSN expressed genes compared to a ran-
dom set of genes. Through in vivo reporter analysis, 
we demonstrate that this clustering constitutes a 
regulatory signature that is sufficient for de novo 
identification of HSN neuron functional enhancers. 
This regulatory signature contains certain syntac-
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tic constrains that further improve the prediction of 
enhancer expression in the cell.
Mouse orthologues of most members of the HSN 
TF collective are known regulators of the mam-
malian serotonergic differentiation programme. 
This homology in both serotonergic regulatory pro-
grammes allows for the identification of an additio-
nal candidate TF in the worm (PHA-4), orthologue 
to the mouse FOXA2, and a mouse TF (SALL2), or-
thologue of the worm SEM-4. Moreover, we prove 
that mouse orthologues can functionally substi-
tute for their worm counterparts. Finally, Principal 
Coordinates Analysis suggests that, among C. ele-
gans neurons, the HSN transcriptome most close-
ly resembles that of mouse serotonergic neurons, 
which reveals deep homology.
Our results show that a regulatory signature based 
on a defined set of TFs is sufficient for enhan-
cer identification using primary DNA sequence. 
Moreover, our results identify rules governing the 
transcriptional regulatory code of a critically im-
portant neuronal type in two species separated by 
over 700 million years.
Lógica de regulación transcripcional de las 
neuronas serotonérgicas en Caenorhabditis 
elegans
La diversidad del sistema nervioso se genera me-
diante la activación de múltiples baterías únicas 
de genes efectores, que definen las propiedades 
funcionales de los diferentes subtipos neuronales. 
Está bien establecido que los factores de trans-
cripción (FT) se unen de una manera combinatoria 
y cooperativa a secuencias de ADN presentes en 
los elementos de regulación en cis del genoma, lla-
mados potenciadores (enhancers en inglés). Esto 
otorga a los FT un papel central en la regulación de 
la expresión génica. Sin embargo, no se conocen 
los mecanismos por los que estas combinaciones 
de FT identifican y activan sus secuencias diana. 
En este trabajo se han utilizado las neuronas se-
rotonérgicas como paradigma de investigación de 
las leyes que regulan la selección del transcripto-
ma de un tipo neuronal concreto durante la diferen-
ciación terminal. 
Las neuronas serotonérgicas se encuentran pre-
sentes en todos los grupos de eumetazoos y se 
definen por su habilidad de sintetizar y liberar se-
rotonina (5-HT), lo cual es posible gracias a la ex-
presión de los llamados ‘genes de la vía de la 
5-HT’. Aprovechando esta conservación filo-
genética, hemos utilizado el organismo modelo 
Caenorhabditis elegans para diseccionar la lógica 
de regulación transcripcional de las neuronas se-
rotonérgicas. Los hermafroditas C. elegans con-
tienen tres subclases de neuronas serotonérgicas 
con diferente función: la neurona motora HSN, la 
neurona secretora ADF y la neurona motora neuro-
secretora NSM. Mediante un análisis de regulación 
in vivo de los genes de la vía de la 5-HT, hemos iden-
tificado módulos de regulación en cis (MRC) inde-
pendientes responsables de su expresión en cada 
uno de los tres subtipos serotonérgicos. Esta orga-
nización modular sugiere que cada subclase utiliza 
una lógica de regulación diferente. Para profundi-
zar en los mecanismos de selección y activación 
del transcriptoma específico de un tipo neuronal 
decidimos enfocar el resto de nuestro trabajo en el 
estudio de la neurona HSN, por ser la mejor carac-
terizada hasta la fecha.
El análisis de mutantes de pérdida de función, junto 
con el estudio detallado de los MRC de la neurona 
HSN, revelan que un código de seis FT es capaz de 
activar directamente el transcriptoma de la neurona 
HSN. Este código, al que hemos llamado ‘Colectivo 
de FT de HSN’, está formado por AST-1 (de la fami-
lia de FT ETS), UNC-86 (POU), SEM-4 (SPALT), HLH-3 
(bHLH), EGL-46 (INSM) y EGL-18 (GATA). Esta com-
binación, es suficiente, en algunos contextos celu-
lares para la inducción del fenotipo serotonérgico y 
necesario durante toda la vida del animal para man-
tener la identidad de la neurona HSN.
Por otro lado, estudios bioinformáticos de predic-
ción de sitios de unión para los seis FT del código, 
muestran que los genes expresados en la neurona 
HSN están enriquecidos en la presencia de agru-
paciones de estos seis sitios de unión, en com-
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paración a un conjunto de genes elegidos al azar. 
Mediante el análisis de reporteros in vivo, demos-
tramos que esta agrupación constituye una huella 
reguladora que es suficiente para la identificación 
de nuevos potenciadores funcionales para la neu-
rona HSN. Además, esta huella reguladora contie-
ne normas sintácticas que mejoran la predicción de 
potenciadores expresados en la célula.
Curiosamente, el programa de diferenciación de las 
neuronas serotonérgicas en ratón está controlado 
por FT que son ortólogos a los del nematodo. Esta 
elevada homología en la regulación nos ha permiti-
do identificar nuevos candidatos a regular las neu-
ronas serotonérgicas del gusano (PHA-4, ortólogo 
a FOXA2) y del ratón (SALL2, ortólogo a SEM-4). 
Asimismo, los ortólogos de ratón son capaces de 
sustituir funcionalmente a los FT equivalentes en 
gusano. Finalmente, el Análisis de Coordenadas 
Principales sugiere que, de entre todas las neuro-
nas del gusano, el transcriptoma de la neurona HSN 
es el que más se asemeja a aquel de las neuronas 
serotonérgicas de ratón, revelando relaciones de 
homología profunda.
En conclusión, hemos demostrado que la presencia 
de una huella reguladora basada en un conjunto de-
finido de FT es suficiente para identificar potencia-
dores, utilizando únicamente la secuencia primaria 
de ADN. Además, hemos identificado las reglas que 
gobiernan el código de regulación transcripcional 
de un tipo neuronal relevante en dos especies sepa-
radas hace más de 700 millones de años.
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Introduction
The nervous system is the most complex tissue, re-
garding cell diversity and structure. At the function-
al level it controls a wide repertoire of behaviours; 
from basic behaviours like appetite, breathing or 
arousal, to more sophisticated behaviours such as 
learning and memory. In order to understand how 
the brain functions, it is essential to learn the prin-
ciples of how the nervous system develops: how 
neurons are made, how they differentiate into dis-
tinct and specialised neuron types and how they 
are assembled into circuits that produce behav-
iours. According to recent estimates there are 86-
100 billion neurons in the human brain (Muotri & 
Gage 2006; Azevedo et al. 2009), with a total of 1015 
synapses, an average of 5,000-20,000 synapses 
per neuron in the neocortex (Pakkenberg et al. 2003; 
Milo et al. 2010) and about 10,000 different neu-
ronal types (Muotri & Gage 2006). The first descrip-
tions of nerve cells were attributed to Ehrenberg 
and Purkinje during the mid-1830s and in the early 
1870s Camillo Golgi discovered a revolutionary way 
to stain the nervous system (reviewed in (López-
Muñoz et al. 2006)). Ramón y Cajal was the first to 
postulate that the functional units of the nervous 
system were discrete cells that were beautifully 
represented in his drawings. His work established 
the notion that brain function could be understood 
by studying its component cells (Ramón y Cajal 
1909). This, together with the discovery that nerve 
cells communicate with each other through the re-
lease of chemical neurotransmitters at specialised 
sites (Dale 1954; Dale 1934; Loewi 1954), marked the 
beginning of modern neuroscience. An addition-
al revolution in the neuroscience field has taken 
place recently, with the advent of deep sequencing 
technologies and single cell transcriptomics. In the 
light of molecular neurobiology and transcriptome 
analysis of different neuron types, we now know 
that the morphological and functional diversity of 
neuronal cell types is a reflection of the astounding 
degree of diversity in their molecular composition 
(Hawrylycz et al. 2012; Darmanis et al. 2015). On top 
of this, a higher level of complexity appears when 
neuronal connections organise into functional cir-
cuits constituting the brain connectome (Sporns 
2011). 
Although research in the past decades has shed 
light on the basic principles of nervous system 
development, less is known about the molecular 
mechanisms that control neuron subtype speci-
fication and how those identities are maintained 
throughout the life of the animal.
In this Thesis we are interested in understanding 
how particular neuronal types are specified at the 
terminal level, with a special focus on how the cell 
can decode the information of the regulatory ge-
nome to select the complement of genes that are 
required for its function. As a paradigm we use the 
serotonergic neurons to unravel the regulatory 
rules that select a cell type-specific transcriptome 
during terminal differentiation. The Introduction 
has been divided in three main parts: the first part 
deals with neuron terminal specification from a mo-
lecular and transcriptional point of view, the second 
one focuses on the serotonergic system, providing 
an update on serotonergic terminal differentiation 
in mammals, and the third proposes the nema-
tode Caenorhabditis elegans as an optimal model to 
study serotonergic terminal differentiation.
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Neuronal cell fate specification
In order to generate a neuron, a cell or lineage gen-
erally will undergo the following steps: choose a 
neural versus non-neural fate, commit to a spe-
cific neuronal lineage, mature and terminally dif-
ferentiate into a specific neuron class or subclass 
(Hobert 2005). Next, we will describe the develop-
mental states needed until terminal differentiation 
is achieved.
In vertebrates, the earliest step in the generation of 
the nervous system is the acquisition of a neuronal 
fate by a specific group of ectodermal cells of the 
embryo that generate a structure termed neuronal 
plate (neuronal precursors), which will generate the 
entire nervous system (reviewed in (Stern 2006)) 
→ Figure 1.1. Through temporal and concentration 
gradients of signalling molecules, known as mor-
phogens, the expression of patterning transcrip-
tion factors (TFs) is induced, which mainly belong 
to the homeodomain (HD) TF family. Through mu-
tual cross-inhibition, transcriptional domains are 
established, which define the progenitor cells that 
will give birth to specific neuron types (Briscoe et 
al. 1999; Ericson et al. 1997; Wilson & Maden 2005). 
Proneural genes are activated, which promote the 
generation of progenitors that are committed to 
neuronal differentiation. Proneural genes mainly 
belong to the basic-helix-loop-helix (bHLH) TF fam-
ily and, via Notch signalling, inhibit their own ex-
pression in adjacent cells in a process called lateral 
inhibition (Bertrand et al. 2002). In vertebrates, mu-
tations in the Asc TF Ascl1 (also known as Mash1) 
and Ato related Neurogenin 2 (Ngn2) result in loss 
of neuronal progenitors and premature genera-
tion of astrocytic progenitors (Bertrand et al. 2002; 
Gómez-Skarmeta et al. 2003). This observation sug-
gests that, consistent with a proneural role, Ngn2 
and Ascl1 play a role in both the commitment of 
multipotent progenitors to a neuronal fate and in 
the inhibition of glial fate. 
In order to acquire their highly specialised fea-
tures, neurons must proceed through two final 
stages of neuronal development: maturation and 
differentiation. During maturation newly born neu-
rons undergo axonal and dendritic morphogenesis, 
synaptogenesis and synapse elimination there-
by assembling into functional circuits. This pro-
cess occurs simultaneously with differentiation, 
in which neurons come to express the battery of 
genes required for their mature function in the cir-
cuit → Figure 1.2. This set of genes, known as ef-
fector genes, are expressed throughout the life 
of an adult differentiated neuron and confer the 
unique identity to a neuron (Hobert 2016); in other 
words, the ‘molecular identity’ of a neuron or its 
‘molecular signature’. The composition of the neu-
ron type-specific gene batteries is combinatori-
al, meaning that individual neuron types do not 
uniquely express exclusive gene products, but it 
is rather the unique combination of genes that are 
more broadly expressed what defines a neuron 
type-specific gene battery (Wenick & Hobert 2004). 
This so called ‘combinatorial coding’ can support 
Part I
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Postmitotic  
neuronal precursor
Immature Differentiating  
neuron
Mature neuron
Progenitor cells first acquire 
the neuronal fate through the 
action of morphogens and 
signalling molecules. Next, 
they exit the cell cycle to 
become postmitotic neuronal 
precursors that do not yet
possess neuron type identity. 
Identity is acquired after neu-
ronal differentiation through 
coordinate expression of 
neuron type gene batteries. 
The newborn neurons remain 
phenotypically immature until
they accomplish the 
maturation process that 
includes cell body migration, 
dendritic growth, expression 
of neurotransmitter 
pathways, formation of  
axonal pathways and
synaptogenesis. At this point, 
neurons become integrated 
into neural circuitry and 
acquire functional properties.
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Figure 1.3  
Key features of gene 
regulatory logic in mature 
neuron types 
A) Unique neuronal identity 
Terminal selector codes 
co-regulate a battery of 
terminal identity features 
(subtype-specific transcrip-
tome) of a given neuron type. 
They do it through recognition 
of the terminal selector motif 
(blue/red/green rectangle). 
TFs appear as coloured 
circles. Sustained expression 
of terminal selectors is often, 
but not always, ensured by 
autoregulation. Xn are effector 
genes. Sometimes, terminal 
selector codes further activate 
additional TFs that control other 
subroutines (purple and yellow 
circles). 
B) Identity shared with other 
neuron types 
Parallel regulatory routines 
such as those that regulate 
pansensory features (via 
DAF-19) or panneuronal 
features (via TF1 in the scheme) 
are controlled by factors that 
could also be considered 
terminal selectors, with the dif-
ference that they do not assign 
unique identities. For example, 
morphology regulators (TF2) 
control generic aspects of 
the morphology of a neuron, 
such as placement of axons/
dendrites into specific fascicles 
or axo/dendritic polarity.
C) Modular organisation 
of terminal effector genes 
Modular organisation of the 
regulatory sequences of ef-
fector genes: X1 represents 
a hypothetical effector gene 
expressed in more than one 
neuron type. It contains dif-
ferent cis-regulatory modules 
activated by the different com-
bination of terminal selectors 
that are active in each cell type. 
This schematic reflects a key 
principle of combinatorial 're-
usage' of the same terminal 
selector in different neuron 
types (green circles). Adapted 
from (Hobert 2016).
Direct coregulation
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Figure 1.1  
Stages of neuronal 
development
Figure 1.2  
Terminal features of  
a mature neuron 
Terminal selectors directly 
control the expression of 
terminal differentiation genes 
(also known as effector 
genes), of which represent-
ative examples are depicted 
here. Adapted from (Hobert 
2011).
Progenitor 
cell
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the construction of an almost infinite number of dif-
ferent neuron type-specific expression patterns, 
and thus almost infinite number of neuron types. 
The problem of neuronal differentiation and neu-
ron type specification is therefore to be reframed 
as how these neuron type-specific gene expres-
sion programmes are executed.
Terminal selector codes regulate terminal 
differentiation and neuron type-specific gene 
expression
A prevailing model for how neurons acquire a post-
mitotic identity is the ‘terminal selector hypothe-
sis’, proposed by Dr. Oliver Hobert (Hobert 2008). 
A few decades ago, Dr. Garcia-Bellido coined the 
term ‘selector gene’ for genes that define the iden-
tity of specific domains of a developing organism 
and that act transiently during specific phases of 
development (Garcia-Bellido 1975). Building on this 
concept, the term ‘terminal selector’ was later pro-
posed for TFs that are activated around the time 
of the final mitosis or in early postmitotic neu-
rons and that directly control the terminal iden-
tity of individual cell types in the nervous system 
(Hobert 2008) → Figure 1.3-A. Terminal selec-
tors act via recognition and direct binding to spe-
cific regulatory regions common to all effector 
genes of the cell, named ‘terminal selector motifs’ 
(Heinz et al. 2015; Hobert 2016). It is believed that the 
expression of these terminal selectors is initially 
activated by proneural genes, transient regulatory 
factors and signalling cues such as the Wnt path-
way (Bertrand & Hobert 2009; Hobert 2016). 
The terminal selector concept was first described 
in the nematode Caenorhabditis elegans. Examples 
exist in the worm where a unique terminal selector 
controls the terminal differentiation programme of 
a specific neuronal subtype. Such is the case of the 
COE-type Zn-finger TF UNC-3 and the cholinergic 
command interneurons of the worm (Kratsios et al. 
2011; Pereira et al. 2015). However, much more com-
mon is the observation of combinatorial activity of 
several TFs that constitute what has been termed 
‘terminal selector codes’. For example, in the dopa-
minergic neurons of the worm, AST-1 (ETS TF) acts 
in combination with the CEH-43 (Dlx TF) and CEH-
20/CEH-40 (Pbx TFs) to directly regulate the termi-
nal fate of the four dopaminergic subtypes (Flames 
& Hobert 2011; Doitsidou et al. 2013). In the glutama-
tergic system, thirteen different TFs act in distinct 
combinations in the twenty-five different glutama-
tergic neuron classes to initiate and maintain the 
expression of eat-4 (vesicular glutamate transport-
er Vglut), the key defining feature of glutamatergic 
neurons (Serrano-Saiz et al. 2013). Many more exam-
ples have been described in the worm and are list-
ed in → Table 1.1.
Although terminal selectors act mostly through 
gene activation, repressive mechanisms have also 
been described to be important to achieve prop-
er cell type-specific profiles. For example, in C. el-
egans ventral cord motorneurons there is a subset 
of these neurons that are directly activated by the 
common terminal selector UNC-3 (Kratsios et al. 
2011; Kratsios et al. 2015). However, this motorneu-
rons regulated by UNC-3 belong to different sub-
classes. Kerk et al. have recently shown that their 
diversification is controlled by distinct combina-
tions of class-specific transcriptional repressors. 
Furthermore, these repressors are continuously 
required in postmitotic neurons to prevent UNC-3 
from activating class-specific effector genes in 
specific motorneuron subsets and they do it via dis-
crete cis-regulatory elements. This works proposes 
that antagonising the activity of broadly acting ter-
minal selectors of neuron identity in a subtype-spe-
cific fashion may constitute a general principle of 
neuron subtype diversification (Kerk et al. 2017). In 
vertebrates, although not studied in such depth, re-
pressor TFs are also relevant for neuron subtype 
specification (William et al. 2003; Muhr et al. 2001).
Table 1.1 
Terminal selectors 
of Caenorhabditis elegans 
neurons
Known regulators of most  
C. elegans sensory, inter- and 
motorneurons have been 
included. These genes code 
for TFs that show key features 
of terminal selectors and are
expressed in mature neurons 
throughout their lifetime, 
likely a reflection of their 
continuous role in maintaining 
the differentiated, terminal 
state. Early or transiently acting
regulators are not included. 
‘NT’: neurotransmitter. 
‘(–)‘: unknown neurotrans-
mitter used. ‘/’: redundant 
factors. Adapted from (Hobert, 
2016).
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Terminal selectors are not only required to induce 
specific differentiation programmes, but also in 
some cellular contexts are sufficient to do so (i.e. 
gain-of-function mutants for the terminal selec-
tors result in the activation of the effector genes in 
other cells) (Gordon & Hobert 2015; Flames & Hobert 
2009). This context dependency is likely dictated 
by the need of proper cofactors (Gordon & Hobert 
2015), but also by a chromatin environment that may 
be refractory to terminal selector activity (Tursun et 
al. 2011; Patel & Hobert 2017).
The terminal selector concept entails that an indi-
vidual neuron type may not require a large num-
ber of TFs to regulate different terminal features 
or regulatory routines. Rather, functionally unrelat-
ed effector genes of a cell type (cell-specific tran-
scriptomes) appear to be co-regulated through 
one common terminal selector or, as described, 
a combination of terminal selectors (Xue et al. 
1993; Wenick & Hobert 2004; Doitsidou et al. 2013). 
Parallel regulatory routines (partial cell transcrip-
tomes), such as panneuronal (Stefanakis et al. 2015) 
or pansensory identity (Swoboda et al. 2000) may be 
regulated by parallel-acting terminal selector com-
binations (Hobert 2011) → Figure 1.3-B. 
Additionally, another quality of terminal selec-
tors is that, as they act in combinations, individual 
members can be re-used in distinct neuron types 
constituting different codes that select different 
terminal programmes → Figure 1.3-C. This combi-
natorial action reveals fundamental to TF function 
as it increases the number of roles that a given TF 
can play, it increases the sequence-specificity and 
diversity of DNA-binding, and enhances the signal 
to noise ratio of gene regulation. 
Remarkably, terminal differentiation genes are 
often continuously expressed throughout the life 
of a neuron and it has been observed that they are 
required to actively maintain the active transcrip-
tome of a mature neuron (Deneris & Hobert 2014). 
Although originally described in the invertebrate 
nematode C. elegans (Hobert 2008), the terminal 
selector concept is common to more complex or-
ganisms such as Drosophila and vertebrates. In 
rodents, PET1 (ETS TF) exhibits key features of a 
terminal selector for the serotonergic raphe neu-
rons (Hendricks et al. 1999; Hendricks et al. 2003), 
whereas NURR1 (orphan nuclear hormone recep-
tor TF) and PITX3 (homeodomain TF) have been 
described to regulate the expression of the dopa-
minergic gene battery in the mesencephalic do-
paminergic neurons (Jacobs, van der Linden et al. 
2009; Jacobs, van Erp et al. 2009). Moreover, the 
combination of NGN2, ISL1 and LHX3 are suffi-
cient to reprogramme mouse embryonic stem cells 
into functional spinal motorneurons (Mazzoni et al. 
2013). Furthermore, in some cases nematode and 
mammalian homologs factors have been shown to 
have similar roles on neuron type specification, as 
is the case for AST-1/ER81 regarding dopaminer-
gic fate. ast-1 codes for a Pea3/Er81-like ETS TF in 
the worm whose expression is maintained through-
out the animal’s life and that directly regulates the 
expression of the dopaminergic pathway genes, 
whereas its mouse homolog, Er81/Etv1, also ap-
pears to control at least some aspects of the do-
paminergic fate in olfactory bulb neurons (Flames 
& Hobert 2009). Similarly, the COE (Collier/Olf/EBF)-
type Zn-finger factor UNC-3 controls cholinergic 
identity of most motorneuron classes in the ven-
tral nerve cord of C. elegans and a Ciona intestinalis 
COE factor is also required and sufficient for induc-
ing cholinergic fate (Kratsios et al. 2011; Kratsios et 
al. 2015). These studies point to a possible phyloge-
netical conservation in the terminal selector regu-
lation of some neuronal subtypes.
Cis-regulatory logic of gene expression
According to the terminal selector hypothesis, 
transcriptional regulation of neuron type-specif-
ic effector genes is mediated by particular combi-
Figure 1.4 
Transcriptional regulation  
and its main players  
Enhancers contain short 
sequence motifs that can  
be recognised by TFs.  
TFs, in turn, recruit tran-
scriptional cofactors (COF) 
that recruit and activate 
RNA polymerase II (Pol II) 
at core-promoters (short 
sequences surrounding the 
transcriptional start site)  
to enable transcription. 
Adapted from (Reiter et al. 
2017).
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nations of TFs. In line with this idea, it is generally 
accepted that TFs bind in a combinatorial manner 
to DNA sequences of genomic cis-regulatory ele-
ments called enhancers (Banerji et al. 1981), placing 
TFs as the main regulators of gene expression, ei-
ther activating or repressing it. TFs act as adaptor 
molecules that recognise the basic building blocks 
of regulatory sequences, the TF binding sites 
(TFBSs), thus essentially reading the regulatory in-
formation contained in the enhancer sequence. TF 
binding to enhancers prompts the recruitment of 
the transcription machinery to the core promoter 
(generally spanning ~40 bp upstream and down-
stream of the transcription start site), resulting 
in transcription initiation and the formation of ro-
bust expression patterns (Ptashne & Gann 1997) 
→ Figure 1.4.
Despite the extensive research on transcriptional
regulation, how TFs identify their target sequenc-
es and achieve combinatorial enhancer control
remains a central question in biology. Here, we
will present the current understanding on regu-
latory enhancer function, recently reviewed else-
where (Levo & Segal 2014; Reiter et al. 2017; Spitz and 
Furlong 2012). 
Enhancers are typically a few hundred base pairs in 
size and regulate the location, timing and levels of 
gene transcription. They can be located in non-cod-
ing sequences including introns and, in less fre-
quency, in coding exons (Birnbaum et al. 2014) and 
can regulate their target gene or genes both in the 
same chromosome and in different chromosomes 
(Sanyal et al. 2012). Nucleotide (nt) variation in en-
hancers has been shown to lead to a multitude of 
phenotypes, including morphological differences 
between species (Carroll 2005) and human disease. 
In fact, most genetic associations to disease are lo-
cated in non-coding sequences that are thought to 
be regulatory sequences (Mathelier et al. 2015). 
In the past decade, development of several 
high-throughput methods have enabled the char-
acterisation of genome wide TFBSs and active 
enhancers in vitro and in vivo. Methods such as 
chromatin immunoprecipitation followed by mi-
croarray (ChIP–chip) (Harbison et al. 2004; Venters 
et al. 2011) or high-throughput sequencing (ChIP–
seq) (Arvey et al. 2012), its variation using exonu-
clease trimming (ChIP-exo) (Rhee & Pugh 2011), 
DNase I hypersensitive site sequencing (DNase-
seq) or ATAC-seq to measure accessible chroma-
tin, have measured the occupancy of sites along 
034
the genome, and this has been used to delineate 
TF binding preferences. ChIP profiling of chroma-
tin marks has also been used to trace the active 
regulatory landscape of specific cell types as his-
tone H3K27ac correlates with active enhancers 
(Creyghton et al. 2010; Rada-Iglesias et al. 2011). 
Complementary to the ChIP experiments, in vitro 
affinity measurements of chosen TFs to many short 
sequences have been used to predict potential 
binding events genome wide. For example, meth-
odologies like protein binding microarrays (PBMs)
(Berger & Bulyk 2009), high-throughput systemat-
ic evolution of ligands by exponential enrichment 
(HT-SELEX) (Jolma et al. 2013), mechanically induced 
trapping of molecular interactions (MITOMI) (Maerkl 
& Quake 2007) and high-throughput sequenc-
ing–fluorescent ligand interaction profiling (HiTS–
FLIP) (Nutiu et al. 2011) have examined the binding 
of hundreds of TFs from various organisms includ-
ing yeast (Badis et al. 2008), C. elegans (Grove et al. 
2009), mice (Badis et al. 2008) and humans (Jolma 
et al. 2013). However, functional characterisation of 
the enhancer activity of many genomic sequenc-
es (Whitfield et al. 2012; Kheradpour et al. 2013; White 
et al. 2013; Kwasnieski et al. 2014) have revealed that 
only a small fraction of the potential TFBSs in eu-
karyotic genomes are actually occupied by TFs in 
any given cell type, and that these sites vary sub-
stantially across cell types and conditions (Spitz 
& Furlong 2012; Whitfield et al. 2012; Biggin 2011). 
Moreover, only a subset (25-50%) of bound TFBSs 
correspond to active enhancers assessed by their 
ability to drive transcription in reporter assays 
(Kwasnieski et al. 2014; White et al. 2013; Fisher et 
al. 2012), stressing that it is unclear what distin-
guishes TFBSs actually bound by the TF from those 
that are unoccupied, as well as functional sites. 
Understanding the ‘transcriptional code’ involves 
being able to explain the sequence features and 
mechanisms underlying the ability of TFs to bind 
specific enhancers and to drive transcription in a 
given cellular context. It is likely that, going beyond 
the isolated TFBSs and considering combinatorial 
regulatory properties, regulatory architecture and 
sequence context effects will help in our better un-
derstanding of the regulatory genome.
Transcription factor cooperativity at the level of 
DNA binding is common among enhancers
Multiple lines of evidence suggest that coopera-
tivity (synergism) between TFs can be established 
at the level of DNA binding. For example, experi-
mentally disrupting the recognition sequences of 
some TFs or depleting the corresponding TF pro-
teins can cause loss of binding of other TFs (Heinz 
et al. 2010; Yanez-Cuna et al. 2012; Schulz et al. 2015). 
Combinatorial TF binding enables cell type- and 
time-specific enhancer expression. Such differ-
ential TF binding has indeed been seen in D. mela-
nogaster. pMAD (the phosphorylated form of MAD) 
provides the competence for cells to adopt particu-
lar cell specific fates through combinatorial binding 
with Tinman in the dorsal mesoderm and Scalloped 
in the wing imaginal disc (Xu et al. 1998; Guss et al. 
2001). Moreover, a similar scenario can be observed 
within the same cell, but at different developmental 
times. For instance, Twist binds to sites co-bound 
by Zelda during early Drosophila embryogenesis, 
but at later stages, when Zelda is not expressed, it 
binds to different sites co-bound by different part-
ners (Schulz et al. 2015; Yanez-Cuna et al. 2012).
Interactions between TFs or between a TF and a co-
factor (protein-protein interactions; PPIs) can, di-
rectly → Figure 1.5-A or indirectly → Figure 1.5-B, 
result in modified DNA binding preferences (Slattery 
et al. 2011). Moreover, the enhancer architecture, 
meaning TFBSs arrangements, can also indirectly 
influence TF cooperativity. For example, the binding 
affinity of a TF to the DNA and its ability to promote 
expression can increase as a result of PPIs with a 
nearby binding TF → Figure 1.5-C’. Also DNA bend-
NNNTGATTWAYNNNNNN
Preferred site GATTWAY
NNNTGATTGATNNNNNN
Preferred site GATTGAT
NNNTGATTTACNNNNNN
Preferred site GATTTAC
cofactor
transcriptional synergy
TFBTFA
Genomic location 1
Pol II
Genomic location 2
Non-stable binding
A
B
TFATFB +
A B
TFBTFA
Figure 1.5  
Mechanisms of transcription 
factor cooperativity
A) Latent specifity 
Interactions between TFs, 
termed protein-protein 
interactions (PPIs), or 
between a TF and a cofactor, 
can result in modified DNA 
binding preferences. In the 
figure, TFA (red) preferentially 
binds different nucleotide 
sequences depending on the 
presence of TFB (purple) or 
TFC (blue).  
B) Co-binding 
Two or more TFs co-bound to 
the same enhancer element 
may recruit a common cofac-
tor (e.g. p300), or different 
components of a multiprotein 
complex (e.g. the Mediator or 
SAGA complexes), which may 
lead to a net increase in the 
affinity of each TF for their 
TFBS. Alternatively, it may 
increase the retention time of 
the TFs at the enhancer.
C’) Enhancer architecture: 
Binding through PPI  
The regulatory sequence 
architecture (location, 
orientation and distance of 
a TFBS relative to nearby 
TFBSs) can favour or inhibit 
specific PPIs, affecting 
enhancer expression. In the 
figure, TFA is only able to bind 
to the DNA, effectively recruit 
Pol II and drive messenger 
RNA transcription (orange 
curved lines) if its BS is close 
enough to TFB so that both 
proteins can interact.
C’’) Enhancer architecture: 
Binding through DNA bending  
Some TFs can induce local 
DNA bending, making addi-
tional TFBSs more accessible 
and thus, increasing the 
affinity of other TFs for sites 
in the enhancer.
N=A/T/C/G W=A/T Y=T/C
↳
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ing can help reveal BSs and increase the affinity of 
other TFs for sites in the enhancer → Figure 1.5-C’’ 
(Falvo et al. 1995). Moreover, some TFs may act co-
operatively by activating chromatin remodelling, 
without the need to show PPIs, and are called ‘pio-
neer factors’. Pioneer factor binding can also pas-
sively reduce the number of additional factors that 
are needed to bind at a later time in order to create 
an active enhancer. Such ‘priming’ can increase the 
velocity of a transcriptional response and is seen 
during development and in hormonal regulation 
(Zaret & Carroll 2011). For example, PHA-4 (FOXA TF 
in C. elegans), has been shown to recruit a histone 
variant to promoters (Updike & Mango 2006) and to 
open chromatin in vivo (Fakhouri et al. 2010). Similar 
roles have been described for mammalian FOXA1 
and GATA4 (Cirillo et al. 2002) → Figure 1.5-D. 
Finally, blocking nucleosome repositioning may 
also serve as a place-holder to facilitate the binding 
of another factor (assisted loading or collaborative 
competition) to a neighbouring site that otherwise 
could become inaccessible if the place-holder fac-
tor was removed (Miller & Widom 2003; Voss et al. 
2011) → Figure 1.5-E.
Regulatory architecture has an effect on 
enhancer functionality
The regulatory architecture refers to the multiplic-
ity, identity, affinity and position of TFBSs present 
in an enhancer or a regulatory sequence. The dis-
tribution of TFBSs has been studied in detail in only 
a few enhancers. For example, a study of the de-
velopmental enhancer Sparkling, a specific en-
hancer of the Drosophila Pax2 gene, revealed an 
unexpected high density of essential TFBSs that 
required specific arrangements for its function-
ality (Swanson et al. 2010). Although informative, 
these one-by-one approaches are not able to re-
veal any general molecular logic underlying regula-
tory landscapes. 
The recently introduced techique of massive par-
allel reporter assays (MPRAs) allows to test thou-
sands of synthetic sequences for their enhancer 
activity in vivo, thereby obtaining a better under-
standing of the rules determining enhancer func-
tion (‘the regulatory code’) (Grossman et al. 2017). 
For example, using twelve liver-associated TFBSs, 
it was determined that gene expression levels in-
crement monotonically with increasing numbers of 
TFBSs in a homotypic TFBS cluster and, more im-
portantly, that the highest level of expression di-
rected from an enhancer is achieved with clusters 
of binding sites (BSs) for different TFs (Smith et al. 
2013). Further experiments support these results 
(Levo & Segal 2014), suggesting that the stronger 
activity of heterotypic clusters of TFBSs compared 
to homotypic ones may be a general cis-regulatory 
rule. Studies in yeast found that a ~10 bp periodici-
ty of TFBS location was important for transcription-
al activity (Sharon et al. 2012). Not only the number 
of TFBSs but also the affinity has an effect in en-
hancer functionality. Low-affinity TF–DNA inter-
actions are abundant in vivo and quantifiable from 
current high-throughput ChIP experiments. They 
have been shown to contribute quantitatively and 
spatially to the formation of proper expression pat-
terns and have implications in evolution (Segal et al. 
2008; Evans et al. 2012; Tanay 2006).
MPRAs have also been used to carry out exhaus-
tive mutational analysis of genomic regulatory el-
ements to discover their functional architecture 
at single-nucleotide resolution (also called mu-
tagenesis saturation) (recently reviewed in (Inoue & 
Ahituv 2015)). In vivo studies using the RhoCRE3 en-
hancer of the Rho gene (mouse retina) found that 
86% of single nucleotide substitutions showed sig-
nificant effects on enhancer activity. Changes in 
activity were explained not only by mutations with-
in putative TFBSs but also by complex phenomena, 
including TF competition and TFBS turnover during 
evolution (Mogno et al. 2013). Additionally, disrup-
tion of repressor BSs sometimes results in report-
er activity in the wrong cell type, suggesting that 
the cell type specificity in many cases requires the 
presence of a repressor (Kheradpour et al. 2013). 
Models for enhancer functionality
Specific enhancer architectures might contain 
constraints on properties such as the number, lo-
cation, orientation and order of TFBSs, which are 
referred to as ‘grammatical or syntactic rules’. It 
is still not well stablished if such rules have an im-
portant role in the regulation of gene expression, 
accordingly, three models have been proposed to 
explain enhancer function based on their syntactic 
constrains (Spitz & Furlong 2012).
In the first model, termed the ‘enhanceosome 
model’, TFBSs show a rigid distribution in order, 
spacing and orientation → Figure 1.6-A. Here the 
DNA serves as a scaffold for cooperative protein 
binding. With such an enhancer, the target gene 
Figure 1.5  
Mechanisms of transcription 
factor cooperativity
D) Activating chromatin re-
modeling 
Some TFs may act coopera-
tively by activating chromatin 
remodelling. In the schematic, 
the binding motifs for TFA and 
TFB are located in a nucle-
osome-bound region of the 
DNA. Following the binding of 
TFA to site A, the nucleosome 
is actively repositioned, which 
exposes BS B. This allows TFB 
to bind without the require-
ment for PPIs.
E) Blocking nucleosome 
repositioning 
By remaining bound to a given 
site, a TF (TFA in the figure) 
can prevent nucleosome 
repositioning and may there-
fore serve as a place-holder 
to facilitate the binding of 
another factor (TFB in the 
figure) to a neighbouring site 
that otherwise could become 
inaccessible if the place-hold-
er factor was removed. This 
may act as a passive method 
of enhancer priming. Adapted 
from (Spitz and Furlong, 2012; 
Levo and Segal, 2014).
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Figure 1.6 
Current models of enhancer 
activity 
A) Enhanceosome 
The enhanceosome model 
represents a situation in 
which all TFs that bind to an 
enhancer are essential for the 
cooperative occupancy and 
activation of the enhancer. 
The DNA motif composition 
and its relative positioning 
(motif grammar) act as a 
scaffold to cooperatively 
recruit all TFs, which form a 
higher-order protein interface 
to regulate transcription. 
B) Billboard
The billboard model. For 
any given enhancer, the 
positioning of TFBSs is flexible 
and subject to loose distance 
or organisational constraints. 
Only a subset of sites in the 
enhancer may be active at  
a given time, reflected in  
the different binding profiles 
of the enhancer 1.
C) TF collective 
The TF collective represents  
a situation in which the 
same set of TFs bind to many 
enhancers. They can occupy 
each one of these enhancers 
in a different manner, with 
all or a subset of TFs directly 
contacting the DNA. For cases 
in which the motifs for only  
a subset of TFs are present,  
the remaining TFs are still 
recruited to the enhancer 
through protein–protein 
interactions between  
the participating TFs.  
The collective binding can 
therefore occur using diverse 
motif composition and flexible 
motif positioning. Adapted 
from (Spitz and Furlong 2014).
Enhancer 1
Enhancer 1
Enhancer 1
Enhancer 2
Enhancer 1
Enhancer 3
would be activated only upon the assembly of a 
complex, providing a precise on/off binary tran-
scriptional switch in response to the appropriate 
stimulus. This also implies that motif composition 
is fixed regarding number, distance and orientation 
between TFBSs; in other words, all TFs must bind to 
generate an enhancer output. One of the best stud-
ied examples of an enhanceosome is the interferon 
ß-enhancer, where small sequence changes within 
the 55 bp element alter the binding potential of the 
eight factors that occupy the enhancer (Thanos & 
Maniatis 1995; Merika & Thanos 2001). The alterna-
tive ‘billboard model’ proposes a totally flexible dis-
tribution of TFBSs → Figure 1.6-B. In this second 
model, also termed ‘information display’, differ-
ent enhancer configurations are possible; i.e. motif 
composition can vary. TFs can act additively or co-
operatively to recruit the transcriptional machinery 
but with no constraints on the relative positioning 
of their BSs (Smith et al. 2013). In this model it is the 
transcription machinery that ‘reads’ or ‘samples’ 
discrete regions of the enhancer, giving different 
and graded enhancer outputs. This was proposed 
for the Drosophila enhancers containing repres-
sors Giant or Knirps and the activators Twist and 
Dorsal (Kulkarni & Arnosti 2003). The billboard and 
the enhanceosome models, both shaped by evi-
dence derived from a relatively small set of proto-
typic examples, are useful approaches to explain 
general characteristics of enhancers, but evi-
dence available for many other enhancers sug-
gests that they merely represent the extreme ends 
of a spectrum of architectural diversity (Borok et 
al. 2010). Supporting this, studies in Drosophila and 
human adipocytes indicate that enhancers often 
fall somewhere on a continuum between complete 
modularity, where the spatial relationship between 
domains is unimportant, and total spatial constraint 
(Swanson et al. 2010; Grossman et al. 2017). Thus, the 
final model called the ‘transcription factor collec-
tive model’ represents an intermediate situation 
→ Figure 1.6-C. It shows flexibility in the spacing
and order of TFBSs and in the motif composition;
some TFs will bind to DNA and others may interact
with already DNA-bound TFs. An elegant example
came from the analysis of five TFs that are essen-
tial for cardiac development in Drosophila (Junion 
et al. 2012). The five TFs are found at a large set of
enhancers even though each enhancer only har-
bours a variable subset of motifs required for DNA-
binding of all factors. PPIs are though to facilitate
the collective occurrence of all TFs, as loss of one
member inhibits enhancer activation. In this exam-
ple, no specific grammar rules were reported but
the model predicts the presence of some rules that 
will or will not be required depending on the specif-
ic context of each regulatory sequence.
The importance of sequence context and 
regulatory landscapes
A description of regulatory sequences that only ac-
count for the regulatory building blocks and their 
arrangements views regulatory sequences as inert 
strings on which functional elements are thread-
ed. However, accumulating evidence suggests that 
TF access to motif sites may be governed by se-
quence context, nucleosomes or the larger chro-
matin landscape.
TFBSs flanking base pairs are important to deter-
mine if a particular TFBS will be active or not, as 
they contribute to TF binding specificity (Maerkl 
& Quake 2007). Such effect may be also mediat-
ed by DNA shape, such as deviations from ideal 
β-DNA structure (Aow et al. 2013; Siggers & Gordan 
2014). One specific type of flanking sequences that 
have a role in TF binding are A- or T-tracts (Jolma 
et al. 2013), yet other studies point to the impor-
tance of high local GC content for transcriptional 
activation (White et al. 2013). As described earlier, 
TF binding can also affect nucleosome occupan-
cy and positioning → Figure 1.5-E. Two main se-
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Part II
The next part of the Chapter consists of a detailed 
description of how the murine serotonergic sys-
tem is specified, paying special attention to the key 
regulators of the terminal differentiation steps, and 
the clinical relevance of serotonergic neurons. 
The mammalian serotonergic system
The mammalian serotonergic system is composed 
by a relative small number of neurons, between 
300,000 in humans and 26,000 in mice (Baker et al. 
1991; Ishimura et al. 1988; Hornung 2003), yet it in-
nervates nearly all of the cytoarchitectonic regions 
of the brain and spinal cord and has been implicat-
ed in the modulation of seemingly every human be-
haviour and physiological process orchestrated by 
the nervous system. For example, it regulates body 
temperature, sleep, appetite, pain and motor activ-
ity and modulates higher brain functions, includ-
ing cognition and emotional behaviour (Jacobs & 
Azmitia 1992).
The defining feature of all serotonergic neurons in 
any organisms is the ability to use serotonin (5-HT) 
as a neurotransmitter. The biosynthesis of 5-HT 
is regulated by the coordinated action of a bat-
tery of phylogenetically conserved enzymes and 
transporters known as the 5-HT pathway genes 
→ Figure 1.7. Tryptophan hydroxylase (TPH2 in 
mouse and humans) catalyses the first and rate-lim-
iting step of the pathway, transforming the amino 
acid tryptophan into 5-hydroxytryptophan (5-HTP). 
To do so, it requires the GTP cyclohydrolase I (GCH1). 
Next, the dual functional 5-HTP/L-DOPA decarbox-
ylase (AADC) matures 5-HTP to 5-HT. The vesicu-
lar monoamine transporter SLC6A1/2 (also called 
VMAT2) pumps 5-HT from the cytoplasm into small 
synaptic vesicles or dense core vesicles (Liu & 
Edwards 1997) for their transport to the synaptic 
terminal, thereby controlling the releasable pool of 
5-HT. The 5-HT reuptake transporter SLC6A4 (also 
called SERT) in the plasma membrane absorbs ex-
tracellular 5-HT into the cytoplasm (Ramamoorthy 
et al. 1993; Blakely et al. 1991), and 5-HT is degraded 
by the oxidase MAO, common to all monoamine bi-
osynthesis pathways (Youdim et al. 2006). SERT is 
present not only in the presynaptic plasma mem-
brane of 5-HT-producing neurons to reuptake 5-HT 
from the synaptic cleft, but also in a range of neu-
rons that are capable of absorbing 5-HT from extra-
synaptic space but do not synthesise it. Moreover, 
also present in the pre-synaptic terminal are the 
two 5-HT auto-receptors (HTR1A and HTR1B). 
The 5-HT synthesis pathway is highly conserved 
in evolution as there are known homologues for all 
of its components in multiple organisms from hu-
mans and mouse, to fish, flies and worms (Flames 
& Hobert 2011).
Mouse serotonergic neuron specification 
Brain serotonergic progenitors are located in the 
ventral hindbrain and form two main clusters – ros-
tral (rombomeres 1 to 3) and caudal (rombomeres 
4 to 6) → Figure 1.8-B (Alonso et al. 2013; Okaty et 
quence features are associated with this: a ~10 bp 
periodic signal of dinucleotides (AA, TT, AT or TA) 
that are favoured when the DNA backbone faces 
inwards towards the histone core and vice versa, 
and poly(dA:dT) tracts, which facilitate the accessi-
bility of the DNA to binding TFs, thereby influencing 
the resulting expression (Struhl & Segal 2013; Segal 
& Widom 2009).
Many works in the last decades have shown that 
regulatory DNA can act at long distances, often 
more than 1 Mb, by contacting the promoters of 
target genes through chromatin loops, forcing a 
change from a two-dimension to a three-dimen-
sion vision of the genome (reviewed in (Maeso  et al. 
2016)). Chromosome conformation capture tech-
niques that identify DNA–DNA contacts throughout 
the genome (reviewed in (Denker & De Laat 2016)) 
have shed light on the cis-regulatory architecture 
of the genome, which is compartmentalised into 
structures known as topologically associating do-
mains (TADs), and are elucidating the complexity in-
tricate to gene regulatory landscapes, such as the 
existence of ‘regulatory archipelagos’ (Montavon 
et al. 2011), hierarchal relationships between dif-
ferent enhancer elements (Leddin et al. 2011) and 
even hierarchies within TADs that are specific of 
each genomic locus (architectural signature) that 
is thought to reflect the functional activity of that 
region (Phillips-Cremins et al. 2013). Finally, it has 
also been suggested that the active regulatory 
landscapes of a cell could be organised in what has 
been termed ‘transcription factories’, although the 
existence of this nuclear domains is still a matter of 
debate (Iborra et al. 1996; Jackson et al. 1993).
In summary, thanks to the work from may labora-
tories in this last decade, we are rapidly increas-
ing our knowledge on transcriptional regulation, 
however, additional studies and data are required 
in order to be able to predict the functional regu-
latory sequences from the genome sequence of a 
given organism as well as when and where they are 
activated.
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is direct or is an indirect consequence of the loss of 
expression of the other post-mitotic serotonergic 
fate determinants remains unclear.
LMX1B and PET1 are expressed in postmitotic ser-
otonergic neurons just before the onset of Tph2 
expression, and their expression is maintained 
throughout the life of the animal (Ding et al. 2003; 
Hendricks et al. 2003; Asbreuk et al. 2002). Pet1 and 
Lmx1b null mutants show defects in expression of 
the 5-HT pathway genes (Tph2, Sert, Vmat2, Aaad) 
but show no defects in the expression of earlier 
markers → Figure 1.9. In both mutants, postmitotic 
cells are still generated, and at least in the case of 
Pet1 mutants, they still express panneuronal fea-
tures and they do not switch their fate to that of 
another neuron type (Cheng et al. 2003; Ding et al. 
2003; Hendricks et al. 2003). This phenotype is very 
similar to the ones described for the terminal selec-
tors NURR1 and PITX3 in dopaminergic specifica-
tion (Jacobs, van Erp et al. 2009). In addition, PET1 
and LMX1B have other characteristics typical of 
terminal selectors. PET1 directly binds to regulato-
al. 2015). The rostral cluster includes subgroups of 
dorsal and median raphe nuclei and sends most-
ly ascending projections to the forebrain and mid-
brain, modulating higher brain functions, whereas 
the caudal cluster has primarily descending con-
nections to the spinal cord. At the molecular level, 
recent transcriptome analyses and single-cell se-
quencing have mapped the differences in gene ex-
pression between and within the rostral and caudal 
raphe nuclei (Wylie et al. 2010; Okaty et al. 2015). 
These studies propose the existence of specialised 
subtypes of serotonergic neurons that regulate 
specific biological functions and will have tran-
scendental health implications, such as tailored 
therapies to particular serotonergic dysfunctions. 
In the developing embryo, the secreted signalling 
molecules sonic hedgehog (SHH) and fibroblast 
growth factors 4 and 8 (FGF4, FGF8) regionally pat-
tern the mid-hindbrain neuroepithelium, to speci-
fy serotonergic progenitors in the ventral hindbrain 
that will later give rise to the different seroton-
ergic nuclei (Ye et al. 1998; Cordes 2005). Visceral 
motor neurons (VMN) and serotonergic neurons 
arise sequentially from the same progenitors 
→ Figure 1.8-A. Two rhombomeres are the excep-
tion to this rule: r1, which produces only seroton-
ergic neurons and will constitute more than half 
of the total serotonergic population, and r4, which 
never produces serotonergic neurons. At embry-
onic stage E10.5, rhombomeres r2, r3, and r5–7 
shift from VMN generation to serotonergic neu-
ron production by inhibiting the expression of the 
homeodomain TF Phox2b (paired-like homeodo-
main protein 2b). This temporal switch is controlled 
by the homeobox TF NKX2.2 (Pattyn et al. 2003).
Several TFs are known to be expressed in the pro-
genitors of the serotonergic neurons and instruct 
serotonergic fate. The proneural bHLH factor 
ASCL1 (also known as MASH1 and recently shown 
to act as a pioneer factor (Raposo et al. 2015)), is ex-
pressed during the serotonergic progenitor stag-
es at all rhombomeric levels of the hindbrain, and 
its induction is likely an early response to morph-
ogens (Briscoe et al. 1999; Pattyn et al. 2003). Its 
expression is extinguished as progenitors exit 
the cell cycle to become postmitotic precursors 
→ Figure 1.9. FOXA proteins (forkhead TFs) are well 
known for having multiple roles in single-cell line-
ages (Kaestner 2010). In the case of the serotoner-
gic lineage, FOXA2 expression is highly induced as 
the progenitors switch to serotonergic neurogen-
esis. ASCL1 and FOXA2 act upstream and regulate 
the expression of the serotonergic postmitotic fac-
tors, as described next → Figure 1.9. 
Two GATA TFs (GATA2 and GATA3) participate in 
serotonergic postmitotic specification. GATA2 is 
required for the activation of the serotonergic neu-
ron-specific TF Pet1 (Craven et al. 2004) and also 
Gata3 (Haugas et al. 2016) → Figure 1.9. It seems 
to act high in the regulatory network as neuronal 
precursors adopt alternative fates in Gata2 con-
ditional mutants (Haugas et al. 2016). Contrary to 
GATA2, GATA3 seems to act late in the developmen-
tal pathway as it has been proposed to regulate 
Tph2, although GATA3 BSs in the Tph2 regulatory 
region have not been identified → Figure 1.9 (van 
Doorninck et al. 1999; Pattyn et al. 2004). Rostral ser-
otonergic neurons are not affected in Gata3 mutant 
embryos. This observation indicates the presence of 
slightly different regulatory mechanisms between 
anterior and posterior serotonergic populations. 
Gata3 expression is maintained in adult serotoner-
gic neurons (Zhao et al. 2008), but it has not been de-
termined if Gata3 conditional mutant adult animals 
have serotonergic neuron defects (van Doorninck 
et al. 1999). Another serotonergic postmitotic TF is 
INSM1, a Zn Finger TF that regulates LMX1B, GATA2 
and PET1 expression. In null Insm1 mutants, the ex-
pression of these TFs and the serotonergic termi-
nal marker Tph2 are significantly downregulated 
→ Figure 1.9 (Jacob et al. 2009). However, whether 
the regulation of the tryptophan hydroxylase gene 
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Figure 1.9 
Mouse serotonergic 
transcription regulatory logic 
Arrows indicate activation 
of a downstream TFs. 5-HT 
pathway genes appear as 
white boxes. Short dotted 
lines indicate previously 
described relationships 
between TFs that more recent 
reports question. Long dotted 
lines indicate a described 
role of a TF in the regulation 
of the 5-HT pathway genes 
that could be due, however, 
to an indirect effect.  
Adapted from (Deneris and 
Wyler 2012; Haugas et al. 2016, 
Haugas et al. 2016, Scheuch et 
al. 2007 and Nasu  et al. 2014).
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Figure 1.8  
Neuroanatomical features 
of serotonergic neuron 
development in the mouse
B) Adult serotonergic system 
Schematic sagittal view of 
the adult midbrain depicting 
the location of serotonergic 
neurons clusters (raphe 
nuclei). All serotonergic 
neurons in the mature dorsal 
raphe nucleus (B4, B6 and B7 
groups) are born in r1 (green). 
Serotonergic neurons in the 
median raphe nucleus (B5 
and B8 groups) and laterally 
extending supraleminscal 
serotonergic neurons  
(B9 cluster) are derived from 
serotonergic progenitors in 
r1, r2 and r3 (green, yellow, 
red). Serotonergic neurons 
born in r5–r8 migrate to form 
the raphe pallidus (B1), raphe 
obscurus (B2), raphe magnus 
(B3) and cell bodies in the 
ventrolateral medulla (B3) 
(grey). Serotonergic neurons 
in the rostral portion of B3 are 
born in r5 (blue). Adapted from 
(Deneris & Wyler 2012).
A) Developing serotonergic
system 
Schematic sagittal view of the 
developing mouse brain. All 
mouse serotonergic neurons 
are born in two longitudinal 
domains, rostral (r1–r3) and 
caudal (r5–r8), on either 
side of the floor plate in the 
ventral rhombencephalon or 
hindbrain. 
r1 derived 
r2 derived 
r3 derived 
r5 derived 
r6-8 derived
A B
ry elements in all the 5-HT pathway genes and also 
autoregulates its own maintenance of expression, 
and both PET1 and LMX1B are required to maintain 
the serotonergic phenotype (Hendricks et al. 1999; 
Liu et al. 2010; Scott 2005). More recently, it has been 
shown that continuously expressed PET1 acts as 
a postnatal maturation-promoting factor of sero-
tonergic neuron excitability, controlling synaptic 
input, and it also directly binds to secondary matu-
ration regulatory factors, such as Engrailed (Wyler 
et al. 2016; Fox & Deneris 2012). Despite the central 
role for PET1 in serotonergic specification, sever-
al observations indicate that it does not act alone 
to control serotonergic terminal fate: 1) although in 
the brain is specific for serotonergic neurons, PET1 
is expressed in additional tissues that do not ex-
press the serotonergic gene battery (Fyodorov et 
al 1998), 2) 20% of serotonergic cells remain unal-
tered in Pet1 null mutants (Hendricks et al. 2003), 
and 3) ectopic expression of LMX1B or PET1 indi-
vidually is not sufficient to turn on expression of the 
5-HT pathway genes when electroporated into E2
chick neural tube (Cheng et al. 2003).
One such additional factor could be BRN2. A hy-
pomorphic allele of Brn2 (also known as POU3F2), 
shows decreased levels of 5-HT production in the
brain (Nasu et al. 2014). Interestingly, a polymor-
phism in the regulatory region of Tph2 caused 
reduced binding of BRN2 (Scheuch et al. 2007), sug-
gesting that the serotonergic phenotype observed 
in Brn2 mutants could be due to a direct effect of 
the TF over Tph2 regulation → Figure 1.9. However, 
the precise role of Brn2 on serotonergic specifica-
tion should be further addressed.
In contrast to the mammalian serotonergic sys-
tem that arises only from the hindbrain, other ver-
tebrates contain additional serotonergic nuclei 
in other brain regions. In zebrafish, for example, 
apart from the raphe serotonergic neurons that, 
as in mammals, express and are dependent on 
Pet1, there are additional PET1-independent ser-
otonergic cell groups in the forebrain (Lillesaar et 
al. 2007). Invertebrate serotonergic systems are 
also composed by nuclei from different origins. In 
Drosophila, two broad groups of serotonergic neu-
rons are known (brain and ventral ganglion) that 
are regulated by distinct sets of TFs (Dittrich et al. 
1997; Lundell & Hirsh 1998). 
Serotonergic link to mental disorders
Evidence from decades of studies in humans, non-
human primates and rodents strongly support an 
association of altered serotonergic function with 
behavioural and physiological pathogenesis such 
as depression, obsessive-compulsive disorder, 
anxiety or autism (Albert et al. 2011; Holmes 2008; 
Waider et al. 2011; López-Arvizu et al. 2011). Genetic 
manipulation of the levels of Sert, Tph2 or Htr1a in 
mice have been linked to emotional and stress-re-
lated behaviours (Murphy et al. 2008; Richardson-
Jones et al. 2011). These studies provide a compelling 
impetus to find gene variation that affects seroton-
ergic signaling and confer risk for neuropsychiat-
ric diseases. Perhaps the most convincing example 
of disease-associated variation of the serotonergic 
pathway is the multiple, rare, non-synonymous var-
iants in SERT that create gain-of-function alleles 
that produce elevated levels of the transporter or 
enhanced trafficking-independent 5-HT transport 
activity (Prasad et al. 2005). Notably in a large sam-
046 047
Caenorhabditis elegans as a model system
Sydney Brenner defined Caenorhabditis elegans 
as ‘an experimental organism which was suitable for 
genetical study and in which one could determine the 
complete structure of the nervous system’ (Brenner 
1974), highlighting for the first time its great appli-
cability in the field of neurobiology. Since Brenner’s 
pioneering work more than four decades ago, many 
have joined in his quest to exploit the simplicity of 
C. elegans nervous system to answer fundamental
questions that can be translated to far more com-
plex nervous systems such as the human brain. 
In nature, C. elegans can be found in actively grow-
ing stages in compost and rotting fruits or in ar-
rested dauer stage in various locations including
shells of the snail Helix aspera, in parasitic associ-
ation with isopods or in soil (Chen et al. 2006). The
canonical wild type strain was isolated in 1954 from 
a compost heap at Bristol (England) and was given
the strain designation ‘N2’. In the laboratory, C. el-
egans can be cultured on a diet of Escherichia coli 
on a nutrient agar surface. Its small size (approx-
imately 1 mm in length), rapid generation time
(three and a half days at 20 °C) and large brood
size (~300 offspring) facilitates the culture of large
populations amenable to genetic screens. C. ele-
gans is androdioecious, which means it is primari-
ly self-fertilising (hermaphrodite), facilitating strain 
maintenance and assuring an isogenic background 
(Brenner 1974). However, males (XO) occur due to
rare meiotic non-disjunction of the X chromosome,
with a frequency lower than 0.2 %. C. elegans nuclei 
contain five pairs of autosomal chromosomes (I-V) 
and one sexual chromosome (X). Hermaphrodites 
are XX and males XO. The existence of males allows 
for cross-fertilisation, a very useful trait for genet-
ic manipulation. Additionall, for long-term storage, 
lines can be maintained as frozen stocks.
C. elegans was the first multicellular organism for
which the complete genome sequence was deter-
mined and annotated (The C. elegans Sequencing
Consortium 1998; Waterston & Sulston 1995). This
was made feasible by the compact size of its ge-
nome: 100 Mb in comparison to the 3137 Mb in
humans. Importantly, at least 83% of C. elegans
proteome has human homologous genes and 70%
of human genes contain a C. elegans orthologue
(Lai et al. 2000). Thus, a very important feature of
the C. elegans genome is the compactness of the
non-coding genome, including the regulatory ge-
nome. This feature makes it unique to study the
cis-regulatory logic of cell differentiation. Several
related nematode species have also been isolat-
ed and fully sequenced (Stein et al. 2003; Ghedin
et al. 2007; Abad et al. 2008; Opperman et al. 2008;
Dieterich et al. 2008), being very useful for compar-
ative genomics and phylogenetic filtering of con-
served gene regulatory regions.
Another advantage of C. elegans is the resolved
cell lineage of the worm → Figure 1.10. Animals
develop from fertilised zygotes through an invari-
ant cell lineage into adult hermaphrodites contain-
Part 3ple of multiplex autism families, it was shown that these variants are significantly associated with 
autism and rigid compulsive behaviours (Sutcliffe 
et al. 2005). However, as described in the previous 
section, most of the genetic associations lie out-
side the coding genome. Whether variation in the 
serotonergic transcription regulatory network af-
fects the functionality of serotonergic neuron and 
susceptibility to mental illness is still unknown.
Despite variation with such an effect has not been 
discovered in humans, different pieces of evidence 
support this idea. First, Lmx1b- and Pet1–deficient 
mice show several emotion- and stress-related be-
havioural abnormalities that mimic those observed 
in Tph2, Sert and Htr1a targeted mice, including in-
crease aggression, anxiety-like behaviour and fear 
responses (Hendricks et al. 2003; Kiyasova et al. 
2011). Notably, LMX1B and PET1–dependent tran-
scription is required in adulthood to maintain nor-
mal anxiety-like behaviours (Liu et al. 2010), raising 
the possibility that behavioural pathogenesis might 
derive from adult onset disruption, genetically or 
environmentally, of serotonergic transcription. 
Finally, a recent Genome-wide association study 
(GWAS) detected 56 significant single nucleotide 
polimorphisms (SNPs) associated with bipolar dis-
order including a novel region between MIR2113 
and BRN2 (Mühleisen et al. 2014), once again, point-
ing to BRN2 action in serotonergic differentiation 
and highlighting network variation as a potentially 
important mechanism in neuropsychiatric disease 
pathogenesis.
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A) Different tissues in the 
adult hermaphrodite 
From (Sulston and  
Horvitz 1977).
B) Caenorhabditis elegans 
nervous system 
C. elegans nervous system. 
Neurons appear in red. In 
the first larval stage, shown 
here schematically, there are
222 neurons. During larval 
development a number of 
neurons are added resulting 
in a total number of 302 
neurons. From (Hobert 2010).
Figure 1. 11  
Schematic diagrams showing 
anatomical features of 
Caenorhabditis elegans
ing 959 somatic cells (Sulston et al. 1983), organised 
in differentiated tissues as pharynx, gut, cuticle, 
muscle, reproductive system and nervous sys-
tem → Figure 1.11-A. This knowledge allows us to 
study how a cell establishes its fate and to analyse 
the effect of mutations and environmental factors 
at single cell resolution. 
In addition, C. elegans is highly amenable to ge-
netic studies. Mutants are readily generated and 
are made available upon request to the research 
community by multiple consortia. Interferance 
RNA (RNAi) provides another powerful method for 
gene knockdown and it is easily performed just by 
feeding the animals with RNAi producing bacterial 
clones (Timmons & Fire 1998). Forward and reverse 
genetics have led to the molecular identification 
of many key genes in a plethora of developmental 
and cell biological processes. Moreover, germline 
transformation is easily achieved by microinjection 
of DNA into the gonad, yielding transgenic lines in 
a few days (Mello et al. 1991). Recent introduction 
of CRISPR-Cas9 technology to C. elegans has fur-
ther improved the specificity in the creation of mu-
tant and transgenic worms (Dickinson et al. 2013; 
Friedland et al. 2013; Shen et al. 2014). The transpar-
ency of the worm allows for in vivo imaging tech-
niques. Expressing fluorescent proteins under the 
control of specific promoters allows in vivo visuali-
zation of specific neuron types (Chalfie et al. 1994). 
The possibility to use different fluorescent proteins 
(Fradkov et al. 2000) next to the knowledge of the 
genetic linage of every cell in the worm favours for 
neuron identification.
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Caenorhabditis elegans nervous system
Even though C. elegans is one of the simplest or-
ganisms with a nervous system, its nervous sys-
tem is the most complex tissue in the organism, 
both in terms of numbers and neural diversity. The 
adult hermaphrodite contains exactly 302 neurons 
and 56 glial cells, comprising more than one third of 
the somatic cells (White et al. 1986). A similar ratio 
is maintained in the males: 385 neurons in a total 
of 1031 somatic nuclei (Sammut et al. 2015; White et 
al. 1986). Neurons are organised in several ganglia 
in the head called the nerve ring (similar to a worm 
brain) and tail, and into a ventral nerve cord resem-
bling the spinal cord → Figure 1.11-B. Perhaps the 
most striking difference between neuronal specifi-
cation in C. elegans and other organisms is that neu-
rons are largely non-clonally derived → Figure 1.10 
and arise from several different lineages (Sulston et 
al. 1983). Some lineage sub-branches give rise to 
neurons only, but most oftenly lineages give rise to 
neurons and non-neuronal cells such as muscle.
C. elegans neurons may look simple on a gross an-
atomical level, but their connectivity, behaviour
and gene expression batteries are intricate and
complex. The pattern of connectivity of the entire
C. elegans nervous system has been successfully
mapped for hermaphrodites (White et al. 1986) and
males (Jarrell et al. 2012). To date there is no similar
report for any other living organism. Based on this
work, the 302 neurons of the hermaphrodite are
categorised in 118 morphologically and anatomi-
cally distinct neuron classes (White et al. 1986). In
many cases, contrary to more complex nervous
systems, individual cells rather than groups of cells 
define neuronal subtypes. C. elegans contains in-
terneurons, motorneuron and sensory neurons;
and the diversity of neurotransmitters and neuro-
peptides used is comparable to vertebrate nerv-
ous systems (Rand & Nonet 1997; Hobert 2013). 
Functional assignments have been made to differ-
ent neuronal classes based on genetic screens and 
laser ablation studies. Only two neuron classes are 
essential to the survival (Bargmann & Avery 1995), 
allowing for perturbation of many aspects of C. ele-
gans neurobiology without affecting viability.
At a genomic level, the neuronal genome of C. el-
egans consists of approximately 2800 effec-
tor genes, excluding gene regulatory factors and 
structural and regulatory genes involved in cy-
toskeleton organisation or basic cellular process-
es (Hobert 2013), and represent most of the families 
present in vertebrates. 
The extraordinary wealth of knowledge already 
available, combined with the genetic amenability 
of the worm and its straight-forward neuronal clas-
sification, confers the possibility to study neuron 
type and subtype specification at single cell reso-
lution, making of C. elegans a peerless system with 
which to dissect the nuts and bolts of gene expres-
sion regulation in the context of terminal cell fate 
specification within the nervous system.
Caenorhabditis elegans serotonergic system
The serotonergic system of the hermaphrodite 
C. elegans is defined by a subset of five neuronal
subtypes that are immunoreactive to 5-HT antibod-
ies. They are the NSM, ADF, AIM and RIH neurons in
the head, and the HSN neuron in the mid-body of the 
worm → Figure 1.12-A (Rand & Nonet 1997; Desai et 
al. 1988; Sze et al. 2000; McIntire et al. 1992; Horvitz
et al. 1982). All except RIH appear as bilateral pairs,
summing a total of nine serotonergic neurons. An
additional pair of neurons, termed VC4 and VC5,
have been reported to present weak and unrelia-
ble 5-HT immunoreactivity → Figure 1.12-A (Duerr 
et al. 2001; Duerr et al. 1999). Moreover, 5-HT stain-
ing has been reported in the I5 head neuron and in
the PHB bilateral neurons in the tail, although it has
not been further replicated (Sawin et al. 2000). The
serotonergic system is sexually dimorphic, being 
HSN and VC4/5 hermaphrodite specific neurons; 
i.e. HSN undergoes programmed cell death in the
males and VC4/5 are not generated. Males contain
at least twelve additional 5-HT-immunoreactive
neurons that are born postembryonically: six CPs
(CP1-6) located along the ventral nerve cord (Loer 
& Kenyon 1993; Sze et al. 2000) and three pairs of
Ray B neurons in the tail (Ray 1, 3 and 9) associat-
ed to the sensory ray structures at the tip of the tail 
of the male (Loer & Kenyon 1993) → Figure 12-D. An 
additional unilateral cell located at the right prea-
nal ganglion (RPAG) has also been described to be
5-HT-immunoreactive (Loer & Kenyon 1993).
According to their source of 5-HT, serotonergic
neurons can be classified in two distinct groups:
5-HT producing neurons are those that express
the enzymes for the biosynthesis of 5-HT, includ-
ing tryptophan hydroxylase enzyme (TPH-1), and 
thus are able to synthesise 5-HT cell-autonomous-
ly → Figure 1.12-B. These cells may or may not ex-
press the sole serotonin reuptake transporter in C. 
elegans (MOD-5). Within this subgroup lay the NSM 
and ADF neurons, and the sexually dimorphic HSN, 
CP1-6 and Ray 1, 3 and 9 neurons. All of them ex-
press the tph-1, cat-1, bas-1 and cat-4 genes (Loer 
& Kenyon 1993; Duerr et al. 1999; Sze et al. 2000; 
Sze et al. 2002; Hare & Loer 2004). Contrary, sero-
tonin absorbing neurons are those that use 5-HT 
as a neurotransmitter but do not synthesise it. 
They do not express TPH-1 so, in order to achieve 
5-HT neurotransmission, they uptake the molecule
from the extrasynaptic space using MOD-5 trans-
porter (Jafari et al. 2011). 5-HT absorbing neurons
NSML/R HSNL/RADFL/R
RIH
VC4
AIML/R
VC5
NSML/R HSNL/RADFL/R
RIH
AIML/R
Rays L/R 
1 3
9
NSML/R ADFL/R
RIH
AIML/R
CP1 CP2 CP3 CP4
CP5
CP6
Figure 1.12 
Caenorhabditis elegans 
serotonergic system
A) Complete serotonergic
system 
B) 5-HT-producing neurons
C) 5-HT-absorbing neurons
D) Male serotonergic system
Complete hermaphrodite 
serotonergic system, includ-
ing all 5-HT immunoreactive 
neurons.
Specific serotonergic sub-
population of 5-HT producing 
neurons, expressing the 
tryptophan hydroxylase gene, 
in hermaphrodites. 
Specific serotonergic sub-
population of 5-HT absorbing 
neurons, expressing the 5-HT 
re-uptake transporter, in 
hermaphrodites.  
Complete male serotonergic 
system. L/R: bilateral left/
right neurons.
5-HT-producing neuron (NSM, ADF and HSN)
5-HT-absorbing neuron (AIM and RIH) 
Unreliable 5-HT staining (VC4 and VC5)
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Figure 1.13 
HSN anatomical description
Immature HSN Embryo
HSN
gonad 
Larval stages 1- 4
gonad 
HSN
Mature HSN — adult worm
vulva
gonad
DIC + GFP
10 ×
HSNR
HSNL
tph-1::gfp
10 ×
vulval muscle
DIC + GFP
60 ×
HSNL
HSNR
tph-1::gfp
60 ×
100 µm
10 µm
B) Micrographs of bilateral 
HSNs expressing tph-1::gfp
in a ventral plane at low 
magnification (left) and at 
higher magnification (right)
GFP signal in the head 
corresponds to the NSM and 
ADF serotonergic neurons. 
Gonad and vulva (arrow head) 
are indicated. R: right, L: left.
A) Schematic representation 
of the localisation of the HSN 
neuron in the embryo (top-
left) and the corresponding 
location in larvae (top-right)
The HSNs are generated in 
the tail of the embryo and 
then migrate anteriorly to 
the gonad primordium, near 
the middle of the animal. This 
occurs in both sexes but the 
HSN undergoes
programmed cell death in 
the males (Sulston & Horvitz 
1977). At this point HSN are 
immature; they do not express 
the tryptophan hydroxylase 
enzyme TPH-1, nor they 
synthesise 5-HT. 
Blue circles represent 
immature HSN neuron. The 
arrow indicates the migratory 
route. Note that only one of 
two bilaterally symmetric 
HSNs is illustrated. 
are AIM and RIH → Figure 1.12-C. Both neurons 
express the vesicular monoamine transporter (CAT-
1) and AIM additionally expresses the decarboxy-
lase BAS-1. Certain reporters for mod-5 expression 
have been also reported to be expressed in the
NSM and ADF neuron (Ranganathan et al. 2001).
Serotonergic neurons, like many other subclass
specific neurons in the worm, arise from very dif-
ferent progenitors in development → Figure 1.10. 
However, in contrast to other aminergic neurons
such as the dopaminergic that are all sensory neu-
rons, serotonergic neurons belong to different
functional classes. NSM is a neurosecretory mo-
torneuron, ADF is a ciliated chemosensory neuron,
AIM and RIH are interneurons and HSN and the spe-
cial class VC4/5 are motorneurons. Male CP1-6 are
motorneurons while the Rays 1,3 and 9 are ciliated
sensory neurons. This heterogeneity is reflected in
the diversity of behaviours that have been linked
to serotonin signalling in the worm. For example,
the ADF neurons play a role in chemosensation,
aerotaxis, immunity and food detection (Pocock &
Hobert 2010; Chang et al. 2006; Xie et al. 2013; Jafari
et al. 2011), while the NSM neurons are involved in
pharyngeal pumping and food memory (Albertson
and Thomson, 1976; Sawin et al. 2000). AIM and RIH
5-HT absorbing neurons are temporal-spatial reg-
ulators of extrasynaptic 5-HT and modulate the re-
sponse to food deprivation (Jafari et al. 2011). The
hermaphrodite HSN neuron appears as a cen-
tral regulator of the egg-laying motor programme
(Waggoner et al. 1998; Shyn et al. 2003; Hardaker et
al. 2001) and the male specific neurons have been
mainly related with mating behaviour (Loer &
Kenyon 1993). Four receptors have been identified
that bind 5-HT, including three G protein coupled
(metabotropic) receptors (SER-1, SER-4 and SER-7) 
and one serotonin-gated chloride channel (MOD-1)
(Olde & McCombie 1997; Hamdan et al. 1999; Hobson 
et al. 2003; Ranganathan et al. 2001). Analysis of mu-
tants for these receptors has shed light on the
mechanisms by which 5-HT modulates locomotion, 
pharyngeal pumping and egg-laying.
The HSN serotonergic neuron
An important part of this Thesis focuses on dis-
secting HSN neuron regulatory programme, there-
fore, in this section we will describe in a little more 
detail some aspects of HSN biology. 
Hermaphrodite specific motorneurons, HSNs, are 
generated in the tail of the embryo but migrate an-
teriorly before hatching. The HSN cell bodies are 
located lateral and slightly posterior to the vulva, 
and extend a long process ventrally, into the ven-
tral nerve cord, and then anteriorly, into the nerve 
ring (Desai et al. 1988) → Figure 1.13. Contrary to 
the rest of the serotonergic neurons that mature 
prior hatching, synapse formation in the HSN oc-
curs at L3 and L4 stages and, thus, HSN neuron 
fully matures and synthesises 5-HT at early young 
adult stage. The main function of the cell is to in-
nervate the vulval muscles and stimulate egg-lay-
ing. Genetic ablation of HSN (via egl-1 apoptotic 
semidominant mutants) or mutations in genes re-
lated with HSN function and development, result 
in animals that fail to lay eggs normally and retain 
them in the uterus, showing an egg laying defective 
(egl) phenotype (Trent et al. 1983; Desai et al. 1988). 
HSNs are particularly important for inducing the 
onset of egg-laying active phases, releasing 5-HT 
to the vulval muscles, and for inhibiting the process 
(Waggoner et al. 1998; Shyn et al. 2003). However, 
tph-1 mutants show a mild egl phenotype (Sze et al. 
2000), thus other neuropeptides and neurotrans-
mitters as acetylcholine may be implicated in the 
process (Kim et al. 2001; Weinshenker et al. 1995). 
Moreover, 5-HT neurotransmission leads to a burst 
in velocity prior to egg-laying events (Hardaker et 
al. 2001), placing the HSN as a central regulator of 
the egg-laying motor programme.
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Terminal selectors of Caenorhabditis elegans 
serotonergic neurons
As described earlier in the Introduction, neu-
ronal specification and the terminal selector con-
cept have been extensively studied in C. elegans 
(Hobert 2008). In the case of cholinergic neurons, 
the unique COE (Collier, Olf, EBF)-type TF UNC-3 
co-regulates all members of the cholinergic gene 
battery in most cholinergic subtypes (VA, VB, DA, 
DB and AS) (Kratsios et al. 2011; Kratsios et al. 2015). 
In dopaminergic neurons, a combination of three 
TFs regulates all dopaminergic subtypes (Flames & 
Hobert 2009; Doitsidou et al. 2013). Contrary to these 
and other neuronal types in C. elegans, to date, 
there is no unique TF (or combination of TFs) known 
to be involved in the differentiation of all seroton-
ergic neurons. This resembles, as aforementioned, 
the serotonergic systems of other organisms as 
mouse, fish and Drosophila. 
Among the C. elegans serotonergic cells, the HSN is 
the best characterised. Using an extensive forward 
genetic screen, 38 distinct genetic loci affecting 
different aspects of HSN development and func-
tion were isolated → Table 1.2 (Desai et al. 1988; 
Desai & Horvitz 1989). Several candidates to play a 
role in HSN terminal differentiation came out from 
this study. Especially interesting are those genes 
that code for TFs and whose mutants showed 5-HT 
staining defects and will be briefly described next.
egl-5 encodes a homeodomain TF, orthologous 
to Drosophila Abd-B and the vertebrate Hox9-13 
proteins. EGL-5 is expressed in the HSN neuron 
(Baum et al. 1999) and this expression is maintained 
throughout adulthood (Ferreira et al. 1999). Two 
pieces of evidence suggest that egl-5 acts higher 
in the cascade of HSN neural differentiation. One is 
that in egl-5 mutant HSN cells change their fate into 
PHB neurons (HSN sister cell) (Baum et al. 1999). 
The second is that egl-5 regulates the survival and 
fate of HSN/PHB precursor (Singhvi et al. 2008). 
egl-43 encodes a zinc finger protein, related to the 
zinc fingers of the murine Evi-1 proto-oncoprotein 
(Morishita et al. 1988). Mutations in egl-43 result in 
a modest loss of 5-HT stainig and the most severe 
HSN migration defect of all HSN migration mutants, 
and EGL-43 expression is restricted to embryon-
ic stages (Baum et al. 1999, Garriga, Guenther et al. 
1993). This observation, together with the fact that 
other mutations that cause severe HSN displace-
ments also result in low penetrance defects in HSN 
5-HT synthesis (Garriga, Desai et al. 2013), suggest 
that migration might be the only HSN trait that is af-
fected directly by the absence of the egl-43 gene.
ham-2 mutants (C2H2 zinc finger-containing TF), 
similarly to egl-43, show mild 5-HT staining defects 
that are probably due to their role in the control of 
HSN migration (Desai et al. 1988; Baum et al. 1999). 
egl-44 encodes a member of the transcription en-
hancer factor family of the TEA domain (TEAD) 
class. Mutant animals show multiple HSN defects 
including abnormalities in cell migration, axonal 
outgrowth and 5-HT production (Desai et al. 1988; 
Desai & Horvitz 1989). The same phenotypes were 
observed in egl-46 mutants (Wu et al. 2001). It has 
been determined that EGL-44 additionally regu-
lates the expression of EGL-46 (Wu et al. 2001) but 
it remains unclear whether these TFs directly acti-
vate the 5-HT pathway genes. 
sem-4 (SPALT type zinc finger TF) controls HSN cel-
lular morphology, axon pathfinding and 5-HT syn-
thesis (Basson & Horvitz 1996; Desai et al. 1988), and 
its expression is maintained in HSN during all the 
life of the animal (Grant et al. 2000). As before, it is 
unknown whether sem-4 works at the terminal dif-
ferentiation stage or if it is an upstream regulator of 
other factors.
The best candidate retrieved from Desai et al. work 
to be a terminal selector for HSN serotonergic dif-
ferentiation (i.e., a TF that directly controls differ-
entiated features of HSN) is the POU-homeodomain 
TF UNC-86 (Desai et al. 1988). HSN shows normal 
Table 1.2 
Potential regulators of HSN 
development and function 
 
The list includes genes that 
exclusively code for TFs 
and whose loss of function 
mutants show an egg-laying 
defective phenotype. 
Highlighted in pink are those 
genes that have been studied 
in this Thesis. Adapted from 
(Desai et al. 1988).
Gene name
egl-5 
 
egl-43 
egl-44 
egl-46
ham-2 
hlh-3 
sem-4 
unc-86 
 
ast-1 
egl-18
Known phenotype / function
5-HT staining defect. Acts earlier in HSN 
development; i.e. regulates the fate and 
survival of HSN/PHB precursor.
Small 5-HT staining defect.  
Exclusive role in migration.
5-HT staining, migration, axon pathfinding 
defects. Acts upstream of other TFs.
5-HT staining, migration, axon pathfinding.
Small 5-HT staining defect.  
Exclusive role in migration. 
5-HT staining, 5-HT pathway gene 
expression, axon pathfinding defects.
5-HT staining, morphology,  
axon pathfinding defects.
5-HT staining, 5-HT pathway gene expression 
defects. Acts exclusively at the terminal step 
of differentiation.
5-HT staining, 5-HT pathway gene expression 
defects.
Migration and 5-HT staining defects. 
expression defects.
Reference 
(Baum et al. 1999);  
(Guenther & Garriga 1996);  
(Singhvi et al. 2008)
(Baum et al. 1999)
 
(Wu et al. 2001)
 
(Wu et al. 2001)
(Baum et al. 1999) 
(Doonan et al. 2008)
 
Basson & Horvitz 1996) 
 
(Sze et al. 2002)
 
 
Observation in the laboratory
 
Observation in the laboratory
early differentiation in unc-86 mutants but exhibits 
terminal differentiation defects, including lack of 
expression of some 5-HT pathway genes and con-
sequently 5-HT synthesis (Sze et al. 2002). UNC-86 
protein binds to the tph-1 upstream regulatory re-
gion, arguing that the regulation is direct (Sze et al. 
2002). UNC-86 also regulates terminal differentia-
tion of the serotonergic NSM, AIM and RIH neurons 
(Sze et al. 2002). In fact, it is the only known regu-
lator for the RIH neuron. In the AIM neuron, UNC-
86 also regulates other features of the cell such as 
mbr-1 expression; a TF involved in neurite pruning 
(Kage et al. 2005). Recently, CEH-14  (LIM homeodo-
main) has also been described to regulate AIM ser-
otonergic fate (Pereira et al. 2015). However, UNC-86 
is not exclusively expressed in serotonergic neu-
rons. In fact, a classic terminal selector exam-
ple in the worm is the combined action of UNC-86 
and MEC-3 to determine the identity of a group of 
six mechanosensory neurons (Way & Chalfie 1988; 
Chalfie et al. 1981; Finney & Ruvkun 1990). Thus, it 
seems that, as it is the case for other terminal se-
lectors, UNC-86 is used with different partners to 
select different cell fates.
HLH-3, a basic-Helix-Loop-Helix TF, also appears 
as a good candidate terminal selector of the HSN. 
hlh-3 mutants show normal generation and migra-
tion of HSN but fail to express tph-1 and to synthe-
sise 5-HT, while other serotonergic neurons are not 
affected in these mutants. unc-86 expression is not 
affected in hlh-3 mutants either, which suggests 
that both factors act in parallel to specify HSN ser-
otonergic terminal fate (Doonan et al. 2008).
Regarding NSM specification, as anticipated, UNC-
86 is also a bona fide terminal selector for this 
neuron (Sze et al. 2002). Indeed, we have recent-
ly shown that it acts in combination with the LIM-
homeodomain TF TTX-3 in order to regulate the 
terminal features of the NSM neuron (Zhang et al. 
2014). TTX-3 action is specific of the NSM, as the 
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rest of serotonergic neurons remain unaffected in 
the single mutants, but TTX-3 acts as a terminal se-
lector together with other TFs to select different 
terminal fates (Wenick & Hobert 2004).
Despite the ADF neuron is known to regulate multi-
ple processes and behaviours, very little is known 
about the genes that regulate this serotonergic 
pair of neurons. ADF does not express unc-86 and, 
as expected, is not affected in unc-86 mutants (Sze 
et al. 2002). The LIM homeobox gene lim-4 appears 
to control the serotonergic phenotype of the ADF 
neuron (Zheng et al. 2005). However, lim-4 is only ex-
pressed in the progenitor cell of ADF, thus it must 
act upstream of an additional TF yet to be identi-
fied. DAF-19, orthologue of the regulatory factor 
X (RFX) TFs has been shown to regulate tph-1 in the 
ADF and thus 5-HT staining. However, DAF-19 seems 
not to act directly to regulate tph-1 expression.
To conclude the Introduction, we have reviewed 
how serotonergic neurons are specified both in 
nematodes and in mammals. Serotonergic neurons 
have been extensively studied during the past dec-
ades, probably due to their clinical relevance and 
the countless processes in which they are involved. 
Although several TFs are known to be involved in 
their differentiation (Flames & Hobert 2011; Deneris 
& Wyler 2012), very little is known about how they 
act together at the level of gene expression and en-
hancer regulation, activating the correct gene pro-
file to confer their unique properties. Despite recent 
technical advances, addressing these questions in 
vivo in complex model organisms such as rodents 
is a challenging task, as their potential regulato-
ry genome is large and genetic manipulations are 
time consuming. We believe that the use of simple 
model organisms like C. elegans, which is especial-
ly suitable for transcriptional regulatory studies, is 
key to unravel novel and fundamental aspects of 
cell type-specific transcriptional regulation.
Objectives
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1 To dissect in vivo the cis-regulatory logic 
of the serotonin pathway genes in the serotonergic 
neurons subtypes NSM, ADF and HSN.
2 To identify and characterise in detail the 
transcription factors that control the terminal 
differentiation programme of the HSN serotonergic 
neuron subtype (HSN terminal selectors).
3 To interrogate the transcriptome of the HSN 
neuron for the presence of a DNA-coded regulatory 
signature that allows for the identification of HSN 
active enhancers from the whole genome of  
C. elegans.
4 To determine if the serotonergic regulatory 
programme between nematodes and mammals 
is phylogenetically conserved, in molecular and 
functional terms.
The global aim of this Thesis is to unravel  
the regulatory transcriptional logic that governs  
the selection and activation of the terminal features 
expressed in the phylogenetically conserved 
serotonergic neurons, using the nematode 
Caenorhabditis elegans as an animal model.
The specific objectives of this Thesis are the 
following:
Materials & methods
063
Experimental Procedures
This section describes how experiments were per-
formed, following the same order as will be pre-
sented in the Results section. In this way, this part 
is divided into the corresponding Chapters I to IV.
Chapter I 
C. elegans strains and genetics
C. elegans culture and genetics were performed
as previously described (Brenner 1974). Briefly,
worms were grown in NGM (Nematode Growth
Medium, see composition in the Materials section)
agar plates (55 mm × 16 mm, non-vented), over a
lawn of OP50 bacteria (Caenorhabditis Genetic
Center), a uracil-requiring mutant of Escherichia
coli. The wild type strain used in this study was
Bristol N2. All transgenic strains used in Chapter I 
were generated by microinjection into the N2 strain. 
Strain names and the transgenes that they express 
are listed in → Table 2.21.
Generation of C. elegans transgenic lines 
for cis-regulatory analysis
Gene constructs for cis-regulatory analyses were 
generated by standard cloning into the pPD95.75 
expression vector, which contains the gfp coding 
sequence, the muscle myosin unc-54 3’ UTR and 
seems to have a basal promoter in the synthetic 
intron ahead of the gfp (Addgene Plasmid #1494) 
→ Figure 2.1. Plasmid DNA was purified using QIA-
prep Spin Miniprep Kit (QIAGEN #27106) and re-
suspended in miliQ water (Sigma, #W4502). DNA
sequences were checked by Sanger sequenc-
ing using the ABI Prism 3100 platform (Applied 
Biosystems), at the Sequencing Unit of the Institute 
for Plant Molecular and Cellular Biology (IBMCP) 
— Polytechnic University of Valencia.
Transgenic strains were generated by intragonad-
al microinjection of the DNA as a simple array into
the N2 strain. The injection mix consisted of 50 ng/
µL of the plasmid and rol-6(su1006) (pRF4, (Mello 
et al. 1991)) at 100 ng/µL as a co-injection marker
(final concentration: 150 ng/µL). rol-6(su1006) is a
dominant negative mutation of a collagen gene that 
confers worms a ‘roller’ phenotype: they twist into
a right-handed helix allowing for the easy identifi-
cation of animals bearing the transgene under the
dissecting scope (Kramer et al. 1990).
Prior to the injection, DNA was centrifuged at full
speed for about 10 min in order to pellet impurities
present in the tube, which could plug the needle.
1 µL of the mix was loaded into a 0.5 µm diame-
ter-capillary tip or needle (Femtotip II, Eppendorf
# 930000043). This needle was then adjusted to a
micromanipulator that holds it firmly and brings it
into the correct angle for gonad injection (15°-45°). 
Adult worms, with clearly visible gonads, were se-
lected for injection and placed straight in 2 % aga-
rose pads. Halocarbon oil 700 (Sigma, #H-8898)
was used to prevent the worms from fast dehy-
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dration while lying in the agarose bed. Finally, the 
pad was placed in a high-resolution inverted micro-
scope (Axio Vert.A1 Zeiss) and worms were pene-
trated with the needle at the syncytial gonad arm, 
where DNA was liberated. Worms were allowed to 
recover for several minutes in M9 1X solution and 
then placed in individual plates (see composition in 
Materials section). All microinjections procedures 
were performed at 20 °C. 
The progeny of the injected worms (F1) was fol-
lowed up and worms expressing the rol-6 co-mark-
er were selected and singled in individual plates. 
Plates where worms were able to transmit the array 
to the second generation (F2) were considered 
stable independent lines. Several extrachromosal 
lines were normally generated in each injection 
event and 2-4 transgenic lines with high transmis-
sion efficiency were selected and maintained to 
score. 
Scoring
Cis-regulatory reporter scoring was performed 
using young adult worms maintained at 25 °C. At 
least three independent lines per construct were 
scored to assess the variability between transgen-
ic lines. A minimum of 30 animals (60 cells) per line 
was scored. For the scorings, worms were mounted 
in 4 % agarose pads (prepared with distilled water) 
placed over standard microscope slides (Rogo 
Sampaic #11854782) and sealed with standard 
coverslips (22 × 22 mm) (VWR #631-1570). Sodium 
azide (100 µM) (Sigma, #26628-22-8) was used to 
immobilise worms. 
Scoring and images were performed using 60X ob-
jective in a Zeiss Axioplan 2 microscope. Percen-
tages of GFP expression in the cell were calculated 
as the total number of GFP positive cells over the 
total number of cells scored. Results are shown for 
individual lines, where +: > 60% GFP positive cells; 
+/−: 20-60% GFP cells; − < 20% GFP cells, relative to 
mean wild type values.
Chapter II
Generation of mutant strains
Mutant animals for the six TFs of interest were 
crossed with several reporter lines. Many mutant 
and reporter strains used in this chapter were ob-
tained from the Caenorhabditis Genetic Center 
(CGC). For the specific source of the strain see 
→ Table 2.21. Newly generated mutant or double
mutant strains were genotyped to confirm their
mutant nature. The alleles used in this work have
been previously curated (www.wormbase.org), un-
less indicated, so primers were designed to test the 
presence of the specific mutations by Polymerase
Chain Reaction (PCR) → Table 2.4. Mutations were
finally confirmed by sequencing. 
Genomic DNA preparation for genotyping: 
worm lysis
Well-grown, non-starved plates were used to ob-
tain genomic DNA to genotype strains. Worms 
were collected in M9 1X buffer and transferred to a 
0.5 mL Eppendorf tube, on ice. Worms were al-
lowed to deposit at the bottom of the tube for 
10 min. Supernatant M9 1X was removed and 
replaced by lysis solution (see Materials section) 
containing 1 % Proteinase K (Roche Life Science, 
#3115879001). Tubes were vortexed and stored at 
−80 °C during ≥ 20 min. Then they were placed at 
65 °C during ≥ 1 h, followed by 30 min at 95 °C, to
inactivate Proteinase K. Genomic DNA was then
ready to use as template for genotyping PCRs.
Mutant genotyping
PCRs to genotype mutant strains were carried out 
using 1 U of Go Taq® DNA polymerase (Promega, 
#M7806) and 1.5 mM MgCl₂ buffer in a final 25 µL 
volume. The DNA template used was genomic DNA 
obtained from the worm lysis protocol, without pu-
rification or quantification (approx. 200-300 ng). 
Primers were added to a final concentration of 0.5 
µM each and dNTPs 0.2 mM each. Go Taq® DNA pol-
ymerase requires a 2 min initial denaturation step 
at 95 °C and a 5 min final extension step at 72 °C.
When genetic crosses where carried out using the 
ast-1(hd92) L1 lethal allele, we used a rescuing array 
containing a wild type copy of ast-1, represented as 
ast-1(+), plus a rol-6(su1006) co-marker (hdEx237). 
In order to identify homozygous strains for the mu-
tation, we selected plates were all animals showed 
a roller phenotype, indicating that the hd92 lethal-
ity was rescued by the hdEx237 array. Moreover, 
when genetic crosses where carried out using the 
lin-11(n389), which has not been curated, the muta-
tion was followed by chromosome repulsion using a 
fluorescent marker in chromosome I. 
Mutant scoring
Mutant scoring was performed using young adult 
worms maintained at 25°C. At least 50 animals (100 
HSN cells) were scored for each genotype and per-
centages of expression were calculated in the same 
way as described in Chapter I. Standard Error of the 
Proportion (SEP) was calculated and Fisher Exact 
Test, two tailed, was applied for statistical analy-
sis. Calculations were performed using Graphpad 
QuickCalcs online software (www.graphpad.com/
quickcalcs/). Each strain was usually scored on 
different days to assess the reproducibility of the 
results. The total number of cells scored over the 
different days were considered as the "n" in the 
final percentage of expression. Whenever the 
worms fell laterally on the slide, only one side was 
scored. This turned out to be particularly important 
with reporter strains whose intensity of fluores-
cence was low. Mutant strains were scored in par-
allel to wild type reporter strains. In → Figure 3.2.5, 
to globally represent how the terminal battery of 
features of the HSN neuron is affected in the dif-
ferent mutant backgrounds in comparison to wild 
type, we constructed a heatmap. Heatmaps.2 from 
R-gplots package was used.
Image processing
Images were acquired using the Zen System 2011 
(Zeiss) and processed using the free software 
Figure 2.1 
Schematic of the pPD95.75 
plasmid 
MCS: multiple cloning site, 
where cis-regulatory modules 
(CRM) are cloned.
pPD95.75
MCS
gfp
unc-54 3’ UTR
AmpR
artificial intron
Table 2.1 
Description of the allelic 
nature of the mutations for 
the HSN transcription factor 
candidates
For more details,  
see Figure 3.3.2.
Gene (allele) Mutation type Chromosome Reference
unc-86(n846) G>A substitution disrupts splice acceptor site at intron 2, 
coinciding with the POU domain (potentially null).
III (Finney 1987;  Zhang et al. 
2014)
unc-86(n848) G>A substitution disrupts splice donor site in intron 4, 
coinciding with the homeodomain (hypomorph allele).
III (Finney 1987;  Zhang et al. 
2014)
sem-4(n1971) G>A substitution disrupts splice donor site in exon 2 of sem-4 
long isoform, before any of the seven ZnF domains (predicted
null allele).
I (Basson & Horvitz 1996)
sem-4(n2654) C>T missense mutation in exon 6 of sem-4 long isoform,  
coinciding with the second ZnF domain (hypomorph allele).
I (Toker et al. 2003)
hlh-3(tm1688) 1244 bp deletion spanning all exon 1 (predicted null allele). II (Doonan et al. 2008)
egl-46(sy628) G>A substitution generates early stop in exon 1. Although Yu et al.
describe sy628 as not necessarily null, in our hands it showed a 
stronger neuronal phenotype than gk692 (predicted null allele), 
which instead showed a more severe egl phenotype.
V (Yu et al. 2003;  
The C. elegans Deletion 
Mutant Consortium 2012)
ast-1(ot417) G>A substitution in exon 6, coinciding with ETS domain 
(hypomorph allele).
II (Flames & Hobert 2009)
ast-1(hd92) Deletion spanning exon 6 and 7 that abolishes the ETS domain 
(predicted null allele).
II (Flames & Hobert 2009)
egl-18(ok290) 698 bp deletion spanning from exon 2 to exon 4 that abolishes 
the zinc finger domain (predicted null allele).
V (Koh et al. 2002)
end-1&ric-
7(ok558)
879 bp deletion spanning part of intron 2 and exon 3.  
Includes last 246 bp the 3’ UTR’ of ric-7 gene.
V (Maduro et al. 2005;  
The C. elegans Deletion 
Mutant Consortium 2012)
ceh-14(ch3) 1277 bp deletion spanning from intron 2 to exon 4, including both 
LIM domains.
X (Cassata et al. 2000)
lin-11(n389) Not curated (putative null allele). I (Trent et al. 1983)
Table 2.2 
PCR genotyping programme
Table 2.3 
PCR genotyping mix
Step Temperature (°C) Time (min) # of cycles
Initial denaturation 95 2 1
Denaturation 95 0.5 20-35
Annealing 42-65 0.5
Extension 72 1/kb
Final Extension 72 5 1
Soak 10 ∞ 1
Component Final Volume (µL) Final Concentration
5X GoTaq ® Reaction Buffer 5 1X (1,5 mM MgCl₂)
PCR Nucleotide Mix 0.5 0.2 mM
Fwd Primer 0.5 0.5 µM
Rev Primer 0.5 0.5 µM
GoTaq® DNA Polymerase  
(5U/ µL)
0.2 1 U/25 µL
Template DNA X 0.2-0.3 µg/25 µL
Nuclease-Free Water up to 25
ImageJ 1.50i (Rasband, W.S., https://imagej.nih.gov/ 
ij/), Adobe Photoshop CC and Adobe Illustrator CC.
Population synchronisation
Plates full of gravid adults were used for popu-
lation synchronisation via bleaching (Egg Prep). 
M9 1X was poured onto the plates and they were 
gently swirled to dislodge worms. Using a glass pi-
pette, worms were transferred to a 15 mL conical 
tube placed on ice. Worms were allowed to sedi-
ment for 10 min and/or centrifuged at 2500 rpm for 
2 min. Most M9 1X buffer was aspired without dis-
turbing the worm pellet. A 12% alkaline hypochlo-
rite solution (Egg Prep Solution) (see Materials 
section) was added to the tube and vortexed during 
≤ = 8 min. Tubes were centrifuged at 3000 rpm for 
3 min. Egg Prep Solution was discarded and worms 
were resuspended in M9 1X solution. This ‘bleach-
ing’ process was repeated a maximum of three 
times, until an obvious decrease in the number of 
intact adult worms and a consequential increase in 
free eggs was observed. Worms were then washed 
with M9 1X a minimum of 3 times to eliminate any 
possible persisting bleach. Finally, worms were 
resuspended in 5 mL fresh M9 1X and incubated 
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Gene (allele) Primer design Sequence Tm (°C) Ext (s) # of cycles Product 
size (bp)
ast-1(ot417) Flanking point 
mutation
Fwd  ccaagcccaagcctaagtc
Rev  ggcgcacacctattttcatt
60 60 30 793
Mismatch Fwd (wt)  aaagtcaaagccaaacatg
Fwd (mut)  aaagtcaaagccaaacata
Rev  cggcaatattcagagatcg
58 50 20 297
unc-86(n848) Flanking point 
mutation
Fwd  atagcctcttcagctttctccag
Rev  aatctacttaggcttctgccacc
58 60 30 551
unc-86(n846) Flanking point 
mutation
Fwd  ttatcccagtccacgatctgc
Rev  gtggacccattactgctgctg
56 60 30 555
sem-4(n2654) Flanking point 
mutation
Fwd  gaagagagagtgggcggagc
Rev  gccgctaaattatctgtgtaaatgg
59 60 30 500
sem-4(n1971) Flanking point 
mutation
Fwd  ttccaccgtttgcagcgtttc
Rev  cgtcgttggagttggcataacc
64 60 30 875
hlh-3(tm1688) External to the 
deletion
Fwd  cgacatgttctctccgtgtttctc
Rev  gctgattagaggacatcatttgtgg
65 120 30 1785(wt) 
541(mut)
Internal to the 
deletion
Fwd  gccctcccttatttggttgcc
Rev  ctttgccttgtttccagcagc
68 60 30 505 (wt) 
0 (mut)
egl-46(sy628) Flanking point 
mutation
Fwd  gctcactcgctccccttcttg
Rev  gctttgtctttttcgggtctatcgg
64 60 30 794
Mismatch Fwd (wt)  tacacttccaatgttctgg
Fwd (mut)  tacacttccaatgttctga
Rev  gtcggttcttggaaaagc
65 50 20 344
egl-18(ok290) External to the 
deletion
Fwd  caacaatccgtgagcccacc
Rev  cttcaaggatcggcaggacc
64 120 30 1315(wt) 
617(mut)
Internal to the 
deletion
Fwd  ccggaagctcccaaagttgc
Rev  cgatagtagagcccacacgg
65 60 30 498 (wt) 
0 (mut)
end-1(ok558) External to the 
deletion
Fwd  cgaactctgtctgctccaatcc
Rev  cacctgttcgatcctgcaaccc
60 120 30 1354(wt) 
475(mut)
ceh-14(ch3) External to the 
deletion
Fwd  tctctcttgttcctccaacctg
Rev  cgagtagctctttatggaggac
62 120 30 1818(wt) 
541(mut)
Internal to the 
deletion
Fwd  gcttggtgcgacatgtttcc
Rev  gcaagtttacggtaacgcactg
58 60 30 525(wt) 
0(mut)
Table 2.4 
Primers and PCR specifica-
tions for HSN transcription 
factor candidate genotyping
←
overnight with gentle rocking at the desired tem-
perature, to let eggs hatch. Since there is no food in 
the media larvae are arrested at L1 stage allowing 
for population synchronisation. 
The next day, tubes were centrifuged at 2500 rpm 
and M9 was discarded up to 3 mL. Worms were re-
suspended in the remaining buffer and the desired 
volume (50-100 uL) was aliquoted onto seeded 
plates.
Worm immunohistochemistry
Antibody staining was performed using a tube fix-
ation protocol adapted from (McIntire et al. 1992). 
Briefly, synchronised young adult hermaphro-
dites were fixed with 4% paraformaldehyde (PFA) 
in phosphate buffer saline (PBS), for 18 h at 4 ºC. 
The next day worms were washed with with a solu-
tion of 1% PBS – 0.5% Triton X-100 five times and 
incubated for 18 h at 37 ºC in a nutator mixer with 
a solution of 5% β-mercaptoethanol – 1% Triton 
X-100 – 0.1M Tris (pH 7.5). The third day worms were 
rinsed five times with a solution of 1% PBS – 1% 
Triton X-100 – 0.1 M Tris (pH 7.5) and treated with 
1 mg/mL collagenase type IV (Sigma, #C5138) in 
collagenase buffer (1% Triton X-100 – 0.1 M Tris – 
pH 7.5 – 1 mM CaCl₂) for 90 min at 37 ºC, 700 rpm. 
Worms were washed with a solution of 1% PBS – 
0.5% Triton X-100, and proceeded to stain. Blocking 
solution (PBS 1X – 0.2% Gelatine – 0.25% Triton 
X-100) was added to the worms for 30 min at room 
temperature and then they were incubated for 24 
h at 4 ºC in primary antibody (rabbit anti-5-HT an-
tibody 1:5000 (Sigma, #S5545)) diluted in a solu-
tion of PBS 1X – 0.1% Gelatine – 0.25% Triton X-100. 
The last day worms were washed five times (PBS 
1X – 0.25% Triton X-100) and incubated with the 
secondary antibody (Alexa 555-conjugated don-
key anti-rabbit (Molecular Probes, #A31572)) for 3 
h at room temperature.Finally, worms were rinsed 
two times more, incubated in 4,6-diamidino-2-phe-
nylindole (DAPI) (Sigma, #D95425MG), and mount-
ed on FluorSave (Merck Millipore, #34578920ML).
Silencing of the GATA family through RNAi 
feeding assays
RNAi plates were prepared using E. coli HT115 
(CGC); an RNase III-deficient strain with iso-pro-
pyl-β-D-1-thiogalactopyranoside-inducible (IPTG) 
T7 polymerase activity. HT115 clones bearing the 
C. elegans genes of interest were obtained from 
Dr. Ahringer library (Kamath & Ahringer 2003) (gen-
erated at the Wellcome CRC Institute, Cambridge 
University; distributed by Source BioScience 
LifeSciences) → Table 2.5. These bacteria were 
cultured overnight (15-13 h) in LB media (Sigma, 
#L3522) with ampicillin (50 µg/mL) at 37 °C. 3 h be-
fore seeding, the cultures were inoculated with an 
IPTG solution (0.6 M), in order to induce the produc-
tion of double strand (dsRNA). Clones were seed-
ed on NGM plates containing ampicillin and IPTG, at 
the same concentration as mentioned above.
RNAi experiments were performed to induce gene 
silencing of all of the members of the GATA TF fam-
ily, except for elt-4 whose clone is not available. 
RNAi experiments were performed by the standard 
feeding protocol (Kamath et al. 2001). rrf-3 (pk1426) 
background was used to sensitise worms to the 
RNAi effects. This mutation turns out to be lethal at 
25 °C, so all experiments were performed at 20 °C 
(Simmer et al. 2002). rrf-3 adult worms were trans-
ferred to IPTG plates and deposited within a drop 
of alkaline hypochlorite solution (Drop Bleach, see 
Materials section). Larva that survived the treat-
ment became the parental generation (P0) which 
experienced post embryonic effects of the RNAi. 
We analysed their progeny (F1), which developed 
under the embryonic effects of the RNAi (F1 scor-
ing). Whenever the RNAi was lethal at F1, we per-
formed P0 scoring. As a negative control the empty 
vector L4440 (Addgene, #1654) was used. The ex-
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periment was done once. A minimum of 30 worms 
was scored. The statistic applied was Fisher exact 
test, *: pV< 0.05.
Identification of PHB neuron: DiI staining
The PHB neuron, generated in the same division as 
HSN, is a phasmid neuron that has its cilia exposed 
to the environment. It has been shown that amphid 
and phasmid neurons can take up lipophilic dyes, 
such as fluorescein isothiocyanate (FITC), DiI, DiO, 
and DiD, from their surroundings (Hedgecock et al. 
1985; Collet et al. 1998). These dyes label all parts of 
the neuron, from cilia to soma. Thus, we used DiI 
to visualise PHB neurons in the different mutant 
backgrounds.
A young adult synchronised population was collect-
ed from 1-2 plates using 1mL M9 1X and transferred 
to an 1.5 mL Eppendorf tube. Worms were rinsed 
twice in M9 1X (2000 rpm, 2 min) to remove bacterial 
contamination. Worms were resuspended in 300 µL 
M9 1X, transferred to a 0.5 mL tube and centrifuged 
one last time. 1 µL of 2 mg/mL DiI (1,1’-Dioctadecyl-3, 
3,3’,3’-Tetramethylindocarbocyanine Perchlorate) 
(Molecular Probes, #D282) diluted in N,N-dimethyl 
formamide (Sigma, #D4551) was added to 200 µL 
of M9 1X, vortexed and then added to the worms. 
Tubes were covered with aluminium foil and incu-
bated 3 h in a rocking nutator. After three washes 
with M9 1X, worms were immediately scored at the 
fluorescence microscope. A Texas Red filter (585 
nm) was used to visualise the dye.
Mutagenesis analysis of cis-regulatory modules
To predict putative TFBSs, we searched for the cor-
responding position weight matrixes (PWM) in both 
orientations 5’-3’ and 3’-5’ → Table 2.6. The spe-
cific sequences of the TFBSs were obtained from 
published papers and online libraries such as 
Transcription Factor encyclopedia (TFe), CIS-BP, 
JASPAR and MatInspector.
Table 2.5 
RNAi clones used in this work
Gene name TF family Library
egl-18 GATA Julie Ahringer
elt-1 GATA Julie Ahringer
elt-2 GATA Julie Ahringer
elt-3 GATA Julie Ahringer
elt-6 GATA Julie Ahringer
elt-7 GATA Julie Ahringer
end-1 GATA Julie Ahringer
end-3 GATA Julie Ahringer
med-1/med-2 GATA Julie Ahringer
ast-1 ETS Julie Ahringer
egl-18 GATA Julie Ahringer
egl-46 INSM-ZnF Julie Ahringer
sem-4 SPALT-ZnF Julie Ahringer
unc-86 POU-HD Julie Ahringer
ceh-14 LIM-HD Julie Ahringer
exc-9 LIM-HD Julie Ahringer
lim-4 LIM-HD Julie Ahringer
lim-6 LIM-HD Julie Ahringer
lim-7 LIM-HD Marc Vidal
lin-11 LIM-HD Julie Ahringer
mec-3 LIM-HD Julie Ahringer
ttx-3 LIM-HD Julie Ahringer
unc-95 LIM-HD Julie Ahringer
valv-1 LIM-HD Julie Ahringer
attf-4 FKH Julie Ahringer
C34B4.2 FKH Our laboratory
daf-16 FKH Julie Ahringer
fkh-10 FKH Julie Ahringer
fkh-2 FKH Marc Vidal
fkh-3/4 FKH Marc Vidal
fkh-5 FKH Julie Ahringer
fkh-6 FKH Julie Ahringer
fkh-7 FKH Julie Ahringer
fkh-8 FKH Marc Vidal
fkh-9 FKH Our laboratory
let-381 FKH Julie Ahringer
lin-31 FKH Julie Ahringer
pha-4 FKH Marc Vidal
T27A8.2 FKH Julie Ahringer
unc-130 FKH Julie Ahringer
Table 2.6 
Position weight matrixes used 
in bioinformatics prediction 
analysis
Gene TF Family PWM Mutation Reference
ast-1 ETS CGGAA/T A/G CcGAA/T A/G , 
CaGAA/T A/G
TFe
unc-86 POU C/T G/T CATN A/T/C A/T
/GCCATAATAAAA-
CAAT 
C/T G/T gggN A/T/C A/T 
/ GtGtATAccA-
cAACAAT 
(Sze et al. 2002; 
Verrijzer et al. 
1992)
sem-4 SPALT / MYT TTGT C/GT / 
AAATTT
CTag C/GT, TTag  
C/GT / AAgggg
(Toker et al. 2003)
hlh-3 bHLH C/GCAGAA / 
TGACGTG
tttGAA , aaAaAA / 
TGcCGaa
MatInspector, 
TFe
egl-46 INSM G/TNN A/TGC/GGG G/TNNA/TGaaa,  
G/TNNA/TaaaG,  
G/TNNA/Taaaa
TFe
egl-18 GATA A/G/TGATAA/G/T DtATAD, DGAaAD (Merika & Orkin 
1993)
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Electrophoretic Mobility Shift Assay (EMSA)
Full-length unc-86 (kindly provided by Dr. Hobert) 
and ast-1 cDNA were cloned into the pET-21b His 
tag expression vector (EMD Millipore, kindly pro-
vided by Dr. Hobert). They were transformed into 
E. coli Rosetta2(DE3) (Novagen, #71400) strain.
Overexpression was done first by growing the cells 
at 37 °C in LB and PowerBroth medium (Molecu-
lar Dimensions, #MD121061) respectively, supple-
mented with 100 µg/mL ampicillin and 100 µg/mL
chloramphenicol to OD₆₀₀ = 0.5-0.6, and then in-
ducing expression with 0.5 mM IPTG (Acros Organ-
ics, #BP1755100) at 37 °C for 3 h or 20 °C for 16 h,
respectively. 
UNC-86 protein was obtained as previously ex-
plained (Zhang et al. 2014) with minor changes.
Briefly, cells were collected by centrifugation and
resuspended in buffer A (100 mM NaH₂PO₄ – 10mM 
Tris (pH 7.5) – 10% glycerol) supplemented with 1
mM phenylmethanesulfonyl fluoride (PMSF). Cells
were lysed by sonication and soluble and insol-
uble fractions were separated by centrifugation
and analysed by SDS/PAGE. Protein was subtract-
ed from insoluble fraction as follows: the insoluble
fraction was resuspended in solubilisation buff-
er (buffer A supplemented with 8 M urea) and load-
ed on a pre-equilibrated His Trap HP column (GE
Healthcare Life Sciences, #17524801). The resin
was washed with solubilisation buffer supplement-
ed with 10 mM imidazole, and protein was eluted
with the same buffer supplemented with 500 mM
imidazole. Elution buffer was exchanged by pro-
gressive dialysis to 20 mM HEPES (pH 7.5) – 100 mM 
NaCl – 10% glycerol – 2 mM MgCl₂, and the protein
was concentrated by centrifugation up to 1.3 µg/µL 
and stored at -80°C.
For AST-1 protein, cells were collected by centrifu-
gation and resuspended in buffer B (200 mM MES
(pH 6.0) – 500 mM NaCl – 2 mM MgCl₂ – 10% glycer-
ol) supplemented with 1 mM phenylmethanesulfo-
nyl fluoride (PMSF). Cells were lysed by sonication 
and soluble proteins were loaded on a His Trap HP 
column pre-equilibrated with buffer B. The resin 
was washed with buffer B supplemented with 
10 mM imidazole, and protein was eluted with buff-
er B supplemented with 300 mM imidazole. Eluted 
fraction was analysed by SDS/PAGE. Imidazole was 
removed and protein concentrated by centrifuga-
tion up to 0.3 µg/µL, and stored at −80°C.
egl-18 cDNA was cloned into pcDNA.3 vector fol-
lowed by His tag sequence and transfected with 
Lipofectamine-2000 (Invitrogen, #11668019) in 
HEK293T cells (kindly provided by Dr. Hobert, 
#ATCC:CRL-3216). HEK293T cells were grown in 
DMEM – 10% FBS. After 24 h, cells were lysed with 
the following buffer: 1mM EDTA – 0.5% Triton – 
20 mM β-glycerol – 0.2 mM PMSF – 100 µM Na₃VO₄ 
– protease inhibitor. 
EMSAs were performed incubating UNC-86 and
AST-1 proteins in a buffer containing the labelled
probes and 10 mM Tris (pH 7.5) – 50 mM NaCl – 1
mM MgCl₂ – 4% glycerol – 0.5 mM DTT – 0.5 mM
EDTA – 1µg of poly(dIdC) – 6 µg of bovine serum
albumin (BSA) and labelled probes for 20 min at
room temperature. For EGL-18, protein extracts
were incubated in 20 mM HEPES – 50 mM NaCl
– 5 mM MgCl₂ – 5% glycerol – 1 mM DTT – 0.1 mM
EDTA – 1 µg of poly(dIdC) – 6 µg of BSA – 1 µg an-
ti-6xhistag antibody (Abcam, #ab18184) at 4 °C
for 30 min. As negative control anti-GFP antibody
(Roche, #11814460001) was used. Then labelled
probes were added and incubated for 20 min at
room temperature. For AST-1 and UNC-86, 1 µl (30
ng/µl) labelled probe was added, and for EGL-18
4 µl (30 ng/µl) were added. Finally, samples were
loaded onto a 6% (37.5:1 acrylamide: bisacryla-
mide) gel and run at 150 V for 4 h. Gels were then
dried and visualised using Fujifilm FLA-500. Probe
sequences are listed in → Table 2.8. Primers were
annealed and end-labelled with ATP (γ-32P) (Perkin 
Elmer, #NEG502A250UC) using T4 PNK (Thermo
Construct Sequence
t1p26 aggaggtgtctttgtttgtgtataccacaacaagcgatcaacacagcaaag
t1p31 ttctccggatattagattaggtggcaggcggctccattg
t1p44 gtatattacgtgccgaatttttgaagcaccacgccatcggat 
t1p43 caatcaacacagcaaagatttctctcaacctcatttcatgattttc 
t1p60mut1 cgtttttttttctccggaaattagattgtgtggcaggc
t1p60mut2 gaagcaccacgccatcgtatatttaaaagaggaggtg
t1p52 gaaaccatgacagcaaaaataggtagagtggcgccttattcg
t1p54 gaagcaccacgccatcgtatatttaaaagaggaggtg
t1p55 cgtttttttttctccggaaattagattgtgtggcaggc
t1p58 cgccttattcgactcatttcgtttttttttcttaatatctggtccggaaattagattgtgtggca
t1p59 cggctccattgtatattacgtgccgaagcttctggaaaccacgccatcggatatctaaaagagg
c1p63 gaatcattcatcattctggtttcggttgttacccattcc 
c1p61 gtgttaagcattattctttactgaatcattgggcattctggtttccgttg 
c1p60 cccaccatctactgttagaaaactagcttggatccccggga
c1p73mut1 ctttactgaatcattcatcatttttttttccgttgttacccattccgccc
c1p73mut2 ccaccaaatttttcaatgttttccctgccgaaagaaaatatgaaaatatcaacg
c1p71 gcccgttggtttctcttctcctgcttttaccatctactgttagaaaattg 
c1p74 gttctttcaagtttatatcaacaaaatataaattccagtttttttttgatagcg 
c1p75 caacaaaagataaattccagttttttttttatagcgtgtcatacagtatg 
c1p76mut1 caacaaaatataaattccagttttttttttatagcgtgtcatacagtatg 
c1p76mut2 gttctttcaagtttatatcaacaaaatataaattccagtttttttttgatagcg 
c1p79mut1 ccgtgggaatctaaaacgtgttttttgctcgcttattcttgcgtatagac 
c1p79mut2 gcccgttggtttctcttctcctgcttttaccatctactgttagaaaattg
c1p79mut3 gcgatgaacatagtgggtacttgttagaaatcgggccaaaatatcacc
c1p83 cgcagttttgttctttcaagtttatatcggcaaaagataaattccag
c1p85 cattattctttactgaatcattcataaccagaatgggtttccgttgttacccattccgcccgttgg
c1p86 cttctcctgcccccaccatctactgttagaacaagacaattggatccccgggattggccaaagg
c1p87 gcattattctttactgaatcattcatcattctggaacggaaaccgttacccattccgcccgttggtttctc
b1p73 ctcattctcaaaccagtttctatcggtttgtttgcattcaattaa
b1p71 ccagtttctatccgtttgtttggggtcaattaaattttttttttcagcgta 
b1p65 gaagaatacgctgaaaaaaaccccttaattgaatgcaaacaaacggatag
b1p78 catctcattctcaaaccagtttctttccgtttgtttgcattcaattaa
b1p77 cctatccccggctttctgtttgaattccagtaacacattgatattc
b1p76 ccagtaacacattgatattcttctttaacaccacattattcatgtatttcctcc
b1p83 cgcaaacgttttggagaatatagacaactttaggaagtcatc
b1p84 ccagaattccagtaacacatttatattcttccccaacaccac
b1p86mut1 ccagaattccagtaacacatttatattcttccccaacaccac
b1p86mut2 catctcattctcaaaccagtttctttccgtttgtttgcattcaattaa
b1p86mut3 cgcaaacgttttggagaatatagacaactttaggaagtcatc
b1p87 cgatcactatcctatccccggtggcagaaagtgccagaattccagtaacacattgatattcttcccc
b1p89 ccatctcattctcaaaccagtttctttccgttacagatagattgtttgcattcaattaaatttttt
Table 2.7 
Primers for site-directed 
mutagenesis (forward 
sequences)
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cence intensity was low, identification of the HSN 
nucleus using DIC previous to fluorescence scoring 
was required. HLH-3 expression was only detected 
in embryonic stages. Embryos were selected and 
mounted at 1 to 4 cell-stage (0 hours post-fertilisa-
tion (hpf) to 1.25 hpf, respectively), incubated at 25 
°C and analysed at 5 hpf. HSN neuroblast precursor 
cells were identified relative to nearby landmark 
cell deaths (Sulston et al. 1983). Scoring and imag-
es were performed using 60X objective in a Zeiss 
Axioplan 2 microscope. Two-tailed Fisher’s exact 
test was used for statistical analysis.
Generation of fluorescent reporters 
via CRISPR/Cas9
ast-1 gene reporter strain was generated using 
CRISPR/Cas9-mediated GFP knock-in strategy, 
as described in (Dickinson et al. 2015; Dickinson et 
al. 2013). Plasmids used were kindly provided by 
Dr. Boxem. The protocol followed is described 
below and depicted in → Figures 2.2-2.4.
We first designed primers to amplify PCR products 
flanking ast-1 stop codon, which would serve as 
homology arms. To increase the efficiency, we did 
nested PCRs → Table 2.9. As template we used N2 
genomic DNA, purified using the DNeasy Blood & 
Tissue Kit (Qiagen, #69504). Expand Long template 
PCR system (Sigma, #11681834001) and Q5 Hot 
Start High-Fidelity 2X Master Mix (NEB, #M049S) 
polymerases were used. PCR products were puri-
fied using QIAquick PCR Purification Kit (QIAGEN, 
#28106). One PCR product (5’ homology arm) in-
cluded the last 715 bp of the ast-1 gene except for 
the STOP codon, while the other (3’ homology arm) 
included the ast-1 stop codon and the following 
653 bp. In this way, the desired fluorescent protein 
(FP) would be inserted in frame at ast-1 C-terminus. 
Moreover, both homology arms contained a flexi-
ble linker (GGAGCATCGGGAG CCTCAGGAGCATCG) 
that will separate ast-1 from FP::3XFlag in 9 amino 
acids, and sequence overlaps that will allow for 
Gibson assembly. For homology arm recombination 
we used the pJJR82 plasmid (Addgene, #75027) 
containing GFP, ccdB negative selection markers 
and a self-excising selection cassette. Homology 
arms were inserted in these ccdB sites (SEC) 
through Gibson assembly cloning method (Gibson 
et al. 2009). The mix consisted of 4 µL 2X AMM (see 
Materials section), 1 µL 5’ homology arm, 1 µL 3’ 
homology arm, 2 µL plasmid. TOP10 electrocompe-
tent cells (Invitrogen, #C404010) were transformed 
with 1 µL of the mix and several clones were se-
quenced to confirm the presence of both homolo-
gy arms in the plasmid.
In order to choose the Cas9 target site two CRISPR 
design tools were used: http://crispr.mit.edu and 
http://benchling.com, both based in the Zhang 
Laboratory’s Method (Hsu et al. 2013). We select-
ed as single guide RNA (sgRNA) the GGGGTGAC-
TATCGATAAAGA sequence, which overlapped with 
the stop codon and showed 100 % specificity (only 
1 off-target: B0001.2 gene, known to be involved 
in embryonic development). Through site-directed 
mutagenesis (Quickchange II XL site-directed mu-
tagenesis kit, Agilent Technologies #200522) we 
introduced the Cas9-sgRNA into the pDD162 plas-
mid (Addgene, #4754) and confirmed its presence 
by sequencing.
60 N2 worms were injected with the following 
injection mix: 50 ng/µL Cas9–sgRNA plasmid, 10 ng/
µL repair template, and 2.5 ng/µL pCFJ90 (Pmyo-2::m-
Cherry pharyngeal co-injection marker, Addgene, 
#19328). Worms were grown in individual plates at 
25 °C for 3 days, then filter-sterilised hygromycin B 
solution (final concentration of 250 µg/mL; Gibco, 
#10687010) was added to the plates to select ini-
tial knock-in worms. Plates with candidate worms 
were obvious: many animals survived the antibiot-
ic, showed roller phenotype (due to the presence of 
the sqt-1(e1350) dominant allele in the plasmid) and 
expressed no red co-marker (loss of extrachromo-
Scientific, #EK0031) according to the manufactur-
er’s specifications.
In vivo transcription factor expression analysis 
For TF developmental expression analysis dif-
ferent reporter strains were used → Table 2.21. 
To assess UNC-86, HLH-3, SEM-4 and EGL-18 ex-
pression we used fosmid reporters (kindly provided 
by Dr. Hobert and CGC). For SEM-4 we also analysed 
a truncated translational reporter that encodes ap-
proximately half of SEM-4 fused in frame to GFP, 
whose expression was significantly more intense 
than the fosmid strain. For egl-46 we injected a tran-
scriptional reporter that covered all the intergenic 
region (4,477 bp) (kindly provided by Dr. Pocock). The 
injection mix consisted of 50 ng/µL of the pNF303 
plasmid (egl-46prom::NLS::DsRed in pPD96.04) and 
rol-6 (su1006) (pRF4) at 100 ng/µL as an co-injection 
marker (final concentration: 150 ng/µL). Finally, for 
AST-1 we generated a CRISPR/Cas9 mediated GFP 
knock-in (detailed in the next section).
Worms were scored at all developmental stages, 
from embryo to adult. Whenever reporter fluores-
Protein Probe Size (bp) Sequence
AST-1 tph-1 wt 44 cgtttttttttctccggatattagattgtgtggcaggcggctcc
tph-1 mut 44 cgtttttttttctcttagattgtgtggcaggcggctcc
cat-1 wt 41 tttactgaatcattcatcattctggtttccgttgttaccca
cat-1 mut 35 tttactgaatcattcatcattctggttgttaccca
bas-1 wt 48 ctcattctcaaaccagtttctatccgtttgtttgcattcaattaaatt
bas-1 mut 42 ctcattctcaaaccagtttctttgtttgcattcaattaaatt
UNC-86 tph-1 wt 40 gtgtctttgtttgcgcataataaaacaatcaatcaacaca
tph-1 mut 40 gtgtctttgtttgtgtataccacaacaagcgatcaacaca
cat-1 wt 41 tttactgaatcattcatcattctggtttccgttgttaccca
cat-1 mut 41 tttactgaatccccgggcattctggtttccgttgttaccca
bas-1 wt 57 aaaccagtttctatccgtttgtttgcattcaattaaattttttttttcagcgtattc
bas-1 mut 56 aaccagtttctatccgtttgtttggggtcaattaaattttttttttcagcgtattc
EGL-18 Control 31 catttatatcagccgtttttatcttttcctg
tph-1.1 wt 97 ttttttctccggatattagattgtgtggcaggcggctccattgtatattacgtgccgaattccagaagcac-
cacgccatcggatatctaaaagagga
tph-1.1 mut 97 ttttttctccgtatattagattgtgtggcaggcggctccattgtatattacgtgccgaattccagaagcac-
cacgccatcgtatatttaaaagagga
cat-1 wt 54 gtttatatcaacaaaagataaattccagtttttttttgatagcgtgtcatacag
cat-1 mut 54 gtttatatcaacaaaatataaattccagttttttttttatagcgtgtcatacag
Table 2.8 
Probe sequences for EMSA 
analysis (forward sequences)
Figure 2.3 
GFP ast-1 gene tagging 
protocol using CRISPR/Cas9 
and a self-excising drug 
selection cassette. Adapted 
form (Dickinson et al. 2015).
A) Endogenous locus of the 
ast-1 gene; coding exons are 
in red and the stop codon 
appears in yellow. A small 
diagram shows the resulting 
mRNA of the gene. The single
guide RNA (sgRNA, blue line) 
containing a PAM sequence 
that will be recognised by 
CRISPR/Cas9, is designed 
to overlap the stop codon 
region. Wild type worms are 
injected with a mixture of the 
GFP-SEC-3XFlag plasmid
containing the homology 
arms previously introduced 
by Gibson assembly (repair 
template), and the Cas9-
sgRNA plasmid (Figure 2.4). 
B) Cas9 recognises the 
PAM sequence at the STOP 
codon of ast-1 and cuts the 
DNA. Homology arms in the 
repair template allow for 
homologous recombination 
with the worm endogenous 
ast-1 locus.
C) Homologous insertion 
strains are recognised 
by choosing animals that 
segregated 100% rol progeny,
due to the presence of the 
sqt-1(d) marker in the SEC 
cassette. 
D) Heat shock treatment 
activates the hsp::Cre present
in the SEC cassette, which 
recognises the LoxP sites and 
excises the cassette. In this 
way, an ast-1::gfp knock-in is 
generated, that will be 
transcribed into an ast-1::gfp 
fused mRNA containing a 
flexible linker (blue) between 
the ast-1 (red) and the gfp 
(green) cDNA, and a 3XFlag 
(purple) before the stop codon 
(yellow).
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Figure 2.2 
Genome engineering using a 
self-excising drug selection 
cassette. Adapted form 
(Dickinson et al. 2015).
A) In order to tag the gene of 
interest in the C-terminus, two
PCRs are required; PCR 1 will 
amplify a region of 500-700 
bp just before the gene 
stop codon, while PCR 2 will 
amplify a region of 500-700 bp 
starting with the stop codon. 
Primers (arrows) will add 
overhangs that overlap with 
the GFP-SEC vector.
B) Schematic of an 
expedited cloning procedure 
for insertion of homology 
arms into a GFP–SEC vector 
(pJJR82). The GFP–SEC 
vector is first digested 
with restriction enzymes to 
release the ccdB markers, 
and 500–700 bp homology 
arms (light pink) are inserted 
by Gibson assembly to 
generate the repair template 
plasmid. Grey angled lines 
indicate overlapping DNA. The
self-excising cassette (SEC) 
for drug selection consists of 
a hygromycin resistance gene 
(hygR), a visible roller marker 
(sqt-1(d)), and an inducible 
Cre recombinase (hsp::Cre). 
SEC is flanked by LoxP sites 
and placed within a synthetic 
intron in an GFP::3xFlag tag, 
so that the LoxP site that 
remains after marker excision 
is within an intron.
somal arrays). 20 worms from each candidate plate 
were picked and singled to new plates. Plates were 
all descendants were roller were selected as ho-
mozygous for the insertion. Only one line form each 
plate in the previous step was kept as independ-
ent lines, because it is impossible to tell whether 
two strains that originated from the same injection 
plate derive from independent insertion events or a 
single insertion event.
To remove the rol selectable marker, 8-10 L1-L2 lar-
vae were picked to three new plates from several 
homozygous independent lines and heat shocked 
at 34 °C, for 4 h. This activated the expression of 
hsp-16.41prom::Cre, which recognised LoxP sites 
that flank the Cre, hygromycin and sqt-1 sequenc-
es. 5-7 days later, F1 progeny L4 non-roller worms 
were selected as candidate knock-in worms that 
had lost the selectable cassette.
HSN fate maintenance assays. RNA interference 
(RNAi) by feeding at the adult stage
RNAi experiments were performed, as previously 
described, but to induce gene silencing of our can-
didate TFs after HSN maturation, i.e. adult stage 
→ Table 2.5. A synchronised population of ani-
078 079
Figure 2.4 
Cas9-sgRNA plasmid used in 
this Thesis 
pDD162 plasmid contains 
the Cas9 cDNA, plus the 
sgRNA that will recognise 
the desired genomic target 
(i.e. C-terminus). sgRNA is 
expressed under the U6 small 
nuclear RNA promoter, which 
drives transcription by RNA 
polymerase II (Dickinson et 
al. 2013).
Cas-9 sgRNA
U6 promoter
G
mals (alkaline hypochlorite treatment) were grown 
under normal food (OP50) until young adult stage, 
when the HSN has already matured. At this time 
point the worms were scored for the 5-HT path-
way gene reporter tph-1::yfp (otIs517), and then 
they were transferred to RNAi plates. These plates 
contained dsRNA for ast-1, unc-86, sem-4, egl-46 
and egl-18. As a positive control dsRNA against 
GFP was used. As a negative control empty vector 
L4440 (Addgene, #1654) was used. Animals were 
incubated for 72 h at 15 °C before the final scoring. 
The experiment was performed in three independ-
ent replicates with similar results. A minimum of 50 
worms was scored. The statistic applied was Fisher 
exact test, *: pV< 0.05.
Heat shock overexpression experiments
For overexpression of the six candidate TFs, 
cDNAs were obtained from total worm RNA extrac-
tion (Genelute Mammalian Total RNA kit (SIGMA, 
#RTN70-1KT)), followed by reverse transcription 
(Quantitec reverse Transcription Kit, (QIAGEN, 
#205311)) and PCR amplification. In the case of 
unc-86, the genomic locus was amplified from N2 
genomic DNA (DNeasy Blood & Tissue Kit (Qiagen, 
#69504)). In all cases, cDNA or gene locus were 
cloned into the pPD49.78 (Addgene, #1447) ex-
pression vector, which includes the heat shock in-
ducible promoter from hsp-16.2 gene and the 3’ 
UTR of muscle myosin unc-54. In the case of egl-
18, (hsp-16.2::egl-18 cDNA::3’UTR unc-54) the 
backbone plasmid is pPD49.83 (kindly provided 
by Dr. Pocock). For ast-1, otIs198 (hsp-16.2::ast-1, 
hsp-16.2::NLS::mCherry, ttx-3::DsRed) integrated 
strain was used. Details of the primers and en-
zymes utilised are found in → Table 2.10. Plasmids 
were injected, alone or in combination, into N2 
strain together with the co-markers rol-6(su1006) 
and ttx-3::mCherry. pUC19 was used as filler DNA 
when necessary. Different plasmid concentrations 
were used depending on the toxicity of the array 
→ Table 2.11. Resulting extrachromosomal strains
were crossed with zdIs13(tph-1::gfp). This reporter
is initially expressed in the NSM and ADF neurons
in the embryo at comma stage. ast-1 overexpres-
sion strain (otIs198) carries an extra internal con-
trol (hsp-16.2::NLS::mCherry) to validate the heat
shock experiment. All strains generated are listed
in → Table 2.21.
Analysis of the effect of transcription factor 
ectopic expression at embryonic stages
Gravid hermaphrodites were placed in an M9 1X 
drop on a glass slide and they were sectioned to re-
lease the eggs with the help of a 0.3 mm × 13 mm 
needle (BD Microlance 3, #304000). 1-2 cell embry-
Table 2.9 
Primers for CRISPR-Cas9 
mediated GFP knock-in
Table 2.10 
Plasmids for the overexpres-
sion of HSN transcription 
factor candidates
Use Primer sequence
Amplify 5’ homology arm. External. Fwd tgctcctgatttctcatcgtgg
Rev tcgataaagagggaatgctcg
Amplify 5’ homology arm. Nested. Fwd acgttgtaaaacgacggccagtcgccggcacgatctctgaatattgccggg
Rev catcgatgctcctgaggctcccgatgctcctcgataaagagggaatgctcgtg
Amplify 3’ homology arm. External. Fwd tagtcaccccccataattcct
Rev gcgagacccaccaaattgattc
Amplify 3’ homology arm. Nested. Fwd cgtgattacaaggatgacgatgacaagagatagtcaccccccataattcctcc
Rev ggaaacagctatgaccatgttatcgatttcattgattccgtgcgcctttg
sgRNA Fwd ctcctattgcgagatgtcttgggggtgactatcgataaagagttttagagctagaaatagcaag
Rev cttgctatttctagctctaaaactctttatcgatagtcacccccaagacatctcgcaataggag
Plasmid Construct Primers used to amplify cDNA Enzymes Backbone
pNF197 hsp-16.2::unc-86 
genomic
Kindly provided by Dr. Hobert NheI / NcoI pPD49.78
pNF204 hsp-16.2::sem-4 cDNA Fwd tagagagctagcatgaatgagctgctcgc
Rev  tagagaggtaccctaagagggtggtgg
NheI / KpnI pPD49.78
pNF283 hsp-16.2::hlh-3 cDNA Fwd  gagagagctagcatgaccgcatccacctc 
Rev  gagagaggtaccttaataagtttctgtatgcg
NheI / KpnI pPD49.78
pNF284 hsp-16.2::egl-46 cDNA Fwd  gagagagctagcatggtgcctatgaatg 
Rev  gagagaggtaccttacattgttggaataac
NheI / KpnI pPD49.78
pNF314 hsp-16.2::egl-18 cDNA Kindly provided by Dr. Pocock (–) pPD49.83
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os were isolated by aspiration with a manually pulled 
micropipette (Blaubrand intraMARK, #6121414), 
and mounted in a 4% agarose slide sealed with 
Vaseline to avoid dehydration. Embryos were incu-
bated at 20 °C for 4 h, transferred to a 37 °C incu-
bator for 20 min (heat shock), and moved back to 
20 °C. 22 h later embryos carrying the ttx-3::m-
Cherry co-marker were scored for tph-1::gfp re-
porter expression at the fluorescent microscope. 
To note, animals bearing the different heat shock 
arrays and that received the heat shock treatment 
experienced developmental problems and did not 
overpass the embryonic stage. Control animals 
that received the heat shock but did not contain the 
heat shock construct developed normally. Mean, 
standard deviation (SD), standard error of the mean 
(SEM) and distribution of the population were cal-
culated. To calculate normality in the populations 
the D’Agostino & Pearson omnibus normality test 
was performed. For statistics, the non-parametric 
Kruskal-Wallis test with Bonferroni correction was 
applied. A minimum of 50 embryos were scored. To 
calculate the percentage of embryos that respond 
to the heat shock treatment, Fisher exact test 2 
tailed was performed, pV < 0.05.
Gene TF cDNA (ng/µL) ttx-3::mCherry  
(ng/µL)
rol-6(su1004)  
(ng/µL)
pUC19 (ng/µL) Total concentration 
(ng/µL)
unc-86 50 25 25 50 150
sem-4 50 50 50 0 150
hlh-3 50 50 50 0 150
egl-46 50 50 50 0 150
ast-1 integrated integrated integrated integrated integrated
egl-18 50 50 50 0 150
Combo A+U+S 50 25 25 0 200
Combo 6 15 50 50 10 200
Table 2.11 
 Injection mix for the overex-
pression of HSN transcription 
factor candidates
Analysis of the effect of transcription factor 
ectopic expression at larval stages
A L1 synchronised population of worms (Egg Prep) 
was plated and incubated for 2 h at 20°C. Worms 
were transferred to a 37 °C incubator for 30 min and 
then moved back to 20°C. Heat shocks were repli-
cated every 2 h, 3 times. The next L2 stage worms 
were scored for ectopic gfp expression in other 
neurons or tissues. Similar to embryonic overex-
pression, animals bearing the different heat shock 
arrays and that received the heat shock treatment 
at larval stage 1 experienced developmental prob-
lems and did not reach late larval stages. Control 
animals that received the heat shock but did not 
contain the heat shock construct developed nor-
mally. A minimum of 30 worms was scored at each 
age. For statistics, Fisher exact test 2 tailed was 
performed, pV < 0.05.
Chapter III
Bioinformatics analysis
Unless otherwise indicated, all analyses were per-
formed using R (The R Team 2016) and Bioconduc-
tor (Huber et al. 2015).
HSN regulatory signature: ‘sliding window’ 
analysis
For HSN regulatory signature analysis, we built 
PWMs from the functional motifs found in the 5-HT 
pathway genes CRMs → Figures 3.2.8-3.2.10. 
Next, we downloaded upstream and intronic gene 
regions from WormBase version 220 and classi-
fied genes in three groups: genes expressed in 
HSN, genes expressed in neurons (according to 
WormBase annotations on gene expression and 
(Hobert et al. 2016)) and non-neuronal genes. PWMs 
were aligned to genomic sequences and we re-
trieved matches with a minimum score of 70%. To 
increase specificity, we removed all matches that 
did not bear an exact consensus sequence for the 
corresponding TF family and obtained the following 
PWMs: ETS: C/TA/TTCGG, GATA: A/G/TGATAA/G/T, 
HLH: C/GCAGAA, INSM: CCC/GCA/TNNA/C, SPALT: 
TTGTC/GT, POU: A/TTG/TCAT → Figure 3.3.1. Then, 
we performed a sliding window search to find re-
gions that included at least one match for each TF 
type. Embryonic stem cell enhancers median size 
has been reported to be around 800 bp (Parker 
et al. 2013). Therefore, the initial search was per-
formed with a maximum length restriction of either 
600, 700 or 800 bp. Differences between HSN ex-
pressed genes and other gene groups was greater 
when the maximum length was set to 700bp, thus 
we kept this maximum window length for the rest of 
the analyses. In order to assess signature conser-
vation, we performed similar analyses using other 
nematode genomes also available from WormBase 
(C. briggsae, C. japonica, C. remanei, C. brenneri). 
We selected for the conservation analysis C. el-
egans genes with orthologues in at least two ad-
ditional species and considered the signature as 
conserved if HSN regulatory windows were found 
in all orthologous genes.
Gene Ontology (GO) analysis
Gene Ontology analysis was performed using 
GOrilla software and C. elegans coding genome 
(19.276 genes) as control list (Eden et al. 2009).
Generation of reporters for de novo 
identification of HSN expressed genes
Reporters for HSN regulatory signature analy-
sis were generated by fusion PCR (Hobert 2002) 
→ Figure 2.5. Briefly, regulatory windows plus 50
bp flanks were PCR amplified from genomic N2 DNA 
and fused to GFP in the pPD95.75 expression vec-
Table 2.12 
Standard primers for Fusion 
PCR. From (Hobert 2002)
Primer name Primer sequence
C agcttgcatgcctgcaggtcg
D aagggcccgtacggccgacta
D* ggaaacagttatgtttggtata
upstream gene
gene of interest
B
A
24 bp tail
C. elegans genome
PCR # 1.1
unc-54 3’ UTR
D
C
pPD95.75 vector
PCR # 1.2
PCR # 2
amplicon # 3
Inject into C. elegans
amplicon # 1 amplicon # 2
24 bp overlap
unc-54 3’ UTR
unc-54 3’ UTR
A*
D*
Figure 2.5 
Fusion PCR protocol 
Two templates are needed: 
worm genomic DNA and the 
pPD95.75 vector. Note that, 
in the schematic, the fusion 
is made to the enhancer or 
promoter of the gene (i.e. 
transcriptional fusion), but 
it could also be made to the 
coding sequence of the gene 
(i.e. translational fusion). Pink 
box represents the upstream 
regulatory region of interest 
to fuse to gfp; red boxes 
represent coding exons of 
the gene of interest; green 
box represents gfp coding 
DNA; small black arrows 
represent the primers used 
in this protocol. Primer A is 
5’ upstream to the DNA of 
interest; primer A* is nested 
to A; primer B spans the end 
of the enhancers/promoter 
of interest + 24 nucleotides 
of the gfp pPD95.75 vector. 
Primers C and D, flank the gfp 
cDNA plus unc-54 3’ UTR of 
the pPD95.75 vector. PCR 1.1 
renders amplicon 1, while PCR 
1.2 renders amplicon 2. PCR 2 
uses as template amplicons 1 
and 2 and, taking advantage 
of the 24 overlapping nt 
conferred by primer B in PCR 
1.1, renders amplicon 3 (DNA 
of interest::gfp). Purified 
PCR product can be directly 
injected into the worms. 
Adapted from (Hobert 2002).
tor. A list of tested windows and the primers used 
are listed in → Table 2.12 and 2.13. Expand Long 
Template Polymerase (Roche, #11681834001) was 
used. PCR products were injected at 50 ng/µL 
into wild type N2 strain together with 100 ng/µL 
rol-6 (su1006) (final concentration: 150 ng/µL). The 
resulting transgenic lines were analysed under 
the fluorescent dissecting scope and the 3 that 
showed strongest GFP were selected for scoring. 
A minimum of 30 worms was analysed per line. 
HSN regulatory signature syntax analysis
Syntactic rule detection was performed with iTF 
software using the regulatory windows found in 
known HSN expressed genes as input and the short 
consensus sites (ETS: YWTCGG, GATA: DGATAD, 
HLH: SCAGAA, INSM: CCSCWNNM, SPALT: TTGTST, 
POU: YKCATNHW) as PWMs (Kazemian et al. 2013). 
To test syntax functionality, mutagenesis was 
performed over the cis-regulatory modules tph-
1prom2, cat-1prom14 and bas-1prom13, in order to 
invert BSs orientation. Specific nucleotidic chang-
es are described in → Annex 3.3.3. When flipping 
one core site, two flanking nt were usually also 
considered. If two functional BSs overlapped (as in 
ETS-GATA), one was maintained in the original ori-
entation and the other one was flipped and placed 
next to it, leaving a 2 nt spacing between them. 
Mutated plasmids were injected at 50 ng/µL into 
Table 2.13 
Primers used to amplify 
windows to test de novo 
expression in HSN 
Forward primers correspond 
to primer A* and reverse 
primers corresponds to B 
in Figure 2.5. All primers B 
contain an additional 24 bp 
tail (agtcgacctgcaggcatg-
caagctt) before the sequence 
included in the table.
Gene name Primer sequence
C16B8.4 Fwd ggatgtggaacatgaatccgattg
Rev ggggtagaatgggtgaaaaaaaattgt
dgn-1 Fwd gtgaaaaaagtctttcatcgcaaaacc
Rev gcaacacgcatacacacacaa
kel-8 Fwd atcgtaaacataaacaatgcacccg
Rev gggtccaaaaaaatcgtatttttgcg
F37A8.5 Fwd catgtgatgtgagaattcccaatgg
Rev tcgtcatgaatttatttatatattggtacaagcg
npr-3 Fwd acaaatcaaaaccgcaaaaaacagg
Rev acaagcgatatggcatggacc
tkr-2 Fwd ttaattgctacttaatcgagaagttcgaac
Rev agtgaaaaaattatttgaatggccacatc
twk-17 Fwd ggtttacagctttgaagactagtaagc
Rev tcactgatgtctagacttaagcaagattc
tyra-3 Fwd agtgcgtgtatgtctctaacatctaag
Rev gaaatctagttatcggttaggttaatttcgg
lgc-49 Fwd atgaaccctctttcacttttggc
Rev cgaacaaggaacatgtctgtaatgtg
pde-3 Fwd cgtacaatttttttttggaaaaatcaaaaaaaattaagc
Rev actgtgactttttgaaatttttttcccg
daf-38 Fwd catagaaatttctgatgatgagcctcg
Rev tgccttaaaaacatagtgaaacgttagg
fut-1 Fwd ttttttttgaaaacatcgtcaccgc
Rev tttcctgttttacagtgattcacataagc
kcc-1 Fwd cagaaatccatccactgaaacagt
Rev caaaaacccagcagagcgtg
klp-7 Fwd gtctaattgcctctgatatgttttgacc
Rev gatgttatgaaatggcgagtactgc
sprr-1 Fwd cgtcattgtcttggtttgtctcg
Rev tcttgggaaaaaatatgttaagaaggtgc
unc-32 Fwd ctcatgattcatttctctccttattggc
Rev cgcttctttcgagagaaaacatttaaga
C53B4.4 Fwd gcttcaggaagcgaacaagc,
Rev ggagcacacgtttctaagatggg
ckr-2 Fwd ctaagatttgctcctcttattttagccg
Rev catcttcttcttcttccccttcttcta
F32D8.10 Fwd gaattttcatgattcatcttgaaaatcccc
Rev cctgggtagttgatcttctacttgaag
glb-20 Fwd cggagagtgagaaagagagagagg
Rev agggtaaaaagtattcaaaactcaacagg
mgl-2 Fwd agtgtaatgaaccaaaaaataggcgg
Rev acaaaaaagcgttccaattcctcg
snt-1 Fwd aagaaaaggttatgcaacaaactggg
Rev gcgagaaccagcagaataaatacg
unc-7 Fwd gactgagctatcctgcctgc
Rev tcaatgcaagaaagacacgcg
ast-1 Fwd ggtaaattcccaaattttggccaaac
Rev tcaattgcatagaacaattaggttatgcc
acr-24 Fwd aatctgatcaattctaaactatttttttcaacacc
Rev aggtttgaaacatttttttgaaacaaaatttgaag
gab-1 Fwd ccgaggatcagttatgtgaagagtattg
Rev cagacacgaagaaattcattacgaaaatcg
↳
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mec-10 Fwd attgattgcactaataatccactggc
Rev tcctgttttagctcaaaatacgtgc
npr-1 Fwd aatagctctgaatcattctaaaacgcc
Rev attgaatttggaacgagtaatgtgtagg
tol-1 Fwd ccttgttaccttgactatcgggaa
Rev cctaattagtagtcacgagaagagcag
bam-2 Fwd ggaacaagtcaaggtgttcatagaaatag
Rev acattcattggacgcgtacaatttc
shl-1 Fwd gttcgaaaattttggaattgactaattttatccg
Rev gctagcacctattgagcaggaa
sto-5 Fwd gtcactccgaggttctggc
Rev agaagaagaatgtacagatatagtgcgc
tiam-1 Fwd actactcgagttgagtgtgttgc
Rev ctgttatggcaagttgaaactggag
pan-1 Fwd cgaaagtacaacaatgattcctcatagg
Rev gatcgtaaaatcttaattcacagaagctcg
abts-4 Fwd tcctcactctgtcatttgaatgttctc
Rev aactgttatcatatctcacacataatttacgc
cat-1 Fwd gcatttagcagtccatgtttaggc
Rev gactatagctggagtccgcg
aak-2 Fwd tcatcggaccaacttcccc
Rev cccactaaattttcctgtagtttcagc
kal-1 Fwd tcgctaaaaaaatctcttgaagtctgc
Rev aaacatctgtactagtccgggttc
kcc-2 Fwd atttaacaacattgcaaaacagaagaagtc
Rev cagaattggtattaataacgggatgaaagg
sem-4 Fwd aactcttaatgttttgttgcgaccc
Rev ggtcgtaaaaatcgcaacaaaccg
F16G10.5 Fwd cctaactggatgactcagtaccaaaaag
Rev atgaataccttcttcaatccaacagaaag
flp-27 Fwd gcaaatcgacaatttgccgaaaatg
Rev acctctgtgaaagccacgc
gipc-2 Fwd ggcgtcaactaacaatgacgtg
Rev atgtatagatttttgcctcaaaatccagg
irld-53 Fwd gaaagagctaccactaaacgaaacatg
Rev agttttttaaaaatgatttttgggaaattggaaaa
irld-62 Fwd gtaaaaatcctaaacattaggatagttttttgatgtg
Rev caattgaacaaactataatatttttcatgaaaaaatactttaaaacc
lurp-2 Fwd acatcgcagcgacaaagtttttg
Rev ctcgaacgttagagcctccttg
plep-1 Fwd ccaatacatttccagttcaaaaaagttttttttaatac
Rev tctgaatattttttgtgaaatattgaaaaaactcttcg
slc-28.1 Fwd ttcctagcggataaattcaaagtttttttaatg
Rev agcttttggtaactgaaatcagatttttttc
stg-1 Fwd gaaactttcaaattagctgaatcagttgattttc
Rev ttttaaaacaaatatgacggggcttttcg
tub-1 Fwd gctaaaaattatacattcatttatgttg
Rev gattacctggaaactttgaatagtttttgaac
Table 2.14 
Two-step fusion PCR 
programme
Table 2.15 
Two-step fusion PCR mix 
 
Note that, in order to amplify 
the gfp coding DNA, primers 
and template indicated in the 
table must be changed by 
primers C and D, and vector 
pPD95.75.
Step Temperature (°C) Time (s) # of cycles
Initial denaturation 92 120 1
Denaturation 92 10 25
Annealing 58 10
Extension 68 60/kb
Final Extension 68 7 1
Soak 10 ∞ 1
PCR 1
Component Final Volume (µL) Final Concentration
Expand Long Template  
Buffer 2
2.5 1X (2.75 mM MgCl₂)
PCR Nucleotide Mix 0.35 0.2 mM
Fwd Primer (A) 0.3 0.5 µM
Rev Primer (B) 0.3 0.5 µM
Expand Long Template DNA 
Polymerase (5U/ µL)
0.2 1 U/25 µL
Template DNA (genomic) 1 0.2 µg/25 µL
Nuclease-Free Water 20.35 (–)
PCR 2
Component Final Volume (µL) Final Concentration
Expand Long Template  
Buffer 2
2.5 1X (2,75 mM MgCl₂)
PCR Nucleotide Mix 0.35 0.2 mM
Fwd Primer (A*) 0.3 0.5 µM
Rev Primer (D) 0.3 0.5 µM
Expand Long Template DNA 
Polymerase (5U/ µL)
0.2 1 U/25 µL
Template DNA  
(PCR1 + gfp::3’ utr unc-54)
2 0.2 µg/25 µL
Nuclease-Free Water 19.35 (–)
↲
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wild type N2 strain next to 100 ng/µL rol-6 (su1006) 
(final concentration: 150 ng/µL). A minimum of 30 
worms was scored per line. Three independent 
lines were scored.
Chapter IV
Mouse strains
Animals of C57Bl6/JRccHsd (ENVIGO, Harlan) ge-
netic background were housed in our animal care 
facility with a 12 h dark/light cycle and had free ac-
cess to food and water. Timed embryos were ob-
tained from overnight mating and the morning of 
the vaginal plug was considered as embryonic day 
(E) 0.5. All experiments were performed accord-
ing to the animal care guidelines of the European
Community Council (86 ⁄ 609 ⁄ EEC) and to Spanish
regulations (RD1201 ⁄ 2005), following protocols ap-
proved by the ethics committees of the Consejo
Superior Investigaciones Científicas (CSIC). 
Mouse immunohistochemistry
Freshly isolated E11.5 embryos were fixed by im-
mersion in 4% PFA for 3 h (for SALL2 detection) or 
overnight (for BRN2 detection), washed with PBS, 
cryoprotected overnight in 30% sucrose in PBS and 
sectioned coronally at 10 mm using a Leica CM1900 
cryostat. Before SALL2 and BRN2 immunohisto-
chemical staining, the antigen was unmasked by 
boiling samples in 10 mm sodium citrate, pH 6, for 
5 min and allowing them to cool down slowly, or by 
incubation in HCl 2N at 37 °C for 20 min followed by 
washes in borate buffer, respectively. The sections 
were then incubated for 1 h at room temperature in 
blocking buffer (PBS containing 1% bovine serum 
albumin (BSA) and 0.2% Triton X-100), and incubat-
ed overnight at 4 °C with following primary antibod-
ies: rabbit anti-SALL2 (1:100; Sigma, #HPA004162), 
goat anti-BRN2 (1:100; Santa Cruz Biotechnology, 
#SC6029), rabbit anti-5-HT (1:5000; Sigma, #S-
5545), goat anti-5-HT (1:200; Abcam, #Ab66047). 
The next day, sections were washed several times 
with PBS and incubated at room temperature for 
1 h with secondary antibodies: Alexa 555-con-
jugated donkey anti-rabbit (1: 600; Molecular 
Probes, #A31572), Alexa 555-conjugated don-
key anti-goat (1: 600; Molecular Probes, #A21432), 
Alexa 488-conjugated donkey anti-goat (1: 600; 
Molecular Probes, #A11055) and Alexa 488-conju-
gated donkey anti-rabbit (1: 600; Molecular Probes, 
#A21206) diluted in blocking buffer. Cells were 
counterstained with DAPI, washed in PBS, and 
mounted with Fluorsave (Calbiochem). No label-
ling was observed when sections were incubated 
only with secondary antibody (negative control). 
Immunofluorescent samples were analysed and 
photographed using a confocal TCS-SP8 Leica 
microscope. 
RNAi screen to test functionality of additional 
FKH and LIM-HD candidates to regulate HSN 
identity
RNAi plates were prepared as described earlier for 
experiments in Chapter II. We used RNAi clones ob-
tained from J. Ahringer (Kamath & Ahringer 2003) 
and M. Vidal RNAi libraries (Rual et al. 2004) (gen-
erated at Dana-Farber Cancer Institute; distributed 
by Source BioScience LifeSciences) → Table 2.5. 
rrf-3 adult worms were transferred to IPTG plates 
and deposited within a drop of alkaline hypochlo-
rite solution (Drop Bleach). Plates were incubated 
and scored at 20 °C and we performed F1 scoring 
at the adult stage. As a negative control empty vec-
tor L4440 (Addgene, #1654) was used. The experi-
ment was done once. A minimum of 30 worms was 
scored. The statistic applied was Fisher exact test, 
*: pV< 0.05.
Validating functionality of new HSN transcription 
factor binding site candidates
Putative BSs for the new candidate TFs pha-4, 
ceh-14 and lin-11 were searched in tph-1, cat-1 and 
bas-1 cis-regulatory modules. Core binding motif 
used for PHA-4 is A/GC/TNAAC/TA (Wederell et al. 
2008) and for CEH-14 and LIN-11 are TA/TA/TA/TA/
TA (German et al. 1992). PHA-4 putative BSs were 
identified in tph-1prom2 and cat-1prom14 CRMs. 
Directed mutagenesis was carried out to disturb 
their BSs (RYNggYA) and constructs were injected 
at 50 ng/µL into wild type N2 strain next to 100 ng/
µL rol-6 (su1006) (final concentration: 150 ng/µL). 
Everything was performed as previously described 
in the mutagenesis experiments in Chapter II.
Rescuing worm serotonergic defects using 
mouse orthologues
DNA corresponding to the entire coding sequence 
of ast-1, unc-86 (entire genomic locus DNA), sem-4, 
hlh-3, egl-46 and egl-18 and their mouse ortho-
logues Pet1, Brn2, Sall2, Ascl1, Insm1 and Gata3 
were amplified by PCR. These DNAs were cloned 
in front of HSN-specific promoters: bas-1prom1, 
cat-4prom2 or kal-1promA, in the pPD95.75 vec-
tor. All the information for the cloning is collected 
in → Table 2.16.
DNA was injected into N2 animals at different 
concentrations depending on the toxicity of the 
array, being the total concentration of inject-
ed DNA 150 ng/µL → Table 2.17. Transgenic lines 
were then crossed with their respective mutant 
strain (ast-1(ot417), unc-86(n846), sem-4(n1971), 
hlh-3(tm1688), egl-46(sy628) or egl-18(ok290)) 
carrying the zdIs13(tph-1::gfp) transgene or the 
yzIs71(tph-1::gfp, rol-6(su1006) in the case of egl-
18. Mutant scoring was performed using young
adult worms maintained at 25 °C. As negative con-
trol mutant worms that did not harbour the extra-
chromosomal array were scored in parallel. At least 
50 animals (100 HSN cells) were scored for each 
genotype and percentages of expression were cal-
culated in the same way as described in Chapter II.
Principal Coordinate Analysis to compare 
expression profiles of worm neurons with 
expression profiles of mouse raphe serotonergic 
neurons (PCoA) 
For Principal Coordinate Analysis and hierarchical 
clustering we used curated data from WormBase 
(Hobert et al. 2016) to generate a matrix with gene 
expression profiles for the 118 C. elegans hermaph-
rodite anatomical neuronal classes. Panneuronal 
genes and neurons in which less than 30 genes had 
been reported to be expressed were excluded. We 
built a similar matrix with mouse gene expression 
data from RNA-seq experiments, either from adult 
raphe nuclei divided into different rhombomeres 
(R1Dorsal, R1 Medial, R2, R3, R5, R6) (Okaty et al. 
2015) or from cortical neurons, which were used 
as a control (Molyneaux et al. 2015). To transform 
the quantitative RNA-seq data into a presence-ab-
sence binary matrix, we considered values above 
19 counts per million (CPM) as present and values 
below that threshold as absent. With this thresh-
old, it appeared that one third of the genome is ex-
pressed in serotonergic cells, which is what it is 
estimated to be expressed in a cell.
To assign mouse orthologues to C. elegans genes 
we combined orthology relationships between 
mouse and worm genes annotated in the ENSEMBL 
database and worm-human orthology relation-
ships reported in (Shaye & Greenwald 2011). In the 
last case, we used ENSEMBL data base again to 
assign mouse orthologues to human genes. In 
(Shaye & Greenwald 2011), ENSEMBL, OrthoMCL, 
InParanoid and Homologene methods are com-
bined to identify orthologues. Thus, we combined 
Table 2.16 
Rescuing constructs
Plasmid Construct Primers used to amplify DNA Template Enzymes 
pNF104 bas-1prom1::ast-1 cDNA Fwd gagagaggtaccggtagaaaaaatgatgcaa-
gtcgtctcgtcagcc
Rev gagagagaattcctatcgataaagagggaatg
pNF17  
(ast-1 cDNA-pCDNA3.1)
KpnI / EcoRI
pNF391 kal-1promA:: unc-86 
genomic
Fwd gagagaggtaccatgcaacctttcaac 
Rev gagagagaattcctaatcaaagaatccagg
pNF197 (Dr. Hobert) EcoRI/KpnI
pNF395 kal-1promA:: sem-4 
cDNA
Fwd tatatacccgggatgaatgagctgctcgccg  
Rev gagagagtatacctaagagggtggtggggt 
pNF204 XmaI/Bstz17I
pNF370 cat-4prom2:: hlh-3 cDNA Fwd gagagaggtaccatgaccgcatccacctc  
Rev gagagagaattcttaataagtttctgtatgcg
pNF283 KpnI / EcoRI
pNF371 cat-4prom2:: egl-46 
cDNA
Fwd gagagaggtaccatggtgcctatgaatg 
Rev gagagagaattcttacattgttggaataac
pNF284 KpnI / EcoRI
pNF372 cat-4prom2:: egl-18 
cDNA
Fwd gagagagctagcatgtcgatcagcataatg 
Rev gagagaggtaccgttagcagccggatctc
pNF314 KpnI / EcoRI
pNF185 bas-1prom1:: Pet1 cDNA Fwd gagagaggtaccatgagacagagcggcacctc
Rev gagagagaattcctagtgataat-
gaccccccaag
(Source BioScience, 
#8861455) 
KpnI / EcoRI
pNF397 kal-1promA:: Brn2 cDNA Fwd tatataggatccatggcgaccgcagcgtc 
Rev tatatagtatactcactggacgggcgtctgca
(Addgene, #27151) BamHI/Bstz17I
pNF384 kal-1promA:: Sall2 cDNA Fwd gagagacccgggatgtctcggcgaaag 
Rev gagagagtatactcatggcatggtgg
(OpenBiosystems, 
#5706710)
XmaI/Bstz17I
pNF380 cat-4prom2:: Ascl1 cDNA Fwd gagagaggtaccatggagagctctggcaag
Rev gagagagaattctcagaaccagttggtaaa-
gtcc
pNF287 (p2Lox-ALP-V5-
His) generated in the 
laboratory
KpnI / EcoRI
pNF385 cat-4prom2:: Insm1 
cDNA
Fwd gagagaggtaccatgccacggggatttc 
Rev gagagagaattctcaacaagcgggc
Genescript KpnI / EcoRI
pNF383 cat-4prom2:: Gata3 
cDNA
Fwd gagagaaccggtatggaggtgactgcg 
Rev gagagagaattcctaacccatggcggt
(Source BioScience, 
#6826352)
Age/ EcoRI
Promoter Construct Primer Template Enzymes
bas1prom1 Fwd aaaggatccggaaatggcaacatcttagac 
Rev tttggatccccgaactactactgaaagttc
N2 genomic DNA PstI/BamHI
cat-4prom2 Fwd gagagaaagcttcaatcagcccagaaatcgc 
Rev tttggatccgatattatgatgttgatagag
N2 genomic DNA PstI/BamHI
kal-1promA Fwd gagagactgcagatttcgtatttggagc 
Rev gagagaggatcccatgtgctgtaagag
N2 genomic DNA PstI/BamHI
Gene TF cDNA (ng/
µL)
ttx-3::mCherry 
(ng/µL)
rol-6(su1006)  
(ng/µL)
pUC19 (ng/µL) Total concen-
tration (ng/µL)
unc-86 50 50 50 0 150
sem-4 20 50 50 30 150
hlh-3 50 50 50 0 150
egl-46 50 50 50 0 150
ast-1 10 50 50 40 150
egl-18 50 50 50 0 150
Brn2 50 50 50 0 150
Sall2 20 50 50 30 150
Ascl1 50 50 50 0 150
Insm1 50 50 50 0 150
Pet1 10 50 50 40 150
Gata3 50 50 50 0 150
Table 2.17 
Injection mix for rescuing 
experiments using worm and 
mouse orthologue factors
Table 2.18 
Commercial kits used in  
this Thesis
Kit name Source / Reference
QIAprep Spin Miniprep Kit QIAGEN, # 27106
Genelute Mammalian Total RNA kit Sigma, #RTN70-1KT
Quantitec Reverse Transcription Kit QIAGEN, #205311
DNeasy Blood & Tissue Kit QIAGEN, #69504
QIAquick PCR Purification Kit QIAGEN, #28106
Quickchange II XL site-directed  
mutagenesis kit
Agilent Technologies, #200522
both sources to have a wider coverage of orthol-
ogy relationships than using ENSEMBL or (Shaye 
& Greenwald 2011) data alone. Worm genes with-
out any mouse orthologue and genes that were 
not expressed in any worm neuron were removed. 
Whenever a worm gene had more than one mouse 
orthologue, it was duplicated in the worm data set. 
Simple matching coefficient (Sokal & Michener 
1958) was calculated and Principal Coordinate 
Analysis was performed using the dudi.pco func-
tion from the ade4 R package (Dray et al. 2007). 
Finally, to assess which worm cell was closest to 
the mouse raphe nuclei, we calculated the euclid-
ean distance between each of the worm cells and 
each of the raphe nuclei in the space defined by the 
three principal components. As a control, 100 ran-
dom sets of 95 genes (the same number of genes 
that are expressed in the HSN) were generated 
from the worm gene pool, generated with the sam-
ple function of R (The R Team 2016). This data set 
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was merged with mouse raphe nuclei expression 
profile and Principal Coordinate Analysis was per-
formed as before. For hierarchical clustering, the 
same binary matrix containing mouse and worm 
expression data was fed to the pvclust function in 
the pvclust R package (Suzuki & Shimodaira 2006), 
which uses a bootstrapping technique to calcu-
late p-values for each cluster, the AU and BP values 
(Shimodaira 2002). Parameters were set as follows: 
method.hclust = ‘average’, method.dist= ‘binary’, 
nboot = 10000, r = seq(0.5, 1.4, by=0.1). The stand-
ard error of the PV and AU values was approximate-
ly 0.1% for most clusters, including the HSN-raphe 
cluster. 
Materials
This section includes detailed information on rele-
vant reagents, solutions, apparatus and software 
used in this Thesis.
Nematode Growth Media
The NGM agar contains NaCl (3 gL-1), agar (17 gL-1), 
peptone (2.5 gL-1), CaCl₂ (1M, 1 mL L-1), MgSO₄ (1M, 
1 mL L-1), KH₂PO₄ buffer (1M, pH=6.0, 25 mL L-1), cho-
lesterol (5 mg mL-1 in ethanol 95%, 1mL L-1), Milli-Q 
water (Merck Millipore) water and nystatin (Sigma), 
to prevent fungal and bacterial contamination.
M9 Buffer
The M9 buffer is used at 1X to collect worms from 
agar plates and to grow worms without food. M9 
10X is prepared with the following components: 
Na₂HPO₄ × 12H₂O (146g L-1), KH₂PO₄ (30G L-1), 
NaCl (5g L-1) and NH₄Cl (10g L-1).
Worm Lysis Solution
This solution, after the addition of Proteinase K, is 
used to disaggregate the worms and obtain genom-
ic DNA. It is stored at 4 °C and its components are: 
KCl (50 mM), Tris-HCl (10 mM, pH 8.3), MgCl₂ (2.5 
mM), Triton X-100 (0.45% (v/v), Sigma), Tween 20 
(0.45% (v/v), Sigma).
Gibson Assembly Reagents Gibson Assembly 
Master Mix (2X)
The Isothermal Start Mix is prepared with 1.5 g 
Poliethinelglycol 8000 (Promega, #V3011), 3 mL 
1 M Tris-HCl, pH 8.0 (Sigma, # T3253) and 150 µl 
2 M MgCl₂ (Sigma, #M8266) in a volume of 3150 µL.
The Gibson Assembly Master Mix (2X) consists 
of 405 µl Isothermal Start Mix (RT) (described 
above), 25 µl 1 M DTT (4°C) (Sigma, #GE17-1318-
01), 50 µl 10 mM dNTPs (−20°C) (Labclinics, #GC-
013-001), 50 µl NAD (−80°C) (NEB, # B9007S),
1 µl T5 exonuclease (−20°C) (10 U/µl) (NEB,
#M0363S), 31.25 µl Phusion High Fidelity DNA
Polymerse, (2 U/µl) (−20 °C) (NEB #M0530S), 250 µl
Taq Ligase (40 U/µl) (NEB, #M0208L) and 437.75 µl
H₂O, to a final volume of 1250 µl. This mix is aliquot-
ed and stored at −20 °C.
Egg Preparation Solution (Egg Prep)
The Egg Prep solution is used to synchronise large 
worm populations. It consists of 1.2 mL NaClO 
(commercial bleach), 2.5 mL NaOH (1 M) and 6.3 mL 
ddH₂0.
Drop bleach
The Drop Bleach solution is used to kill sensible 
bacteria or fungi that frequently contaminate worm 
plates. It is prepared with 500 µL NaClO (commer-
cial bleach), 200 µL NaOH (5 M) and 300 µL ddH₂0.
Plasmid name Description Source / Reference
pPD95.75 gfp vector used for promoter standard cloning and fusion 
PCR (Dr. Fire laboratory).
Addgene #1494
pRF4 rol-6(su1006) vector, used as co-marker in worm 
microinjection (Dr. Fire laboratory).
(Mello et al., 1991)
pET-21b Expression vector used for cloning for EMSA experiments. EMD Millipore, kindly provided  
by Dr. Hobert laboratory
pNF17 ast-1 cDNA-pCDNA3.1, used in EMSA experiments. This work
pET-21b-ast-1 Vector containing an ast-1 probe for EMSA experiments. This work
pET-21b-unc-86 Vector containing an unc-86 probe for EMSA experiments. (Zhang et al. 2014)
pCDNA3-egl-18 Vector containing an egl-18 probe for EMSA experiments. This work
pPD129.36 Also known as L4440, this vector is used as negative 
control in RNAi experiments.
Addgene, #1654
pNF303 egl-46prom::NLS::DsRed in pPD96.04. Transcriptional 
reporter for egl-46, used in cross-regulation analysis.
This work
pJJR82 GFP-Self-Excising-Cassette vector, used for CRISPR 
genome engineering strategies.
Addgene #75027, kindly provided  
by Dr. Boxem
pDD162 sgRNA/Cas9 containing vector, used for CRISPR genome 
engineering strategies.
Addgene #4754, kindly provided  
by Dr. Boxem
pCFJ90 Pmyo-2::mCherry; pharyngeal co-injection marker used in 
CRISPR/Cas9 GFP knock-in.
Addgene #19328, kindly provided  
by Dr. Boxem
pPD49.78 hsp-16.2 (heat shock promoter) vector used in 
transcription factor overexpression experiments.
Addgene #1447
pPD49.83 hsp-16.2 (heat shock promoter) vector used in 
transcription factor overexpression experiments.
Addgene #1448
pNF101 ttx-3prom::mCherry, used as co-marker in overexpression 
and rescuing experiments.
(Bertrand and Hobert, 2009)
pNF197 hsp-16.2::unc-86 genomic, used to ectopically express 
unc-86 in the worm.
This work
pNF204 hsp-16.2::sem-4 cDNA, used to ectopically express sem-4 
in the worm.
This work
pNF283 hsp-16.2::hlh-3 cDNA, used to ectopically express hlh-3 in 
the worm.
This work
Table 2.19 
Plasmids used in this Thesis
↳
pNF284 hsp-16.2::egl-46 cDNA, used to ectopically express egl-46 
in the worm.
This work
pNF314 hsp-16.2::egl-18 cDNA, used to ectopically express egl-18 
in the worm.
This work
Pet1 Vector containing the cDNA of the mouse gene Pet1, used 
for generating new plasmids for rescuing experiments.
Source BioScience, #8861455
Brn2 Vector containing the cDNA of the mouse gene Brn2, used 
for generating new plasmids for rescuing experiments.
Addgene, #27151
Sall2 Vector containing the cDNA of the mouse gene Sall2, used 
for generating new plasmids for rescuing experiments.
OpenBiosystems, #5706710
Gata3 Vector containing the cDNA of the mouse gene Gata3, used 
for generating new plasmids for rescuing experiments.
Source BioScience, #6826352
pNF104 bas-1prom1::ast-1 cDNA, used to rescue tph-1 defects  
in HSN.
This work
pNF391 kal-1promA:: unc-86 genomic, used to rescue tph-1 defects 
in HSN.
This work
pNF395 kal-1promA:: sem-4 cDNA, used to rescue tph-1 defects  
in HSN.
This work
pNF370 cat-4prom2:: hlh-3 cDNA, used to rescue tph-1 defects  
in HSN.
This work
pNF371 cat-4prom2:: egl-46 cDNA, used to rescue tph-1 defects  
in HSN.
This work
pNF372 cat-4prom2:: egl-18 cDNA, used to rescue tph-1 defects  
in HSN.
This work
pNF185 bas-1prom1:: Pet1 cDNA, used to rescue tph-1 defects  
in HSN.
This work
pNF397 kal-1promA:: Brn2 cDNA, used to rescue tph-1 defects  
in HSN.
This work
pNF384 kal-1promA:: Sall2 cDNA, used to rescue tph-1 defects in 
HSN.
This work
pNF380 cat-4prom2:: Ascl1 cDNA, used to rescue tph-1 defects  
in HSN.
This work
pNF385 cat-4prom2:: Insm1 cDNA, used to rescue tph-1 defects  
in HSN.
This work
pNF383 cat-4prom2:: Gata3 cDNA, used to rescue tph-1 defects  
in HSN.
This work
pUC19 Empty vector used as filler DNA in worm microinjection 
mixes.
Addgene, #50005
Table 2.20 
Living organisms used in 
this Thesis
Strain name Description Source / Reference
OP50 Escherichia coli strain used to feed worms. CGC
HT115 Escherichia coli strain used to feed worms exclusively in 
RNAi experiments.
CGC
TOP10 Escherichia coli electrocompetent cells, used to transform 
and amplify plasmids.
Invitrogen, # C404010
Rosetta2(DE3) Escherichia coli Rosetta2(DE3), used to transform pET-21b 
His tag expression vector.
Novagen, #71400
HEK293T human cells Transfected with egl-18-pcDNA.3 vector in EMSA 
experiments.
ATCC: CRL-3216, kindly provided  
by Dr. Hobert
C57Bl/6JRccHsd  
mouse strain
Used for the expression analysis of the new mouse 
serotonergic candidates.
ATCC: CRL-3216, kindly provided  
by Dr. Hobert
Table 2.21 
Worm strains used in this 
Thesis 
Strains are listed in order of 
appearance in the Results 
section.
Chapter I — Cis-regulatory analysis of the 5-HT pathway genes (Figure 3.1.3)
Strain name Genotype Source
N2 Caenorhabditis elegans wild type strain CGC
NFB343 vlcEx135[tph-1prom1::gfp, rol-6(su1006)] This work
NFB345 vlcEx137[tph-1prom1::gfp, rol-6(su1006)] This work
No name tph-1prom1 Line 3 This work
NFB133 vlcEx32[tph-1prom8::gfp, rol-6(su1006)] This work
NFB134 vlcEx33[tph-1prom8::gfp, rol-6(su1006)] This work
NFB135 vlcEx34[tph-1prom8::gfp, rol-6(su1006)] This work
NFB70 vlcEx1[tph-1prom2::gfp, rol-6(su1006)] This work
NFB71 vlcEx2[tph-1prom2::gfp, rol-6(su1006)] This work
NFB72 vlcEx3[tph-1prom2::gfp, rol-6(su1006)] This work
No name tph-1prom2 Line 4 This work
↲
↳
094 095
No name tph-1prom2 Line 5 This work
No name tph-1prom2 Line 6 This work
No name tph-1prom6 Line 1 This work
No name tph-1prom6 Line 2 This work
NFB137 vlcEx36[tph-1prom5::gfp, rol-6(su1006)] This work
NFB138 vlcEx37[tph-1prom5::gfp, rol-6(su1006)] This work
NFB139 vlcEx38[tph-1prom5::gfp, rol-6(su1006)] This work
NFB73 vlcEx4[tph-1prom3::gfp, rol-6(su1006)] This work
NFB74 vlcEx5[tph-1prom3::gfp, rol-6(su1006)] This work
No name tph-1prom3 Line 3 This work
No name tph-1prom3 Line 4 This work
NFB75 vlcEx6[tph-1prom17::gfp, rol-6(su1006)] This work
NFB76 vlcEx7[tph-1prom17::gfp, rol-6(su1006)] This work
NFB77 vlcEx8[tph-1prom17::gfp, rol-6(su1006)] This work
OH4194 otEx2433[bas-1prom1::gfp, rol6(su1006)] This work
OH4196 otEx2435[bas-1prom1::gfp, rol6(su1006)] This work
OH4198 otEx2437[bas-1prom2::gfp, rol6(su1006)] This work
OH4200 otEx2439[bas-1prom2::gfp, rol6(su1006)] This work
OH8681 bas-1prom13 Line 1 This work
OH8682 bas-1prom13 Line 2 This work
OH8684 bas-1prom14 Line 1 This work
NFB149 vlcEx48[bas-1prom15::gfp, rol6(su1006)] This work
NFB150 vlcEx49[bas-1prom15::gfp, rol6(su1006)] This work
NFB151 vlcEx50[bas-1prom15::gfp, rol6(su1006)] This work
NFB136 vlcEx35[bas-1prom16::gfp, rol6(su1006)] This work
No name bas-1prom17 Line 1 This work
No name bas-1prom17 Line 2 This work
NFB117 vlcEx16[bas-1prom18::gfp, rol6(su1006)] This work
NFB118 vlcEx17[bas-1prom18::gfp, rol6(su1006)] This work
NFB307 vlcEx161[bas-1prom18::gfp, rol6(su1006)] This work
NFB308 vlcEx162[bas-1prom18::gfp, rol6(su1006)] This work
OH4261 otEx2476[bas-1prom3::gfp, rol6(su1006)] This work
OH4263 otEx2478[bas-1prom3::gfp, rol6(su1006)] This work
OH4812 otEx2806[bas-1prom4::gfp, rol6(su1006)] This work
OH4814 otEx2808[bas-1prom4::gfp, rol6(su1006)] This work
NFB206 vlcEx84[bas-1prom5::gfp, rol6(su1006)] This work
NFB207 vlcEx85[bas-1prom5::gfp, rol6(su1006)] This work
NFB208 vlcEx86[bas-1prom5::gfp, rol6(su1006)] This work
No name bas-1prom6 Line 1 This work
No name bas-1prom6 Line 2 This work
NFB116 vlcEx15[bas-1prom7::gfp, rol6(su1006)] This work
NFB120 vlcEx19[bas-1prom7::gfp, rol6(su1006)] This work
NFB121 vlcEx20[bas-1prom7::gfp, rol6(su1006)] This work
OH4209 otEx2448[cat-1prom1::gfp, rol-6(su1006)] This work
OH4208 otEx2447[cat-1prom1::gfp, rol-6(su1006)] This work
No name cat-1prom1 Line 3 This work
OH4217 otEx2455[cat-1prom2::gfp, rol-6(su1006)] This work
OH4218 otEx2456[cat-1prom2::gfp, rol-6(su1006)] This work
OH4219 otEx2457[cat-1prom3::gfp, rol-6(su1006)] This work
OH4228 otEx2460[cat-1prom3::gfp, rol-6(su1006)] This work
OH7435 otEx3249[cat-1prom12::gfp, rol-6(su1006)] This work
OH7436 otEx3250[cat-1prom12::gfp, rol-6(su1006)] This work
NFB236 vlcEx111[cat-1prom11::gfp, rol6(su1006)] This work
NFB237 vlcEx112[cat-1prom11::gfp, rol6(su1006)] This work
NFB241 vlcEx116[cat-1prom35::gfp, rol6(su1006)] This work
NFB242 vlcEx117[cat-1prom35::gfp, rol6(su1006)] This work
↳
↳
096 097
OH7502 otEx3299[cat-4prom6::gfp, rol-6(su1006)] This work
NFB280 vlcEx143[cat-4prom8::gfp, rol-6(su1006)] This work
NFB281 vlcEx144[cat-4prom8::gfp, rol-6(su1006)] This work
NFB332 vlcEx177[cat-4prom58::gfp, rol-6(su1006)] This work
NFB333 vlcEx178[cat-4prom58::gfp, rol-6(su1006)] This work
No name cat-4prom58 Line 3 This work
NFB340 vlcEx182[cat-4prom59::gfp, rol-6(su1006)] This work
NFB341 vlcEx183[cat-4prom59::gfp, rol-6(su1006)] This work
No name cat-4prom59 Line 3 This work
OH6005 otEx2996[cat-4prom9::gfp, rol-6(su1006)] This work
OH6006 otEx2997[cat-4prom9::gfp, rol-6(su1006)] This work
OH6007 otEx2998[cat-4prom9::gfp, rol-6(su1006)] This work
NFB210 vlcEx88[cat-4prom18::gfp, rol-6(su1006)] This work
NFB211 vlcEx89[cat-4prom18::gfp, rol-6(su1006)] This work
NFB212 vlcEx90[cat-4prom18::gfp, rol-6(su1006)] This work
NFB262 lin-15B(n765)X;  
vxIs97[tph-1p::DsRed + lin15(+)];  
vlcEx97[cat-4prom19::gfp,  
rol-6(su1006)] 
This work
NFB263 lin-15B(n765)X;  
vxIs97[tph-1p::DsRed + lin15(+)];  
vlcEx98[cat-4prom19::gfp, rol-6(su1006)]
This work
NFB181 vlcEx67[cat-4prom27::gfp, rol-6(su1006)] This work
NFB196 vlcEx68[cat-4prom27::gfp, rol-6(su1006)] This work
NFB197 vlcEx69[cat-4prom27::gfp, rol-6(su1006)] This work
NFB636 vlcEx344[mod-5prom1::gfp, rol-6(su1006)] This work
NFB637 vlcEx345[mod-5prom1::gfp, rol-6(su1006)] This work
No name mod-5prom1 Line 3 This work
NFB593 vlcEx321[mod-5prom3::gfp, rol-6(su1006)] This work
NFB594 vlcEx322[mod-5prom3::gfp, rol-6(su1006)] This work
NFB638 vlcEx346[mod-5prom8::gfp, rol-6(su1006)] This work
NFB243 vlcEx118[cat-1prom35::gfp, rol6(su1006)] This work
No name cat-1prom36 Line 1 This work
No name cat-1prom36 Line 2 This work
NFB244 vlcEx119[cat-1prom37::gfp, rol6(su1006)] This work
NFB245 vlcEx120[cat-1prom37::gfp, rol6(su1006)] This work
NFB246 vlcEx121[cat-1prom37::gfp, rol6(su1006)] This work
OH6000 otEx2991[cat-1prom13::gfp, rol-6(su1006)] This work
OH6001 otEx2992[cat-1prom13::gfp, rol-6(su1006)] This work
OH6002 otEx2993[cat-1prom13::gfp, rol-6(su1006)] This work
OH7443 otEx3257[cat-1prom14::gfp, rol-6(su1006)] This work
OH7506  otEx3303[cat-1prom14::gfp, rol-6(su1006)] This work
OH7508 otEx3305[cat-1prom14::gfp, rol-6(su1006)] This work
NFB291 vlcEx149[cat-1prom14::gfp, rol6(su1006)] This work
NFB292 vlcEx150[cat-1prom14::gfp, rol6(su1006)] This work
NFB293 vlcEx151[cat-1prom14::gfp, rol6(su1006)] This work
NFB180 vlcEx66[cat-1prom26::gfp, rol6(su1006)] This work
NFB201 vlcEx79[cat-1prom26::gfp, rol6(su1006)] This work
NFB202 vlcEx80[cat-1prom26::gfp, rol6(su1006)] This work
NFB238 vlcEx113[cat-1prom27::gfp, rol6(su1006)] This work
NFB239 vlcEx114[cat-1prom27::gfp, rol6(su1006)] This work
NFB240 vlcEx115[cat-1prom27::gfp, rol6(su1006)] This work
OH4753 otEx2760[cat-4prom4::gfp, rol-6(su1006)] This work
OH4754 otEx2761[cat-4prom4::gfp, rol-6(su1006)] This work
OH4755 otEx2762[cat-4prom4::gfp, rol-6(su1006)] This work
OH4852 otEx2829[cat-4prom5::gfp, rol-6(su1006)] This work
OH4853 otEx2830[cat-4prom5::gfp, rol-6(su1006)] This work
OH7500 otEx3297[cat-4prom6::gfp, rol-6(su1006)] This work
OH7501 otEx3298[cat-4prom6::gfp, rol-6(su1006)] This work
↳
↳
098 099
NFB639 vlcEx347[mod-5prom8::gfp, rol-6(su1006)] This work
No name mod-5prom8 Line 3 This work
NFB574 vlcEx315[mod-5prom6::gfp, rol-6(su1006)] This work
NFB575 vlcEx316[mod-5prom6::gfp, rol-6(su1006)] This work
No name mod-5prom6 Line 3 This work
Chapter II — Loss of function mutant analysis (Figures 3.2.2-3.2.6, 3.4.3)
Strain name Genotype Source
JR2370 egl-18(ok290)IV CGC, (Koh et al. 2002)
VC271 end-1&ric-7(ok558)V CGC, 
(Maduro et al. 2005)
TB528 ceh-14(ch3)X CGC, 
(Cassata et al. 2000)
MT633 lin-11(n389)I; him-5(e1467)V CGC, (Trent et al. 1983)
MK4013 zdIs13(tph-1::gfp)IV (Clark & Chiu 2003)
GR1333 yzIs71[tph-1::gfp, rol-6(su1006)]V (Sze et al. 2000)
OH8777 ast-1(ot417)II; zdIs13(tph-1::gfp)IV Dr. Hobert Lab.
OH9423 unc-86(n846)III; zdIs13(tph-1::gfp)IV Dr. Hobert Lab.
OH11963 sem-4(n1971)I; zdIs13(tph-1::gfp)IV Dr. Hobert Lab.
NFB471 hlh-3(tm1688)II; zdIs13(tph-1::gfp)IV This work
NFB477 egl-46(sy628)V; zdIs13(tph-1::gfp)IV This work
NFB683 egl-18(ok290)IV; yzIs71[tph-1::gfp,  
rol-6(su1006)]V
This work
NFB730 end-1&ric-7(ok558)V; zdIs13(tph-1::gfp)IV This work
OH8246 otIs221(cat-1::gfp)III (Flames & Hobert 
2009)
OH8249 otIs224(cat-1::gfp)V (Flames & Hobert 
2009)
OH8772 ast-1(ot417)II; otIs221(cat-1::gfp)III (Flames & Hobert 
2009)
OH10603 unc-86(n846)III; otIs224(cat-1::gfp)V Dr. Hobert Lab.
NFB60 ast-1(hd92)II; vlcEx845[ast-1(+), cat-1::DsRed]; 
otIs221(cat-1::gfp)III
This work
OH11909 sem-4(n1971)I; otIs221(cat-1::gfp)III Dr. Hobert Lab.
NFB489 hlh-3(tm1688)II; otIs221(cat-1::gfp)III This work
NFB478 egl-46(sy628)V; otIs221(cat-1::gfp)III This work
NFB687 egl-18(ok290)IV; otIs221(cat-1::gfp)III This work
NFB733 end-1&ric-7(ok558)V; otIs221[cat-1::gfp]III This work
NFB926 lin-11 (n389)I; ceh-14 (ch3) X;  
otIs221(cat-1::gfp)III; him-5 (e1467)V
This work
OH4255 otEx2470[cat-4::gfp(50ng/ul), rol-6(su1006)] (Flames & Hobert 
2009)
OH8250 otIs225(cat-4::gfp)II (Flames & Hobert 
2009)
NFB83 ast-1(ot417)II; otEx2470[cat-4::gfp (50ng/ul), 
rol-6(su1006)]
This work
OH10918 unc-86(n846)III; otIs225(cat-4::gfp)II Dr. Hobert Lab.
OH11962 sem-4(n1971)I; otIs225(cat-4::gfp)II Dr. Hobert Lab.
NFB472 hlh-3(tm1688)II; otEx2470[cat-4::gfp (50ng/ul), 
rol-6(su1006)]
This work
NFB479 egl-46(sy628)V; otIs225(cat-4::gfp)II This work
NFB685 egl-18(ok290)IV; otIs225(cat-4::gfp)II This work
NFB732 end-1&ric-7(ok558)V; otIs225[cat-4::gfp]II This work
OH8251 otIs226(bas-1::gfp)IV (Flames & Hobert 
2009)
OH4196 otEx2435[bas-1::gfp(50ng/ul), rol-6(su1006)] (Flames & Hobert 
2009)
OH10562 ast-1(ot417)II; otIs226(bas-1::gfp)IV (Flames & Hobert 
2009)
NFB159 ast-1(hd92); vlcEx844[ast-1(+), cat-1::DsRed]; 
otIs226(bas-1::gfp)IV
This work
NFB160 ast-1(hd92); vlcEx845[ast-1(+), cat-1::DsRed]; 
otIs226(bas-1::gfp)IV
This work
OH10607 unc-86(n846)III; otIs226(bas-1::gfp)IV Dr. Hobert Lab.
OH11910 sem-4(n1971)I; otIs226(bas-1::gfp)IV Dr. Hobert Lab.
NFB455 hlh-3(tm1688)II; otIs226(bas-1::gfp)IV This work
NFB536 egl-46(sy628)V; otIs226(bas-1::gfp)IV This work
NFB715 egl-18(ok290)IV; otEx2435[bas-1::gfp (50ng/ul), 
rol-6(su1006]
This work
NFB731 end-1&ric-7(ok558)V; otIs226(bas-1::gfp)IV This work
LX1376 vsEx580[kcc-2c::gfp, myo-2::gfp] CGC, 
(Tanis et al. 2009)
NFB47 ast-1(ot417)II; vsEx580[kcc-2c::gfp, myo-2::gfp] This work
↳
↳
100 101
NFB153 unc-86(n846)III; vsEx580[kcc-2c::gfp,  
myo-2::gfp]
This work
NFB152 sem-4(n1971)I; vsEx580[kcc-2c::gfp,  
myo-2::gfp]
This work
NFB510 hlh-3(tm1688)II; vsEx580[kcc-2c::gfp,  
myo-2::gfp]
This work
NFB511 egl-46(sy628)V; vsEx580[kcc-2c::gfp,  
myo-2::gfp]
This work
NFB1029 egl-18(ok290)IV; vsEx580[kcc-2c::gfp,  
myo-2::gfp]
This work
QW84 zfIs4(lgc-55::mCherry) CGC, 
(Pirri et al. 2009)
QW122 zfIs6(lgc-55::gfp)II CGC, 
(Pirri et al. 2009)
NFB187 ast-1(ot417)II; zfIs4(lgc-55::mCherry) This work
NFB448 unc-86(n846)III; zfIs6(lgc-55::gfp)II This work
NFB156 sem-4(n1971)I; zfIs6(lgc-55::gfp)II This work
NFB473 hlh-3(tm1688)II; zfIs4(lgc-55::mCherry) This work
NFB526 egl-46(sy628)V; zfIs6(lgc-55::gfp)II This work
NFB996 egl-18(ok290)IV; zfIs6(lgc-55::gfp)II This work
BL5752 inIs181(ida-1::gfp); inIs182(ida-1::gfp) CGC, 
(Zahn et al. 2004)
BL5717 inIs179(ida-1::gfp)II CGC, 
(Zahn et al. 2004)
NFB259 ast-1(ot417)II; inIs181(ida-1::gfp);  
inIs182(ida-1::gfp)
This work
NFB42 unc-86(n846)III; inIs179(ida-1::gfp)II This work
NFB155 sem-4(n1971)I; inIs179(ida-1::gfp)II This work
NFB539 hlh-3(tm1688)II; inIs181(ida-1::gfp);  
inIs182(ida-1::gfp)
This work
NFB538 egl-46(sy628)V; inIs179(ida-1::gfp)II This work
NFB1405 egl-18(ok290)IV; inIs179(ida-1::gfp)II This work
RJP255 ynIs34(flp-19::gfp)IV CGC, (Kim & Li 2004)
NFB39 ast-1(ot417)II; ynIs34(flp-19::gfp)IV;  
him-5(e1490)V
This work
NFB38 unc-86(n846)III; ynIs34(flp-19::gfp) IV;  
him-5(e1490)V
This work
NFB157 sem-4(n1971)I; ynIs34(flp-19::gfp) IV;  
him-5(e1490)V
This work
NFB486 hlh-3(tm1688)II; ynIs34(flp-19::gfp) IV This work
NFB518 egl-46(sy628)V; ynIs34(flp-19::gfp) IV This work
OH13083 otIs576(unc-17fosmid::GFP, lin-44::YFP) Dr. Hobert Lab.
NFB844 ast-1(ot417)II; otIs576(unc-17fosmid::GFP,  
lin-44::YFP)
This work
NFB855 unc-86(n846)III; otIs576(unc-17fosmid::GFP, 
lin-44::YFP); him-5(e1490)V
This work
NFB891 sem-4(n1971)I; otIs576(unc-17fosmid::GFP,  
lin-44::YFP); him-5(e1490)V
This work
NFB857 hlh-3(tm1688)II; otIs576(unc-17fosmid::GFP, 
lin-44::YFP); him-5(e1490)V
This work
NFB757 egl-46(sy628)V; otIs576(unc-17fosmid::GFP, 
lin-44::YFP)
This work
NFB858 egl-18(ok290)IV; otIs576(unc-17fosmid::GFP, 
lin-44::YFP)
This work
AL132 icIs132(unc-40::gfp) CGC, (Chan et al. 1996)
NFB252 ast-1(ot417)II; icIs132 (unc-40::gfp);  
him-8(e1489)IV
This work
NFB178 unc-86(n846)III; icIs132 (unc-40::gfp);  
him-8(e1489)IV
This work
NFB179 sem-4(n1971)I; icIs132 (unc-40::gfp);  
him-8(e1489)IV
This work
NFB552 hlh-3(tm1688)II; icIs132 (unc-40::gfp);  
him-8(e1489)IV
This work
NFB453 egl-46(sy628)V; icIs132 (unc-40::gfp);  
him-8(e1489)IV
This work
NFB973 egl-18(ok290)IV; icIs132 (unc-40::gfp);  
him-8(e1489)IV
This work
OH9545 otIs287[rab-3::yfp, rol-6(su1006)]IV (Stefanakis et al. 2015)
OH9609 otIs291[rab-3::gfp, rol-6(su1006)] (Stefanakis et al. 2015)
NFB63 ast-1(ot417)II; otIs287[rab-3::yfp,  
rol-6(su1006)]IV
This work
OH9660 unc-86(n846)III; otIs287[rab-3::yfp,  
rol-6(su1006)]IV
Dr. Hobert Lab.
NFB154 sem-4(n1971)I; otIs287[rab-3::yfp,  
rol-6(su1006)]IV
This work
NFB474 hlh-3(tm1688)II; otIs287[rab-3::yfp,  
rol-6(su1006)]IV
This work
NFB537 egl-46(sy628)V; otIs287[rab-3::yfp,  
rol-6(su1006)]IV
This work
NFB1026 egl-18(ok290)IV; otIs291[rab-3::gfp,  
rol-6(su1006)]
This work
BC13535 sIs13247(nlg-1::gfp) CGC, 
(McKay et al. 2003)
NFB251 ast-1(ot417)II; sIs13247(nlg-1::gfp) This work
NFB158 unc-86(n846)III; sIs13247(nlg-1::gfp) This work
NFB250 sem-4(n1971)I; sIs13247(nlg-1::gfp) This work
NFB517 hlh-3(tm1688)II; sIs13247(nlg-1::gfp) This work
NFB633 egl-46(sy628)V; sIs13247(nlg-1::gfp) This work
OH904 otIs33(kal-1::gfp)IV (Bülow et al. 2002)
↳
↳
102 103
NFB819 vlcEx453[kal-1::gfp, ttx-3::mCherry,  
rol-6(su1006)]
This work
NFB45 ast-1(ot417)II; otIs33(kal-1::gfp)IV This work
NFB44 unc-86(n846)III; otIs33(kal-1::gfp)IV This work
NFB186 sem-4(n1971)I; otIs33(kal-1::gfp)IV This work
NFB475 hlh-3(tm1688)II; otIs33(kal-1::gfp)IV This work
NFB480 egl-46(sy628)V; otIs33 (kal-1::gfp)IV This work
NFB686 egl-18(ok290)IV; vlcEx453[kal-1::gfp,  
ttx-3::mCherry, rol-6(su1006)]
This work
Chapter II — Mutagenesis analysis (Figures 3.2.8-3.2.10, 3.4.3)
Strain name Genotype Source
NFB143 vlcEx42[tph-1prom14::gfp, rol-6(su1006)] This work
NFB144 vlcEx43[tph-1prom14::gfp, rol-6(su1006)] This work
NFB145 vlcEx44[tph-1prom14::gfp, rol-6(su1006)] This work
NFB119 vlcEx18[tph-1prom26::gfp, rol-6(su1006)] This work
NFB164 vlcEx54[tph-1prom26::gfp, rol-6(su1006)] This work
NFB165 vlcEx55[tph-1prom31::gfp, rol-6(su1006)] This work
NFB166 vlcEx56[tph-1prom31::gfp, rol-6(su1006)] This work
NFB277 vlcEx140[tph-1prom31::gfp, rol-6(su1006)] This work
NFB278 vlcEx141[tph-1prom31::gfp, rol-6(su1006)] This work
NFB279 vlcEx142[tph-1prom31::gfp, rol-6(su1006)] This work
NFB398 vlcEx226[tph-1prom44::gfp, rol-6(su1006)] This work
NFB399 vlcEx227[tph-1prom44::gfp, rol-6(su1006)] This work
NFB403 vlcEx228[tph-1prom43::gfp, rol-6(su1006)] This work
NFB404 vlcEx229[tph-1prom43::gfp, rol-6(su1006)] This work
NFB999 vlcEx357[tph-1prom54::gfp, rol-6(su1006)] This work
NFB1000 vlcEx358[tph-1prom54::gfp, rol-6(su1006)] This work
No name tph-1prom54 Line 3 This work
NFB1014 vlcEx546[tph-1prom55::gfp, rol-6(su1006)] This work
NFB1015 vlcEx547[tph-1prom55::gfp, rol-6(su1006)] This work
No name tph-1prom55 Line 3 This work
NFB1110 vlcEx614[tph-1prom60::gfp, rol-6(su1006)] This work
NFB1113 vlcEx615[tph-1prom60::gfp, rol-6(su1006)] This work
No name tph-1prom60 Line 3 This work
NFB1025 egl-18(ok290); vlcEx1[tph-1prom2::gfp,  
rol-6(su1006)]
This work
NFB763 vlcEx406[tph-1prom52::gfp, rol-6(su1006)] This work
NFB764 vlcEx407[tph-1prom52::gfp, rol-6(su1006)] This work
No name tph-1prom52 Line 3 This work
OH7443 otEx3257[cat-1prom14::gfp, rol-6(su1006)] This work
OH7506 otEx3303[cat-1prom14::gfp, rol-6(su1006)] This work
OH7508 otEx3305[cat-1prom14::gfp, rol-6(su1006)] This work
NFB291 vlcEx149[cat-1prom14::gfp, rol-6(su1006)] This work
NFB292 vlcEx150[cat-1prom14::gfp, rol-6(su1006)] This work
NFB293 vlcEx151[cat-1prom14::gfp, rol-6(su1006)] This work
NFB379 vlcEx212[cat-1prom63::gfp, rol-6(su1006)] This work
NFB380 vlcEx213[cat-1prom63::gfp, rol-6(su1006)] This work
NFB381 vlcEx214[cat-1prom63::gfp, rol-6(su1006)] This work
NFB354 vlcEx194[cat-1prom61::gfp, rol-6(su1006)] This work
NFB355 vlcEx195[cat-1prom61::gfp, rol-6(su1006)] This work
No name cat-1prom61 Line 3 This work
NFB330 vlcEx175[cat-1prom60::gfp, rol-6(su1006)] This work
NFB331 vlcEx176[cat-1prom60::gfp, rol-6(su1006)] This work
NFB457 vlcEx259[cat-1prom73::gfp, rol-6(su1006)] This work
NFB460 vlcEx262[cat-1prom73::gfp, rol-6(su1006)] This work
NFB411 vlcEx236[cat-1prom71::gfp, rol-6(su1006)] This work
NFB412 vlcEx237[cat-1prom71::gfp, rol-6(su1006)] This work
↳
↳
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NFB501 vlcEx277[cat-1prom71::gfp, rol-6(su1006)] This work
NFB502 vlcEx278[cat-1prom71::gfp, rol-6(su1006)] This work
NFB528 vlcEx292[cat-1prom74::gfp, rol-6(su1006)] This work
NFB529 vlcEx293[cat-1prom74::gfp, rol-6(su1006)] This work
No name cat-1prom74 Line 3 This work
NFB458 vlcEx260[cat-1prom75::gfp, rol-6(su1006)] This work
NFB459 vlcEx260[cat-1prom75::gfp, rol-6(su1006)] This work
No name cat-1prom75 Line 3 This work
NFB557 vlcEx302[cat-1prom76::gfp, rol-6(su1006)] This work
NFB558 vlcEx303[cat-1prom76::gfp, rol-6(su1006)] This work
OH4219 otEx2457[cat-1prom3::gfp, rol-6(su1006)] This work
OH4228 otEx2460[cat-1prom3::gfp, rol-6(su1006)] This work
NFB773 vlcEx410[cat-1prom83::gfp, rol-6(su1006)] This work
NFB774 vlcEx411[cat-1prom83::gfp, rol-6(su1006)] This work
No name cat-1prom83 Line 3 This work
NFB721 vlcEx387[cat-1prom79::gfp, rol-6(su1006)] This work
NFB722 vlcEx388[cat-1prom79::gfp, rol-6(su1006)] This work
No name cat-1prom79 Line 3 This work
NFB577 egl-46(sy628)V;  
otEx3257[cat-1prom14::gfp, rol-6(su1006)]
This work
NFB1027 egl-18(ok290)IV;  
otEx3257[cat-1prom14::gfp, rol-6(su1006)]
This work
NFB423 vlcEx241[bas-1prom73::gfp, rol6(su1006)] This work
NFB424 vlcEx242[bas-1prom73::gfp, rol6(su1006)] This work
No name bas-1prom73 Line 3 This work
No name bas-1prom71 Line 1 This work
NFB408 vlcEx233[bas-1prom71::gfp, rol-6(su1006)] This work
No name bas-1prom71 Line 3 This work
NFB282 vlcEx145[bas-1prom65::gfp, rol-6(su1006)] This work
NFB283 vlcEx146[bas-1prom65::gfp, rol-6(su1006)] This work
NFB284 vlcEx147[bas-1prom65::gfp, rol-6(su1006)] This work
NFB711 vlcEx382[bas-1prom78::gfp, rol-6(su1006)] This work
NFB712 vlcEx383[bas-1prom78::gfp, rol-6(su1006)] This work
No name bas-1prom78 Line 3 This work
NFB663 vlcEx354[bas-1prom77::gfp, rol-6(su1006)] This work
NFB664 vlcEx355[bas-1prom77::gfp, rol-6(su1006)] This work
NFB661 vlcEx352[bas-1prom76::gfp, rol-6(su1006)] This work
NFB662 vlcEx353[bas-1prom76::gfp, rol-6(su1006)] This work
NFB840 vlcEx465[bas-1prom83::gfp, rol-6(su1006)] This work
NFB841 vlcEx466[bas-1prom83::gfp, rol-6(su1006)] This work
No name bas-1prom83 Line 3 This work
NFB878 vlcEx476[bas-1prom84::gfp, rol-6(su1006)] This work
NFB900 vlcEx487[bas-1prom84::gfp, rol-6(su1006)] This work
NFB920 vlcEx494[bas-1prom86::gfp, rol-6(su1006)] This work
NFB921 vlcEx495[bas-1prom86::gfp, rol-6(su1006)] This work
No name bas-1prom86 Line 3 This work
NFB735 ast-1(ot417)II; vlcEx16[bas-1prom18::gfp,  
rol-6(su1006)]
This work
NFB837 ast-1(ot417)II; vlcEx382[bas-1prom78::gfp,  
rol-6(su1006)]
This work
↳
106 107
Chapter II — Cross-regulation analysis (Figures 3.2.14-3.2.15)
Strain name Genotype Source
OH10425 otIs337(unc-86fosmid::NLS::YFP::H2B; 
ttx-3::mCherry)
(Zhang et al. 2014)
VH1195 hdIs42 [ast-1::YFP, rol-6(su1006)] (Schmid et al. 2006)
NFB1369 ast-1(vlc19[ast-1::gfp])II This work
OP57 unc-119(eds)III; wgIs57[sem-4TY1::EGFP::3XFLA
G(92C12)+unc-119(+)]
CGC, 
(Sarov et al. 2012)
MH1337 kuIs34(sem-4::gfp)IV CGC, 
(Grant et al. 2000)
MH1346 kuIs35(sem-4::gfp) CGC, 
(Grant et al. 2000)
RW11606 unc-119(tm4063)III;  
stIs11606[egl-18a::H1-mCherry + unc-119(+)]
CGC, 
Dr. Waterston Lab
NFB608 vlcEx324[egl-46::DsRed; ttx-3::mCherry; 
 rol-6(su1006)]
This work
OH9345 otEx4140[hlh-3fosmid::YFP, rol-6(su1006)] (Murgan et al. 2015)
OP650 unc-119(tm4063)III;  
wgIs650[hlh-3::TY1::EGFP::3XFLAG  
+ unc-119(+)]
CGC,  
(Sarov et al. 2006)
NFB62 ast-1(ot417)II;  
otIs337(unc-86fosmid::NLS::YFP::H2B, 
ttx-3::mCherry)
This work
NFB100 ast-1(hd92)II;  
otIs337(unc-86fosmid::NLS::YFP::H2B,  
ttx-3::mCherry)
This work
NFB189 sem-4(n1971)I;  
otIs337(unc-86fosmid::NLS::YFP::H2B,  
ttx-3::mCherry)
This work
NFB476 hlh-3(tm1688)II;  
otIs337(unc-86fosmid::NLS::YFP::H2B,  
ttx-3::mCherry)
This work
NFB481 egl-46(sy628)V; otIs337(unc-
86fosmid::NLS::YFP::H2B, ttx-3::mCherry)
This work
NFB843 egl-18(ok290)IV; otIs337(unc-
86fosmid::NLS::YFP::H2B, ttx-3::mCherry)
This work
NFB1375 unc-86(n846)III; ast-1(vlc19[ast-1::gfp])II This work
NFB1381 sem-4(n1971)I; ast-1(vlc19[ast-1::gfp])II This work
NFB1377 hlh-3(tm1688)II; ast-1(vlc19[ast-1::gfp])II This work
NFB1379 egl-46(sy628)V; ast-1(vlc19[ast-1::gfp])II This work
NFB1383 egl-18(ok290)IV; ast-1(vlc19[ast-1::gfp])II This work
NFB962 ast-1(ot417)II; kuIs34(sem-4::gfp)IV This work
NFB173 ast-1(hd92)II; kuIs34(sem-4::gfp)IV This work
NFB190 unc-86(n846)III; kuIs34(sem-4::gfp)IV This work
NFB516 hlh-3(tm1688)II; kuIs34(sem-4::gfp)IV This work
NFB525 egl-46(sy628)V; kuIs34(sem-4::gfp)IV This work
NFB1300 egl-18(ok290)IV; kuIs35(sem-4::gfp) This work
NFB754 ast-1(ot417)II;  
stIs11606[egl-18a::H1-mCherry + unc-119(+)]
This work
NFB997 ast-1(hd92)II; hdEx237[ast-1(+),  
rol-6(su1006)]; unc-119(tm4063)III; 
stIs11606[egl-18a::H1-mCherry + unc-119(+)]
This work
NFB688 unc-86(n846)III; 
stIs11606[egl-18a::H1-mCherry + unc-119(+)]
This work
NFB430 sem-4(n1971)I; 
stIs11606[egl-18a::H1-mCherry + unc-119(+)]
This work
NFB607 hlh-3(tm1688)II; 
stIs11606[egl-18a::H1-mCherry + unc-119(+)]
This work
NFB419 egl-46(sy628)V; 
stIs11606[egl-18a::H1-mCherry + unc-119(+)]
This work
NFB717 ast-1(ot417)II; vlcEx324[egl-46::DsRed; 
ttx-3::mCherry; rol-6(su1006)]
This work
NFB930 ast-1(hd92)II; hdEx237[ast-1(+), 
rol-6(su1006)]; vlcEx324[egl-46::DsRed; 
ttx-3::mCherry; rol-6(su1006)]
This work
NFB652 unc-86(n846)III; vlcEx324[egl-46::DsRed; 
ttx-3::mCherry; rol-6(su1006)]
This work
NFB720 sem-4(n1971)I; zdIs13(tph-1::gfp)IV; 
vlcEx324[egl-46::DsRed; ttx-3::mCherry; 
rol-6(su1006)]
This work
NFB651 hlh-3(tm1688)II; vlcEx324[egl-46::DsRed; 
ttx-3::mCherry; rol-6(su1006)]
This work
NFB871 egl-18(ok290)IV; vlcEx324[egl-46::DsRed; 
ttx-3::mCherry; rol-6(su1006)]
This work
NFB584 ast-1(hd92)II; otEx4140[hlh-3fosmid::YFP,  
rol-6(su1006)]
This work
NFB583 unc-86(n846)III; otEx4140[hlh-3fosmid::YFP, 
rol-6(su1006)]
This work
NFB586 sem-4(n1971)I; otEx4140[hlh-3fosmid::YFP, 
rol-6(su1006)]
This work
NFB969 egl-46(sy628)V; otEx4140[hlh-3fosmid::YFP, 
rol-6(su1006)]
This work
NFB1299 egl-18(ok290)IV; otEx4140[hlh-3fosmid::YFP, 
rol-6(su1006)]
This work
NFB188 ast-1(hd92)II; zdIs13(tph-1::gfp)IV;  
hdIs42 [ast-1::YFP, rol-6(su1006)]0
This work
LX960 lin-15B(n765);  
vsIs97[tph-1p::DsRed + lin-15(+)]
(Tanis et al. 2008)
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Chapter II — Genetic interaction within the HSN regulatory code (Figure 3.2.21)
Strain name Genotype Source
MT1862 unc-86(848)III CGC, Dr. Horvitz Lab.
MT6921 sem-4(n2654)I CGC, (Basson  
& Horvitz 1996)
NFB1031 hlh-3(tm1688)II; egl-46(sy628)V;  
otIs226(bas-1::gfp)IV
This work
NFB695 ast-1(ot417)II; egl-46(sy628)V;  
otIs226(bas-1::gfp)IV
This work
NFB605 sem-4(n2654)I; ast-1(ot417)II;  
otIs226(bas-1::gfp)IV
This work
NFB253 ast-1(ot417)II; unc-86(n848)III;  
otIs226[bas-1::gfp]IV
This work
NFB958 hlh-3(tm1688)II; egl-18(ok290)IV;  
otIs221(cat-1::gfp)III
This work
NFB755 egl-18(ok290)IV; sem-4(n2654)I;  
otIs221(cat-1::gp)III
This work
NFB756 egl-18(ok290)IV; sem-4(n2654)I;  
zdIs13(tph-1::gp)IV
This work
NFB1033 egl-18(ok290)IV; egl-46(sy628)V;  
otIs221(cat-1::gfp)III
This work
NFB1032 hlh-3(tm1688)II; egl-46(sy628)V;  
otIs221(cat-1::gfp)III
This work
NFB395 sem-4(n2654)I; ast-1(ot417)II;  
zdIs13(tph-1::gfp)IV
This work
NFB648 sem-4(n2654)I; unc-86(n848)III;  
otIs224(cat-1::gfp)V
This work
NFB650 hlh-3(tm1688)II; unc-86(n848)III;  
otIs224(cat-1::gfp)V
This work
NFB931 hlh-3(tm1688)II; egl-18(ok290)IV;  
otex2435 [bas1prom1 gfp (50ng/ul), rol-6]
This work
Chapter II — Overexpression of the HSN regulatory code (Figures 3.2.17-3.2.19)
Strain name Genotype Source
NFB6 zdIs13(tph-1::gfp); otIs198(hsp-16.2::ast-1; hsp-
16.2::NLS::mCherry, ttx-3::DsRed)
This work
NFB440 zdIs13(tph-1::gfp)IV; vlcEx255[hsp-16.2:unc-86; 
ttx-3::mCherry; rol-6(su1006)]
This work
NFB257 zdIs13(tph-1::gfp)IV; vlcEx96[hsp-16.2::sem-4; 
ttx-3::mCherry; rol-6(su1006)]
This work
NFB509 zdIs13(tph-1::gfp)IV; vlcEx284 [hsp-16-2:hlh-3; 
ttx-3::mCherry; rol-6(su1006)]
This work
NFB624 zdIs13(tph-1::gfp)IV; vlcEx334 [hsp-16.2:hlh-3; 
ttx-3::mCherry; rol-6(su1006)]
This work
NFB506 zdIs13(tph-1::gfp)IV; vlcEx281 [hsp-16.2:egl-46; 
ttx-3::mCherry; rol-6(su1006)]
This work
NFB507 zdIs13(tph-1::gfp)IV; vlcEx282 [hsp-16.2:egl-46; 
ttx-3::mCherry; rol-6(su1006)]
This work
NFB725 zdIs13(tph-1::gfp)IV; vlcEx391(hsp-16.2::egl-18; 
ttx-3::mCherry; rol-6(su1006)]
This work
NFB726 zdIs13(tph-1::gfp)IV; vlcEx392(hsp-16.2::egl-18; 
ttx-3::mCherry; rol-6(su1006)]
This work
NFB267  zdIs13(tph-1::gfp); vlcEx130[hsp-16.2::unc-86; 
hsp-16.2::ast-1; hsp-16.2::sem-4; ttx-
3::mCherry; rol-6(su1006)]]
This work
NFB268  zdIs13(tph-1::gfp); vlcEx131[hsp-16.2::unc-86; 
hsp-16.2::ast-1; hsp-16.2::sem-4; ttx-
3::mCherry; rol-6(su1006)]]
This work
NFB1386 zdIs13(tph-1::gfp)IV; vlcEx810[hsp::ast-1, 
hsp::unc-86, hsp::sem-4, hsp::hlh-3, 
hsp::egl-46, hsp::egl-18 (all at 15ng/ul), rol-
6(su1006)(50ng/ul), ttx-3::mCherry(50ng/ul)]
This work
NFB1387 zdIs13(tph-1::gfp)IV; vlcEx811[hsp::ast-1, 
hsp::unc-86, hsp::sem-4, hsp::hlh-3, 
hsp::egl-46, hsp::egl-18 (all at 15ng/ul), rol-
6(su1006)(50ng/ul), ttx-3::mCherry(50ng/ul)]
This work
Chapter II — HSN fate maintenance & GATA family RNAi (Figures 3.2.6, 3.2.16, 3.4.3)
Strain name Genotype Source
NL2099 rrf-3(pk1426)II CGC, Dr. Plasterk Lab.
NFB689 rrf-3(pk1426)II; otIs517[(tph-1::SL2::YFP::H2B), 
ttx-3::mCherry, rol-6(su1006)]
This work
NFB49 rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV This work
NFB643 rrf-3(pk1426)II; otIs221(cat-1::gfp)III This work
Chapter III — Reporter fusion analysis for de novo expression in the HSN (Figures 3.3.3-3.3.6)
Strain name Genotype Source
NFB1354 vlcEx802 [abts-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1355 vlcEx803 [abts-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1211 vlcEx705 [acr-24::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1212 vlcEx706 [acr-24::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1089 vlcEx598 [ast-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1090 vlcEx599 [ast-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1221 vlcEx715 [bam-2::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
↳
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NFB1222 vlcEx716 [bam-2::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1133 vlcEx635 [C16B8.4::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1134 vlcEx636 [C16B8.4::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1173 vlcEx675 [C53B4.4::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1174 vlcEx676 [C53B4.4::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1175 vlcEx677 [ckr-2::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1176 vlcEx678 [ckr-2::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1157 vlcEx659 [daf-38::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1158 vlcEx659 [daf-38::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1135 vlcEx637 [dgn-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1136 vlcEx638 [dgn-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1177 vlcEx679 [F32D8.10::gfp::unc-54 3'UTR (50ng/
ul), rol-6(su1006) (100ng/ul)]
This work
NFB1178 vlcEx680 [F32D8.10::gfp::unc-54 3'UTR (50ng/
ul), rol-6(su1006) (100ng/ul)]
This work
NFB1139 vlcEx641 [nlp-10::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1140 vlcEx642 [nlp-10::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1159 vlcEx661 [fut-1::gfp::unc-54 3'UTR (50ng/ul),  
rol-6(su1006) (100ng/ul)]
This work
NFB1160 vlcEx662 [fut-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1213 vlcEx707 [gab-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1214 vlcEx708 [gab-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1179 vlcEx681 [glb-2::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1180 vlcEx682 [glb-2::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1161 vlcEx663 [kcc-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1162 vlcEx664 [kcc-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1137 vlcEx639 [kel-8::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1138 vlcEx640 [kel-8::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1163 vlcEx665 [klp-7::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1164 vlcEx666 [klp-7::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1149 vlcEx651 [lgc-49::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1150 vlcEx652 [lgc-49::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1215 vlcEx709 [mec-10::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1216 vlcEx710 [mec-10::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1181 vlcEx683 [mgl-2::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1182 vlcEx684 [mgl-2::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1217 vlcEx711 [npr-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1218 vlcEx712 [npr-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1141 vlcEx643 [npr-3::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1142 vlcEx644 [npr-3::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1352 vlcEx800[pan-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1353 vlcEx801 [pan-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1151 vlcEx653 [pde-3::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1152 vlcEx654 [pde-3::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1223 vlcEx717 [shl-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1224 vlcEx718 [shl-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1183 vlcEx685 [snt-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1184 vlcEx686 [snt-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1167 vlcEx669 [sprr-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1168 vlcEx670 [sprr-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1227 vlcEx721 [sto-5::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1228 vlcEx722 [sto-5::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1229 vlcEx723 [tiam-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1230 vlcEx724 [tiam-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1143 vlcEx645 [tkr-2 w2-6::gfp::unc-54 3'UTR  
(50ng/ul), rol-6(su1006) (100ng/ul)]
This work
NFB1144 vlcEx646 [tkr-2::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1219 vlcEx713 [tol-1::gfp::unc-54 3'UTR (50ng/ul),  
rol-6(su1006) (100ng/ul)]
This work
NFB1220 vlcEx714 [tol-1::gfp::unc-54 3'UTR (50ng/ul),  
rol-6(su1006) (100ng/ul)]
This work
NFB1145 vlcEx647 [twk-17::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
↳
↳
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NFB1238 vlcEx732 [irld-53::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1239 vlcEx733 [irld-62::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1240 vlcEx734 [irld-62::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1241 vlcEx735 [lurp-2::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1242 vlcEx736 [lurp-2::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1243 vlcEx737 [plep-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1244 vlcEx738 [plep-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1245 vlcEx739 [slc-28.1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1246 vlcEx740 [slc-28.1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1261 vlcEx755 [stg-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1262 vlcEx756 [stg-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1283 vlcEx773[tub-1::MDM2::gfp::unc-54 3'UTR 
(50ng/ul), rol-6(su1006) (100ng/ul)
This work
NFB1284 vlcEx774[tub-1::MDM2::gfp::unc-54 3'UTR 
(50ng/ul), rol-6(su1006) (100ng/ul)
This work
NFB1146 vlcEx648 [twk-17::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1147 vlcEx649 [tyra-3::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1148 vlcEx650 [tyra-3::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1171 vlcEx673 [unc-32::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1172 vlcEx674 [unc-32::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1185 vlcEx687 [unc-7::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1186 vlcEx688 [unc-7::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1079 vlcEx588 [aak-2::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1080 vlcEx589[aak-2::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1077 vlcEx586 [cat-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006)(100ng/ul)]
This work
NFB1078 vlcEx587 [cat-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1081 vlcEx590 [kal-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1082 vlcEx591 [kal-1::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1083 vlcEx592 [kcc-2::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1084 vlcEx593 [kcc-2::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1127 vlcEx629 [sem-4 w3-13::gfp::unc-54 3'UTR 
(50ng/ul), rol-6(su1006) (100ng/ul)]
This work
NFB1128 vlcEx630 [sem-4 w3-13::gfp::unc-54 3'UTR 
(50ng/ul), rol-6(su1006) (100ng/ul)]
This work
NFB1087 vlcEx596 [sem-4 w15-16::gfp::unc-54 3'UTR 
(50ng/ul), rol-6(su1006) (100ng/ul)]
This work
NFB1088 vlcEx597 [sem-4 w15-16::gfp::unc-54 3'UTR 
(50ng/ul), rol-6(su1006) (100ng/ul)]
This work
NFB1131 vlcEx633 [sem-4 w18-23::gfp::unc-54 3'UTR 
(50ng/ul), rol-6(su1006) (100ng/ul)]
This work
NFB1132 vlcEx634 [sem-4 w18-23::gfp::unc-54 3'UTR 
(50ng/ul), rol-6(su1006) (100ng/ul)]
This work
NFB1231 vlcEx725 [f16g10.5::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1232 vlcEx726 [f16g10.5::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1233 vlcEx727 [flp-27::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1234 vlcEx728 [flp-27::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1235 vlcEx729 [gipc-2::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1236 vlcEx730 [gipc-2::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
NFB1237 vlcEx731 [irld-53::gfp::unc-54 3'UTR (50ng/ul), 
rol-6(su1006) (100ng/ul)]
This work
↳
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Chapter IV — Rescue of HSN mutant phenotype with mouse factors (Figure 3.4.4)
Strain name Genotype Source
NFB290 ast-1(ot417)II; zdIs13(tph-1::gfp)IV; 
vlcEx148[bas-1prom::ast-1, ttx-3::mCherry; 
rol-6(su1006)]
This work
NFB336 ast-1(ot417)II; zdIs13(tph-1::gfp)IV; 
vlcEx148[bas-1prom::Pet1, ttx-3::mCherry;  
rol-6(su1006)]
This work
NFB499 unc-86(n846)III; zdIs13(tph-1::gfp)IV; 
vlcEx503[kal-1prom::unc.86 genomic,  
ttx-3::mCherry, rol-6(su1006)]
This work
NFB649 sem-4(n1971)I; zdIs13(tph-1::gfp)IV; 
vlcEx511[kal-1prom::Sall2; ttx-3::mCherry,  
rol-6(su1006)]
This work
NFB938 hlh-3(tm1688)II; zdIs13(tph-1::gfp)IV; 
vlcEx458[cat-4prom::hlh-3; ttx-3::mCherry, 
rol-6(su1006)]
This work
NFB912 hlh-3(tm1688)II; zdIs13(tph-1::gfp)IV; 
vlcEx479[cat-4prom::Ascl1, ttx-3::mCherry, 
rol-6(su1006)]
This work
NFB913 hlh-3(tm1688)II; zdIs13(tph-1::gfp)IV; 
vlcEx480[cat-4prom::Ascl1, ttx-3::mCherry, 
rol-6(su1006)]
This work
NFB939 egl-46(sy628)V; zdIs13(tph-1::gfp)IV; 
vlcEx471[cat-4prom::egl-46, ttx-3::mCherry, 
rol-6(su1006)]
This work
NFB940 egl-46(sy628)V; zdIs13(tph-1::gfp)IV; 
vlcEx472[cat-4prom::egl-46, ttx-3::mCherry, 
rol-6(su1006)]
This work
NFB914 egl-46(sy628)V; zdIs13(tph-1::gfp)IV; 
vlcEx481[cat-4prom::Inms1; ttx-3::mCherry, 
rol-6(su1006)]
This work
NFB941 egl-18(ok290)IV; yzIs71[tph-1::gfp, rol-
6(su1006)]V; vlcEx469[cat-4prom2::egl-18, 
ttx-3::mCherry, rol-6(su1006)]
This work
NFB942 egl-18(ok290)IV; yzIs71[tph-1::gfp, rol-
6(su1006)]V; vlcEx470[cat-4prom2::egl-18, 
ttx-3::mCherry, rol-6(su1006)]
This work
NFB899 egl-18(ok290)IV; yzIs71[tph-1::gfp, rol-
6(su1006)]V; vlcEx485[cat-4prom2::Gata3, 
ttx-3::mCherry, rol-6(su1006)]
This work
Chapter IV — Orientation bias in HSN cis-regulatory modules (Figure 3.3.7)
Strain name Genotype Source
NFB1060 vlcEx570[tph-1prom58::gfp, rol-6(su1006)] This work
NFB1061 vlcEx571[tph-1prom58::gfp, rol-6(su1006)] This work
No name tph-1prom58 Line 3 This work
NFB1062 vlcEx572[tph-1prom59::gfp, rol-6(su1006)] This work
NFB1063 vlcEx573[tph-1prom59::gfp, rol-6(su1006)] This work
No name tph-1prom59 Line 3 This work
NFB1064 vlcEx574[cat-1prom85::gfp, rol-6(su1006)] This work
NFB1065 vlcEx575[cat-1prom85::gfp, rol-6(su1006)] This work
No name cat-1prom85 Line 3 This work
NFB1066 vlcEx576[cat-1prom86::gfp, rol-6(su1006)] This work
NFB1067 vlcEx577[cat-1prom86::gfp, rol-6(su1006)] This work
No name cat-1prom86 Line 3 This work
NFB1068 vlcEx578[cat-1prom87::gfp, rol-6(su1006)] This work
NFB1069 vlcEx579[cat-1prom87::gfp, rol-6(su1006)] This work
No name cat-1prom87 Line 3 This work
NFB1070 vlcEx580[bas-1prom87::gfp, rol-6(su1006)] This work
NFB1071 vlcEx581[bas-1prom87::gfp, rol-6(su1006)] This work
NFB1074 vlcEx584[bas-1prom89::gfp, rol-6(su1006)] This work
NFB1075 vlcEx585[bas-1prom89::gfp, rol-6(su1006)] This work
No name bas-1prom89 Line 3 This work
Table 2.23 
Apparatus used in this Thesis
Table 2.24 
Software and Data Bases 
used in this Thesis
Apparatus Source / Reference
Dissecting scope Zeiss Stemi 2000
Fluorescence scope 1FAxioZoom V16, Zeiss
Microinjection inverted microscope Axio Vert.A1 Zeiss
Epifluorescence microscope Zeiss Axioplan 2 microscope
Cryostat Leica CM1900
Confocal microscope TCS-SP8 Leica microscope
Image reader: detection of radioactive-marked 
membranes
Fujifilm FLA-500
Table 2.22 
Other reagents and materials 
used in this Thesis
Reagent Source / Reference
Worm mounting for visualisation under the microscope
Sodium azide Sigma, #26628-22-8
Microscope glass slides Rogo Sampaic, #11854782
Coverslips (22*22mm) VWR, #631-1570
Glass micropipette Blaubrand intraMARK, #6121414
PCR
Go Taq® DNA polymerase Promega, #M7806
Expand Long template PCR system Sigma, #11681834001
Q5 Hot Stat High-Fidelity 2X Master Mix NEB, #M049S
dNTPs Promega, #U1420
Nuclease-Free water Sigma, #W4502
Proteinase K Roche Life Science, #3115879001
Primers Sigma and Metabion
Worm microinjection
Halocarbon oil 700 Sigma, #H-8898
Microinjection capillary Femtotip II, Eppendorf, #930000043
Needles BD Microlance 3, #304000
Electrophoretic Mobility Shift Assay
Anti-6xhistag antibody Abcam, #ab18184
PowerBroth medium Molecular Dimensions, #MD121061
His Trap HP column GE Healthcare Life Sciences, #17-5248-01
Lipofectamine-2000 Invitrogen, #11668019
Isopropyl-β-D-thiogalactopyranoside (IPTG) Acros Organics, #BP1755-100
Anti-GFP antibody Roche, #11814460001
ATP [γ-32P] Perkin Elmer, #NEG002A250UC
T4 PNK Thermo Scientific, #EK0031
Worm and mouse immunohistochemistry
Collagenase type IV Sigma, #5138
Rabbit anti-5-HT antibody Sigma, #S-5545
Rabbit anti-Sall2 Sigma, #HPA004162
Goat anti-Brn2 Santa Cruz Biotechnology, #SC6029
Goat anti-5-HT Abcam, #Ab66047
Alexa 555-conjugated donkey anti-rabbit Molecular Probes, #A31572
Alexa 555-conjugated donkey anti-goat Molecular Probes, #A21432
Alexa 488-conjugated donkey anti-goat Molecular Probes, #A11055
Alexa 488-conjugated donkey anti-rabbit Molecular Probes, #A21206
DAPI Sigma, # D9542-5MG
FluorSave Merck Millipore, #34578920ML
Phasmid neuron staining
DiI Molecular Probes, # D-282
N,N-dimethyl formamide Sigma, #D4551
CRISPR/Cas9 GFP knock-in
Hygromycin B solution Gibco, #10687010
Isothermal Start Mix See specific components above
Gibson Assembly Master Mix (2X) See specific components above
Software Reference / Link to web
ImageJ (–)
Adobe Photoshop CC (–)
Adobe Illustrator CC (–)
WormBase version 220 http://www.wormbase.org/#012-34-5
Genome Browser https://genome.ucsc.edu
Transcription Factor Encyclopedia http://www.cisreg.ca/cgi-bin/tfe/home.pl
CIS-BP http://cisbp.ccbr.utoronto.ca
MatInspector (Genomatix) https://www.genomatix.de/online_help/help_
matinspector/matinspector_help.html
JASPAR http://jaspar.genereg.net/cgi-bin/jaspar_db.pl
CRISPR Design http://crispr.mit.edu 
Benchling http://benchling.com
iTF (Kazemian et al. 2013); 
http://veda.cs.uiuc.edu/iTFs 
GOrilla (Eden et al. 2009); 
http://cbl-gorilla.cs.technion.ac.il
R (The R Team 2016); 
https://www.r-project.org/
Bioconductor (Huber et al. 2015); 
https://www.bioconductor.org/
pvclust (R package) (Suzuki et al. 2006); www.sigmath.es.osaka-u.
ac.jp/shimo-lab/prog/pvclust
ade4 (R package) (Dray et al. 2007); pbil.univ-lyon1.fr/ade4/
home.php?lang=eng
GraphPad QuickCalcs http://www.graphpad.com/quickcalcs/
Results
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Serotonergic neurons share a battery of phy-
logenetically conserved enzymes and transport-
ers, known as the 5-HT pathway genes, that allow 
the neurons to use 5-HT as a neurotransmitter 
→ Figure 1.7-B. In this Chapter, we investigate 
how the expression of the 5-HT pathway genes 
is regulated in the different serotonergic neuron 
subtypes. First, we propose different models for 
serotonergic cis-regulatory logic and then we use 
GFP-based reporters to distinguish between them. 
This part of the project was performed in collabora-
tion with Dr. Miren Maicas.
Establishment of possible models for the 
regulation of serotonin pathway gene expression 
in different serotonergic classes
C. elegans adult hermaphrodites contain three an-
atomically different 5-HT sinthesising neuron sub-
classes, which express the 5-HT pathway genes: 
the NSM neurosecretory motorneuron, the ADF 
chemosensory neuron and the HSN motorneu-
ron → Figure 1.12. In our study we focused on the 
tph-1 expressing, and thus 5-HT-producing neu-
rons (NSM, ADF and HSN) and, from now on, will 
be referred to as serotonergic neurons, unless 
specified. These three serotonergic subclasses 
arise from different progenitors in development 
→ Figure 1.10, fulfil different functions and, with 
the exception of the shared expression of 5-HT 
pathway genes, express different sets of terminal 
features → Figure 3.1.1.
As reviewed in Chapter I, distinct TFs are known to 
be required to control differentiation of NSM, ADF 
and HSN neurons (Desai et al. 1988; Sze et al. 2002; 
Xie et al. 2013; Zhang et al. 2014). However, how these 
TFs precisely regulate 5-HT pathway gene expres-
sion in each neuron subclass remains unknown. 
One can envision two possible models to explain 
serotonergic regulatory logic. In model 1, sub-
class-specific TFs directly activate 5-HT pathway 
gene expression through independent cis-regu-
latory modules (CRMs) → Figure 3.1.2, Model 1. 
Alternatively, in model 2, subclass-specific TFs may 
activate a universal serotonergic subroutine of TFs 
that would then drive 5-HT pathway gene expres-
sion in all different subclasses of serotonergic neu-
rons using the same CRM → Figure 3.1.2, Model 2. 
To distinguish between these possibilities, we 
decided to perform in vivo cis-regulatory analy-
ses of the tph-1(TPH2), cat-1(VMAT), bas-1(AADC), 
cat-4(GCH1) and mod-5 (SLC6A4/SERT) 5-HT 
pathway genes. We systematically dissected the cis- 
regulatory regions of these five 5-HT pathway 
genes in the context of gfp reporters expressed 
in transgenic worms. We reasoned that the depth 
of this cis-regulatory analysis would provide ev-
idence to identify the model or models that ex-
plain serotonergic regulatory logic. If serotonergic 
gene expression were controlled in a modular man-
ner by distinct TFs in the different neuron subtypes 
(Model 1), we would observe that independent re-
porters would be specifically expressed in individ-
ual neuron subtypes. Alternatively, if 5-HT pathway 
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Figure 3.1.2 
Models for serotonergic 
subclass specification
Model 1 
Different TFs in each 
neuron subclass directly 
regulate 5-HT pathway gene 
expression through different 
cis-regulatory modules 
(CRMs), represented by 
different couloured boxes. 
5-HT: serotonergic
Model 2 
Different TFs in each neuron 
subclass are required to 
activate the expression of 
a common TF that directly 
regulates 5-HT pathway gene 
expression through the same 
CRM in all subclasses.
HSN ADFNSM
5-HT pathway genes
gene expression were defined by a master-regu-
lator(s) that was activated by neuron-subtype TFs 
(Model 2) we would find CRMs globally expressed in 
all serotonergic subtypes. 
Distinct cis-regulatory modules control 
serotonin pathway gene expression in the 
different subclasses of serotonergic neurons
To start, we analysed the expression pattern of the 
five 5-HT pathway genes using integrated reporters 
containing the complete upstream cis-regulato-
ry region (full-length). The tph-1 full-length report-
ers used in this project (zdIs13 and yzIs71) (Clark & 
Chiu 2003; Sze et al. 2000) are exclusively expressed 
in the 5-HT producing neurons NSM, ADF and HSN. 
We found that zdIs13 is additionally expressed in 
the pair of cholinergic neurons VC4 and VC5 that 
have been reported to contain weak and variable 
5-HT immunoreactivity (Rand & Nonet 1997; Duerr
et al. 1999) → Table 3.1.1, → Figure 1.12. Although
VMAT antibody has been reported to be detected in 
all monoaminergic neurons (Duerr et al. 1999), cat-1 
full-length reporter (otIs221) is expressed in all
monoaminergic except AIM. This includes the sero-
tonergic NSM, ADF, RIH and HSN neurons, the sero-
tonin-like VC4 and VC5 neurons, the dopaminergic 
CEPV, CEPD, ADE and PDE neurons, the tyramin-
ergic neurons RIM and the octopaminergic neu-
rons RIC → Table 3.1.1. bas-1 full-length reporter 
(otIs226) is expressed in all serotonergic (NSM, 
ADF, AIM, HSN) neurons, except RIH, and dopamin-
ergic neurons, as previously reported (Hare & Loer 
2004) → Table 3.1.1. Finally, cat-4 full-length re-
porter (otIs225) shows the same neuronal expres-
sion pattern as bas-1 (Sze et al. 2002; Loer et al. 2015) 
→ Table 3.1.1. In regard to mod-5 expression, a
7.6 kb reporter containing all intergenic plus the
first two exons and first intron of the mod-5 gene
(mod-5B::gfp in → Figure 3.1.3-E, → Table 3.1.1) 
has been described to be expressed in NSM, ADF
and AIM neurons, but not in HSN (Jafari et al. 2011). 
A smaller version of the reporter (mod-5A::g-
fp in → Figure 3.1.3-E) containing only upstream
cis-regulatory regions, was exclusively expressed in
the ADF neuron (Jafari et al. 2011).
Our cis-regulatory study was carried out using ex-
trachromosomal reporter lines. Prior to any analy-
sis, we injected the full-length reporters containing 
upstream regulatory regions into the worms to see
if they reproduced the expected expression. If this 
was the case, we kept these reporters for their 
posterior dissection. Conversely, if the upstream 
region did not recapitulate the expression of the 
gene, we also considered intronic regions as candi-
date CRMs, as is the case for mod-5. All transgenic 
strains generated are listed in → Table 2.21. We es-
tablished three categories of GFP fluorescence ac-
cording to the following criteria: expression values 
between 100-60% of scored cells are considered 
as ‘+’ sign; values between 60-20% of expression 
would be considered ‘partial expression’ in the cells 
(‘+/−’); values lower than 20% would be considered 
‘loss’ of expression (‘−’). Primary data for this part 
of the project is included in → Annex 3.1.1.
We began the analysis with the most specific ser-
otonergic reporter, the tryptophan hydroxylase 
tph-1 gene. We named tph-1prom1 to the pPD95.75 
plasmid containing all the intergenic regulatory se-
quence of the tph-1 gene (1719 bp upstream plus 
the first 30 bp of exon 1, expressed as (−1719/+30)). 
As expected, we found expression in the NSM, ADF 
and HSN neurons. Additionally, we found expres-
sion in the VC4/5 neurons, similar to the integrated 
strain version (zdIs13) → Figure 3.1.3-A. We then 
cloned the first 377 bp preceding tph-1 start codon 
into the pPD95.75 to generate tph-1prom2. This 
construct was expressed at comparable levels to 
the previous reporter in all the neuronal subtypes. 
The remaining 1341 bp upstream to tph-1prom2 
were cloned to generate a new construct named 
tph-1prom8, which was not expressed in any neu-
ron, indicating that all the information about ser-
otonergic regulatory logic must be contained in 
tph-1prom2. We then cloned the first 5’ 146 bp from 
tph-1prom2 to generate tph-1prom6 but, again, 
showed no expression at all. The remaining 231 bp 
(tph-1prom5), however, was only expressed in the 
NSM neurons, indicating that it does not contain 
sufficient regulatory information to be activated 
in ADF and HSN neurons. Nonetheless, we want-
ed to know if an even smaller sequence would be 
still able to drive expression in the NSM neuron. We 
found out, indeed, that a 178 bp sequence right next 
Figure 3.1.1  
Heat map representation  
of HSN, NSM and ADF known 
expressed genes 
Each serotonergic neuron 
subtype expresses different 
sets of genes. Only the 5-HT 
pathway genes and two 
additional genes (aho-3 and 
nlp-3) are expressed by the 
three serotonergic subtypes. 
Data obtained from  
www.wormbase.org and 
(Hobert 2016).
gene expressed 
gene not expressed
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to the start codon (tph-1prom3) drove high levels of 
GFP in NSM. Therefore, we established this region 
as the CRM of the tph-1 gene, in the NSM neuron. 
However, as GFP fluorescence was lost in ADF and 
HSN neurons in tph-1prom6 and tph-1prom5, we 
hypothesised that maybe the regulatory elements 
controlling tph-1 expression in these cells could be 
somewhere in the middle of both constructs. With 
this in mind, we cloned 99 bp containing the 3’ end 
of tph-1prom6 and the 5’ start of tph-1prom5 to 
generate tph-1prom17 and assessed expression. 
ADF neuron regained robust GFP expression with 
this construct, so we considered this small DNA 
fragment the tph-1 CRM in the ADF. As HSN GFP ex-
pression was only observed with the tph-1prom2 
reporter, we concluded that this is the tph-1 CRM 
in the HSN. Our cis-regulatory analysis of the tph-1 
gene revealed that independent modules are re-
quired to achieve expression of this gene in the dif-
ferent serotonergic subtypes.
We next moved on to dissect the regulatory ele-
ments of the cat-1 gene. cat-1prom1 contained 
2.5 kb upstream of the cat-1 gene start codon; al-
most all the intergenic region. This construct is 
expressed in all the cells that are known to ex-
press CAT-1, as observed with antibody staining 
(Duerr et al. 1999), except for AIM → Figure 3.1.3-B, 
→ Annex 3.1.1. We then cloned the furthest 752 
bp from the ATG (cat-1prom2) and expression was 
lost in all serotonergic cells although maintained 
in dopaminergic cells, suggesting that this se-
quence is not required for serotonergic expression 
of cat-1. The remaining 1584 bp (cat-1prom3) were 
expressed in the same neurons as cat-1prom1, ex-
cept for RIH and RIC neurons. We further divided 
this promoter in two new ones: cat-1prom12 and 
cat-1prom11. The former was  expressed in NSM, 
ADF and HSN serotonergic neurons and also in all 
dopaminergic neurons. The latter, however, was 
only expressed in the ADF serotonergic neuron. 
This construct was also expressed in VC4 and VC5 
serotonergic-like neurons and in the octopaminer-
gic RIC neuron. Next, we wanted to know if an even 
smaller DNA sequence could be enough to drive 
cat-1 expression in the ADF neuron, similarly to its 
tph-1 CRM. We further divided it into cat-1prom35 
and cat-1prom36 and only the second one main-
tained GFP expression exclusively in the ADF cell. 
Finally cat-1prom37, an even shorter piece from the 
cat-1prom36 that contains the first 185 bp from 
the start codon, was established as the minimal 
CRM for the cat-1 gene in the ADF neuron. Next, we 
aimed to identify the CRM of NSM and HSN seroton-
ergic neurons, so we moved back to cat-1prom12. 
We divided this promoter in two, generating cat-
1prom13 and cat-1prom14. The former lost expres-
sion in all the cells while the latter maintained GFP 
in the three serotonergic neurons, in similar levels. 
Expression in all dopaminergic neurons was still 
observed too. We divided this cat-1prom14 into cat-
1prom26 and cat-1prom27. While the first one lost 
GFP expression, the second one was exclusively 
expressed in the NSM neuron. Therefore, we con-
sidered this sequence the minimal CRM of the cat-1 
gene in the NSM neuron. Interestingly, this report-
er was ectopically expressed in several neurons lo-
cated between the head and the vulva of the worm. 
This could be indicating that this DNA sequence 
is missing a repressor element that in wild type 
worms acts to suppress cat-1 expression in these 
cells. Lastly, as happened with tph-1, we were un-
able to find a smaller region that was expressed 
in the HSN neuron. For this reason, we used cat-
1prom14 (522 bp) as the minimal CRM of the cat-1 
gene in the HSN neuron. This CRM, however, also 
contained regulatory information for the ADF neu-
ron. Thus, we found two independent CRMs for the 
ADF neuron, suggesting that cat-1 expression in 
this cell is redundantly regulated.
We then focused on the study of the bas-1 gene. 
bas-1prom1 reporter, which consists of 1.5 kb up-
stream of the start codon of the gene, recapitulates 
Table 3.1.1 
Expression of the serotonin 
pathway genes in the 
monoaminergic neurons 
of Caenorhabditis elegans
5-HT: serotonergic neurons, 
DA: dopaminergic neurons, 
Tyr: tyraminergic neurons, 
Oct: octopaminergic neurons. 
(+): Expression depends on 
the use of a reporter or an 
antibody; VC4/5 express
zdIs13(tph-1::gfp) but not 
yzIs71 or the fosmid reporter 
otIs517; AIM are immunore-
active to VMAT but do not 
express the otIs221(cat-1::g-
fp) reporter.
Gene NSM ADF HSN RIH AIM VC4/5 CEPV CEPD ADE PDE RIM RIC Reference
5-HT DA Tyr Oct
tph-1
+ + + − − (+) − − − − − −
(Sze et al. 2000), VC4/5  
laboratory observation
cat-1
+ + + + (+) + + + + + + +
(Duerr et al. 1999), 
(Sze et al. 2000)
bas-1
+ + + − + − + + + + − −
(Hare and Loer 2004)
cat-4
+ + + − + − + + + + − −
(Sze et al. 2002), 
(Loer et al. 2015)
mod-5
+ + − + + − − − − − − −
(Jafari et al. 2011)
the previously described expression pattern (Hare 
& Loer 2004) → Figure 3.1.3-C, → Annex 3.1.1. We 
next isolated the first 647 bp of the reporter to cre-
ate bas-1prom2, which was only expressed in NSM 
and in HSN. We concentrated in these pair of sero-
tonergic neurons and divided the reporter into two 
parts (bas-1prom13 and bas-1prom14). The first, 
but not the second, construct was also exclusive-
ly expressed in both neuronal subtypes. We re-
peated this procedure, dividing bas-1prom13 into 
bas-1prom15 and bas-1prom16, and only one re-
porter (bas-1prom16) maintained GFP expression 
in NSM and HSN. Once again, after dividing bas-
1prom16 into bas-1prom17 and bas-1prom18, only 
bas-1prom18 kept the expression in both neuronal 
subtypes, although its penetrance in the HSN neu-
ron was lower than that of bas-1prom1 reporter. We 
concluded that NSM and HSN share the same min-
imal CRM of bas-1 gene. Next, going back to ADF 
neuron, we analysed bas-1prom3 that carries the 
860 bp complementary to bas-1prom2. In this case, 
we did see GFP expression in the ADF neuron and 
also in all dopaminergic neurons. A further division 
of bas-1prom3 into bas-1prom4 and bas-1prom5 
revealed that the vital information for ADF neuron 
was found in the 285 bp contiguous to the bas-1 
start codon (bas-1prom5). We did an extra division 
of the reporter to generate bas-1prom6 and bas-
1prom7. The former only showed expression in the 
PDE dopaminergic neuron, while the latter was only 
expressed in the ADF neuron. Consequently, we as-
signed this 162 bp, adjacent to the start codon, as 
the minimal CRM of the bas-1 gene in the ADF. As 
with the previous 5-HT pathway genes, we identi-
fied independent modules for different seroton-
ergic neuron subtypes, with the difference that 
NSM and HSN seem to share a common regulato-
ry module.
Next, we assessed cat-4 regulatory logic. Previous 
studies in the laboratory had identified an 896 
bp enhancer, just before the cat-4 ATG codon, 
that mirrored cat-4 full length integrated report-
er strain (otIs225). Thus, we started our cat-4 
analysis using this shorter reporter (cat-4prom4) 
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Figure 3.1.3 
Cis-regulatory analysis of  
the serotonin pathway genes 
in the serotonergic neurons
White boxes underneath each 
gene summarise the smallest 
CRM that drives expression 
in each serotonergic neuron 
subclass. Yellow line indicates 
NSM minimal, purple line indi-
cates HSN minimal and blue 
line indicates ADF minimal.
Thick black lines symbolise 
the genomic region placed
in front of GFP (green box) 
and dashed lines are used to 
place each construct in the 
context of the locus. Numbers 
in brackets represent the 
coordinates of each construct 
referred to the ATG.  
+ : > 60% GFP positive cells; 
+/− : 20-60% GFP cells;  
− < 20% GFP cells.
n > 30 worms per line.  
See Annex 3.1.1 for primary 
data and for complete 
analysis in all monoaminergic 
neurons that express the 
5-HT pathway genes. 
Work performed next to  
Dr. Miren Maicas.
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Cis-regulatory analysis 
reveals that serotonergic 
regulatory logic follows model 
1 (Figure 2.2), where different 
CRMs are required for the 
expression of the 5-HT 
pathway genes in a neuron 
subtype-specific manner and 
is predicted to be activated by 
different TFs.
Figure 3.1.4  
Summary of serotonergic 
cis-regulatory logic
→ Figure 3.1.3-D, → Annex 3.1.1. The first 270 bp 
of the reporter (furthest from the start codon) did 
not show any GFP expression (cat-4prom5), while 
the complementary 626 bp (cat-4prom6) showed 
an identical expression pattern as cat-4prom4. We 
then divided cat-4prom6 into two new reporter lines 
(cat-4prom8 and cat-4prom9). cat-4prom8 was ex-
clusively expressed in the HSN neuron. To test if a 
smaller sequence could contain all the information 
required for cat-4 expression in this cell, we further 
divided the promoter into two (cat-4prom58 and 
cat-4prom59). However, none of them showed GFP 
expression in the HSN or in any other neuron. Thus, 
we concluded that cat-4prom8 is the minimal CRM 
of cat-4 in the HSN. To continue with ADF and NSM, 
we analysed cat-4prom9, the complementary se-
quence to cat-4prom8, with respect to cat-4prom4. 
This reporter showed GFP expression in the sero-
tonergic NSM neuron, and also in all dopaminergic 
neurons. To delimit the NSM minimal, we further di-
vided the sequence to generate two new report-
ers (cat-4prom18 and cat-4prom19) but both lost 
expression in the cell, although some remained in 
the dopaminergic neurons. Nonetheless, we found 
that a 136 bp sequence that overlapped the 3’ end 
of cat-4prom18 and the 5’ start of cat-4prom19 
was sufficient to drive GFP expression specifically 
in the NSM serotonergic neuron (cat-4prom27). Of 
note, some expression in the dopaminergic CEPV 
neurons persisted too. We considered this cat-
4prom27 as the minimal CRM of the cat-4 gene in 
the NSM neuron. None of the reporters analysed 
but cat-4prom6 was enough to drive GFP expres-
sion in the ADF. Hence, we considered that this 
should be the CRM of cat-4 in the ADF neuron.
Finally, as mod-5 is the only gene from the 5-HT 
pathway that is not expressed in all 5-HT produc-
ing neurons (it is absent in the HSN neuron) we did 
not analyse its regulatory logic in such detail. We 
designed a reporter with more than 2 kb of the up-
stream regulatory region (mod-5prom1) to see if 
it could recapitulate the previously described ex-
pression pattern (Jafari et al. 2011). However, this 
reporter showed no GFP expression in any sero-
tonergic neuron, although it was expressed in a pair 
of unknown neurons in the tail → Figure 3.1.3-E, 
→ Annex 3.1.1. As this cis-regulatory region did 
not contain the information required for expression 
in serotonergic neurons, we decided to analyse in-
tronic regions. We generated a second reporter 
containing the whole intron 1 (mod-5prom3) and 
detected GFP expression in NSM and ADF neurons. 
A 335 bp long intronic region contained within this 
reporter (mod-5prom6) was considered the mini-
mal CRM required for mod-5 expression in the ADF 
neuron. 
In summary, to decipher the regulatory logic of ser-
otonergic gene expression we generated more 
than 100 transgenic lines containing 49 different 
reporter gene fusions, spanning from about 100 
to 2500 base pairs. → Figure 3.1.4 summarises 
what we have learnt from this promoter bashing re-
garding the 5-HT producing neurons NSM, ADF and 
HSN. Briefly, different CRMs are required for 5-HT 
pathway gene expression in the three neuron sub-
types. These CRMs can be found in up to 2 kb up-
stream cis-regulatory regions of the genes, except 
for mod-5 that exhibits intronic control of its ex-
pression. We detected ectopic expression in other 
neurons that do not normally express the 5-HT 
pathway genes in one of the short reporters for 
cat-1. Additionally, two independent and redundant 
cat-1 CRMs were identified for the ADF neuron. The 
fact that different CRMs are active in specific sub-
classes of serotonergic neurons supports the idea 
that different TFs directly regulate 5-HT pathway 
gene expression in NSM, ADF, and HSN neurons 
(Model 1) and discards the possibility of having a 
common target gene that will in turn activate the 
same CRM for all of them (Model 2). 
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A candidate approach to identify 
terminal selectors for HSN neuron 
serotonergic fate
Chapter II
In Chapter I we have shown that the cis-regulato-
ry logic of C. elegans serotonergic system is neuron 
subtype-specific. We have identified independ-
ent and generally non-redundant CRMs that drive 
expression of the 5-HT pathway genes in NSM, 
ADF and HSN serotonergic neurons. Recently, our 
group has contributed to elucidate the NSM regu-
latory logic: a terminal selector code composed by 
TTX-3 and UNC-86 TFs directly regulates the ter-
minal fate of the neuron, including direct activa-
tion of the 5-HT pathway genes (Zhang et al. 2014). 
Regarding the ADF neuron, only the TF DAF-19 is 
known to be required for tryptophan hydroxylase 
expression, although it is not clear if it is a direct or 
indirect action (Xie et al. 2013). The HSN neuron has 
been very well characterised in the past and sever-
al TFs are known to regulate its development (Desai 
et al. 1988; Doonan et al. 2008; Wu et al. 2001; Sze et 
al. 2002). To deepen our understanding of how cell 
type-specific transcriptional programmes are im-
plemented we decided to focus the rest of this 
Thesis on the best characterised serotonergic neu-
ron subtype, the HSN neuron, and carried out an 
extensive dissection of HSN terminal differentia-
tion transcriptional rules. Dr. Miren Maicas and PhD 
student Ángela Jimeno, both coworkers at the labo-
ratory of Dr. Nuria Flames, have collaborated in the 
elaboration of this Chapter, with the mutagenesis 
and electrophoretic mobility shift assay (EMSA) ex-
periments and with the RNAi assays.
Transcription factors from six different families 
are required for HSN terminal differentiation
As described in the Introduction, Desai and col-
leagues carried out a mutant screen looking for 
genetic components of the HSN function (Desai et 
al. 1988). In this study, 38 genes were identified as 
HSN-defective mutants, mainly distinguished by an 
evident egl phenotype → Table 1.2. Additionally, 
as the egl phenotype is so easy to identify, sever-
al laboratories have reported mutants with HSN de-
fects. In the present work, we decided to follow a 
candidate approach and select mutant alleles for 
TFs that showed reduced or absent amounts of 
HSN 5-HT staining and exhibited egl phenotype. 
We discarded genes that code for TFs known to 
act early in the developmental pathway of the HSN, 
such as egl-5 that affects the HSN precursor cell 
(Baum et al. 1999; Guenther & Garriga 1996; Singhvi 
et al. 2008), or egl-44 that is known to control other 
candidate regulators for the HSN as egl-46 (Wu 
et al. 2001). We also did not consider those genes 
whose 5-HT staining defects in the mutant have 
been linked to severe migration defects, as egl-43 
and ham-2 (Baum et al. 1999). Following these cri-
teria we ended up with a list of four TFs that ap-
pear as potential regulators of the HSN terminal 
fate: EGL-46 (INSM ZnF TF) (Wu et al. 2001; Desai 
et al. 1988), HLH-3 (bHLH TF) (Doonan et al. 2008), 
SEM-4 (SPALT ZnF TF) (Basson & Horvitz 1996; Grant 
et al. 2000) and  UNC-86 (POU TF) (Sze et al. 2002; 
Finney & Ruvkun 1990). All of them are known to 
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be expressed in the HSN and, additionally, UNC-86 
and HLH-3 are known to regulate some of the 5-HT 
pathway genes (Doonan et al. 2008; Sze et al. 2002). 
In the specific case of UNC-86, this regulation is 
known to be direct upon tph-1 and it is also lineage 
independent. For these reasons, UNC-86 appears 
as a good terminal selector candidate to regulate 
HSN serotonergic fate.
Furthermore, we included two more candidates in 
the analysis whose mutant alleles are defective for 
5-HT staining although this phenotype has not been 
described in the literature to date: the ETS TF AST-1 
and the GATA factor EGL-18. Previous work in the 
laboratory identified the ast-1 gene as an important 
inducer of dopaminergic fate; i.e. AST-1 directly 
binds and activates the transcriptome of dopamin-
ergic cells (Flames & Hobert 2009). Dopaminergic 
and serotonergic neurons are both monoaminer-
gic and share some components of the monoam-
ine synthetic pathway. During the analysis of ast-1 
mutants cat-1 (vesicular monoamine transporter 
VMAT) gene expression defects were incidentally 
detected in the HSN neuron, while other seroton-
ergic cell types remained unaffected. With regard 
to EGL-18, mutants were originally reported as HSN 
migration defective (in terms of cell position along 
HSN migrating path, cell position relative to the 
ventral nerve cord and branching) and to display an 
egl phenotype (Garriga, Desai et al. 1993; Desai et al. 
1988). These studies used n474, n475 and n162 al-
leles that, although predicted to encode polypep-
tides that are truncated before the DNA-binding 
domain, showed normal levels of 5-HT in the HSN. 
However, there are reports describing how non-
sense mutations can lead to exon skipping or alter-
native start site usage (Ginjaar et al. 2000; Davuluri 
et al. 2008), thus we decided to use the ok290 al-
lele, an 816 bp deletion spanning intron 2 and exon 
3 that removes the zinc finger region (Koh et al. 
2002) → Figure 3.2.1. We noticed a 5-HT staining 
phenotype with this allele that had not previously 
been described, and thus decided to include it in 
the analysis.
First, we obtained null loss-of-function mutants 
for the six genes from the Caenorhabditis Genetic 
Center (CGC). For the analysis of ast-1, we used the 
ot417 hypomorphic allele (G>A substitution affect-
ing the DNA binding domain) because null alleles 
show an L1 larval arrest phenotype, whilst HSN 
matures at late L4 larval stage. Details on the spe-
cific allelic nature of the mutants used in this work 
are summarised in → Figure 3.2.1 and → Table 2.1.
Next, we wondered if the loss of these six TFs 
could induce an incapability of the cell to synthe-
sise 5-HT. Anti-5-HT staining in mutant worms re-
veals significant defects in neurotransmitter 
production that ranges in severity; mutants for ast-
1, unc-86 and sem-4 show practically no detecta-
ble levels of 5-HT, while in hlh-3, egl-46 and egl-18 
mutants there is a partial loss of 5-HT staining 
→ Figure 3.2.2-A and B, → Annex 3.2.1. In agree-
ment to our cis-regulatory analysis, these 5-HT de-
fects seem exclusive of the HSN neuron, as we did 
not observe any significant defect in the NSM or 
ADF neurons → Annex 3.2.1. 
We then investigated to what extent was the 5-HT 
biosynthetic pathway gene expression affected in 
these mutants. We crossed mutant animals with 
the four 5-HT pathway gene transcriptional report-
ers that are expressed in HSN: tph-1 (zdIs13, yzIs71), 
cat-1 (otIs221, otIs224), bas-1 (otIs226, otEx2435) 
and cat-4 (otIs225, otEx2470) and scored the result-
ing fluorescent protein expression in the HSN. We 
found that gene expression is affected at differ-
ent levels → Figure 3.2.2-A and B, → Annex 3.2.1. 
unc-86 and sem-4 showed the strongest pheno-
types with a complete loss of expression of the four 
5-HT pathway genes analysed, except for tph-1 
(TPH2) whose expression was reduced by half in 
sem-4 mutant background. ast-1 mutants also ex-
hibited complete loss of tph-1 and cat-1 (VMAT) 
expression, but bas-1 (AADC) and cat-4 (GCH1) 
II:  4127 kb 4135 kb
ast-1 (T08H4.3)
hd92
ot417: G>A
I:  7038 kb 7049 kb
1 2 3 4 6 71
sem-4 (F15C11.1)
5
n1971: G>A n2654: C>T
II:  9085 kb 9088 kb
hlh-3 (T24B8.6)
tm1688
V:  6679 kb 6682 kb
egl-46 (K11G9.4)
sy628: G>A
IV:  1902 kb 1918 kb
egl-18 (F55A8.1a.1)
egl-18 (F55A8.1a.2)
egl-18 (F55A8.1b)
ok290
III:  8212 kb 8217 kb
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unc-86 (C30A5.7b)
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Figure 3.2.1 
Genetic locus of HSN candi-
date regulators and mutant 
alleles used in this work
E) ast-1 locus
A) unc-86 locus 
 
1: POU DNA binding domain, 
2: Homeodomain DNA binding 
domain.
B) sem-4 locus 
 
1-7: Zinc finger domains. 
Intron 1 has been shortened 
in the image as indicated by 
—//—.
C) hlh-3 locus 
 
D) egl-46 locus
F) egl-18 locus 
 
egl-18 isoform a1 contains 
a long intron that has been 
shortened in the image, as 
indicated by —//—. For specific 
description of the alleles see 
Table 2.1.
Schematic representations 
are to scale. Thick black lines 
symbolise the genomic region 
and chromosomal location 
is indicated. Red boxes 
symbolise exons. Exons, grey 
lines symbolise introns and
grey boxes symbolise 
untranslated RNA of the 
gene. DNA binding domains 
are indicated with red/white 
stripes: alternative gene 
isoforms are included. Allelic 
mutations used in this work
are indicated in blue: vertical 
lines correspond to point 
mutations and horizontal 
lines indicate gene deletions. 
Specific nucleotide changes 
are also included in blue. 
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Figure 3.2.2 
Analysis of serotonin pathway 
gene expression in mutant 
animals for the six candidate 
regulators of the HSN
A) Serotonin pathway analysis 
in mutant animals
Micrographs showing 5-HT 
pathway gene expression 
and 5-HT staining defects 
in unc-86(n846), sem-
4(n1971), hlh-3(tm1688), 
egl-46(sy628), ast-1(ot417)
and egl-18(ok290) mutants. 
Different reporters were used 
for the same 5-HT pathway 
gene whenever the reporter 
transgene was integrated in 
the same chromosome as the
mutation (tph-1::gfp: zdIs13 
and yzIs71; cat-1::gfp: otIs221 
and otIs224, bas-1::gfp: 
otIs226 and otEx2435, 
cat-4::gfp: otIs225 and 
otEx2470). 
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B) Quantification of serotonin 
pathway gene defects
Quantification of 5-HT 
pathway gene expression 
and 5-HT staining defects in 
the six mutant backgrounds.
Black: gene expression 
Red: no gene expression
n>50 worms per condition. 
Statistical significance was 
calculated using the two 
tailed Fisher exact test,  
*: pV<0.05. See Annex 3.2.1.
remained unaffected. hlh-3 and egl-46 mutants 
showed severe defects in tph-1 and partial defects 
in cat-1 and bas-1 expression, while cat-4 levels 
remained comparable to wild type. Finally, egl-18 
showed the weakest phenotype, with only partial 
tph-1 expression defects.
Regarding ast-1 phenotype, to discard the possi-
bility that the lack of bas-1 and cat-4 expression 
defects was due to the nature of the ot417 hypo-
morph allele, we decided to perform mosaic anal-
ysis using the hd92 null allele → Figure 3.2.3, 
→ Table 2.1. We rescued null ast-1(hd92) lethality 
with an extrachromosomal array containing ast-1 
cDNA and a cat-1::mCherry red marker that is ex-
pressed in all monoaminergic neurons, including 
the HSN → Figure 3.2.3-A, → Table 2.1. We scored 
for bas-1 expression in viable young adult worms, 
in which the array had rescued ast-1 lethality, but 
that had lost the rescuing array in the HSN neu-
ron, assessed by the lack of red marker. 87 out of 
87 analysed mutant cells showed normal bas-1 
reporter expression. In this way, we confirmed 
that bas-1::gfp expression does not require AST-1 
→ Figure 3.2.3-B. As a control we analysed cat-1::g-
fp expression in these mosaic animals and saw sim-
ilar defects in expression as in ot417 animals (26 out 
of 29 mutant cells lost expression in the HSN).
Again, expression defects are generally specif-
ic for the HSN subclass while ADF and NSM remain 
mainly unaffected. An exception is unc-86 mutant 
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ast-1(hd92) 
L1 larval arrest
ast-1(hd92); vlcEx844[ast-1(+); cat-1::mCherry]
Mosaic rescued worm
wild type HSN
Mosaic rescued worm
mutant HSN
       rescue array
       cat-1::mCherry
       mutant cell
A) Mosaic strategy 
ast-1(hd92) null animals 
are L1 larval lethal due to a 
detachment of the pharynx. 
Lethality can be rescued 
expressing an extrachro-
mosomal array that carries 
a wild type copy of the ast-1 
gene, next to cat-1::mCherry 
red marker to follow the HSN 
neuron (vlcEx844, vlcEx845). 
Mosaicism is based on the 
somatic loss of the
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B) Quantification of 
bas-1::gfp and cat-1::gfp 
expression in mutant HSNs 
For bas-1::gfp expression 
lines vlcEx844 and vlcEx845 
were used. n= 87 mutant cells. 
cat-1::gfp (otIs221) was used 
as a control of the technique. 
1 line was used. n=29 mutant 
cells. Statistical significance 
was calculated using the two 
tailed Fisher exact test, *: pV< 
0.05.
extrachromosomal DNA in 
some cells o lineages. Mutant 
HSNs (purple circle) in the 
context of an ast-1 rescued 
viable worm (light pink) can 
be identified via loss of the 
red cat-1 marker (red circles). 
Of note, many other cells may 
have lost the rescuing array 
(purple circles along the body) 
but only cat-1 expressing cells 
can be detected.
Figure 3.2.3 
ast-1 null mutant analysis 
in the HSN using a mosaic 
strategy
C) Mosaic rescued worm 
(wild type HSN) 
Representative images of 
an ast-1(hd92) rescued HSN 
showing wild type cat-1::gfp 
and bas-1::gfp expression.
D) Mosaic rescued worm
(mutant HSN) 
Representative images of ast-
1(hd92) mutant HSNs, in the 
context of an ast-1(+) rescued 
worm, lacking cat-1::gfp 
expression but showing 
normal bas::gfp expression.
that showed expression defects for the four 5-HT 
pathways genes in the NSM neuron, as previously 
described (Sze et al. 2002; Zhang et al. 2014). In addi-
tion, we also observed very mild phenotypes in the 
ADF for tph-1 in egl-46 mutant background (90±3%) 
and for bas-1 in sem-4 (90±3%) and hlh-3 (86±3%) 
mutants → Annex 3.2.1.
As explained in the introduction, terminal selectors 
do not only control a specific feature of the cell, as 
can be neurotransmitter type. Instead, they tend to 
broadly regulate expression of the terminal tran-
scriptome of the neuron (Hobert 2008). Therefore, 
we wanted to test if these six TFs were also re-
quired for a more extensive regulation of the HSN 
transcriptome and analysed nine additional tran-
scriptional reporters of HSN expressed genes 
not related to 5-HT biosynthesis: kcc-2c (potassi-
um chloride co-transporter), lgc-55 (amine-gated 
chloride channel), ida-1 (tyrosine phosphatase-like 
receptor), flp-19 (FMRF-like peptide), unc-17 (ve-
sicular acetylcholine transporter), unc-40 (netrin 
receptor), rab-3 (ras GTPase), nlg-1 (neuroligin) 
and kal-1 (human Kallmann syndrome homologue). 
We observed expression defects in all the alleles. 
sem-4, hlh-3 and egl-46 showed the broadest, al-
though partially penetrant, defects affecting 9/9, 
8/9 and 8/9 genes, respectively, while unc-86 and 
sem-4 showed the strongest phenotypes (exhibit-
ing the greatest loss of reporter expression) in the 
genes that they regulate (4/9 in the case of unc-86) 
→ Figure 3.2.4-A and B, → Annex 3.2.2. As with
the 5-HT pathway genes, egl-18 and ast-1 showed
the weakest phenotypes, regulating 3/7 genes an-
alysed → Figure 3.2.4-A and B, → Annex 3.2.2. flp-
19 and nlg-1 could not be analysed in egl-18(ok290) 
animals because we did not manage to achieve re-
combination between the reporter and the mu-
tant allele in the same chromosome. Of note, the
potassium chloride co-transporter kcc-2 was af-
fected in all mutant backgrounds, while the extra-
cellular matrix gene kal-1 was mainly unaffected
→ Figure 3.2.4-A and B, → Annex 3.2.2. The ex-
pression of all reporters in the HSN started at L4-
young adult stage, when the HSN projects its axon
and differentiates, except for rab-3 (L3 stage) and 
kal-1 (L1 stage). We reason that kal-1 expression 
remains practically unaltered in all mutant back-
grounds because its transcription might be reg-
ulated by an earlier-acting programme such as 
the factors we discarded (egl-5, egl-44, etc.). 
Quantification of gene expression in every mutant 
background is summarised in the heat map pres-
ent in → Figure 3.2.5. 
Our results demonstrate that the six TFs select-
ed in our candidate approach are required for the 
expression of the 5-HT pathway genes as well as 
more globally for the acquisition of the HSN neu-
ron specific identity. Although most terminal fea-
tures are affected, the fact that the expression of 
some effector genes is maintained in every mu-
138
Figure 3.2.4 
Analysis of non-serotonergic 
terminal features of the HSN 
neuron in mutant animals 
for the six candidate HSN 
regulators
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Wild type ast-1(ot417)unc-86(n846) sem-4(n1971) egl-46(sy628)hlh-3(tm1688) egl-18(ok290)
5 µm
A) Micrographs showing 
expression defects in the 
K+/Cl- cotransporter kcc-2 
(vsEx580) and normal
expression of the extracel-
lular matrix kal-1 (otIs33), in 
unc-86(n846), sem-4(n1971), 
hlh-3(tm1688), egl-46(sy628),
ast-1(ot417) and egl-18(ok290) 
mutants. 
B) Quantification of kcc-2::gfp 
(vsEx580), lgc-55::gfp (zfIs6), 
lgc-55::mCherry (zfIs4), 
flp-19::gfp (ynIs34), ida-1::gfp 
(inIs179), ida-1::gfp (inIs181, 
inIs182), unc-17::gfp (otIs576),
unc-40::gfp (inIs132), nlg-1::g-
fp (sIs13247), rab-3::yfp 
(otIs287), rab-3::gfp (otIs289) 
and kal-1 (otIs33) expression 
defects in A). 
Black: gene expression, red: 
no gene expression, grey: 
dim expression. n>50 worms 
per condition. Statistical 
significance was calculated 
using the two tailed Fisher
exact test, *: pV< 0.05. 
See Annex 3.2.2.
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tant background indicates that HSN is generat-
ed and partially differentiates in each case, but 
fails to activate the expression of the complete 
HSN transcriptome. Furthermore, sem-4, egl-46, 
egl-18 and, more severely, hlh-3 exhibit a signif-
icant loss of the panneuronal marker rab-3, indi-
cating that these mutants may not only be acting 
to specify the particular transcriptome of the HSN, 
but also more globally to regulate its neuronal fea-
tures. Worth commenting is also the fact that the 
phenotypic profile of each mutant is slightly differ-
ent from each other, which suggests that these TFs 
will probably not function in a cascade-like linear 
pathway. Importantly, although with some excep-
tions, the six TFs do not tend to act upon NSM or 
ADF serotonergic neurons. This matches our pro-
moter bashing results presented in Chapter I, in 
which the independent CRMs found in the regula-
tory regions of the 5-HT pathway genes were pre-
dicted to be regulated by different subsets of TFs in 
a neuron specific manner.
Study of the possible redundant role of 
GATA transcription factor members in HSN 
serotonergic differentiation
Inclusion of the GATA factor egl-18 in our HSN anal-
ysis is particularly interesting because, to date, no 
GATA TF has been implicated in neuronal speci-
fication in nematodes. In mouse, however, GATA 
TFs have been shown to have neuronal functions. 
For example, GATA2 and GATA3 are required for 
the correct differentiation of certain serotonergic 
and glutamatergic neurons of the raphe nuclei and 
they act in a redundant manner (Haugas et al. 2016). 
Moreover, the same GATA pair acts redundantly as 
postmitotic selector genes to promote GABAergic 
and suppress glutamatergic identity in certain 
rhombencephalic regions (Lahti et al. 2016).
Interestingly, more examples have been reported 
of GATA factors acting redundantly during the de-
velopment of other tissues: in mouse, GATA1 and 
GATA2 redundantly regulate primitive hematopoie-
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tic development (Fujiwara et al. 2004), in Xenopus, 
GATA4, 5 and 6 act redundantly in the specification 
of the myocardium (Peterkin et al. 2005). Perhaps 
the most exacerbated example of redundancy in 
the GATA family is observed in Arabidopsis. There 
are 29 GATA factors encoding-genes, which is in 
contrast to the relatively low number of these TFs 
found in other eukaryotes: six in humans, eight in 
D. melanogaster and eleven in C. elegans. The ex-
planation for the expansion of this gene family in 
plants remains obscure but it suggests a high func-
tional redundancy and may explain the low success 
of classical genetic strategies in the elucidation of 
the function of GATA factors in plants (Reyes et al. 
2004).
In C. elegans there are also examples of redundan-
cy in the GATA family. For example, EGL-18 (a.k.a 
ELT-5) and its paralogue ELT-6, are redundantly re-
quired to regulate cell fates and fusion in the vul-
val primordium and are essential to form the vulva 
(Koh et al. 2002). ELT-6 and EGL-18 also function 
redundantly during larval seam cell development 
(Gorrepati et al. 2013). Although C. elegans gut spec-
ification was first explained through a sequential 
cascade of redundant GATA TFs (MED-1, MED-2; 
END-1, END3; ELT-2, ELT-7), non-redundant func-
tions have been later assigned to these GATA fac-
tors (reviewed in (Maduro 2017)). What is common 
in all cases is that several GATA members tend to 
act together in the same pathway. For this reason, 
we hypothesised that the EGL-18 GATA factor could 
be working together with other GATA factors, in a 
redundant or in a non-redundant manner, to regu-
late HSN terminal differentiation. This redundancy 
might explain the relative subtile phenotype of egl-
18 mutants.
C. elegans GATA family consists of eleven members: 
ELT-1, ELT-2, ELT-3, ELT-4, EGL-18, ELT-6, ELT-7, END-
1, END-3, MED-1 and MED-2. We decided to perform 
RNAi experiments upon all of them to see if some 
other GATA factors could have a role in HSN spec-
ification. As HSN differentiation markers we chose 
cat-1::gfp (otIs221) and tph-1::gfp (zdIs13) tran-
scriptional reporters and we analysed F1 progeny 
to identify TFs that have a role during development. 
RNAi against egl-18, end-1, elt-3 and elt-6 showed 
a significant decrease in the number of cat-1::gfp 
positive HSN cells but only RNAi against egl-18 and 
end-1 showed a significant decrease in tph-1::g-
fp expression → Figure 3.2.6-A, → Annex 3.2.3. 
Moreover, egl-18, elt-3 and elt-6 show a migra-
tion defect in the HSN, which was normally poste-
riorly displaced (data not quantified). egl-18 RNAi 
was used as a positive control, as we had already 
demonstrated its requirement for tph-1 expression. 
However, interestingly, the effect on cat-1::gfp had 
not been observed in the null mutant what could be 
indicating off target effects for egl-18 RNAi clone. 
As elt-1 and elt-2 were embryonic lethal, we per-
formed RNAi at P0 stage with the same reporters. 
No defects were observed in terms of GFP expres-
sion → Figure 3.2.6-B, → Annex 3.2.3, yet elt-1 
treated animals showed egl phenotype and migra-
tion defects in the HSN.
Our results point to a possible role of end-1 in the 
regulation of HSN that could act redundantly with 
egl-18. Therefore, we ordered the loss of function 
mutant ok558 for this gene. This null allele con-
sists of an 879 bp deletion that removes the zinc 
finger DNA binding domain. Not-conveniently, 
it also affects 246 bp of the 3’ UTR of ric-7 gene 
→ Figure 3.2.6-C → Table 2.1. We crossed this 
allele with the four 5-HT pathway genes reporters 
(tph-1, cat-1, cat-4 and bas-1) and stained for 5-HT, 
but only observed a very subtle 5-HT staining 
defect in the HSN neuron → Figure 3.2.6-D, 
→ Annex 3.2.1. This, together with the fact that 
end-1 reporter expression is only detected tran-
siently in L3 and L4 stage and not in adult worms 
(data not shown) suggests that end-1 could have 
a minor role in the induction of HSN serotonergic 
specification. Alternatively, it could act redundant-
ly with egl-18 in this process. As the contribution of 
end-1 to HSN serotonergic differentiation seems 
to be small, from now we focuse on EGL-18 as the 
GATA member that is participating in the process.
HSN candidate regulatory factors do not affect 
HSN lineage
The described HSN defects could be specific of 
the HSN or an indirect consequence of a more an-
terior lineage defect. In fact, most of our TF candi-
dates are known to affect cellular lineages in other 
contexts. For instance, it has been described that, 
in some lineages, unc-86 mutants affect the divid-
ing neuroblast giving rise to reiteration lineage de-
fects where one neuronal subtype is not generated 
and another one appears repeatedly. This occurs, 
for example, in the dopaminergic deirid and post-
deirid neurons ADE and PDE (Chalfie et al. 1981). In 
addition, sem-4 is known to affect the M lineage 
in a way that cells that normally become sex myo-
blasts are generated but fail to exhibit the appro-
priate characteristics of sex myoblasts and also fail 
to undergo cell division. Also in sem-4 mutants, the 
cells that normally become coelomocytes are gen-
erated but undergo an extra round of cell division 
(Basson & Horvitz 1996). Importantly, bHLH TFs are 
commonly referred to as proneural factors, mean-
ing that they are usually both necessary and suf-
ficient for the specification of neural precursors 
or neural lineages. In Drosophila, expression of Ac/
Sc or Atonal genes (bHLH) within uncommitted ec-
todermal cells results in competence to adopt a 
neural cell fate (Bertrand et al. 2002). In addition, 
the lineages of the Q neuroblasts (the precursors 
of AVM and PVM neurons) have extra terminal di-
visions in egl-46 mutants (Desai & Horvitz 1989). 
Finally, it has been reported that egl-18 expression 
in selected embryonic lineages and larval seam 
cells is responsible for normal seam cell develop-
ment and viability (Koh & Rothman 2001). Contrary, 
ast-1 has never been reported to act early in cell lin-
Figure 3.2.5 
Heat map summary of single 
mutant characterisation 
 
Statistically significant 
expression defects, 
compared to wild type, 
are indicated with a black 
frame. n.a.: not analysed. 
kcc-2: potassium chloride 
co-transporter, lgc-55: 
amine-gated Cl- channel, 
ida-1: Tyr phosphatase-like 
receptor, flp-19: FMRF-like 
peptide, unc-17: vesicular 
acetylcholine transporter, 
unc-40: netrin receptor, nlg-1: 
neuroligin, rab-3: ras GTPase, 
kal-1: human Kallmann 
syndrome homologue. 
n>50 worms per condition. 
Statistical significance was 
calculated using the two 
tailed Fisher exact test,  
*: pV< 0.05. See Annexes 3.2.1. 
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eages. Instead, it is known to act late in dopamin-
ergic and pharyngeal specification (Schmid et al. 
2006; Flames & Hobert 2009). However, nothing is 
known about the action of these six TFs in the HSN 
lineage (AB pl/rapppappa). 
Thus, in order to study the possible impact of the 
different mutants in the HSN lineage, we scored 
the presence of the PHB neuron (AB pl/rapppappp), 
the sister of the HSN neuron → Figure 3.2.7-A. The 
PHB is a phasmid neuron that can uptake lipophilic 
dyes from the environment and, thus can be de-
tected using fluorescein isothiocyanate (FITC), DiI, 
DiO, or DiD (Collet et al. 1998; Hedgecock et al. 1985). 
These dyes diffuse and label all the plasma mem-
brane of the neuron, from cilia to soma. In the tail 
of the worm, two bilateral neurons uptake this dye, 
the PHB and the PHA → Figure 3.2.7-C. Thus, we 
used DiI to visualise PHB neurons in the different 
mutant backgrounds. Although DiI staining is var-
iable, this technique still allowed us to determine 
that the PHB neuron appears in the different mu-
tant backgrounds in similar numbers as in the wild 
type N2 strain, except for egl-18, were we saw a sig-
nificant loss of staining (87±4% in the wild type, vs 
61±6% pV= 0.039 in the mutant) → Figure 3.2.7-B 
and → 3.2.7-D, → Annex 3.2.4. Hence, ast-1, unc-
86, sem-4, hlh-3 and egl-46 mutant defects ob-
served in the HSN seem to be cell specific, while 
egl-18 could have a dual role in HSN and PHB 
specification. 
The six transcription factor candidates act 
directly on their target genes to regulate their 
expression in the HSN neuron
We next aimed to assess if the TFs regulating HSN 
terminal differentiation act directly on the genes 
they regulate. To this end, we performed a compre-
hensive in vivo cis-regulatory analysis, using the 
CRMs previously determined in Chapter I. 
We studied in depth the three 5-HT pathway genes 
that showed stronger phenotypes in the mutant 
analysis: tph-1 (TPH2), cat-1 (VMAT) and bas-1 
(AADC). We wanted to assess the existence of BS 
matches for the six TFs in the minimal CRMs that 
drive expression in the HSN. To this purpose we 
looked for the consensus BSs of each family ac-
cording to several sources (published referenc-
es, TF Data Bases (TFe) and JASPAR). The specific 
searched sequences were: CGGAA/TA/G (for the 
ETS BS), C/TG/TCATNA/T/CA/T (for the POU BS), 
TTGTC/GT (For SPALT BS), C/GCAGAA (for bHLH 
consensus), G/TNNA/TGC/GGG (for INSM BS) and 
A/G/TGATAA/G/T (for GATA BS). In the cases where 
several hits were found for a specific TFBS we pri-
oritised mutations of phylogenetically conserved 
sites (present in different Caenorhabditis species) 
→ Figure 3.2.11. If a phenotype was not detected
upon mutation or if none of the sites were phyloge-
Figure 3.2.6 
Analysis of the GATA 
transcription factor family as 
possible regulator of the HSN 
serotonergic fate
A) Loss of function (RNAi) 
experiments against eight 
members of the GATA family 
Quantification of tph-1::gfp 
(zdIs13) and cat-1::gfp 
(otIs221) in the HSN of adult 
worms. F1 scoring. The RNAi 
clone against med-1 also has 
med-2 as a predicted common 
target. n=30 worms per clone. 
Statistical significance was 
calculated using the two 
tailed Fisher exact test,  
*: pV< 0.05. 
B) Loss of function (RNAi) 
experiments against elt-1 
and elt-2 GATA members that 
showed RNAi lethality with F1
scoring 
P0 scoring using the same 
tph-1 and cat-1 reporters. 
See Annex 3.2.3. RNAi 
experiments were performed 
by Ángela Jimeno. 
C) Genomic locus of end-1 
Thick black line symbolises 
the genomic region, red boxes 
symbolise exons, grey lines 
symbolise introns and grey 
boxes symbolise untranslated 
RNA of the gene. DNA binding 
domain is indicated with red/
white stripes. Alternative 
gene isoforms are included. 
The ok558 deletion allele 
(blue) used in this work 
affects the 3’ UTR of the ric-7 
neighbouring gene (Maduro et 
al. 2005). 
D) Quantification of 5-HT 
staining and 5-HT pathway 
gene expression in the HSN of 
end-1 null mutants 
 n>50 worms per condition. 
Statistical significance was 
calculated using the two 
tailed Fisher exact test, 
*: pV< 0.05. See Annex 3.2.1.
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netically conserved, then we combined mutations 
in several sites.
The HSN minimal CRM for tph-1, tph-1prom2, is 
377bp long and contains predicted BSs for the six 
TF members → Figure 3.2.8-A. This enhancer is 
highly expressed in the HSN neuron in 4 out of 6 
lines tested. We established three levels of GFP ex-
pression according to the following criteria: if the 
mutated construct shows 100-60% expression of 
mean wild type construct values would be repre-
sented with a ‘+’ sign; expression values 60-20% 
lower than mean wild type expression values would 
be considered ‘partial loss’ of expression in the 
HSN and would be represented with a ‘+/−’ sign; val-
ues less than 20% of mean wild type values would 
be considered ‘total loss’ of expression in the cell 
and would be represented with a ‘−’ sign.
Starting with the ETS TF family, we found three pu-
tative ETS sites that matched the consensus. We 
decided to check if any of them could be conserved 
in six additional Caenorhabditis species (brenneri, 
briggssae, japonica, remanei, sp. 5 ju800 and tropi-
calis) using Genome Browser database. Two of them 
were conserved in 6/6 species → Figure 3.2.11. We 
decided to mutate a conserved ETS BS first, through 
site directed mutagenesis, generating the tph-
1prom14 construct (ETS MUT in → Figure 3.2.8-A. 
We found GFP expression was specifically lost from 
HSN in 3/3 lines analysed. Searching for POU fami-
ly BSs we found five matches, but only one of them 
conserved in 6/6 species that, importantly, coin-
cided with a previously characterised function-
al BS (Sze et al. 2002) → Figure 3.2.11. We mutated 
this site (tph-1prom26, POU MUT) and, as expect-
ed, we saw a total loss of GFP in the cell in 2/2 lines 
→ Figure 3.2.8-A. Regarding the SPALT family, only 
one BS was found that was conserved in 5/6 spe-
cies considered → Figure 3.2.11. After truncat-
ing the motif (tph-1prom31, SPALT MUT) expression
was partially lost in the HSN in 4/5 lines analysed
→ Figure 3.2.8-A. Only one HLH and one INSM
motif were found in the tph-1 CRM and they were 
not conserved in any other Caenorhabditis spe-
cies → Figure 3.2.11. However, for HLH BS, 6/6 
species aligned to a CAGAA motif instead of the 
SCAGAA motif that we had chosen for our analy-
sis. Both HLH and INSM BSs turned out to be func-
tional → Figure 3.2.8-A. Finally, we found three 
highly conserved GATA sites (6/6 species), one in-
dependent and two overlapping → Figure 3.2.11. 
Nonetheless, neither single (tph-1prom54, tph-
1prom55) nor combinatorial (tph-1prom60) muta-
tion affected tph-1 expression → Figure 3.2.8-A. 
In summary, in vivo reporter analyses revealed that 
all except GATA BSs are required for proper tph-1 
expression in HSN. Paradoxically, egl-18 (GATA) 
mutants show defects in tph-1prom2 expression 
→ Figure 3.2.2, → Figure 3.2.8-B. Therefore, EGL-
18 may act upstream of another TF to regulate tph-
1prom2 expression. Alternatively, EGL-18 may be
recruited the tph-1 promoter even in the absence
of functional GATA sites, perhaps through PPIs
with other TFs of the regulatory code. Similar BS-
independent recruitment of TFs has been previ-
ously reported for the LIM homeodomain TF mec-3 
(Xue et al. 1993).
The HSN minimal CRM for cat-1, cat-1prom14, is
a bit larger than the one for tph-1, spanning 523
bp and it also contains predicted BSs for the six
TF members → Figure 3.2.9-A. We found only
one consensus BS for ETS that was conserved
in 6/6 species considered → Figure 3.2.11, so
we mutated that single site (cat-1prom63) and
assessed the resulting expression in the HSN.
3/3 lines lost GFP expression specifically in the
HSN, indicating that it is a functional site in vivo 
→ Figure 3.2.9-A. With regard to the POU family,
there were three predicted sites. We mutated the
only conserved site, generating the cat-1prom61 
reporter, and saw a clear expression defect in HSN
→ Figure 3.2.11, → Figure 3.2.9-A. Similarly, only
one predicted SPALT site was found which was con-
Figure 3.2.7 
DiI staining analysis
A) Partial lineage of the HSN 
The HSN neuron is born 
at approximately 400 min 
post-fertilisation, next to 
its sister the PHB phasmid 
neuron. nb: neuroblast,  
p: precursor, X: death event. 
B) Quantification of DiI 
staining defects in the PHB 
neuron of adult worms 
n>50 worms per condition. 
Statistical significance was 
calculated using the two 
tailed Fisher exact test, 
*: pV< 0.05. See Annex 3.2.4.
C) Schematic representation
of the tail of a worm with the 
two DiI filling neurons in red, 
PHA (anterior) and the PHB 
(posterior)
D) Representative micro-
graphs of DiI staining in the 
PHB neuron in the different 
mutant backgrounds
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served in 6/6 species → Figure 3.2.11. Our point 
mutation analysis reveals that the site is function-
al (cat-1prom60) → Figure 3.2.9-A. Regarding HLH 
family, we found two putative BSs that, when mu-
tated (cat-1prom73), exhibited a total loss of GFP 
in the HSN → Figure 3.2.9-A, → Figure 3.2.11 and 
also in the ADF neuron (data not shown). Regarding 
the INSM family, as with tph-1, only one predicted 
site was found that was not conserved in any other 
Caenorhabditis species → Figure 3.2.11. After point 
mutation analysis (cat-1prom71) no defect was ob-
served in the cell → Figure 3.2.9-A, indicating that 
cat-1 CRM probably does not contain a functional 
BS for EGL-46. In agreement with this lack of func-
tional INSM BSs in cat-1prom14 we found that the 
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expression of this reporter is not affected in egl-
46 mutants → Figure 3.2.9-C. However, we noticed 
that the penetrance of HSN expression for cat-
1prom14 is much lower than the full-length report-
er cat-1prom1 (55% compared to 100% expression 
respectively, → Figure 3.2.9-C), which indicates 
that additional information exists outside the min-
imal CRM to promote robust HSN expression. 
Interestingly, cat-1prom1 expression is affected in 
egl-46 mutants, suggesting that EGL-46 depend-
ent cis-regulatory elements must exist and will 
be found outside cat-1prom14 → Figure 3.2.9-C. 
In fact, we found three predicted INSM BSs in the 
larger CRM cat-1prom3 (1584 bp) that is highly ex-
pressed in the HSN → Figure 3.2.9-B.  After mu-
tating all of the BSs, we detected a partial loss of 
expression in the HSN → Figure 3.2.9-B. These re-
sults suggest that, although partial cat-1 expression 
can be achieved without EGL-46, this TF is required 
for robust expression in the context of the full cat-1 
promoter. To finalise cat-1 analysis, we searched 
for GATA putative BSs. Six sites were identified but 
none of them was conserved → Figure 3.2.11. We 
individually mutated two GATA sites (cat-1prom74 
and cat-1prom75) without seeing an effect, but the 
double mutation (cat-1prom76) showed partial loss 
of expression in the HSN, indicating that GATA fac-
tors can bind in vivo, at least, to these sites in order 
to regulate cat-1 expression → Figure 3.2.9-A. 
This surprisingly contrasts with the lack of expres-
sion defects of a full-length cat-1 reporter in egl-18 
(GATA) mutants → Figure 3.2.2. We analysed min-
imal cat-1 CRM (cat-1prom14) expression in egl-18 
mutants and found its expression is affected in this 
mutant background → Figure 3.2.9-C. These re-
sults reveal that egl-18 has a direct role in regulat-
ing cat-1 expression, but also that egl-18 loss can 
be compensated in the context of big regulatory 
regions but not in the context of the minimal CRM 
cat-1prom14. As we will explain next, electropho-
retic mobility shift assay (EMSA) experiments, con-
Figure 3.2.8 
tph-1 minimal HSN CRM 
mutational analysis
A) Black crosses represent 
point mutations to disrupt 
the corresponding BS. TFBSs 
belonging to different families 
are represented with different
coloured boxes. +: 100 to 60%
of mean wildt type construct 
values, +/−: expression values 
60-20% lower than mean wild 
type expression values; −: 
values are less than 20% of 
mean wildt type values. n>30
animals per line. See Annex 
3.2.5 for mutated sequences.
B) tph-1prom2::gfp expression
is partially affected in 
egl-18(ok290) mutants. 
n>50 each genotype. These 
experiments were performed 
by Dr. Miren Maicas.
Figure 3.2.9 
cat-1 minimal HSN CRM 
mutational analysis
A) cat-1 minimal HSN CRM 
(cat-1prom14) mutational 
analysis. n>30 animals per 
line. These experiments 
were performed by Dr. Miren 
Maicas.
B) cat-1 HSN CRM (cat-
1prom3) mutational analysis.
The shorter version of the 
CRM (cat-1prom14) does 
not contain functional INSM 
BSs, but the longer version 
(cat-1prom3) does. 
C) cat-1prom14::gfp expression 
is unaffected in egl-46(sy628) 
mutants, which coincides with 
the lack of phenotype when 
INSM BS are mutated in this 
construct. cat-1prom14::gfp 
contains functional GATA 
sites and, as expected, its 
expression is affected
in egl-18(ok290) mutants. 
Expression of a longer 
reporter (cat-1prom1::gfp) is 
independent of egl-18, reveal-
ing compensatory effects in 
the context of big regulatory 
sequences. n>50 animals per 
genotype. See Annex 3.2.5 for 
mutated sequences.
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firmed direct binding of EGL-18 to cat-1 CRM.
The last HSN minimal CRM that we studied was bas-1 
(AADC) (bas-1prom18) that is 117 bp long and shows 
no alignment at all with the rest of Caenorhabditis 
species → Figure 3.2.11. It contains predicted BSs 
for ETS, POU, GATA and SPALT TFs, but lacks any 
predicted INSM or HLH BSs → Figure 3.2.10-A. 
Interestingly, the penetrance of expression of this 
construct is lower than the full reporter: only 2/4 
lines show expression levels above 60%, reinforc-
ing the idea that although all TFBSs might not be 
strictly required, they might be required for robust 
expression. First, we focused on the minimal CRM 
(bas-1prom18) and our reporter analyses revealed 
that, indeed, ETS, POU and SPALT but not GATA 
BSs are required for reporter expression in HSN 
→ Figure 3.2.10-A. Similar to cat-1, bas-1 func-
tional BSs in the context of small CRMs do not al-
ways correlate with the phenotypes observed for
the full-length reporter in the mutant background.
For example, we found functional ETS BSs in bas-
1prom18 while expression of the full-length bas-1 
reporter is unaffected in ast-1(ot417) hypomorph
and ast-1(hd92) null mutants → Figure 3.2.10-A,
→ Figure 3.2.2-A, → Figure 3.2.3-B. We analysed
bas-1prom18 expression in ast-1(ot417) mutants
and found a small but significant reduction in the
percentage of GFP positive HSNs (66% in mutants
vs 83% in N2 animals → Figure 3.2.10-C). Moreover, 
EMSA experiments indicate direct binding of AST-1
to bas-1 CRM. Altogether, these results suggest
that AST-1 can bind and activate transcription from 
the bas-1 minimal CRM. This resembles the just de-
scribed relationship between EGL-18 and cat-1. In
both cases, however, other factors can compen-
sate for their loss by activating transcription from
regulatory sequences outside the minimal CRMs.
This genetic redundancy for some members of the
HSN TF collective at specific 5-HT pathway genes
possibly acts as a mechanism to ensure that dif-
ferentiation is robust.  Although HLH-3 (HLH) and
EGL-46 (INSM) are required for full-length bas-1 ex-
pression → Figure 3.2.2, no functional HLH or INSM 
BSs were found in the minimal bas-1 CRM 
(bas-1prom18). Similar to the minimal cat-1 CRM, 
GFP expression of the short bas-1prom18 is partially 
penetrant, while a longer construct (bas-1prom13) is 
more robustly expressed → Figure 3.2.10-B. We 
checked for presence of predicted HLH, INSM and 
other GATA BSs in bas-1prom13. We found two 
overlapping HLH sites that, when mutated simul-
taneously (bas-1prom77), slightly reduced the ex-
pression in the HSN. The single INSM site found was 
potentially functional, as mutations (bas-1prom76) 
clearly disrupt GFP expression in the HSN. This 
suggests a direct role for hlh-3 and egl-46 in robust 
bas-1 expression. Finally, we mutated several GATA 
BSs, alone or in combination (bas-1prom83, 
bas-1prom84, bas-1prom86), but did not find any 
defect in the HSN → Figure 3.2.10-B. The fact that 
we did not find functional GATA BSs in bas-1 CRMs, 
next to the observation that egl-18 (GATA) mutants 
do not show bas-1 expression defects, could 
suggest that GATA factors are dispensable for the 
regulation of this gene. However, as we had already 
observed genetic redundancy in other CRMs, we 
wondered whether this could also be the case for 
bas-1 reg-ulation. To address this question, we 
analysed the expression of a bas-1 minimal CRM 
carrying GATA BS mutations (bas-1prom78) in the 
ast-1(ot417) sensitised genetic background. 
Interestingly, while GATA BS mutations have no 
significant effects in wild type worms, we found a 
complete loss of expression of this construct in 
ast-1(ot417) mutants → Figure 3.2.10-D. These 
results revealed both a direct role for GATA factors 
in bas-1 expression and redundancy and or 
compensatory effects between egl-18 and ast-1.
Altogether, our exhaustive in vivo cis-regulatory 
analyses revealed that all six TFs (AST-1, UNC-86, 
SEM-4, HLH-3, EGL-46 and EGL-18) act directly on 
Figure 3.2.10 
bas-1 minimal HSN CRM 
mutational analysis
A) bas-1 minimal HSN CRM 
(bas-1prom18) mutational 
analysis. n>30 animals per 
line. See Annex 3.2.5 for 
mutated sequences. 
These experiments were per-
formed by Dr. Miren Maicas.
B) A longer bas-1 construct 
(bas-1prom13) is more ro-
bustly expressed in HSN (90%
expression compared to 48%
expression of bas-1prom18). 
This construct contains 
functional HLH and INSM BSs, 
unlike the shorter version 
bas-prom18.
C) bas-1prom18 contains 
functional ETS sites and its 
expression is affected in ast-
1(ot417) mutants. Expression 
of a longer reporter (bas-
1::prom1) is independent of 
ast-1, revealing compensatory
effects in the context of big 
regulatory sequences. n>50 
each genotype.
D) GATA BS point mutation 
does not significantly affect 
bas-1::gfp expression in the 
wild type background (in any 
CRM context). However, it 
synergises with ast-1 mutant
background leading to a com-
plete loss of GFP expression. 
These results unravel a direct
role for GATA sites in bas-1 
gene expression and synergy 
between egl-18 and ast-1.
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the regulatory regions of the 5-HT pathway genes. 
Further supporting these results, in the next sec-
tion we will describe how UNC-86, AST-1 and EGL-
18 bind to serotonergic CRMs in vitro. Our extensive 
analysis provides us with additional information 
about how the individual roles of each TF depend 
on specific DNA contexts. For instance, we detect-
ed several examples of genetic redundancy that 
provide robustness of expression to the system 
and that can be unravelled in the context of small-
er CRMs or mutant backgrounds. Notably, redun-
dancy is specific to the CRM architecture as two 
TFs can act redundantly in one CRM but not in oth-
ers. In addition, we have observed clear examples 
of genetic enhancement between TFs, suggesting 
that they act as a regulatory code (HSN regulatory 
code). Moreover, each CRM has a different dispo-
sition of TFBS arrangements supporting a flexible 
function of these TFs in the HSN. Finally, we also 
found that short HSN CRMs that lack TFBSs for 
some HSN TF collective members can drive par-
tially penetrant HSN expression, while longer CRMs 
with functional BSs for all HSN TF collective mem-
bers drive more robust expression.
UNC-86, AST-1 and EGL-18 directly bind to the 
regulatory regions of the serotonin pathway 
genes in vitro
In order to validate the previously inferred direct 
binding of the HSN regulatory code to the 5-HT 
pathway genes, Electrophoretic Mobility Shift 
Assays (EMSA) were performed. DNA probes for 
tph-1, cat-1 and bas-1 genes were labelled with the 
radioactive isotope phosphorous-32 (32P) and incu-
bated with the purified proteins of some members 
of the HSN code. One or two p robes targeting previ-
ously identified functional BSs for every member in 
the regulatory regions of the genes were designed. 
EMSA experiments reveal that UNC-86 is able to 
bind to the tph-1, cat-1 and bas-1 probes in vitro 
→ Figure 3.2.12-A. We had previously shown UNC-
86 binding to tph-1 and bas-1 (Zhang et al. 2014) but 
not to cat-1. The binding is also dose dependent
because we observe a stronger band in the gel as
we add increasing concentrations of the probe. To
test for POU BS specificity, the EMSA experiments
were repeated using probes with mutations in the
functional POU sites determined from our cis-reg-
ulatory analysis. UNC-86 binding is absent in these 
conditions → Figure 3.2.12-A, indicating that UNC-
86 specifically and directly binds to the DNA at this 
specific location.
In addition, AST-1 is able to bind in vitro to cat-1 
and bas-1 in a specific manner but we did not 
observe binding to tph-1 regulatory regions 
→ Figure 3.2.12-B. In the same way as with UNC-
86, binding is dose dependent and deletion of the
ETS site that is required for reporter gene expres-
sion in vivo resulted in the loss of AST-1 binding in 
vitro → Figure 3.2.12-B.
We also detected in vitro binding of EGL-18 to
the cat-1 probe, but no interaction was seen with
two different tph-1 probes (tph-1.1 and tph-1.2; 
→ Figure 3.2.12-C). EGL-18 binding to cat-1 was
specific as we only observed a supershift in the
EGL-18 band when EGL-18-His tagged protein was
incubated with the anti-6xhistag antibody and not
when it was incubated with an anti-GFP antibody
→ Figure 3.2.12-C. As a positive control the 3’ en-
hancer region of the Wilms Tumour 1 gene (WT1) was 
used. GATA2 (closest human orthologue to EGL-18)
has been shown to bind to this region in several solid 
tumour cell lines and to be critical in the expression
of WT1 (Furuhata et al. 2009). Moreover, the cat-1 
DNA probe was modified in order to truncate both
GATA BSs that had been shown to reduce expres-
sion in the HSN in vivo when simultaneously delet-
ed → Figure 3.2.9-A. As with UNC-86 and AST-1,
the band was lost, indicating that EGL-18 binds to
cat-1 regulatory regions in vitro, through GATA BSs.
Unfortunately, no binding corresponding to SEM-4, 
HLH-3 or EGL-46 was detected under these exper-
imental conditions. Our results show that, at least, 
AST-1, UNC-86 and EGL-18 are able to bind in vitro 
to the in vivo determined CRMs. A summary of posi-
tive EMSA assays is shown in → Figure 3.2.13.
The HSN regulatory code is expressed in the HSN
So far, we have described that our six candidate 
TFs are required for proper HSN terminal differ-
entiation. In order to confirm the cell autonomous 
actions of the proteins, and to start studying their 
inter-relationships, we analysed their expression in 
the HSN, as it had only been partially assessed. All 
strains and the corresponding genotypes used are 
listed in → Table 2.21.
When possible, integrated fosmid reporter strains 
were used. Unlike transcriptional reporters, which 
consist on a DNA fragment of a few kilobases imme-
diately 5’ upstream of the start codon of the gene 
of interest, fosmids cover large genomic regions 
(around 40 kb) and in C. elegans are considered a 
good approach for endogenous gene expression 
assessment, as they usually contain all regulato-
ry information (Tursun et al. 2009). Fortunately, in 
C. elegans a fosmid library that covers 80% of the
genome and 90% of the worm genes is available
(http://www.sourcebioscience.com). As it shows
5.74 X clone coverage of the genome, one can usu-
ally find a fosmid where the gene of interest is close 
to the centre, with at least 2–3 additional genet-
ic loci on either side. Engineering fluorescently la-
belled genes of interest in a genomic clone context 
allows for evaluation of the expression pattern and
functionality of the tagged gene. Previous to the
appearance of CRISPR-Cas9 technology, insert-
ing tags at the target gene locus contained within
these fosmids by homologous recombination (also
called ‘recombineering’) represented the most ac-
curate method to generate reporters that recapit-
ulate full endogenous expression of a given gene. 
Starting with UNC-86, it is well-known when and
where this TF is expressed. Using rabbit antisera
against UNC-86 protein, expression is detect-
ed in the embryonic Q lineage and is maintained
in the adult, including in the HSN neuron. UNC-86
is first detected in the postmitotic HSN in the em-
Figure 3.2.11 
Conservation of the putative 
transcription factor binding 
sites of the six candidate 
regulators of the HSN in 
tph-1, cat-1 and bas-1 CRMs 
Conservation between six 
Caenorhabditis species  
(C. brenneri, C. brigssae,  
C. japonica, C. remanei, 
C. sp. 5 ju800, C. tropicalis) 
was assessed generating 
multiple alignments using 
the Multiz and PhyloP tools 
from UCSC Genome Browser. 
TFBSs belonging to different 
families are represented with 
different coloured boxes. 
Numbers below TFBS indicate
the number of species in 
which is conserved. 
tph-1prom2::gfp (-378/-1)
1 2 5 6 6 6 5 0 2 6 6 6 0 0 conservation in # / 6
GFP
cat-1prom14::gfp (-1088/-566)
0 0 0 0 0 0 1 0 0 0 6 6 0 66 conservation in # / 6
GFP
bas-1prom13::gfp  (-1510/-1183)
0 0 0 0 0 0 0 0 0 0 000 conservation in # / 6
GFP
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Figure 3.2.12 
Electrophoretic mobility 
shift assays to assess direct 
binding of the six candidate 
regulators of the HSN
A) Purified UNC-86 binds 
tph-1, cat-1 and bas-1 CRMs 
in a concentration dependent 
manner (depicted by 
arrowheads). UNC-86 binding 
is abolished by point mutation 
in the POU BS.
B) Purified AST-1 binds to 
cat-1 and bas-1 CRMs in a 
concentration dependent 
manner (arrowheads). AST-1 
binding is lost upon ETS BS 
mutation. 
C) Cellular extracts from 
HEK293T cells overexpressing 
EGL-18:HIS bind to the cat-1 
CRM. Supershift of the band 
with HIS antibody, but not 
with GFP antibody, indicates 
that the binding involves 
EGL-18 protein. Moreover, 
point mutation of GATA site 
abolishes cat-1 sequence 
binding by the cellular extract. 
These experiments were 
fully performed by Dr. Miren 
Maicas.
bryo (Finney & Ruvkun 1990). We wanted to check 
if we could reproduce these results using the in-
tegrated fosmid otIs337 strain (Zhang et al. 2014), 
so we could next proceed to analyse its expres-
sion in different mutant backgrounds. With this 
configuration, the onset of expression and tissue 
specificity of unc-86 gene product can be easi-
ly assessed. Expression was first detected in the 
HSN at embryonic comma stage (approximate-
ly 7 hours post-fertilisation), and was maintained 
in adult worms → Figure 3.2.14-A and B. We next 
crossed the otIs337 reporter with a tph-1 transcrip-
tional reporter strain that carried a red fluorescent 
protein (vsIs97) and confirmed that unc-86 is also 
expressed in the NSM but not in the ADF neuron, al-
though no quantification was carried out. 
Basson and Horvitz first reported sem-4::lacZ fu-
sion transgene expression in the HSN (Basson & 
Horvitz 1996). In the present work, in order to eval-
uate sem-4 expression, we first used the integrat-
ed fosmid wgIs57 (Sarov et al. 2012). Expression was 
hard to detect in the HSN during embryonic stages 
but GFP was localised to the HSN in L1 larva and it 
was maintained throughout the life of the animals 
→ Figure 3.2.14-A. However, as fluorescence in-
tensity in the HSN was very faint and worms showed 
a relatively high level of background GFP signal, we 
next analysed a translational fusion reporter strain, 
kuIs34, that had been previously described to be ex-
pressed in the adult HSN (Grant et al. 2000). A small-
er percentage of L1 worms showed GFP expression 
in the HSN but, already at L2 stage, GFP penetrance 
was comparable to those of the fosmid report-
er and expression was also maintained during the 
rest of the life of the worms → Figure 3.2.14-B. We 
concluded that both reporters could be indistinct-
ly used to study the HSN neuron. Similarly to unc-
86, sem-4 is expressed in many other neurons and 
cells: hypodermal 8, 9 and 10 cells, all rectal cells, 
DVC, VPCs, ventral nerve cord neurons, cells in the 
head and in the preanal ganglion (Grant et al. 2000; 
Jarriault et al. 2008). After crossing this kuIs34 re-
porter with the tph-1::DsRed reporter strain vsIs79, 
we saw that sem-4 is not expressed in any other 
serotonergic neuron (not in NSM nor in ADF).
According to some reports, hlh-3 appears to be 
expressed in all neuronal precursors during em-
bryogenesis (Krause et al. 1997). A different report 
describes that, using either a full-length transla-
tional reporter or transcriptional fusion reporters, 
this expression is maintained in most neurons of the 
nerve ring ganglia upon hatching and that already 
at larval stage 1, expression is almost undetecta-
ble except for the endodermal-like P cells (Doonan 
et al. 2008). Expression is maintained in the 53 re-
sulting postmitotic motor neurons, including HSN, 
throughout larval development. In our work, we 
chose two fosmid reporter strains to assess HLH-3 
expression in the HSN. One was the otEx4140 ex-
trachromosomal transgene  (Murgan et al. 2015) and 
the other one was wgIs650 (Sarov et al. 2006), both 
constructs corresponding to recombineered fos-
mids. In our hands, expression was only detected in 
the HSN precursor cell, the HSN/PHB neuroblast, at 
5 hpf. Both reporters show comparable expression 
pattern and timing. → Figure 3.2.14-A and B show 
expression of otEx4140. Expression was rapidly 
lost as we did not manage to see hlh-3::yfp expres-
sion in the HSN at the time unc-86::yfp (otIs337) in-
itiates its expression in the cell (430 min after the 
first cleavage, approximately 7 hpf). We mounted in 
parallel one cell stage embryos of the two reporter 
strains, otIs337 and otEx4140, and 4 hours later we 
scored the total number and the position of fluores-
cent cells in the embryonic tail. We scored at dif-
ferent time points and up to 6 hours after mounting 
the embryos (7 hpf). We never saw YFP express-
ing cells at the same location and at the same time, 
so we concluded that hlh-3 expression in HSN/PHB 
precursor cell must be turned off before the last 
postmitotic division takes place, coinciding with 
unc-86 onset. This would be in agreement with 
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hlh-3 acting as a proneural gene during neurogen-
esis. We did not assess expression of hlh-3 in NSM 
or ADF precursor neurons.
egl-18 reporters and EGL-18 anti-sera had been 
previously shown to be strongly expressed in seam 
cells, neurons in the head, VPCs and hyp7 cell, 
amongst others (Koh & Rothman 2001; Koh et al. 
2002), but never before in the HSN cell. To study egl-
18 expression we used the fosmid strain stIs11606 
(Dr. Waterston laboratory). We observed fluores-
cent expression in the HSN in all larval stages and 
in adult worms → Figure 3.2.14-A and B. egl-18 ex-
pression in embryos was broad, so we assessed ex-
pression in the embryonic HSN crossing unc-86::yfp 
reporter into the egl-18::mCherry background. Both 
reporters co-localised in the HSN postmitotic cell 
at 7 hpf. Using the tph-1 reporter zdIs13, we deter-
mined that egl-18 is also expressed in the NSM neu-
ron, but not in the ADF in adult worms.
For the two other TF members, however, there was 
no available fosmid. To study egl-46 expression 
we injected N2 worms with a transcriptional re-
porter that covered all the intergenic region (4,477 
bp) (kindly provided by Dr. Pocock) to create the 
vlcEx324 extrachromosomic reporter line. Although 
DsRed expression was rather variable from scor-
ing to scoring, we detected expression in the HSN 
in all larval stages and in adult worms in 50-60% of 
the cases → Figure 3.2.14-A and B. We did not as-
sess expression in the embryo as it had been al-
ready described that egl-46 expression in the HSN 
starts at 1.5 fold stage (Wu et al. 2001). As with the 
previous TFs, egl-46 is expressed in additional neu-
rons in the head, ventral nerve cord and tail (Wu et 
al. 2001). We also determined that it is expressed in 
the NSM neuron, but not in the ADF neuron.
Finally, to examine ast-1 expression we first ana-
lysed the fusion reporter line hdIs42 that contains 
the entire coding sequence of ast-1 (Schmid et al. 
2006). YFP was observed in the nuclei of approxi-
mately 40 neurons in the worm, but not in the HSN 
neuron. As a way to test if the gene product of the 
hdIs42 array was functional and rescued the ast-1 
HSN phenotype, we crossed it with ast-1(hd92) le-
thal mutants. The array was not able to rescue 
ast-1 lethality, indicating that it missed relevant 
information for its proper expression. As we be-
lieved that ast-1 must be expressed in the HSN, in 
the same way as the rest of its partners, we decid-
ed to generate CRISPR-Cas9 mediated GFP protein 
knock-in, tagging AST-1 protein at the C-terminus. 
More than ten integrated lines were recovered and 
all were undoubtedly expressed in the adult HSN 
→ Figure 3.2.14-A and B. We chose one line to
study the expression and temporal pattern of the
gene (ast-1(vlc19[ast-1::gfp])). Interestingly, AST-
1::GFP signal was first detected in the HSN at late
L3 larval stage and was increasingly up-regulat-
ed until the adult stage, when almost a 100% of the
worms showed GFP in the cell. Moreover, it was ex-
clusively detected in neuronal nuclei, in contrast to
what was previously described (Schmid et al. 2006). 
Apart from HSN, we scored 30-32 neurons in the
head, two HSNs, two PDEs and two ALN neurons in
the tail plus another four neurons in the tail. We did
not observe expression in the NSM or ADF seroton-
ergic neurons. 
In summary, the six members of the HSN regula-
tory code are expressed in the HSN but the onset
expression varies among the different TFs. unc-
86, sem-4, egl-18 and egl-46 are expressed from
early embryo or L1 stage and during the whole
life of the worm, while ast-1 specifically acti-
vates its expression in the cell in the transition be-
tween L3 and L4 stages. The five of them would
be co-expressed at the larval stage 4, when HSN
differentiates and starts expressing most ter-
minal features. In contrast, hlh-3 is only detect-
ed in the HSN at embryonic stages, prior to the
onset of HSN terminal differentiation. As afore-
mentioned, bHLH TFs have a proneural role during
neurogenesis and contribute to the specification
of progenitor-cell identity (Bertrand et al. 2002). 
This could suggest that hlh-3 acts earlier in the de-
velopmental history of the HSN neuron. However, 
HSN sister neuron is not affected in hlh-3 mutant 
background → Figure 3.2.7. There are examples 
in C. elegans where bHLH proneural genes, such 
as lin-32 and hlh-2, have also later roles in terminal 
neuron differentiation (Portman & Emmons 2000). 
HSN terminal differentiation involves parallel 
pathways
To further explore how the HSN TF code regulates 
HSN terminal fate we aimed to assess if they show 
cross-regulation. We analysed TF expression of the 
previously analysed reporters in the different mu-
tant backgrounds of young adult worms. We select-
ed this age for analysis because the HSN neuron 
already should have become mature. For hlh-3 re-
porter analysis, as it is only expressed in the em-
bryo, expression was assessed in 5 hours old 
embryos. → Figure 3.2.15 shows how individual 
factors affect the expression of the different TF re-
porters. Although statistics between wild type and 
mutant values were calculated using raw data, we 
have represented in the graphs mutant values rela-
tive to wild type values for an easier interpretation. 
Moving on to the analysis, the ast-1(ot417) mutation 
does not affect the expression of any other 
HSN code member. The same happens with egl-
18(ok290) and egl-46(sy628) mutants, with the 
exception of egl-46 mutants that show a small 
but significant decrease in ast-1 expression 
→ Figure 3.2.15-A, → Annex 3.2.6. This implies
that AST-1, EGL-18 and EGL-46 TFs are not required 
for the expression of the rest of the code. Note that 
for egl-46 expression analysis in egl-18(ok290) mu-
tants, kuIs34 strain could not be used due to an in-
compatibility in chromosome location. Instead, the
kuIs35 transgene was used, which corresponds to
an independent integration event of the same con-
struct as kuIs34 (Grant et al. 2000). Although we
did not characterise kuIs35 in the same depth as
kuIs34, both transgenes seemed to show identical
expression patterns. 
In contrast to the previous cases, UNC-86 seems
to be required for the expression of several mem-
bers of the HSN TF code. We observed a severe
phenotype in unc-86(n846) mutants upon ast-1 ex-
pression, sem-4 expression and egl-46 expression. 
sem-4(n1971) and hlh-3(tm1688) mutants, in turn,
also seem to affect ast-1 expression. hlh-3(tm1688) 
mutants show an additional mild phenotype over
egl-46 expression → Figure 3.2.15-A. Our results
EGL-18
tph-1 bas-1 cat-1
UNC-86UNC-86
AST-1 AST-1
UNC-86
Figure 3.2.13 
Summary of EMSAs: UNC-86, 
AST-1 and EGL-18 bind to 
serotonin pathway gene CRMs 
in electrophoretic mobility 
assays 
UNC-86 binds to tph-1, cat-1 
and bas-1. AST-1 binds to 
bas-1 and cat-1, but not to 
tph-1, at least with the probe 
and under the conditions 
tested. EGL-18 binds to cat-1, 
but not to either tph-1 probe 
tested.
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Figure 3.2.14 
Expression of the HSN 
regulatory code in the HSN 
neuron
A) Developmental expression 
of the six TFs in the HSN 
neuron, using fluorescent 
reporters. Expression of all, 
except hlh-3, was maintained 
in adult animals. Strains 
used: otIs337(unc-86::yfp), 
wgIs75(sem-4::gfp) and 
stIs11606(egl-18::mCherry) 
fosmid reporters; 
vlcEx324(egl-46::DsRed) 
transcriptional reporter; 
ast-1[vlc19(ast-1::gfp)] 
CRISPR-Cas9-mediated 
gfp knock-in. Error bars 
indicate standard error of the 
proportion (SEP). n>50 worms 
at every developmental stage.
See Annex 3.2.6. 
B) Micrographs showing 
expression of the HSN 
regulatory code in adult and 
embryonic HSN neurons. 
Pictures correspond to the 
same reporters as in A), 
except for sem-4, where the 
brighter kuIs34 transcription-
al reporter is shown. 
DIC images show the HSN 
nucleus and soma (top panel), 
while fluorescence images 
show expression in the cell 
(bottom panel). hlh-3 was only 
detected in the HSN precursor 
(PHB/HSN), prior to the last 
mitotic division. hpf: hours 
post-fertilisation. 
Adult worms 5 hpf embryo
hlh-3
HSN
unc-86 sem-4 egl-46 ast-1 egl-18
5 µm 10 µm
seem to indicate that UNC-86, SEM-4 and HLH-3 
TFs are required for proper ast-1 expression in the 
HSN. As UNC-86 regulates sem-4 expression, loss 
of ast-1 expression in unc-86 mutants could be in-
directly due to sem-4 loss. Alternatively, ast-1 ex-
pression may require both SEM-4 and UNC-86.
To discard the possibility that no phenotype was 
observed in ast-1(ot417) animals due to the hypo-
morphic nature of the mutation, we analysed the 
expression of the same reporters in ast-1(hd92) null 
mutants at larval stage 1. Again, no significant ef-
fect was observed, supporting the idea that AST-1 
is not required for the expression of the rest of the 
HSN regulatory code → Figure 3.2.15-B.
Regarding hlh-3 expression analysis at embryonic 
stages, only loss of EGL-18 protein seems to slight-
ly affect its expression → Figure 3.2.15-C. We have 
previously shown that egl-18 is expressed as early 
as unc-86 (7 hpf). However, this observation sug-
gests that egl-18 must be already expressed at this 
earlier embryonic stage (5 hpf) in order to regulate 
hlh-3 expression in the HSN precursor.
Next, in the few cases where we observed cross-reg-
ulation between factors, we wanted to check if this 
effect could already be observed at early develop-
mental stages, what would suggest a role in initiat-
ing the expression, or, on the contrary, it could be 
specific to late stages, indicating a role in mainte-
nance of expression → Figure 3.2.15-B. We as-
sessed sem-4 and egl-46 expression in the HSNs 
of unc-86(n846) mutants, at L1 larval stage. While 
sem-4 still showed significant reduced expression 
in the cell supporting the requirement of UNC-86 
to start its expression, egl-46 levels were compa-
rable to wild type. The same occurred with egl-46 
expression in hlh-3(tm1688) mutant animals. This 
indicates that UNC-86 and HLH-3 are required for 
the maintenance but not for the initiation of egl-46 
expression in the HSN. Regarding AST-1, this TF is 
not expressed till late third larval stage so L1 scor-
ing could not be addressed.
Our genetic interaction analysis, summarised in 
→ Figure 3.2.15-D, suggests that the expres-
sion of the six TFs is mainly independent of each
other, which strongly suggest that the TFs regulat-
ing HSN terminal differentiation act through paral-
lel pathways. However, we do see certain degree of 
cross-regulation between TFs, where some players 
like UNC-86 seem to act higher in the pathway to
assure the expression of other members of the HSN 
TF code, while the rest of the players seem to ex-
clusively act at the terminal level. Moreover, AST-1
expression seems to be tightly regulated by other
members. Importantly, regardless of the presence
or absence of cross-regulation, our previous mu-
tagenesis experiments and EMSA analyses, show
that all of them act at the terminal level of HSN dif-
ferentiation regulating in parallel the expression of
the 5-HT pathway genes.
AST-1, UNC-86, SEM-4, EGL-46 and EGL-18 
are continuously required to maintain the 
serotonergic identity in the HSN
Although specific features of individual neurons are 
remarkably plastic, most neuron identity features 
remain stable throughout the life of a terminally dif-
ferentiated postmitotic neuron. Neuron types and 
their elaborate con nectivity patterns are main-
tained for up to many decades of life in mitotically 
quiescent cells. It is believed that gene regulatory 
programmes launched early in fetal life to specify 
neuronal type identities continue to function later 
in life to maintain the correct differentiated state 
and that interference with these maintenance 
mechanisms can lead to loss of neuron identity, 
function and circuitry (Deneris & Hobert 2014). We 
just have shown that AST-1, UNC-86, SEM-4, EGL-
46 and EGL-18 are expressed in the HSN of adult 
worms. Therefore, we explored if the stable sero-
tonergic identity of the HSN requires the continu-
ous action of the HSN TF code in the cell.
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D) Summary schematic of the 
cross-regulation relationships 
between TFs. UNC-86 is 
epistatic to SEM-4, EGL-46 
and AST-1 or, alternatively, 
ast-1 reduced expression 
in unc-86 mutants is due to 
an indirect effect of SEM-4 
control over AST-1. EGL-18 is 
also epistatic to HLH-3 and 
HLH-3 is, in turn, epistatic to 
EGL-46.
A) Quantification of reporter 
expression at adult stage 
in the unc-86(n846), 
sem-4(n1971), egl-46(sy628), 
ast-1(ot417) and egl-18(ok290) 
mutant backgrounds. 
Mutant expression relative 
to wild type expression is 
represented. Strains used: 
otIs337(unc-86::yfp) and 
stIs11606(egl-18::mCherry) 
fosmid reporters;
kuIs34(sem-4::gfp), 
kuIs35(sem-4::gfp) and 
vlcEx324(egl-46::DsRed) 
transcriptional reporters; 
ast-1[vlc19(ast-1::gfp)] 
CRISPR-Cas9-mediated 
gfp knock-in. n>50 worms 
per condition. Statistical 
significance was calculated 
using the two tailed Fisher 
exact test, *: pV< 0.05. 
See Annex 3.2.6. 
B) Quantification of reporter 
expression at L1 larval 
stage in the ast-1(hd92) 
L1 lethal mutants and in 
the unc-86(n846) and 
hlh-3(tm1688) mutants 
that showed expression 
defects at adult stages.
C) Quantification of 
otEx4140(hlh-3::yfp) fosmid 
reporter expression at 
5 hours post-fertilisation 
(hpf) in the five null mutant 
backgrounds (unc-86(n846), 
sem-4(n19719), egl-46(sy628), 
ast-1(hd92) and egl-18(ok290)). 
n>35 embryos per condition. 
Statistical significance was 
calculated using the two tailed 
Fisher exact test, *: pV< 0.05.
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Figure 3.2.15 
Cross-regulation between 
the six members of the HSN 
regulatory code
?
EGL-46 SEM-4 AST-1 HLH-3 EGL-18
UNC-86
Strong defect (>50% expression)
Partial defect (25-50% expression)
Minor defect (10-24% expression)
Direct or indirect effect
To address if these TFs are required for a maintained 
expression of the 5-HT pathway genes in the neu-
ron, we took advantage of the readily available RNAi 
technology in C. elegans. → Figure 3.2.16-A de-
scribes the experimental set up to knock down the 
expression of our candidates after HSN maturation. 
Of note, as HLH-3 was not expressed in the adult 
HSN, it was not considered for the maintenance 
analysis. We used the rrf-3 (pk1426) neuronal RNAi 
sensitised strain carrying the tph-1 fosmid report-
er (otIs517). Worms were grown under normal bac-
teria (OP50) until young adult stage, when HSN has 
already matured. At this time point tph-1 expres-
sion in the HSN was assessed, ranging between 
93-98% in all of the cases, and then worms were 
transferred to RNAi treated plates. These plates 
contained dsRNA for ast-1, unc-86, sem-4, egl-46 
and egl-18. As a positive control, dsRNA against gfp 
was used. As a negative control the empty vector 
L4440 was used. Animals were allowed to grow at 
15 °C for three days before the final scoring. This 
was considered enough time to allow GFP signal to 
degrade and see any possible defects in tph-1 ex-
pression in the cell. The temperature was set at 15 
°C to diminish the metabolic rate of the worms and 
allow for late scorings → Figure 3.2.16-A. Under 
these experimental conditions, if any of our candi-
dates is required for the maintenance of the tph-1 
gene in the adult and aging HSN cell, after RNAi 
knock down of the gene, fluorescent protein ex-
pression should be lost. On the contrary, if they are 
not required for this process, expression in the cell 
should remain invariant. In all cases, we observed a 
decrease in the tph-1::yfp signal → Figure 3.2.16-B, 
→ Annex 3.2.3. These results reveal that all mem-
bers of the HSN TF collective that are expressed in 
adult HSN are required for identity maintenance.
Overexpression of the HSN regulatory code is 
sufficient to induce serotonergic fate in some 
cellular contexts
We have shown that a specific combination of six 
TFs is co-ordinately and continuously required for 
proper terminal differentiation of the HSN neuron. 
Next we wanted to explore if, in the same way as 
depletion of any of these candidates causes gen-
eral loss of identity in the HSN, ectopic expression 
of any of these candidates in other cells could force 
the serotonergic fate. This is not unconceivable as 
there are plenty of examples in C. elegans and in 
vertebrates where ectopic expression, or miss-ex-
pression, of specific factors leads to the produc-
tion of extra cells with that particular fate (Duggan 
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et al. 1998; Flames & Hobert 2009; Lodato et al. 2014) 
To address whether the HSN regulatory code is 
not only necessary for proper differentiation of the 
neuron but also sufficient, we used the heat shock 
inducible promoter hsp-16.2 to ectopically induce 
expression of all the members of the code, either 
individually or in combination, at two developmen-
tal times: embryogenesis and L1 larval stage.
The heat shock response, a temperature-depend-
ent stress defence mechanism, offers a straight-
forward strategy for temporal control of transgene 
expression. The heat shock response is common 
to bacteria, plants and mammals. In C. elegans, it is 
mediated by heat shock factor 1 (HSF1), a TF that is 
synthesised constitutively but remains latent dur-
ing unstressed conditions (Lis & Wu 1993). In re-
sponse to heat stress, HSF1 trimerises and binds 
with high affinity to promoters containing specif-
ic binding elements, leading to the transcription 
of different families of heat shock proteins (HSPs) 
(Pelham 1982; Lis & Wu 1993). Thus, transgenes con-
taining HSF1-binding elements (hsp promoters) 
can be induced, albeit with little cellular specifici-
ty, following a shift to stressful temperatures. Such 
hsp promoters are frequently used in C. elegans 
as drivers of gene expression in a time-controlled 
manner. The hsp-16.2 promoter drives expression 
most strongly in hypodermal cells and neurons, 
while the hsp-16.41 promoter is more efficient in di-
recting expression in the intestine and pharyngeal 
tissue (Fire et al. 1990). We chose the former for our 
analysis, reasoning that the HSN regulatory code, if 
able, would induce the serotonergic fate in neurons 
more easily than in non-neuronal tissues.
The strains used in the analysis are N2 worms ex-
pressing the cDNA of the six TFs under the control 
of the hsp-16.2 promoter (what we call the ‘heat 
shock array’). Due to the extrachromosomal nature 
of the strains, the red ttx-3::mCherry co-marker al-
lowed us to identify animals bearing the heat shock 
array. As a serotonergic identity marker we chose 
tph-1, which is specifically expressed in serotoner-
gic neurons and is not shared by other monoamin-
ergic neurons.
We carried out a lineal study to know which was 
the optimum time to induce expression of two fac-
tors, ast-1 and unc-86, in terms of average number 
of tph-1::gfp expressing cells in the whole popula-
tion of heat shocked embryos. Starting with ast-1, 
we analysed embryos that the day before had re-
ceived a heat shock (20 min at 37 °C) at different 
developmental times: 180 min after first cleavage 
(3 hpf), 300 min after first cleavage (5 hpf), 420 min 
after first cleavage (7 hpf) and 540 min after first 
cleavage (9 hpf) → Figure 3.2.17. Optimum time 
for ast-1 expression was 7 hpf, coinciding with the 
start of embryonic elongation (mean ± SEM: 7 ± 
0.4 cells), followed by 5 hpf (6 ± 0.8 cells), corre-
sponding to the start of embryonic neurogenesis 
→ Figure 3.2.17-A. Embryos that received the heat 
shock at 3 hpf, at the start of gastrulation, showed
no more than 4 tph-1::gfp expressing cells or no GFP 
at all, suggesting embryo arrest or embryo death.
For this reason, we did not consider this tempera-
ture in the study of unc-86. The optimum tempera-
ture for unc-86 over expression was 5 hpf (9 ± 1.4
cells), followed by 7 hpf (6 ± 0.8 cells). The same re-
sults were observed for the last temperature an-
alysed (9 hpf, 6.0 ± 0.5 cells) → Figure 3.2.17-B. 
Considering that the difference in number of
tph-1::gfp expressing cells between the two treat-
ments (5 hpf and 7 hpf) is greater for unc-86 than
for ast-1, we decided to select 5 hpf as the standard 
time point for heat shock treatment in the analysis
of the HSN regulatory code. Moreover, it has also
been reported that ast-1 over expression at 5 hpf
conferred the maximum response in dat-1::gfp (do-
paminergic marker) expressing embryos (Flames & 
Hobert 2009). 
Following the same heat shock protocol we ectop-
ically expressed the six members of the HSN reg-
ulatory code individually and scored the resulting
number of tph-1::gfp expressing cells. As control 
we used heat shocked reporter animals (zdIs13), 
without the heat shock array (termed ‘wild type’). 
We analysed different independent lines with the 
exception of the ast-1 strain that was integrated. 
→ Figure 3.2.18-A shows the mean and stand-
ard error of the mean of tph-1::gfp expressing cells
in the whole population of embryos bearing the
heat shock array (ttx-3::mCherry positive), pool-
ing together the different lines for the same TF.
→ Figure 3.2.18-B shows this information broken
down into the different lines → Table 3.2.1 and
→ Table 3.2.2. Our results indicate that over ex-
pression at embryonic stages of ast-1, unc-86 and
sem-4, but not hlh-3, egl-46 and egl-18 provokes 
an increase in the number of tph-1::gfp expressing 
cells, in comparison to wild type.
Next, we decided to analyse the effect of the com-
bined expression of the 6 members of the HSN reg-
ulatory code (termed ‘combo 6’), and also of the 
three members that significantly increased the 
number of tph-1::gfp cells in the population: ast-1, 
unc-86 and sem-4 (termed ‘combo A+U+S’), to see 
if tph-1::gfp ectopic expression could be enhanced. 
Indeed, both combinations achieved a higher num-
ber of tph-1::gfp expressing cells (combo A+U+S: 
mean = 10.7 ± 0.5; combo 6: mean = 10.2 ± 0.6) that 
A) Experimental set up for 
RNA interference assay. 
rrf-3(pk1426) animals are 
grown at 20 °C on normal 
food (E. coli OP50 strain) until 
late L4 stage, when the 5-HT 
pathway genes activate their 
expression in the HSN neuron.
Animals were scored for 
tph-1::yfp expression in the 
HSN neuron (day 0). Next,
animals were moved to plates 
containing RNAi treated bac-
teria (HT115); RNase deficient 
E. coli strain transformed 
with individual clones for the 
unc-86, sem-4, egl-46, ast-1 
and egl-18. Animals were 
allowed to feed upon this food
during 72 hours, at 15 °C, and 
then tph-1::yfp expression in 
the HSN was scored (day 3).
B) Loss of function (RNAi) 
experiments after HSN 
differentiation show that 
AST-1, UNC-86, SEM-4, 
EGL-46 and EGL-18 are 
required to maintain proper
tph-1 expression.
L4440 is the .empty vector 
usead as negative control. 
n > 50 worms per condition. 
Statistical significance was 
calculated using the two 
tailed Fisher exact test;  
*pV < 0.05. See Annex 3.2.3. 
Figure 3.2.16 
Requirement of the HSN 
regulatory code for the 
maintenance of HSN identity
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was statistically different from wild type animals 
and from all single members except for unc-86. 
However, there was no difference between ec-
topic expression of the complete HSN regulatory 
code (combo 6) and combo A+U+S. Again, joint-
ly or independent analysis of the lines showed the 
same results, except for the difference between 
sem-4 and combo A+U+S, which is no longer sta-
tistically significant → Figure 3.2.18-A, B and E, 
→ Table 3.2.1 and → Annex 3.2.7. 
We realised that in → Figure 3.2.18-A and B there
are two components contributing to the ectopic
number of tph-1::gfp positive cells: the total number 
of GFP positive cells that every individual embryo
expresses, and the total number of embryos that
respond to the heat shock. For this reason we next
treated our data separately and represented, on the 
one hand, the average of tph-1::gfp positive cells per 
‘positive embryos’ (>4 tph-1::gfp cells) in compari-
son to all wild type animals → Figure 3.2.18-C for 
combined lines, and → Figure 3.2.18-D for individ-
ual lines). In this way we see how embryos, in which 
over expression of a factor (or factors) has an ef-
fect, differ from wild type animals. Notably, the
maximum number of tph-1::gfp positive cells scored 
in wild type animals is six → Table 3.2.1 and 3.2.2, 
two more than expected. This additional pair cells
are ASG neurons. Other reports have also de-
scribed that 5% of ASG neurons express tph-1::gfp 
in normoxic conditions (Pocock & Hobert 2010).
On the other hand, we represented the percent-
age of ‘positive embryos’ in relation to the total
number of embryos analysed, to see the ability
that a particular TF, or a combination of them, has
to elicit an ectopic response → Figure 3.2.18-F. 
→ Figure 3.2.18-C shows that embryos that re-
spond to over expression of ast-1, unc-86, sem-4, 
hlh-3, egl-18, combo A+U+S and combo 6, but not to 
egl-46, show higher numbers of serotonergic-like
cells that wild type animals, being unc-86 the sin-
gle factor that produces the most tph-1::gfp + cells
(mean = 11.1 ± 0.5; maximum = 18) → Table 3.2.3. 
→ Figure 3.2.18-G shows representative images
of ‘positive embryos’ and non-responding embry-
os. Although combo A+U+S and combo 6 show em-
bryos with up to 19 and 20 cells, respectively, their
means (combo A+U+S: 11.6 ± 0.4; combo 6: 11,2 ±
0.6) are not statistically different from unc-86 sin-
gle over expression and neither are their means
different from each other. However, sem-4 single is 
statistically different from combo ‘A + U + S’ but not 
to combo 6, and ast-1, hlh-3 and eg-18 singles are
statistically different to both combos. Similar re-
sults are obtained when considering the different
lines individually → Figure 3.18-D, → Table 3.2.4.
Regarding the percentage of embryos that re-
spond to the heat shock treatment (‘positive em-
bryos’), → Figure 3.2.19-F clearly shows that over
expression of the members of the HSN regulato-
ry code (either individually or in combination) dra-
matically increases the number of embryos that
show more than 4 GFP positive cells in all treat-
ments. Although overexpression of egl-46 did not
lead to a higher mean number of tph-1::gfp positive
cells compared to wild type animals, the fraction of 
embryos that are able to express  the serotonergic
marker in more than four cells is higher than wild
type animals (pV=0.0026). Remarkably, ‘singles’
render lower percentages of positive embryos than 
‘combos’, with the exception of sem-4 that shows
no statistical difference only with combo 6 (pV=
0.0967). Moreover, there are two clearly differenti-
ated groups within single factors: high responding
(ast-1, unc-86 and sem-4) and low responding (hlh-
3, egl-46 and egl-18). This correlates with the fact
that combo 6 does not further enhance the per-
centage of embryos that are able to respond to the
ectopic expression of the complete HSN regulatory 
code, in comparison to combo A + U + S. For specif-
ic data see → Annex 3.2.7.
Overexpression of the HSN regulatory code, either
of single members or in combination, inhibited pos-
Figure 3.2.17 
Lineal study of ast-1 and 
unc-86 ectopic expression  
in the embryo
A) Schematic representation 
of the heat shock-induced 
ast-1 and unc-86 factors
B) Schematic representation
of the heat shock-induced 
ast-1 overexpression 
experiments 
Embryos carrying the heat 
shock array received the 
treatment (20’ at 37 °C) at
different developmental 
time points, and were scored 
the next day (23 hours 
post-fertilisation). Red lines 
indicate misexpression of the 
gene. Green lines represent 
the mean number of GFP cells 
after the treatment and error
bars represent the standard 
error of the mean (SEM). ast-1 
and unc-86 overexpression 
leads to ectopic tph-1::gfp 
expression in 7 and 8 cells, 
respectively, compared to 4 
gfp cells in wild type.
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terior development of the worms. Embryos rarely 
reached comma stage or, if they did, their morphol-
ogy was so atrophied that the embryonic stage was 
difficult to determine. This did not occur, however, 
in the majority of the wild type worms. We argued 
that if we over expressed the HSN TF collective at 
posterior developmental times, we would allow 
worms to grow and we would be able to identify the 
ectopic GFP cells, if any, as neuronal or non-neu-
ronal. For this reason, we decided to perform simi-
lar analyses at the first larval stage. 
Taking into consideration the results obtained in 
the previous heat shock over expression experi-
ments, we decided to analyse ectopic expression 
at L1 stage of the ‘high responding’ strains (ast-1, 
unc-86 and sem-4). As we observed no differences 
between the two combos used, we selected combo 
6 for L1 overexpression. The heat shock regime fol-
lowed was different: we heat shocked a synchro-
nised population of L1 larva three times (30 min, 
37 °C) with 2 hours resting intervals at 20 °C. 
Worms were scored the next morning, when most 
of them were already L2 larva although some re-
mained at L1 stage. In this case, ectopic expres-
sion of tph-1::gfp was not as broad as during 
embryonic development. In animals where we in-
duced ectopic expression of ast-1, we repeated-
ly observed tph-1::gfp expression in two pairs of 
neurons in the tail. 27% of the worms analysed 
(20/74) showed GFP in at least one and up to four 
cells in the tail → Figure 3.2.19-B. Due to its mor-
phology, position and co-localisation with other 
reporters (lgc-55, unc-17, ast-1, unc-86 but not eat-
4) we identified the pair that stains fainter as ALN 
→ Figure 3.2.19-A. The identity of the other pair 
of neurons remains uncertain. Moreover, 7% of 
worms (7/74) showed GFP expression in the PVT 
neuron → Figure 3.2.19-A and B. This neuron is 
unilateral and has a big soma, making it really easy 
to identify. However, this value was not statistical-
ly different from wild type, as a small percentage 
of them (3%) also showed GFP expression in this 
cell (pV=0.2975). Nonetheless, overexpression of 
unc-86 induces tph-1 expression in the PVT cell in 
69% of the cases (pV<0.0001) and sem-4 over ex-
pression in 17% of the worms (pV=0.04). Also in 
hsp::unc-86 and hsp:.sem-4 heat shocked animals, 
tph-1::gfp is observed in a single unidentified neu-
ron in the head (91% in the first case, 33% in the 
second) → Figure 3.2.19-A and B. None of these 
strains show tph-1::gfp expression in the tail neu-
rons. When we ectopically express the six members 
of the HSN regulatory code, we do not observe an 
enhanced phenotype. Instead, it seems to reflect 
the previously reported phenotype of the additive 
single factor over expression → Figure 3.2.19-B. 
Thus, the ectopic induction of tph-1 expression 
seems mostly restricted to embryonic stages. This 
is probably due to the more compact state of the 
chromatin in mature postmitotic neurons. On the 
other hand, the limited effect observed with the 
embryonic induction of the six factors could sug-
gest that there are additional factors playing a role 
on the selection of the terminal genes expressed by 
the HSN neuron. 
HSN regulatory code shows both synergic and 
additive genetic interactions
Our phenotypic analysis of HSN regulatory code 
single mutants shows that all members of the HSN 
regulatory code are required for proper HSN ter-
minal differentiation. However, each null mutant 
often shows only partial defects in the expression 
of most analysed reporters (only unc-86 and to a 
less extent sem-4 generally show 100% off phe-
notypes) → Figure 3.2.5. Moreover, our cis-regula-
tory analysis indicates that all members of the TF 
regulatory code act on the CRMs to direct their ex-
pression → Figure 3.2.8-3.2.10. Cooperativity is 
common among TFs acting on the same enhanc-
er, via protein-DNA interaction and/or protein-pro-
Measure wt ast-1 unc-86 sem-4 hlh-3 egl-46 Combo 
A+U+S
Combo 
6
N 196 150 68 57 56 52 75 54
Mean 3.3 5.1 8.2 6.5 3.6 3.4 10.8 10.2
SD 1.2 2.2 4.7 2.5 1.8 1.3 4.5 4.6
SEM 0.1 0.2 0.3 0.3 0.2 0.2 0.5 0.6
Median 4 5 8 7 3 4 11 10
25-50% 
percentiles
2-4 4-7 4-12 5-8 2-5 2-4 8-15 6.75-
12.5
Max # 6 10 18 14 9 6 19 20
Ex 1 (Is) 1 (Is) 1 (Ex) 1 (Ex) 2 (Ex) 2 (Ex) 2 (Ex) 2 (Ex)
Table 3.2.1 
Variability and distribution 
analysis of tph-1::gfp expres-
sion in the whole population 
of embryos, considering the 
average of all lines 
 
Statistic description of 
embryonic over expression 
of the HSN regulatory code 
collective, considering the 
whole population of animals. 
Wild type values refer to 
tph-1::gfp expressing animals 
without the heat shock 
array. Combo A+U+S refers 
to the combination of ast-1, 
unc-86, sem-4. Combo 6 
refers to the combination of 
all the members of the HSN 
regulatory code. Independent 
lines analysed for individual 
factors are considered jointly. 
Is: integrated line, Ex: 
extrachromosomal array.
Table 3.2.2 
Variability and distribution 
analysis of tph-1::gfp 
expression in the whole 
population embryos, 
considering individual lines 
independently
See Table 3.2.1 for 
explanation.
Measure wt ast-1 unc-86 sem-4 hlh-3 egl-18 egl-46 Combo 
A+U+S
Combo 6
Lines 1 2 1 2 1 2 1 2
N 196 154 68 57 26 30 19 33 52 15 75 46 8
Mean 3.3 5.1 8.2 6.5 3.0 4.1 3.5 3.4 3.3 4.5 10.8 10.1 10.8
SD 1.2 2.2 4.7 2.5 1.1 2.1 1.2 1.3 2.1 2.2 4.5 4.8 3.4
SEM 0.1 0.2 0.7 0.3 0.2 0.4 0.3 0.2 0.3 0.6 0.5 0.7 1.2
Median 4 5 8 7 3 4 3 4 3 4 11 10 10.5
25-50% 
percentiles
2-4 4-7 4-12 5-8 2-4 2-6 3-4 2-4 2-5 2-6 8-15 6-14 9.25- 
12
Max # 6 10 18 14 5 9 6 6 5-7 6-6 19 20 17
Lines (Is, 
ex)
Is Is Ex  Ex Ex Ex Ex Ex Ex Ex Ex Ex Ex
166 167
Measure wt ast-1 unc-86 sem-4 hlh-3 egl-46 egl-18 Combo  
A+U+S
Combo 6
N 196 82 44 44 16 9 22 68 47
Mean 3.3 6.7 11 7.4 5.8 5.3 6.1 11.7 11.2
SD 1.2 1.3 3.1 2.1 1.1 0.5 1.1 3.6 4.0
SEM 0.1 0.1 0.5 0.3 0.3 0.2 0.2 0.4 0.6
Median 4 6 11 7 5.5 5 6 11 11
25-50% 
percentiles
2-4 6-7.25 8.25-13.75 6-8.75 5-6 5-6 5-7 9-15 8-14
Max # 6 10 18 14 9 6 10 19 20
positive 
embryos (%)
3.1 54.7 62.9 77.2 28.6 17.3 32.8 90.7 87.0
lines (Is. ex) 1 (Is) 1 (Is) 1 (Ex) 1 (Ex) 2 (Ex) 2 (Ex) 2 (Ex) 2 (Ex) 2 (Ex)
Table 3.2.3 
Variability and distribution 
analysis of tph-1::gfp expres-
sion in heat shock responding 
embryos, considering the 
average of all lines
Statistic description of 
embryonic overexpression of 
the HSN regulatory code. Wild 
type values refer to the total 
embryos analysed.  Single 
and combo values exclusive-
ly refer to heat shock-re-
sponding embryos; ‘positive 
embryos’ (carriers of the heat 
shock array and positive for 
the treatment > 4GFP cells). 
Combo A+U+S refers to the 
combination of ast-1, unc-86, 
sem-4. Combo 6 refers to the 
combination of all the mem-
bers of the HSN regulatory 
code collective. % of positive 
embryos refers to the pro-
portion of positive embryos 
regarding the total number of 
embryos analysed (positive 
and negative). Independent 
lines analysed for individual 
factors are considered jointly. 
Is: integrated line, Ex: extra-
chromosomal array.
Table 3.2.4 
Variability and distribution 
analysis of tph-1::gfp 
expression in heat shock 
responding embryos, 
considering individual lines 
independently.
See Table 3.2.3 for 
explanation.
Measure wt ast-1 unc- 86 sem-4 hlh-3 egl-46 egl-18 Combo 
A+U+S
Combo 6
Lines 1 2 1 2 1 2 1 2
N 196 82 44 44 2 14 4 5 1 2 68 39 8
Mean 3.3 6.7 11 7.4 5 5.9 5.25 5.4 15 7 11.7 11.3 10.8
SD 1.2 1.3 3.1 2.1 0 1.1 0.5 0.5 6.0 6.4 3.6 4.1 3.4
SEM 0.1 0.1 0.5 0.3 0 0.3 0.3 0.2 0.8 1.6 0.4 0.7 1.2
Median 4 6 11 7 5 6 5 5 0.2 0.6 11 11 10.5
25-50% 
percentiles
2-4 6- 7.25 8.25-
13.75
6 - 
8.75
5-5 5- 6.25 5.75-  
6
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tein interaction (Levo & Segal 2014). A readout of 
cooperativity is observing genetic interaction be-
tween TFs and a way to assess genetic interactions 
is doing double mutant analysis. Before presenting 
the results, we will explain the concepts of genetic 
interaction and cooperativity.
Frequently, genes interact with one another, dis-
torting simple Mendelian ratios or even leading to 
novel phenotypes. In general terms, a genetic in-
teraction occurs when two alleles affecting dif-
ferent genes combine within an organism to yield 
a phenotype not simply explained by adding to-
gether the phenotypes associated with each of 
the two alleles. Hence, when analysing a double 
mutant animal, the null hypothesis is that the two 
genes act in independent pathways and the ex-
pected outcome is that double mutant phenotype 
is the product of the sum of its component sin-
gle-locus effects (additive phenotype). Whatever 
deviates from this result will be considered syner-
gy or a genetic interaction. Synergy and genetic in-
teraction are terms indistinctly used by geneticists. 
Genetic interactions indicate a functional connec-
tion between two genes, which is distinct from 
physical interactions. Cooperative binding of TFs 
to the enhancer DNA is one mode of synergy. TFs 
can bind cooperatively to DNA interacting physical-
ly with another TF or cofactor, or without the need 
to physically interact, via changes in DNA acces-
sibility or DNA conformation (Levo & Segal 2014; 
Spitz & Furlong 2012) → Figure 1.5. It has been pro-
posed that the RNA polymerase II transcriptional 
machinery is designed to respond in a synergis-
tic (greater-than-additive) manner upon binding of 
multiple activators to achieve specificity to signal 
response. This is possible if an RNA pol II enhancer 
is organised in unique combinations of activators, 
closely packed, that promote their interaction and 
cooperative binding to DNA. In this way, the bind-
ing of one TF will facilitate o hamper the binding 
of another TF and the recruitment of the RNA pol 
II complex, hence affecting gene expression, in a 
greater-than-additive fashion (Carey 1998).
Although genetic analysis by itself will not allow for 
elucidation of the detailed molecular mechanism 
by which the members of HSN regulatory code in-
teract, it will allow us to distinguish between two 
situations: TFs bind independently to the DNA 
to regulate the expression of the 5-HT pathway 
genes, or they genetically interact in some way to 
achieve gene expression. A third situation can be 
envisioned, where one factor regulates the expres-
sion of the other (epistasis). W. Bateson coined the 
term epistasis to describe those cases where a 
mutation in one gene masks the effect of a muta-
tion in a second gene (Bateson 1911).  We have de-
Figure 3.2.18 
Induction of serotonergic fate 
through over expression of 
the HSN regulatory code at 
embryonic stages
Embryos carrying the heat 
shock array received the 
treatment (20’ at 37 °C) 
during neurogenesis (5 hours 
post-fertilisation) and were
scored the next day. Wild 
type animals (without the 
transgene) were compared to 
animals that over expressed 
ast-1, unc-86, sem-4, hlh-3,
egl-46 and egl-18 single factors, 
and the combinations of ast-1, 
unc-86 and sem-4 (combo 
‘A+U+S’) and the six factors 
(combo 6).
A), B) Mean number of 
tph-1::gfp expressing cells 
in the whole population 
of embryos analysed, 
considering independent lines 
together (A) or separately (B).
Error bars represent the SEM.  
n > 50 animals per condition. 
D'Agostino & Pearson 
omnibus normality test 
indicate that two groups, wild 
type and unc-86, do not
follow a normal distribution. 
L: independent line number. 
*: statistical significant 
difference between wild type 
and the rest of conditions 
using the non-parametric 
Kruskal-Wallis test with 
Dunn's correction for multiple 
comparisons. See Figure 
3.2.18-E for all comparisons.
C), D) Mean number of 
tph-1::gfp expressing cells 
exclusively in the population 
of heat shock responding 
embryos with more than 4 gfp 
positive cells (positive
embryos), considering 
independent lines together (C) 
or separately (D). D'Agostino 
& Pearson omnibus normality 
test indicate that none except 
unc-86, egl-46 and combo 6
follow a normal distribution. 
L: independent line number. 
*: statistical significant 
difference between wild type 
and the rest of conditions 
using the non-parametric 
Kruskal-Wallis test with 
Dunn's correction for multiple 
comparisons. See Figure 
3.2.18-E for all comparisons.
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Analysis of the heat shock-responding population of embryos (positive)
F) Percentage of positive 
embryos relative to the 
whole population of embryos 
analysed. All factors, alone 
or in combination, are able to 
enhance tph-1::gfp expres-
sion in more than 4 cells, 
when overexpressed during 
neurogenesis. Statistical 
significance was calculated 
using Fisher exact test; 
*pV<0.05. See Annex 3.2.7.
G) Representative images of a 
wild type (control animal that 
receive the heat shock but 
does not carry the heat shock 
array), a positive embryo 
(that carries the heat shock 
array and responds to the 
treatment) and a negative 
embryo (that carries the array 
but does not respond to the 
treatment).
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E) Statistical significance in 
(A)-(D) was calculated using 
Kruskal-Wallis non-paramet-
ric test, with Dunn’s multiple 
test correction. 
The schematic includes rela-
tionships between wild type, 
single factors and combina-
tions of factors, considering 
all the independent lines
for each condition together. 
See Annex 3.2.7 for complete 
statistical analysis. 
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Figure 3.2.19 
Induction of serotonergic 
fate in specific neurons 
through overexpression of 
the HSN regulatory code at 
larval stages
A) Micrographs showing 
ectopic tph-1::gfp expression 
in the head and tail of L1-L2 
larvae. Top panels show highly 
magnified DIC and fluores-
cence images of the neurons. 
White dotted circles indicate 
neurons whose identity has 
been determined (PVT and 
ALN), while red dotted circles 
indicate unknown neurons. 
The bottom panel shows a low 
magnification picture in order 
to visualise the anatomy of the 
worm. White arrows indicate 
PVT and ALN neurons, while 
red arrows indicate unknown 
neurons.
B) Percentage of larvae 
expressing tph-1::gfp in the 
head, PVT and at least one 
neuron in the tail, after the 
heat shock treatment. 
n > 30 worms per condition. 
Statistical significance was
calculated using the two 
tailed Fisher exact test; 
*pV < 0.05. See Annex 3.2.7.
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Synchronised population 
of animals bearing the heat 
shock array for ast-1, unc-86, 
sem-4, combo A+U+S and 
combo 6, received three
heat shock treatments (30’, 
37 °C) every two hours and 
were assessed for tph-1::gfp 
(zdIs13) expression the next 
day.
termined that unc-86 is epistatic of sem-4, and 
egl-46, sem-4 and to a less extent hlh-3 are epistat-
ic of ast-1 → Figure 3.2.15. In these cases, double 
mutant analysis cannot be used to assess cooper-
ativity. Alternatively, we can use hypomorphic al-
leles, although interpretation of the results is more 
difficult.
In order to better understand these genetic interac-
tion concepts and to interpret correctly the double 
mutant results presented next, we have included 
schematic representations of all possible outcomes 
in → Figure 3.2.20. → Figures 3.2.20-A-E show 
the case of two genes, a and b, that code for two 
TFs A and B that regulate the expression of gene 
x. In → Figure 3.2.20-A two recessive null loss-
of-function alleles, a₁ and b₁, show an incomplete
penetrant phenotype over the expression of gene
x. As an example, mutation in gene a shows 60%
expression of the gene (a₁ = 40% loss of gene ex-
pression), while mutation in gene b, leads to 80%
of expression in gene x (b₁ = 20%). When both mu-
tant alleles are present in homozygosis in the same 
animal gene x expression is 40% (a₁b₁ = 60%). So in
this case, assuming the null hypothesis of additivi-
ty a₁b₁ = a₁ + b₁ = 40% + 20% = 60%. The phenotype
observed matches a simple additive relationship
and thus, we infer that A and B act independently
→ Figure 3.2.20-B. By contrast, if the double mu-
tant phenotype also conferred 60% of gene x ex-
pression (40% off), we would infer that A and B act
together in the same linear pathway. As double mu-
tant phenotype mimics a₁ phenotype, this could be
interpreted as ‘epistasis’ where gene a is epistat-
ic to gene b (or gene b is hypostatic to gene a) 
→ Figure 3.2.20-E. 
Alternatively, double mutant analysis can unravel
synergistic enhancement. Considering, for exam-
ple, that single mutant a₁ shows a 40% reduction
in gene x expression (60% of the worms will still
express the gene) and single mutant b₁ shows a
20% decrease (80% on), if the double mutant a₁b₁ 
phenotype is that 90% of the animals lose the ex-
pression of gene x (and only 10% maintain it), 
we talk about genetic or synergic enhancement 
→ Figure 3.2.20-C. In this case, the addition of the
two single mutant phenotypes cannot explain the
total loss observed in the double mutant (a₁b₁ (90%) 
> a₁ + b₁ (40% + 20% = 60%)). Instead, if the double
mutant animals showed less phenotype than any
of the single mutants, then we would talk about ge-
netic or synergic suppression → Figure 3.2.20-D. 
Synergic interactions typically result from appar-
ent functional redundancy. One common reason
for redundancy involves genetic pathways that act
in parallel to elicit a similar outcome, where either
pathway can functionally compensate for the other. 
In these two cases, both genes will be acting in par-
allel pathways over the same substrate (gene x). In
our previous results we have seen some examples
of redundancy when analysing cis-regulatory mo-
tifs, thus we predict similar synergistic effects will
be found in our double mutant analysis. 
Finally, another type of genetic interaction, which
differs from synergic enhancement, is synthetic le-
thality. In this case, two independent mutations are 
viable on their own, but in combination they lead to
dead worms. In this case, both genes must geneti-
cally interact because neither allele alone provokes 
lethality. The lethal phenotype appears when both
alleles are combined; i.e. the lethal phenotype is
synthetic, meaning created de novo. These inter-
actions tell us that normally in the organism, both
genes work together to keep worms alive. 
To be able to detect synergy between the mem-
bers of the HSN regulatory code, we selected 
reporters for genes whose expression is only par-
tially affected in null mutants for the HSN TF col-
lective → Figure 3.2.5. We focused our analysis 
on tph-1, cat-1 and bas-1 gene expression because 
their HSN CRMs contain functional BSs for all six 
factors, thus we know all of them have a termi-
173
Figure 3.2.20 
Models of genetic interaction 
between transcription factors 
to regulate the expression of 
a gene.
A) A and B are two TFs that 
regulate the expression of 
gene x in a particular cell. 
a1 and b1 represent mutant 
phenotypes for gene a and b 
null loss of function alleles, in 
terms of loss of expression of 
gene x. a1b1 indicates double 
mutant phenotype. wt reflects 
normal levels of expression 
of gene x in that particular 
cell. Figures (A)-(D) represent 
hypothetical examples in 
which A and B act in parallel 
to regulate the expression of 
gene x, whereas in Figure E, 
A and B act in the same linear 
pathway. 
 
B) TFs act independently to 
regulate the expression of 
gene x; example of additivity. 
Double mutant for genes a 
and b exhibit a loss of expres-
sion in gene x comparable to 
the sum of the single mutant 
phenotypes. 
 
C) TFs genetically interact to 
regulate the expression of 
gene x; example of synergic 
enhancement. Double mutant 
phenotype is more severe 
than the sum of single mutant 
phenotypes. 
 
D) TFs genetically interact to 
regulate the expression of 
gene x; example of synergic 
suppression. Double mutant 
phenotype is less severe 
than the sum of single mutant 
phenotypes. 
 
E) TFs act in the same linear 
pathway to regulate the 
expression of gene x. In this 
example, a has an additional 
direct role on gene x. Double 
mutant phenotype mimics a1 
single mutant phenotype; A 
acts upstream to B and a is 
epistatic to b.
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nal role → Figure 3.2.8-3.2.10. For example, in 
→ Figure 3.2.21-A we show that bas-1 is slight-
ly affected in egl-46(gk692) (85±3% expression) 
and in hlh-3(tm1688) (49±5% expression) null mu-
tants but in the double mutants, bas-1 expression 
is completely abolished (0±0%, pV<0.0001). The 
double mutant phenotype is greater that the addi-
tion of both single mutant phenotypes (100% OFF 
compared to 15% + 51% = 66% OFF), thus our re-
sults indicate synergy between these two fac-
tors. Of note, from our cross-regulation studies, 
we know that HLH-3 down-regulates the expres-
sion of a transcriptional reporter of egl-46 in 20% 
→ Figure 3.2.15. Hence, perhaps hlh-3 mutant 
phenotype is due to its direct action on bas-1 ex-
pression together with the slight effect on egl-46 
expression. However, if egl-46 did not have an ad-
ditional effect in the regulation of bas-1, the double 
mutant would reveal that hlh-3 is epistatic to egl-
46 (as in the example → Figure 3.2.20-E). As this is 
not the case, we can conclude that HLH-3 and EGL-
46 act in parallel and show synergic enhancement 
over bas-1 regulation. 
As ast-1(hd92) allele shows larval lethality and we 
had previously shown that a mosaic ast-1 strain 
showed the same lack of phenotype for bas-1 ex-
pression as the ast-1(ot417) allele, we used this 
hypomorph allele in the analyses. Double mu-
tant ast-1; egl-46 abolishes completely the ex-
pression of the bas-1 gene, which largely exceeds 
the sum of single mutant phenotypes (pV<0.0001) 
→ Figure 3.2.21-A. Although cross-regulation 
analysis shows that EGL-46 downregulates in 5% 
the expression of endogenous ast-1 expression 
→ Figure 3.2.15, the double mutant has a much 
greater phenotype than egl-46 mutant alone, 
which indicates that both factors act synergis-
tically. Combining ast-1(ot417) with hypomorph 
alleles of unc-86(n848) or sem-4(n2654) also abol-
ishes bas-1 expression from the HSN (pV<0.0001) 
→ Figures 3.2.21-A. However, as ast-1 expression 
is dependent on unc-86 and sem-4, and this analy-
sis is done with hypomorphic alleles we cannot dis-
card that the synergism observed is due to partial 
epistatic effects on AST-1 → Figure 3.2.15. 
ast-1; hlh-3 and ast-1; egl-18 double mutant animals 
showed synthetic lethality. We know that absence 
of the 5-HT neurotransmitter is not lethal as tph-
1(mg280) null mutants are perfectly viable (Sze et 
al. 2000). Therefore, these results tell us that these 
TFs are acting together to regulate a different vital 
process and preclude us from their study in the 
5-HT pathway genes. 
Finally, we analysed the relationship between egl-
18 and hlh-3. Null mutants for the former gene show 
79±3% of bas-1 expression, while mutants for the 
latter 41±5%. Double mutants show 33±5%, which 
is slightly higher than expected by simple addition 
of phenotype (pV = 0.0355) → Figure 3.2.21-D. As 
hlh-3 single mutant phenotype is not statistically 
different form the double mutant phenotype (pV = 
0.2885), this is an example of epistasis, where hlh-3 
is epistatic to egl-18.
cat-1 is another 5-HT pathway gene whose expres-
sion in mutant animals is not completely deleted 
in some cases. Once again, we observed examples 
of synergic enhancement between TFs in the reg-
ulation this gene. For example, → Figure 3.2.21-A 
shows that egl-18 null mutants show wild type lev-
els of cat-1 expression (97±2%) and hlh-3 null mu-
tants only see its expression partially reduced 
(81±3%). Double mutants show 29±4% expres-
sion in the HSN, which exceeds the sum of pheno-
types (pV<0.0001). A similar phenotype is observed 
in the double mutant egl-18 null, sem-4 hypomorph 
→ Figure 3.2.21-A. As there is no cross-regulation 
between them, this phenotype likely reflects syn-
ergic enhancement between two parallel path-
ways. Interestingly, when we analysed the double 
null mutants between egl-46; egl-18 and egl-46; 
hlh-3, synergistic suppression was observed 
→ Figure 3.2.21-B. Focusing on the first case, egl-
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A) Examples of synergistic 
enhancement between 
different pairs of TFs that act 
in parallel routes to regulate 
the expression of the 5-HT
pathway genes. In all cases, 
the double mutant phenotype 
is greater than the sum of the 
single mutant phenotypes.
Figure 3.2.21 
Double mutant analysis to 
assess cooperativity between 
members of the HSN regula-
tory code in the regulation of 
the serotonin pathway genes
B)
C) D)
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B) Examples of synergistic 
suppression between 
different pairs of TFs. The 
double mutant phenotype is
smaller than the sum of the 
single mutant phenotypes. 
C) Examples of no cooper-
ativity. The double mutant 
phenotype can be explained
by the sum of the single 
mutant phenotypes. 
D) Example of epistasis, 
where both TFs act in the 
same linear pathway. The 
double mutant hlh-3, egl-18 
phenotype is equivalent to 
hlh-3 single mutant. 
E) Summary of all the genetic 
relationships observed in 
this work, considering those 
that have not been included 
in A-D. hyp: hypomorph alelle.
n>50 worms in each condition. 
Fisher exact test, *: pV< 0.05. 
For specific data and analysis 
see Annex 3.2.8.
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18 mutants show normal levels of cat-1 (97±2%) 
and egl-46 shows a partial phenotype (61±5%) but 
double mutants rescue cat-1 expression defects 
of egl-46 (94±2% expression in double mutants). 
Once more, this suggest that in the absence of egl-
18 additional factors could be recruited to the pro-
moters to induce expression. 
Lastly, we observed a couple of examples where 
TFs acted in an independent manner to con-
trol cat-1 expression. This is the case of the dou-
ble mutants hlh-3; unc-86 and unc-86; sem-4 
→ Figures 3.2.21-C.
Regarding tph-1 expression sem-4(n2654); egl-
18(ok290) double mutants show synergic enhance-
ment → Figure 3.2.21.A. Considering that reporter 
analysis does not show cross-regulation between 
them, these results suggest both factors act coop-
eratively to regulate expression. Interestingly, we 
find that sem-4 mutants in combination with ast-1 
mutants, shows antagonistic effects (synergic 
suppression) → Figure 3.2.21-B suggesting, once 
again, that in the absence of both factors addition-
al factors are recruited to the regulatory regions of 
those genes.
→ Figure 3.2.21.E summarises the different types
of genetic interactions observed between TFs of
the HSN regulatory code, regardless of the report-
er gene analysed. For specific data → Annex 3.2.8. 
Our double mutant analysis mainly detects syner-
gistic interactions between TFs, suggesting ex-
tensive cooperative relationships among them. 
This cooperativity can explain partial phenotypes 
observed in the single mutant analysis. Moreover, 
it gives us a hint of the great complexity of the sys-
tem, as different combinations of TFs synergise to 
regulate the expression of some genes but not in 
others.
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selects the HSN transcriptome
Chapter III
It is largely unknown why specific regions of the 
DNA function as active regulatory modules in some 
cellular contexts. TFs are the main regulators of en-
hancer function. Each enhancer is bound by spe-
cific combinations of TFs that will either activate or 
repress transcription (Reiter et al. 2017). TFBSs are 
small and degenerate, thus predicted matches for 
TFBSs are widely distributed throughout the entire 
non-coding genome. So far, it is impossible to pre-
dict which ones are actually bound by the corre-
sponding TF.
Our results suggest that the HSN regulatory code 
is required for broad HSN specification (and not 
only for 5-HT gene expression) and it acts direct-
ly on the regulatory regions of their target genes. 
Since the members of the code belong to six dif-
ferent TF families that recognise very different BSs 
→ Figures 3.3.1-A, we wondered whether the clus-
tering of BSs for the HSN regulatory code in puta-
tive regulatory regions of HSN expressed genes
might confer sufficient specificity to impose a de-
fining regulatory signature.
This part of the project was done in collaboration
with Dr. Alejandro Artacho, informatician at the
Department of Genomics and Health, in the Centre
for Public Health Research (CSISP). Carlos Mora,
PhD student, and Dr. Miren Maicas also participat-
ed in this part of the project.
The HSN signature is enriched in regulatory 
regions of HSN expressed genes.
First, based on the functional BSs  that we had pre-
viously identified → Figures 3.2.8-3.2.10, we built 
PWMs for each of the six TFBSs of the HSN regu-
latory code → Figure 3.3.1-A. There are 96 genes 
known to be expressed in the HSN (Hobert et al. 
2016), excluding panneuronal features, which are 
regulated in a very redundant manner (Stefanakis 
et al. 2015) → Annex 3.3.1. We analysed upstream 
and intronic sequences of HSN expressed genes in 
search of DNA windows (up to 700 bp length) con-
taining at least one PWM match for each of the six 
members of the code, termed from now on the ‘HSN 
signature’ → Figure 3.3.1-A. We compared the 
number of windows that contained the HSN signa-
ture in HSN expressed genes with a random set of 
100 genes → Annex 3.3.2. We realised that known 
HSN expressed genes contain large upstream and 
intronic sequences, thus, for comparison purposes, 
we selected random genes with similar upstream 
and intronic distribution → Figure 3.3.1-D and E. 
CRMs and regulatory enhancers comprise defined 
DNA regions usually ranging from 50 to 1500 bp. We 
tried different window sizes and obtained best re-
sults, in terms of largest difference between the 
two sets of genes analysed, using a maximum win-
dow size of 700 bp. This value is consistent with 
our regulatory analysis results in which the long-
est CRM is 522 bp (cat-1prom14), coinciding with 
the mean size of enhancers described for mouse 
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Figure 3.3.1 
HSN regulatory signature 
characterisation
A) Position Weight Matrix 
logos of the HSN transcription
factor code calculated from 
the functional BSs in Figures 
3.2.8-3.2.10.
B) Analysis of the number of 
genes with positive windows 
for the HSN regulatory 
signature. 66% of HSN 
expressed genes contain the 
HSN regulatory signature 
compared to only 50% of a 
comparable random gene set.
Statistical significance was 
calculated using Fisher exact 
test; *: pV<0.05. 
C) Inclusion of the conser-
vation criteria in the HSN 
signature analysis strongly
increases the difference 
between HSN and random 
genes. These result indicate
that the HSN regulatory 
signature is enriched in the 
regulatory regions of HSN 
expressed genes.
D) Comparison of upstream 
sequence length between 
HSN expressed and selected
random genes shows no 
significant differences. 
Statistical significance
was calculated using t test 
(pV=0.89) and wilcox test 
(pV=0.9). Similarly, compar-
ison of intronic sequence 
length between HSN 
expressed and selected
random genes shows not 
significant differences. 
Statistical significance 
was calculated using t test 
(pV=0.36) and wilcox test 
(pV=0.36).
E) Comparison of the number
of motifs per kilo base, con-
sidering upstream regulatory
regions, introns, and both 
together, in both gene lists. 
Density of TFBSs for the HSN
regulatory code (ETS, GATA, 
HLH, INSM, POU and SPALT 
BSs) is similar between HSN 
(pink) and random (green) 
genes. 
These experiments were 
performed in collaboration 
with Dr. Alejandro Artacho.
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Figure 3.3.2 
Functional distribution of the 
HSN regulatory signature 
HSN expressed genes are 
distributed in five function-
al categories. No significant 
difference was found in the 
distribution of these cate-
gories in all HSN expressed 
genes compared to genes 
with HSN regulatory signature 
or HSN genes with conserved 
signature. Statistical 
significance was calculated 
using Chi square test comput-
ing p-values by Monte Carlo 
simulation; pV = 0.59.
Total
33
HSN genes with
conserved signature
Total
96
HSN genes
Total
63
HSN genes
with signature
Morphogens
Axon guidance/migration
Transcription Factors
Neurotransmission
Others
embryonic stem cells (Whyte et al. 2013; Parker et al. 
2013). We found that a higher percentage of HSN ex-
pressed genes (66%) contained the HSN signature 
compared to the random gene list (50%), being the 
ratio between them 1.3 (pV<0.05) → Figure 3.3.1-B. 
We wondered if this difference could be due to a 
higher frequency of TFBSs for some or all members 
of the HSN regulatory code in the HSN expressed 
genes in comparison to random genes, or if it is 
due to specific clustering of the six classes of sites. 
For this purpose, we compared the number of mo-
tifs per kilo base, considering upstream regulato-
ry regions, introns, and both together, in both gene 
lists. → Figure 3.3.1-E clearly shows that there is 
no difference in the global number of BS matches 
for each TF found in HSN genes compared to ran-
dom genes. Thus, we conclude that this difference 
must be specifically due to the clustering of the dif-
ferent TFBS classes.
Non-coding regulatory regions evolve rapidly, 
which limits the use of direct multispecies align-
ment to identify regulatory regions (Villar et al. 
2014). In spite of the fast turnover of specific TFBSs, 
the regulatory logic itself is often conserved among 
species (Doitsidou et al. 2013; Flames & Hobert 2009; 
Villar et al. 2014). To analyse whether our HSN sig-
nature was also conserved, we performed similar 
bioinformatics analyses of the regulatory regions 
in additional Caenorhabditis species. Specifically, 
we selected HSN expressed genes that had ort-
hologues in at least two additional species of the 
Caenorhabditis genus (from the C. brenneri, C. re-
manei, C. briggsae and C. japonica genomes). We 
considered the HSN signature as phylogenetically 
conserved when orthologous genes in all species 
displayed the signature within their upstream or in-
tronic regions. We found that the inclusion of the 
conservation criteria in this analysis strongly in-
creased the difference between HSN and random 
genes; i.e. HSN expressed genes contain almost 
twice the number of windows with HSN conserved 
signature than random genes (ratio 1.8; pV<0.05) 
→ Figure 3.3.1-C. This suggests that the HSN sig-
nature is used by the HSN regulatory code to se-
lect the genes expressed in the neuron, and thus is
strongly preserved in evolution. 
Our results indicate that the HSN signature is only 
found in a subset of HSN expressed genes (64% in 
total HSN genes and 33% in HSN conserved genes). 
We reasoned that maybe only certain genes that 
develop a specific function or participate in a spe-
cific biological process were the ones containing 
the HSN signature. Hence, we explored signature 
distribution across gene categories. We divided 
the 96 genes expressed in the HSN into five groups: 
morphogen signalling (components of the Wnt, 
Notch pathway, etc.), axon guidance and migra-
tion, TFs, neurotransmission and others (terminal 
features, synaptogenesis and extracellular matrix 
components) → Figure 3.3.2, → Annex 3.3.1. The 
category that accounts for the highest percent-
age of genes known to be expressed in HSN is neu-
rotransmission (37%), followed by ‘others’ (28%), 
axon guidance and migration (15%), TFs (13%) and 
morphogen signalling (7%). Next we did the same 
only with the 63 HSN genes that contain the HSN 
signature and with the 33 genes that contain con-
served HSN signature. In both cases we saw sim-
ilar distribution of categories. Therefore, it seems 
that HSN genes with the HSN regulatory signa-
ture were equally distributed across functional 
categories compared to all HSN expressed genes 
→ Figure 3.3.2. This suggests that the HSN regula-
tory code acts broadly upon the HSN transcriptome 
and does not select specific functional subsets of
genes.
Our hypothesis is that the HSN signature selects 
HSN expressed genes. If this is true, then the iden-
tified windows should correspond to functional en-
hancers. We tested HSN signature windows from 
five genes by fusing PCR amplified HSN windows 
to gfp and injecting them into N2 worms. In vivo re-
porter analysis confirmed that they drive expres-
sion in the HSN neuron (4 out of 5 genes tested, 
→ Figure 3.3.3, → Table 3.3.1.) Of note, GFP was
not exclusively expressed in the HSN. Similar to our 
cis-regulatory analysis of the 5-HT pathway genes,
we noticed that C. elegans functional HSN signa-
ture windows do not show a high level of sequence
conservation, which is in agreement with rapid
evolution of regulatory sequences.
The HSN signature allows de novo identification 
of HSN expressed genes
Next, we aimed to identify new genes expressed in 
HSN based solely on the presence of the HSN sig-
nature. First, using the same strategy as before, 
we examined the distribution of the HSN signa-
ture windows across the entire C. elegans genome. 
We classified the genome in two groups: neuronal 
genes and non-neuronal genes. The first group, 
to which we subtracted the previously mentioned 
96 HSN expressed genes → Annex 3.3.1, consists 
of 1.839 genes. The second group corresponds to 
the remaining 18.786 protein coding genes from 
C. elegans genome (Hobert 2013, www.wormbase.
org). Remarkably, the HSN signature is preferen-
tially found in the putative regulatory sequences
of genes known to be expressed in neurons or that
have a neuronal function, compared to the rest of
the genome (ratio 1.7), as would be expected from
putative HSN expressed genes → Figure 3.3.4-A. 
As before, filtering of conserved signatures strong-
ly increased the difference between ‘neuronal’ and 
‘non-neuronal’ genomes, which adds support to its 
functionality (ratio 2.5) → Figure 3.3.4-B. Moreover, 
Gene Ontology analysis of all genes in the C. elegans 
genome with the HSN signature revealed enrich-
ment of processes characteristic of HSN differen-
tiation and function → Figure 3.3.4-C and D. For
example, we found that regulation of locomotion,
positive regulation of transcription and regula-
tion of cell differentiation are the most significant-
ly enriched processes → Figure 3.3.4-C, whereas
more than 200 and more than 100 genes are asso-
ciated to G-protein coupled receptor signalling and 
oviposition, respectively → Figure 3.3.4-D. The
main function of the HSN neuron is to regulate the
egg-laying behaviour (Desai et al. 1988), also HSN
regulates muscle contraction and thus is consid-
ered a motorneuron, which will correlate with loco-
motion as GO term, (Collins et al. 2016).
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Figure 3.3.3 
Validation of the functionality 
of HSN regulatory signature 
windows
In vivo reporter fusion analysis 
to test functionality of HSN 
signature windows in HSN 
expressed genes. Black lines 
represent the coordinates 
covered by bioinformatically
predicted HSN signature 
windows (indicated by ‘w’ and 
a number). Light blue lines 
indicate already published 
reporter constructs. Green 
lines indicate the region used
in our analysis. Dark blue bar 
profiles represent sequence 
conservation in C. briggsae,  
C. brenneri, C. remanei and
C. japonica. See Table 3.3.1 for 
a list of all reporters tested.
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Having characterised the HSN signature in the 
whole C. elegans genome, we attempted to iden-
tify de novo genes expressed in the HSN. To this 
end, we randomly selected 35 neuronal genes with 
a conserved HSN regulatory signature and gener-
ated transgenic reporter lines containing the pre-
dicted HSN signature → Table 3.3.1, → Table 2.21. 
As a control, we randomly picked 10 similar-sized 
intergenic regions of neuronal genes lacking the 
HSN signature → Table 3.3.1. We found that 13 out 
of the 35 constructs (37%) showed GFP expres-
sion in HSN, while none of the controls led to re-
porter expression in this cell → Figure 3.3.5-A-D, 
→ Table 3.3.1. We considered positive reporters
those that fulfilled any of these criteria: 1) expres-
sion in at least two independent lines in >10% of HSN, 
or 2) expression in one independent line in >20% of
HSN cells. Importantly, all reporter constructs, in-
cluding the negative controls, did drive GFP expres-
sion in other neurons → Figure 3.3.6, → Table 3.3.1.
Our results reveal that the presence of the HSN sig-
nature can be successfully used to de novo identi-
fy HSN expressed genes in more than one third of
the cases.
HSN functional enhancers exhibit a distance 
bias in relation to the start codon 
Next, we tried to identify any defining characteris-
tic of the HSN expressed windows (or functional en-
hancers). Multiple BSs for the same TF, also known 
as homotypic clusters of TFBSs, are statistically en-
riched in proximal promoters and distal enhancers 
and have been shown to enhance gene expression 
(Markstein et al. 2002; Lifanov 2003). Conservation 
of such site clusters between vertebrate and inver-
tebrates suggests that homotypic clustering could 
be a general organisation principle of cis-regulato-
ry regions (Gotea et al. 2010). Thus, we calculated 
the number of motifs per kilo base of the different 
members of the HSN regulatory code in the HSN 
signature windows. We did not observe differences 
in motif frequency between the 13 HSN signature 
windows that are expressed in the cell and the 22 
that are not expressed in the cell → Figure 3.3.5-E. 
We also did not observe any difference in the mean 
size of the HSN signature windows that were ex-
pressed in HSN (756bp ± 47.22) from those that 
were not expressed in the neuron (817 bp ± 28.62) 
→ Figure 3.3.5-F. In addition, HSN expressed win-
dows showed a mean GC content of 38 ± 1%,
which was not significantly different from the 
36 ± 1% GC content of the non-expressed windows 
→ Figure 3.3.5-G. It is known that enhancers can
be found at distances ranging from hundreds of
bases to megabases from the transcription start-
ing site (TSS) (Bulger & Groudine 2011). We wanted
to check if there could be any distance bias in the
location of the HSN signature expressed windows
relative to the start codon of the gene assigned to
the window. Distance was calculated independent-
ly of the sign; in other words, with independence of
being upstream or in intronic regions downstream
of the ATG of the gene. We saw that functional HSN
signature windows are located significantly closer
to the ATG of the gene compared to windows that
are not expressed in the HSN. HSN expressed sig-
nature windows are found at a mean distance of 3.3 
kb, while those that are not expressed are found at
a mean distance of 6.7 kb → Figure 3.3.5-H. 11/13
HSN functional enhancers are found 3.3 kb away or 
closer to the start codon of the gene.
The HSN signature contains syntactic rules
Motif positioning, often referred to as ‘syntax’ or 
‘grammar’, is the relative order, orientation, spac-
ing and helical phasing of TFBSs within an enhanc-
er. Motif positioning typically ensures that TFs are 
arranged appropriately to facilitate PPIs and there-
by promote cooperative binding, as well as the re-
cruitment of cofactors and the transcriptional 
Figure 3.3.4 
Distribution of the HSN 
regulatory signature in 
Caenorhabditis elegans 
genome
A) HSN regulatory signature 
is enriched in neuronal genes
compared to the non-neu-
ronal genome. Statistical 
significance was calculated 
using Chi square with Yates 
correction. *: pV<0.0001. 
B) Inclusion of the conser-
vation criteria in the HSN 
signature analysis strongly
increases the difference 
between neuronal and 
non-neuronal genome. 
*: pV<0.0001. 
These experiments were 
performed in collaboration 
with Dr. Alejandro Artacho.
C)-D) Gene ontology analysis 
of genes with HSN regula-
tory signature. p values and 
number of genes corre-
sponding to the biological 
processes enriched in the 
genes with HSN regulatory 
signature are represented in 
(C) and (D), respectively.
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Figure 3.3.5 
HSN regulatory signature can 
be used to identify de novo 
HSN expressed genes
A) Micrographs showing 
representative examples of 
de novo identified HSN active 
enhancers; i.e. HSN signature 
positive windows fused to gfp 
that drive expression in the 
HSN neuron.
B) Micrographs showing 
representative examples of 
false positive enhancers of 
the HSN; i.e. HSN signature 
positive windows fused to gfp 
that do not drive expression in
the HSN neuron. 
C) Micrographs showing 
representative examples of 
negative controls; i.e. reporter 
fusions of windows without 
HSN regulatory signature that 
do not drive gfp expression in 
the HSN neuron. 
D) Thirteen out of thirty five 
(37%) tested HSN regulatory 
windows correspond to active 
enhancers in the neuron. 
See Table 3.3.1.
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E) Comparison of the number 
of motifs per kilobase and per 
gene, between expressed and 
non-expressed HSN signature
positive windows. Statistical 
significance was calculated 
using the Unpaired t test (ETS: 
pV=0.3499; POU: pV=0.8825; 
SPALT: pV= 0.1123; HLH: 
pV=0.5763; INSM pV=0.4265; 
GATA: pV=0.7044). 
F) Comparison of the mean 
size of expressed and 
non-expressed HSN signature
positive windows. Statistical 
significance was calculated 
using the Unpaired t test 
(pV=0.3333). 
G) Comparison of the mean 
GC content in expressed and 
non-expressed HSN signature
positive windows. Statistical 
significance was calculated 
using the Unpaired t test 
(pV=0,2421). 
H) Comparison of the mean 
distance to the start codon 
between expressed and 
non-expressed HSN signature
positive windows. Statistical 
significance was calculated 
using the Unpaired t test 
(pV=0,0275). 
0
10
20
30
40
50
%
 C
G
 / 
w
in
do
w
G) CG content
0
2000
4000
6000
8000
#
 b
p 
to
 A
TG
*
H) Distance to ATG
0
200
400
600
800
1000
F) Size
#
 o
f b
p 
/ w
in
do
w
ETS GATAHLH InsmPOU Spalt
#
 o
f m
ot
if
s 
/ k
b
0
2
4
6
8
E) Motif density
Figure 3.3.5 
HSN regulatory signature can 
be used to identify de novo 
HSN expressed genes
machinery. However, it is still a matter of debate if 
syntax rules do play a role in enhancer function as 
few examples have been reported.
From our cis-regulatory analysis we know that the 
HSN regulatory code acts in a flexible manner, as it 
can activate enhancers with a variable distribution 
and order of TFBSs. Moreover, we observed that, 
in some genomic contexts, the absence of BSs 
for certain TFs can be compensated by the rest of 
the TF code → Figure 3.2.10. This would suggest 
that the HSN regulatory code follows the Billboard 
model for enhancer function (Kulkarni & Arnosti 
2003). However, we decided to use our HSN regula-
tory window analysis to try to identify syntax rules 
governing HSN enhancer functionality.
Thus, we explored if a particular grammar could be 
present in functional HSN signature windows com-
pared to non-functional ones. We failed to find any 
preferential TFBS arrangement, similar to our 5-HT 
pathway gene cis-regulatory analysis and in agree-
ment with the Billboard model. However, bioinfor-
matic analysis (iTF software (Kazemian et al. 2013)) 
revealed particular biases in specific orientations 
between TF pairs. For instance, we found that ETS 
BSs show a statistically significant bias for 3’ to 3’ 
orientations with GATA BSs, and a 5’ to 5’ disposi-
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Figure 3.3.6 
Representative examples of 
de novo identified HSN active 
enhancers 
Black lines represent the 
coordinates covered by 
bioinformatically predicted  
HSN signature windows 
(indicated by ‘w’ and a 
number). Green lines 
indicate the region used in 
our analysis. Dark blue bar 
profiles represent sequence 
conservation in C. briggsae,  
C. brenneri, C. remanei and
C. japonica. See Table 3.3.1 
for a list of all reporters 
tested.
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Figure 3.3.7 
HSN regulatory signature 
contains syntactic rules
A) Transcription factor 
binding site orientation bias 
HSN regulatory windows of 
HSN expressed genes show 
statistically significant biases 
in the orientations of ETS BSs 
with GATA and HLH BSs.
A
E)-F) Transcription factor 
binding site distance bias  
Kernel density plots repre-
senting the distance between 
closest HLH-ETS (E) and 
GATA-ETS (F) BSs. Left graphs 
consider only ETS-HLH 5'-5' 
and GATA-ETS 3'-3' oriented 
sites and right graphs show 
distances between closest 
TFBS pairs in all orientations. 
‘n’ indicates total number of 
motif pairs.
G) Orientation bias in HSN
signature windows 
37% tested HSN regulatory 
windows show expression 
in the HSN. Windows with 
both GATA/ETS 3'3' and 
HLH/ETS 5'5' syntax show a 
higher HSN expression rate 
compared to windows without 
these syntactic rules (50% 
and 20% respectively). This 
differential expression does 
not occur when considering 
non-functional syntactic rules 
such as specific SPALT/ETS 
orientations.
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B)-D) Functional transcription 
factor binding site orientation 
bias in HSN CRMs
Experimentally identified 
minimal HSN CRM for tph-1, 
cat-1 and bas-1 show 
examples of TFBS orientation 
biases between GATA/ETS 
and HLH/ETS. Each number 
represents the % of GFP cells 
in a particular transgenic 
line. +: values rank between 
100 to 60% of mean wild type 
construct expression;
+/−: values indicate 20-60 % 
lower penetrance than mean 
wild type expression;  
−: values are less than 20% of 
mean wild type values.  
n > 30 worms per line. 
Disruption of the original 
TFBS orientation without 
affecting TFBS sequence per 
se produces defects in gfp 
expression. As a negative
control, change in orientation 
of a SPALT BS in cat-1prom14 
does not affect expression. 
Arrows indicate the 
orientation of the BS. In each 
construct, the TFBS for which 
the orientation has been 
changed is marked with an 
asterisk. See Annex 3.3.3 for 
specific nucleotide changes.
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tion bias in relation to HLH BSs → Figure 3.3.7-A. 
These orientation biases were not found in HSN 
signature windows from the non-neuronal genome. 
Interestingly, these specific TF-TF dispositions 
were also found in our experimentally identified 
tph-1, cat-1 and bas-1 CRMs. Starting with tph-1 
CRM (tph-1prom2), we found an example of both 
orientation biases → Figure 3.3.7-B. Experimental 
rearrangement of the GATA BS from 3’ to 5’ orien-
tation (tph-1prom58), led to a complete loss of GFP 
expression in the cell. The same happened when 
we altered the 5’ orientation of the HLH site to 3’ 
(tph-1prom59). Next, we also found both overrepre-
sented motif arrangements in the bas-1 CRM (bas-
1prom13) → Figure 3.3.7-C. Rearrangement of the 
HLH site from 5’ to 3’ orientation had no effect in 
GFP expression (bas-1prom87). Flipping the GATA 
BS from 3’ to 5’ orientation (bas-1prom89), however, 
did provoke complete loss of GFP expression in the 
cell. Finally, we found one more example of the HLH-
ETS 5’-5’ overrepresented pair in the cat-1 CRM 
(cat-1prom14) → Figure 3.3.7-D. Altering the orien-
tation to 3’-5’ (cat-1prom85) or to 5’3’ (cat-1prom87) 
leads to a loss of GFP expression in the HSN.
Our results indicate that these syntactic rules are 
required in some contexts, although they are not 
absolutely necessary for enhancer functionality. 
Moreover, syntactic restrictions seem to be spe-
cific to some TFBS pairs, as we did not observe a 
statistical enrichment in other TF pairs, nor a phe-
notype when the SPALT BS in the cat-1 CRM was 
flipped (cat-1prom86) → Figure 3.3.7-D. Specific 
BSs rearrangements are listed in → Annex 3.3.3.
We also explored the possibility that these TF pairs 
(HLH-ETS and GATA-ETS), in addition to showing an 
orientation bias, could also exhibit a distance bias. 
To this end, we compared the distance distribu-
tion frequencies between the closest HLH-ETS and 
ETS-GATA motif pairs, in HSN functional enhancers 
and in signature windows that were not expressed 
in the cell. → Figure 3.3.7-E shows that the HLH-
ETS pair shows a different distance relationship 
depending on the group (HSN expressed windows 
vs not expressed in HSN). This difference is not ap-
preciable or less pronounced when orientation re-
lationships are not considered. The same is true for 
the ETS-GATA pair → Figure 3.3.7-F.
Having proven the functionality of the orientation 
syntactic rules in our CRMs, we explored the pos-
sibility that the presence of these rules could allow 
discrimination between functional and non-func-
tional HSN signature windows. We found that, from 
our 35 tested HSN signatures, constructs in which 
both ETS/GATA and ETS/HLH syntactic rules were 
obeyed were more likely to be expressed in HSN 
compared to constructs that do not show neither 
these TFBS dispositions (50% compared to 20% 
HSN expression respectively; ratio 2.4). This differ-
ence was not observed when the ETS-SPALT motif 
pair was considered (ratio 1.1) → Figure 3.3.7-G.
In conclusion, we have shown that the HSN signa-
ture is flexible but obeys specific syntactic rules, 
which supports the TF collective model. Syntactic 
rules improve the probability to de novo identi-
fy functional enhancers. Enhancer distance from 
the starting codon and distance between TF motifs 
with the overrepresented orientation can also be 
used as a guide to distinguish between functional 
and non-functional enhancers. However, the pres-
ence of the HSN signature, even with correct syn-
tactic rules, is not sufficient in all cases to induce 
HSN expression. This observation suggests that 
additional factors (either activating or repress-
ing TFs or chromatin remodelers) might be also 
involved.
Gene name HSN signature Reported HSN 
expression 
HSN 
expression
% HSN 
expression
Other neurons Other cells Lines
abts-4 Yes No − 0, 0, 0 + − 0/3
acr-24 Yes No − 0, 0, 0 + + 0/3
ast-1 Yes No + 38, 47, 48 + − 3/3
bam-2 Yes No − 0, 0, 0 + + 0/3
C16B8.4 Yes No − 0, 0 + + 0/2
C53B4.4 Yes No + 85, 89, 90 + + 3/3
ckr-2 Yes No − 0, 0, 0 + + 0/3
daf-38 Yes No − 0, 0, 0 + + 0/3
dgn-1 Yes No − 0, 0, 0 + − 0/3
F32D8.10 Yes No − 0, 0, 0 + + 0/3
F37A8.5 Yes No + 37, 63, 65 + + 3/3
fut-1 Yes No − 0, 0, 0 + + 0/3
gab-1 Yes No − 0, 0, 0 + + 0/3
glb-20 Yes No − 0, 0, 0 + + 0/3
kcc-1 Yes No − 0, 0, 0 + + 0/3
kel-8 Yes No − 0, 0, 0 + − 0/3
klp-7 Yes No + 82, 85, 86, 92 + + 4/4
lgc-49 Yes No + 36, 52, 60 + + 3/3
mec-10 Yes No + 56, 68, 74 + + 3/3
mgl-2 Yes No + 93, 93, 95 + + 3/3
npr-1 Yes No + 43, 51, 70 + + 3/3
npr-3 Yes No − 0, 0, 12 + + 2/3
pan-1 Yes No + 78, 98 + + 2/2
pde-3 Yes No + 2, 13, 50 + + 2/3
shl-1 Yes No − 0, 0, 0 + + 0/3
snt-1 Yes No + 0, 14, 48 + − 2/3
sprr-1 Yes No + 5, 8, 46 + + 1/3
sto-5 Yes No − 0, 0, 0 + + 0/3
tiam-1 Yes No − 0, 0, 0 + + 0/3
tkr-2 Yes No − 0, 0, 0 + + 0/3
tol-1 Yes No − 0, 0, 0 + + 0/3
twk-17 Yes No − 0, 0, 0 + + 0/3
tyra-3 Yes No − 0, 0, 0 + + 0/3
unc-32 Yes No + 41, 53, 71, 87 + + 4/4
unc-7 Yes No − 0, 0, 0 + + 0/3
Controls
aak-2 Yes yes + 72, 83, 87 + + 3/3
cat-1 Yes yes + 83, 86, 93 + − 3/3
kal-1 Yes yes + 56, 72, 81 + + 3/3
kcc-2 Yes yes − 0, 0, 0 + − 0/3
sem-4 Yes yes + 72, 81 + + 2/2
F16G10.5 No No − 0, 0, 0 + + 0/3
flp-27 No No − 0, 0, 0 + + 0/3
gipc-2 No No − 0, 0, 0 + + 0/3
irld-53 No No − 0, 0, 0 + + 0/3
irld-62 No No − 0, 0, 0 + + 0/3
lurp-2 No No − 0, 0, 0 + + 0/3
plep-1 No No − 0, 0, 0 + + 0/3
slc-28.1 No No − 0, 0, 0 + + 0/3
stg-1 No No − 0, 0, 0 + + 0/3
tub-1 No No − 0, 0, 0 + + 0/3
Table 3.3.1 
In vivo reporter fusion 
analysis to identify de novo 
HSN active enhancers
→
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Deep homology in the genetic 
programme regulating serotonergic 
differentiation
Chapter IV
Mouse serotonergic differentiation has been ex-
tensively studied, as described in the Introduction. 
In this work we have identified six members of the 
HSN TF collective that regulate serotonergic spec-
ification in the HSN neuron. Mouse orthologues for 
several of these members are known regulators 
of mammalian serotonergic differentiation, aris-
ing the question of whether mice and nematodes 
could share a phylogenetically conserved seroton-
ergic regulatory programme. This type of phyloge-
netic conservation between C. elegans neurons 
subtypes and more complex organisms has been 
previously shown for the dopaminergic system in 
the mouse olfactory bulb (Flames & Hobert 2009; 
Doitsidou et al. 2013), for a subpopulation of gluta-
matergic neurons in the mouse hippocampus and 
inferior olive (Serrano-Saiz et al. 2013), for choliner-
gic neurons of Ciona intestinalis (Kratsios et al. 2011) 
and midbrain GABAergic neurons (Gendrel et al. 
2016; Kala et al. 2009; Lahti et al. 2016). In this final 
Chapter participated Dr. Laura Chirivella and Dr. 
Isabel Reillo, who performed expression pattern 
analysis in mouse tissue; Ángela Jimeno and Miren 
Maicas, who helped to characterise new regulators 
of the HSN; and Dr. Alejandro Artacho and Carlos 
Mora, who carried out all the bioinformatics.
HSN and mouse serotonergic neuron 
differentiation are controlled by homologous 
regulatory programmes
Mouse orthologues for four out of the six TFs of the 
HSN TF collective are known regulators of mam-
malian serotonergic neuron specification that act 
at different stages of the pathway: ASCL1 (bHLH 
TF orthologue to HLH-3), GATA2 and GATA3 (ortho-
logue factors to EGL-18), INSM1 (Zn Finger TF ort-
hologue to EGL-46) and PET1 (ETS TF orthologue of 
ast-1) (see Introduction for a detailed explanation of 
the role of these factors) → Figure 1.9. Additionally, 
BRN2 (also known as POU3F2, a POU TF from the 
same family than UNC-86) has been recently as-
sociated with serotonergic neuron specification 
(Nasu et al. 2014). However, this paper focused on 
the role of BRN2 in maternal behaviour during pup 
retrieval and did not assess its expression in sero-
tonergic neurons. The effect observed could be due 
to a very early event in the serotonergic lineage or 
could even be non-cell autonomous. Thus, we ana-
lysed BRN2 protein expression in mouse hindbrain 
at E11.5, when mouse serotonergic differentiation 
occurs (Pattyn et al. 2003) → Figure 3.4.1. Double 
fluorescence immunohistochemistry against BRN2 
and 5-HT reveals that this TF is expressed in sero-
tonergic neurons → Figure 3.4.1-B. BRN2 expres-
sion is observed both in progenitors (closer to the 
ventricle) and in differentiating serotonergic neu-
rons, although not in posterior developmental stag-
es. This could be indicating that the TPH2 staining 
defect observed in mice with a truncated version of 
BRN2 could be a cell-autonomous phenotype.
No SPALT TF (TF family of SEM-4) is known to play 
a role in serotonergic specification. → Figure 3.4.2 
shows the phylogenetic relationship between 
mouse and worm TFs (EMBL-EBI TreeFam soft-
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ware; (Ruan et al. 2008)). Phylogenetic analysis re-
veals that SALL2 is more closely related to SEM-4 
that any other member of the mouse TF fami-
ly → Figure 3.4.2-A. Hence, we analysed first if 
SALL2 could have a homologous role in seroton-
ergic specification in the mouse. As with BRN2, we 
assessed SALL2 expression in mouse serotoner-
gic neurons at embryonic stage E11.5.  Similarly, we 
found that it is expressed in progenitors and differ-
entiating serotonergic neurons → Figure 3.4.1-C, 
suggesting it could also be involved in mouse sero-
tonergic specification.
Looking at the mouse serotonergic regulatory pro-
gramme from the opposite perspective, we re-
alised that two transcription factors FOXA2 and 
LMX1B, belonging to the forkhead (FKH) and LIM-
homeodomain (LIM-HD) TF families respectively, 
had no orthologous member in the HSN TF collec-
tive. As RNAi in C. elegans is a quick strategy to get 
insights in gene functions we decided to carry out 
an RNAi screen against all of the members of the 
FKH and LIM-HD TF family. C. elegans FKH fami-
ly is composed by 18 members: ATTF-4, C34B4.2, 
DAF-16, FKH-2, FKH-3, FKH-4, FKH-5, FKH-6, FKH-
7, FKH-8, FKH-9, FKH-10, LET-381, LIN-31, PES-1, 
PHA-4, T27A8.2 and UNC-130. We did RNAi against 
all these factors and found that only RNAi targeting 
pha-4 showed reduced levels of tph-1::yfp (otIs517) 
and cat-1::gfp (otIs221) expression in the HSN, sug-
gesting this member of the regulatory network 
could also be conserved between nematodes and 
mammals → Figure 3.4.3-A. C. elegans LIM-HD 
family has 7 members: CEH-14, LIM-4, LIM-6, LIM-
7, LIN-11, MEC-3 and TTX-3. RNAi against ceh-14 
and lin-11 showed a downregulation of cat-1::gfp 
expression, that was only maintained for tph-1::yfp 
expression in the case of ceh-14 → Figure 3.4.3-B. 
In this way, we identified one FKH member, pha-4 
and two LIM-HD members, ceh-14 and lin-11, as 
potential regulators of HSN serotonergic terminal 
differentiation.
Going back to the phylogenetic tree, we found that, 
in most cases, the worm members of the HSN TF 
collective were closely related to their mouse or-
thologues. For example, HLH-3 appears as the 
phylogenetically closest worm TF to the mouse 
ASCL1 → Figure 3.4.2-B. EGL-46 is the only mem-
ber of the INSM TF family in C. elegans and equal-
ly phylogenetically distant to INSM1 and INSM2 
→ Figure 3.4.2-C. AST-1 is the worm second clos-
est TF to PET1 → Figure 3.4.2-D. Unpublished re-
sults from the laboratory demonstrated that ets-5 
mutants (the phylogenetically closest TF to PET1) 
show no 5-HT pathway defects in any serotonergic 
neuron of the worm. Therefore, AST-1 appears as 
the only functional homologue of PET1. BRN2 ap-
pears closer in the phylogenetic tree to the worm 
POU TF CEH-6, known to be involved in the regu-
lation of several processes as locomotion, molt-
ing and ectodermal and excretory function, but 
not in serotonin regulation → Figure 3.4.2-E. UNC-
86, in turn, is closer to BRN3.1 (Pou4f3), that con-
trols the development of the auditory system (Lee 
et al. 2010). However we did not detect Pou4f3 ex-
pression in the serotonergic neurons by in situ hy-
bridisation (data not shown). The second closest 
common ancestor of BRN2 is UNC-86. In the case 
of GATA2 and GATA3, however, they share the clos-
est common ancestor with ELT-1, then ELT-2 and fi-
nally EGL-18 and ELT-6 → Figure 3.4.2-F. However, 
elt-6 RNAi treated worms showed no obvious 
phenotype at F1 scoring → Figure 3.2.7, where-
as elt-1 and elt-2 RNAi were lethal during devel-
opment but showed no phenotype at P0 scorings 
→ Figure 3.2.7. This exemplifies that, although a 
tendency in serotonergic regulation, not always the 
closest orthologues are the ones that share a spe-
cific function. The newly identified PHA-4 candi-
Figure 3.4.1 
BRN2 and SALL2 expression 
in mouse raphe serotonergic 
neurons
A) Micrograph of mouse 
embryonic day 11.5 hindbrain 
coronal section with DAPI 
staining. Square box indicates 
the region in a, b’ and c’ 
panels. Scale bar represents: 
100 µm. 
 
B) BRN2 and serotonin 
co-staining. BRN2 is 
expressed in progenitors and 
differentiating serotonergic 
neurons. Arrowheads indicate 
double labelled cells. Scale 
bar represents: 20 µm. 
 
C) SALL2 and serotonin 
co-staining. SALL2 is 
expressed in progenitors and 
differentiating serotonergic 
neurons. Arrowheads indicate 
double labelled cells. Scale 
bar represents: 20 µm. 
 
These experiments were 
performed by Dr. Laura 
Chirivella and Dr. Isabel Reillo.
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Figure 3.4.2 
Phylogenetic relationship 
between mouse and worm 
transcription factors 
Cladograms show phyloge-
netic relationships between 
mouse and C. elegans TFs 
known to regulate seroton-
ergic identity in one or both 
organisms. Cladograms were 
calculated using animal model 
data from TreeFam software 
(Ruan et al., 2008), although 
only worm and mouse are 
highlighted.
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Figure 3.4.3 
Characterisation of forkhead 
and LIM-homeodomain 
transcription factor candi-
dates for HSN serotonergic 
regulation
A) RNA interference screen 
against 16 of the 17 members 
of the forkhead (FKH) family. 
L4440 is the empty vector 
negative control. tph-1 and 
cat-1 reporter expression are 
significantly downregulated 
after pha-4 RNAi mediated 
knock-down. > 30 worms 
per condition. Statistical 
significance was calculated 
using the two tailed Fisher 
exact test; *pV < 0.05. 
See Annex 3.2.3. 
 
B) RNA interference screen 
against the seven members 
of the LIM-homeodomain 
(LIM-HD) family. tph-1 and 
cat-1 reporter expression are 
significantly downregulated 
after ceh-14 and lin-11 RNAi 
mediated knock-down.  
See Annex 3.2.3. 
 
RNAi experiments were 
performed by Ángela Jimeno.
C) tph-1 and cat-1 minimal 
cis-regulatory module 
analysis of pha-4 BSs. Black 
crosses represent point 
mutations to disrupt the FKH 
BS (purple box). +: 100 to 60% 
of mean wild type construct 
values; +/−: expression values 
60-20% lower than mean wild 
type expression values;  
−: values are less than 20% 
of mean wild type values. 
n>30 animals per line. See 
Annex 3.2.3 for mutated 
sequences. 
 
These experiments were 
performed by Dr. Miren 
Maicas. 
 
D) Double mutant animals for 
the two LIM-HD candidates, 
ceh-14 and lin-11, show 
normal levels of 5-HT staining 
and a mild phenotype for 
cat-1::gfp reporter expression. 
n > 50 worms per condition. 
Statistical significance was 
calculated using the two 
tailed Fisher exact test;  
*pV < 0.05.
date is the closest worm FKH to the mouse FOXA2 
→ Figure 3.4.2-G. However, LMX1B closest ortho-
logue in C. elegans is LIM-6, which showed no phe-
notype in RNAi experiments → Figure 3.4.3-B. The 
second closest worm TFs are CEH-14, LIN-11 and 
MEC-3 → Figure 3.4.2-H.
Forkhead, but not LIM-homeodomain, 
transcription factors have a role 
in HSN serotonergic terminal differentiation
In order to further characterise the new candidates 
pha-4, ceh-14 and lin-11, we took two complemen-
tary approaches. We first looked within our 5-HT 
pathway gene CRMs for putative FKH and LIM-HD 
BSs (TF encyclopedia) (Wederell et al. 2008). We did 
find FHK sites in the tph-1 (tph-1prom2) and cat-1 
(cat-1prom14) CRMs, but no LIM-HD were retrieved 
form the bioinformatics analysis → Figure 3.4.3-C. 
Directed mutagenesis upon these FKH sites led to 
loss of tph-1 expression (tph-1prom52) and cat-1 
expression (cat-1prom83) in the HSN. Next, we 
aimed to analyse null loss of function mutants for 
our candidates. Unfortunately, pha-4 null mutants 
are embryonic lethal, precluding us from studying 
its role in HSN terminal differentiation. We gener-
ated a double mutant strain using the null alleles 
ceh-14(ch3) and lin-11(n389), and the cat-1::gfp re-
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Figure 3.4.4 
Rescue of HSN transcription 
factor collective mutant 
phenotype with orthologous 
mouse factors
A) Micrographs showing 
tph-1::gfp expression in wild 
type animals, ast-1(ot417) 
mutant, and ast-1(ot417) 
mutants rescued with ast-1 
cDNA or mouse Pet1 cDNA 
expressed under bas-1 
promoter. To the right, the 
quantification. n > 50 worms 
per condition. *: pV<0.05 
Fisher's exact test.  
‘L#’ indicates the transgenic 
line number. See Annex 3.4.1.
B)-D) Same rescue experi-
ments and quantification as in 
(A), using hlh-3/Ascl1, egl-46/
Insm1 and Sall2 cDNAs.  
A cat-4 promoter was used 
to drive expression of all 
the factors except for Sall2, 
where a kal-1 promoter was 
used. 
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E)-F) Neither unc-86 nor 
egl-18/Gata3 are able to 
rescue HSN specific mutant 
defects.
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Figure 3.4.5 
Molecular homology between 
HSN and mouse serotonergic 
raphe neurons
A) Worm-to-mouse vs. raphe 
serotonergic neurons 
 
Principal Coordinate Analysis 
comparing expression profiles 
of worm neurons (grey dots, 
built by assigning mouse 
orthologues to C. elegans 
expressed genes (Hobert et al. 
2016)) with expression profile  
of mouse raphe serotonergic 
 
neurons (blue dots, built from 
RNAseq data (Okaty et al. 
2015)). HSN profile (green dot) 
is molecularly the closest to 
mouse raphe. See Annex 3.4.2 
for the list of worm neurons 
considered in the analysis. 
 
These experiments were 
performed in collaboration 
with Dr. Alejandro Artacho.
B) HSN profile without 5-HT 
pathway genes  
 
Principal component analysis 
C. elegans neurons and mouse 
raphe neurons in which 
four 5-HT pathway genes 
(tph-1, cat-1, bas-1 and cat-4) 
have been eliminated from 
HSN expression profile. HSN 
neuron is molecularly closest 
 
to mouse raphe even without 
considering 5-HT pathway 
gene expression. 5-HT 
pathway gene expression in 
other 5-HT neuron subtypes 
(red dots) is not sufficient to 
provide similarity to mouse 
raphe.
C) Randomised HSN-like 
profiles  
 
HSN expression profile 
is composed by the four 
5-HT pathway genes plus 
additional 92 genes. Analysis 
of 100 artificial HSN profiles 
composed by the same four 
 
 
 
 
5-HT pathway genes plus 92 
genes randomly selected from 
neuronal expressed genes 
shows that real HSN is still 
closest to mouse raphe. 
D) Cortical neurons  
comparison  
 
Principal Coordinates 
Analysis of C .elegans neurons 
compared to three different 
populations of cortical 
neurons at postnatal day one 
(corticothalamic neurons, 
 
 
 
 
cortico-callosal neurons and 
subcerebral cortical neurons) 
shows HSN is not molecularly 
the closest neuron to any of 
them (RNAseq data obtained 
from (Molyneaux et al. 2015)).
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porter (otIs221) that showed the greatest pheno-
type in the RNAi screen. Double mutants showed 
very mild defects in cat-1::gfp expression in the 
HSN (7%±2 off phenotype) and wild type levels of 
5-HT staining → Figure 3.4.3-D, → Annexes 3.2.1. 
and → 3.2.3. Our findings suggest that pha-4, but 
not ceh-14 or lin-11, could also be involved in HSN 
terminal differentiation. 
The serotonergic transcription factor collective 
is functionally conserved between worms and 
mammals
The striking degree of homology of HSN and mouse 
serotonergic regulatory programmes made us 
wonder if the TF regulatory code could be func-
tionally conserved between these two species. To 
answer this question, we performed cell specific 
rescue experiments of C. elegans mutants with the 
corresponding mouse homologue. First of all, we 
performed cell specific rescue of C. elegans mu-
tants with the C. elegans gene and then performed 
similar experiments using the mouse orthologue 
gene. We expressed the cDNA of the TF, under the 
control of a promoter that satisfied these criteria: 
1) drive GFP expression in the HSN, 2) be expressed 
in the minimum cells possible, in addition to HSN, 
and 3) not be regulated by the gene that the animal 
in which the construct will be injected is mutant for. 
For ast-1 we used the bas-1prom1 promoter, that 
drives 90% GFP expression in the HSN and whose 
expression is not affected in ast-1 mutant back-
ground → Figure 3.2.5. For hlh-3, egl-46 and egl-18, 
we used instead cat-4prom4 that is also not affect-
ed in these mutant backgrounds and drives 87% 
GFP expression in the HSN → Figure 3.2.5. Finally, 
as almost every terminal feature tested is affect-
ed in unc-86 and sem-4 mutant backgrounds, we 
chose a kal-1 promoter that is only slightly affect-
ed in sem-4 mutant background and drives expres-
sion in the HSN in 84% of the cases → Figure 3.2.5. 
In the case of unc-86, we used genomic DNA in-
stead of cDNA. Mutant animals bearing the tph-1 
reporters (zdIs13 or yzIs71) were injected with 
these constructs (termed the ‘rescue array’), to-
gether with ttx-3::mCherry co-marker, and GFP 
expression in the cell was assessed. Once we con-
firmed that the worm constructs were able to res-
cue tph-1 defects, we moved on to test the mouse 
Pet1, Brn2, Sall2, Ascl1, Insm1 and Gata3 genes. 
Gata2 was not analysed because we were unable 
to obtain the cDNA. Plasmids and strains are listed 
in → Table 2.16 and → Table 2.21.
We successfully rescued ast-1, hlh-3 and egl-
46 phenotypes with the expression of the worm 
cDNA → Figures 3.4.4-A, B and C. However, 
we did not achieve unc-86 or egl-18 rescue 
→ Figures 3.4.4-E and F. In the case of sem-4, no 
single line was retrieved form the microinjection, 
even when it was injected as low as 10 ng/µl. We 
hypothesise that extra doses of sem-4 are lethal to 
the worms → Figure 3.4.4-D.
When we moved on to analyse the mouse rescues, 
we found that Pet1, Ascl1, Inms1 and Sall2 can func-
tionally substitute ast-1, hlh-3, egl-46 and sem-
4, respectively → Figures 3.3.4-A, B, C and D. In 
the case of the SPALT family, Sall2 does not seem 
as toxic to the worms as we were able to retrieve 
at least one line from the microinjection. These re-
sults suggest that both regulatory programmes 
are functionally conserved. Additionally, they con-
firm that the HSN TF collective, as expected, acts 
cell-autonomously, as specific expression of its 
components in the HSN is sufficient to restore the 
wild type function in a mutant background.
HSN and mouse raphe serotonergic neurons are 
molecularly similar
In evolutionary biology, deep homology refers to 
two structures that share the genetic mechanisms 
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governing their differentiation (Shubin et al. 1997). 
The first example described that showed deep ho-
mology was the distribution of the Distal-less gene 
along the proximo-distal axis of all sorts of append-
ages and body outgrowths. Specifically, Distal-less 
is expressed along the proximo-distal axis of six 
developing coelomate phyla. To explain this, the au-
thors could imagine two situations. One, that Dll/Dlx 
expression in such diverse (analogous) appendag-
es could be convergent, although this would have 
required the independent co-option of Dll/Dlx sev-
eral times in evolution. The other situation, which 
the authors interpreted as more likely, is that ecto-
dermal Dll/Dlx expression along proximo-distal axis 
originated once in a common ancestor (homology) 
and has been used subsequently to pattern anal-
ogous body wall outgrowths in a variety of organ-
isms. In this sense, there is a deep homology of 
genetic mechanism in relation to disparate analo-
gous organs across a wide range of taxa.
Our observation that both mouse and C. elegans 
serotonergic genetic programmes are homologous 
suggests that these two neuronal types share deep 
homology and, thus, correspond to homologous 
structures. If this were the case, then HSN neurons 
and mouse serotonergic raphe neurons should not 
merely share the expression of 5-HT pathway genes, 
which are also present in the other C. elegans sero-
tonergic neurons NSM and ADF, but also should be 
broadly similar in molecular terms. To address this 
question, we used available gene expression infor-
mation from Wormbase to generate partial expres-
sion profiles for the 118 neuronal classes of the 
C. elegans hermaphrodite (Hobert et al. 2016). Due 
to the incompleteness of worm neuronal expres-
sion profiles, we selected neuron classes defined 
by the expression of at least 30 different genes (49 
different classes of neurons match this criteria, list-
ed in → Annex 3.4.2.) Next, we assigned mouse or-
thologues to C. elegans neuronal genes to create a 
new dataset of expression profiles termed ‘worm to 
mouse neuron profiles’. A detailed analysis of adult 
mouse serotonergic neuron transcriptome has 
been recently published (Okaty et al. 2015). We thus 
used this data to compare mouse serotonergic neu-
ron molecular profile to all ‘murine-like’ worm neu-
ron profiles. Principal Coordinates Analysis (PCoA) 
revealed that, out of the 49 analysed C. elegans 
neuronal classes, HSN is molecularly the closest 
to mouse serotonergic neurons → Figure 3.4.5-A. 
Using the same data as for the PCoA analysis, we 
performed hierarchical clustering analysis (HCA). 
Raphe serotonergic neurons are closer to HSN in 
the tree and, indeed, form a very robust cluster 
(AU = 99 ± 0.1 and BP = 97 ± 0.1) → Figure 3.4.6. 
Moreover, 65% of HSN expressed genes have at 
least one orthologous gene expressed in mouse 
serotonergic neurons, which correspond to differ-
ent functional categories including axon guidance 
and migration, neurotransmission and synapto-
genesis, transcriptional regulation, morphoge-
netic pathways and, of course, 5-HT biosynthetic 
pathway → Table 3.4.1.  Interestingly, most of the 
C. elegans genes that have mouse orthologues ex-
pressed in the raphe contain the HSN regulatory 
signature → Table 3.4.1. Finally, we noticed that 
several of the mouse genes with C. elegans ortho-
logues expressed in HSN have been associated to 
serotonin related disorders in genome wide asso-
ciation studies → Table 3.4.2.
Several controls were carried out to verify the ro-
bustness of this analysis. Firstly, we know that the 
similarity observed between the HSN and the raphe 
serotonergic neurons is not merely due to the ex-
pression of the 5-HT pathway genes as the NSM 
and ADF neurons, which also express these genes, 
are molecularly more distant to the mouse raphe 
neurons than HSN → Figure 3.4.5-A. In this line, we 
removed the 5-HT pathway genes from the HSN ex-
pression profile and saw that HSN remains the clos-
est neuron to mouse serotonergic raphe neurons 
→ Figure 3.4.5-B. Next, to discard that the close 
Figure 3.4.6 
Hierarchical clustering 
analysis between the HSN and 
the mouse raphe serotonergic 
neuron profiles
A) Same data used for 
Principal Coordinates Analysis 
(Figure 3.4.5) was used to 
perform hierarchical cluster-
ing. AU (red numbers) and BP 
(green numbers) represent 
the bootstrap probability with 
which each cluster forms.
Thicker lines highlight 
clusters with AU > 95 (AU was 
preferred over BP because it 
systematically varies sample 
size and thus it is less biased). 
Note that HSN and raphe 
nuclei form a very robust 
cluster (AU = 99 ± 0.1 and 
BP = 97 ± 0.1, which means 
that the chances that this 
cluster does not represent a 
real cluster and that it is due 
to sampling error is, at most, 
3%). Moreover, the other worm 
serotonergic neurons NSM 
and ADF do not cluster
together with HSN or mouse 
raphe serotonergic neurons. 
 
This analysis was performed 
by Carlos Mora.
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C. elegans gene name Mammalian gene name Description
bas-1* Dopamine decarboxylase Ddc
cat-1* Vesicular monoamine transporter Slc18a2
cat-4 GTP cyclohydrolase 1 Gch1
tph-1* Tryptophan hydroxylase Tph2
Axon guidance and Migration
ebax-1* Elongin-B/C E3 ligase  Zswim5/6/8
egl-43* PR domain containing  Prdm16
fmi-1 Flamingo homologue Celsr2/3, Fat1/3, Dchs1
madd-2* Trim protein Trim9/36/46, Fsd1/1l, Mid2
mau-2* Chromatid cohesion factor  Mau2
mig-10* Protein with an RA-like, PH domains and proline-rich motif Raph1, Grb10
nck-1 SH2/SH3 domain-containing protein Nck1
rig-6* Neuronal IgCAM Cntn1, 2, 3, 4, 5, 6
tbb-4* Tubulin Tubb2a/2b/4a/4b/5
unc-40* Netrin receptor Dcc, Neo1
unc-51* Serine/threonine protein kinase Ulk1/2
unc-53* Neuron navigator Nav1/2/3
Neurotransmission/Synaptogenesis
abts-1* Anion/Bicarbonate Transporter family Slc4a7/8/10
clh-3 Voltage sensitive chloride channel Clcn2
eat-16 Regulator of G protein signalling Rgs11/19
gar-2* G protein-coupled acetylcholine receptor  Hrh3
ggr-2* GABA/Glycine Receptor  Glra1/2, Glrb
glr-5* Glu Receptor Grid1/2, Grik1
gsa-1* G protein, Subunit Alpha Gnal, Gnas
ida-1* Protein tyrosine phosphatase-like receptor Ptprn, Ptpm2
irk-1* Inward Rectifying K (potassium) channel family  Kcnj3/5/6/9/11/16/
kcc-2* K/Cl cotransporter Slc12a5/6
mpz-1* Multiple PDZ domain protein Mpdz, Pdzd2, Inadl, Lnx1
nhx-5 Na/H exchanger  Slc9a6/7/9
nid-1* Nidogen (basement membrane protein) Lrp1/1b
nra-4 Nicotinic Receptor Associated Nomo1
rsy-1 Regulator of synapse formation Pnisr
syg-1* Ig transmembrane protein Kirrel, Kirrel3
nlg-1* Neuroligin family Nlg1/2/3
unc-2* Calcium channel alpha subunit Cacna1a/1b/1e
unc-77 Voltage-insensitive cation leak channel Nalcn
unc-103* K+ channel Kcnh2/7
Transcriptional regulation
ceh-20* PBX TF Pbx1/2/3
egl-44* TEA domain TF Tead1
gei-8 Nuclear receptor co-repressor  Ncor1
hlh-3* bHLH TF Ascl1
ife-4* Initiation factor 4E Eif4e2
sem-4* Spalt TF Sall2, Zfp236/Znf236
Morphogenetic pathways
dsh-1* Homologue of disheveled Dvl1/3
plr-1* Ring finger protein Rnf215 
prkl-1* Drosophila Prickle homologue Prickle1/2
sel-10* Suppressor/Enhancer of Lin-12(Notch) Fbxw7
Others
aak-2* AMP-activated protein kinases Prkaa1/2
ags-3 G protein signalling modulator Gpsm1
aho-3* Hydrolase Abhd17a/17b
ari-1 Ubiquitin-protein transferase  Arih1
arr-1 G protein signalling adaptor Arrb1/2
arrd-17* Arrestin domain protein Arrdc3
baz-2 Bromodomain adjacent to zinc finger domain Baz2a/2b
elpc-1 Elongator complex protein component Ikbkap
elpc-3 Elongator complex protein component Elp3
goa-1* G protein,O, Alpha subunit Gnao1
kin-20 Protein kinase Csnk1d/1e
puf-9 Pumilio/FBF domain- containing Pum1/2
pxf-1* Rap guanine nucleotide exchange factor Rapgef2/6
rep-1 Rab escort protein  Chm, Chml
ten-1* Type II transmembrane EGF-like repeats Tenm1/3/4
top-1* Topoisomerase Top1/1mt
Table 3.4.1 
Caenorhabditis elegans 
HSN neurons and mouse 
raphe serotonergic neurons 
homology
* indicates C. elegans gene 
with HSN regulatory signature
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C. elegans gene name Description Mammalian gene name GWAS
Axon guidance and Migration
egl-43 PR domain containing Prdm16 FAntipsychotic Agents  
(HGVST461)
fmi-1 Flamingo homologue Fat3 Narcolepsy (HGVST115)
mig-10 Protein with an RA-like, PH 
domains and and a proline-rich 
motif
Grb10 Narcolepsy (HGVST115), 
Schizophrenia (HGVST320)
unc-53 Neuron navigator Nav3 Antipsychotic Agents  
(HGVST461)
Neurotransmission/Synaptogenesis
abts-1 Anion/Bicarbonate Transport-
er family
Slc4a10 Bipolar Disorder (HGVST889), 
(HGVST472)
glr-5 Glu Receptor Grik1 Attention Deficit Disorder with 
Hyperactivity (HGVST429)
mpz-1 Multiple PDZ domain protein Inadl Schizophrenia (HGVST903 and 
HGVST320)
Pdzd2 Narcolepsy (HGVST115)
nhx-5 Na/H exchanger Slc9a9 Tobacco Use Disorder  
(HGVST89)
syg-1 Ig transmembrane protein Kirrel3 Schizophrenia (HGVST903)
nlg-1 Neuroligin family Nlg1/Nlgn1 Narcolepsy (HGVST115)
unc-77 Voltage-insensitive cation leak 
channel
Nalcn Bipolar Disorder (HGVST889 
and HGVST472), Schizophrenia 
(HGVST320)
Transcriptional regulation
ceh-20 PBX TF Pbx3 Narcolepsy (HGVST115)
Others/Undetermined
elpc-1 Elongator complex protein 
component
Ikbkap Bipolar Disorder (HGVST316)
elpc-3 Elongator complex protein 
component
Elp3 Schizophrenia (HGVST903, 
HGVST320)
Cntn4 Antipsychotic Agents  
(HGVST461), 
Cntn6 Bipolar Disorder (HGVST889 
and HGVST472)
ten-1 Type II transmembrane protein 
containing EGF-like repeats
Tenm4 Bipolar Disorder (HGVST163), 
Narcolepsy (HGVST115), 
Schizophrenia (HGVST903)
Table 3.4.2 
Molecular homology between 
HSN and raphe neurons 
include genes associated to 
serotonin related disorders 
 
Data obtained from the 
Genome-wide associated 
study catalogue.
proximity between mouse serotonergic neurons 
and HSN is due to a random combination of genes 
with high degree of homology to raphe neurons, we 
built 100 random HSN profiles composed by the 
four 5-HT pathway genes (tph-1/Tph, bas-1/Ddc, 
cat-1/Vmat, cat-4/Gch) plus 92 additional genes 
from the pool of genes known to be expressed in 
all of the neurons of the worm. Comparison analy-
sis of HSN profile and the 100 random HSN profiles 
shows that the real HSN is much closer to mouse 
serotonergic neurons than any of the random pro-
files → Figure 3.4.5-C. Additionally, we tested if 
HSN similarity to serotonergic neurons is specific 
to this neuron subtype. To test this, we performed 
similar analysis using RNAseq data obtained for 
cortical populations (corticothalamic neurons, cor-
tico-callosal neurons and subcerebral cortical neu-
rons) (Molyneaux et al. 2015). HSN proximity was not 
maintained with these cortical populations, sug-
gesting that it is specific of the serotonergic fate 
→ Figure 3.4.5-D. Finally, although serotonergic 
raphe neurons can be subdivided in different nuclei 
with slightly different transcriptome profiles (Okaty 
et al. 2015), we found that HSN does not show any 
obvious proximity to any specific subtype of mouse 
raphe serotonergic neurons (data not shown).
In sum, these results reveal an unexpected level of 
molecular proximity between C. elegans HSN and 
mouse serotonergic raphe neurons, deep homol-
ogy in the genetic programme that regulates their 
terminal differentiation, and the presence of similar 
regulatory signatures in genes expressed in both 
cell populations. These results demonstrate that 
the serotonergic transcriptional regulatory code is 
highly conserved in evolution.
→
Discussion
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In this work we have revealed insights into how serotonergic 
neuron identity is globally controlled and, focusing on the 
regulatory logic of the HSN serotonergic subtype, we have 
increased our understanding of how the complement of cell 
type-specific enhancers is selected. We found that numerous 
TFs (at least six analysed here) act in conjunction to directly 
activate HSN expressed enhancers. This high number of TFs 
helps to provide specificity and robustness to the HSN regulatory 
signature, which is preferentially found in genes of the neuronal 
genome that are important for HSN function.
Serotonergic neuron subtypes are regulated by independent 
cis-regulatory modules
We first analysed C. elegans serotonergic subtype terminal 
regulation through a cis-regulatory analysis of the 5-HT pathway 
genes. We found that expression of the 5-HT pathway genes in 
the different serotonergic neuron subtypes, NSM, ADF and HSN, 
is controlled through different cis-regulatory modules. 
This modular and independent subtype regulation is in 
agreement with the terminal selector model in which, for each 
cell type, a combinatorial code of TFs directly regulates the 
expression of most terminal features (Hobert et al. 2016). Taking 
into consideration that NSM, ADF and HSN, despite being all 
serotonergic, contain very different transcriptomes, it was 
expected that they are regulated by different TF codes and, thus, 
different CRMs are required for subtype-specific expression of 
each 5-HT pathway gene. We have previously reported that the 
POU TF UNC-86 next to the LIM TF TTX-3 terminally control NSM 
differentiation programme (Zhang et al. 2014) and, here, we have 
shown that a different combination of TFs regulates HSN terminal 
differentiation. Little is known about the TFs required for ADF 
terminal differentiation but, apparently, a different set of TF 
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families, including the RFX family (Xie et al. 2013), controls this 
process. In this sense, it seems that NSM, ADF and HSN could be 
more properly considered different classes of neurons that share 
a particular ‘group identity’ (the serotonergic identity), rather 
than different neuron subclasses. Similar regulatory logic has 
been found in the specification of C. elegans glutamatergic, 
cholinergic and GABAergic neuron subtypes (Serrano-Saiz et al. 
2013; Pereira et al. 2015; Kratsios et al. 2011; Kerk et al. 2017; 
Gendrel et al. 2016). Within these cell types, despite they all share 
the battery of genes responsible for glutamate, acetylcholine or 
GABA metabolism, cell subtypes are regulated by different TFs. 
The exception would be C. elegans dopaminergic neuron subtype 
specification. Although they are also born from different cell 
lineages, the eight dopaminergic neurons are classified in three 
different anatomical subtypes (CEP, ADE and PDE) that are 
functionally and molecularly equivalent (i.e. they are all 
mechanosensory neurons). In this case, a unique code of TFs 
controls dopaminergic terminal differentiation of all 
dopaminergic neuron subtypes (Flames & Hobert 2009; Doitsidou 
et al. 2013). Contrary, serotonergic, glutamatergic, cholinergic 
and GABAergic neurons exhibit very disparate functions and are 
regulated by different combinations of TFs. Moreover, all 
serotonergic neurons except NSM, have been described to signal 
via additional neurotransmitters, while dopaminergic neurons 
exclusively use dopamine (Rand & Nonet 1997; Pereira et al. 2015; 
Loer & Rand 2016). This diversification of function plus signalling 
promiscuity inevitable adds layers of complexity to the regulation 
of neuron subtype terminal fate that must be reflected in the 
transcriptomes of the neuron subtypes and, hence, in their 
regulation by TFs. The higher complexity cannot be only 
associated to broad neuron types like GABAergic (26 neurons), 
glutamatergic (78 neurons) or cholinergic neurons (159 neurons), 
as the serotonergic system, like the dopaminergic system, is 
rather small (Gendrel et al. 2016; Serrano-Saiz et al. 2013; Pereira et 
al. 2015; Chase & Koelle 2007).
Our study on serotonergic regulatory logic also revealed partial 
overlap between the CRMs of the 5-HT pathway genes. This 
suggests that some of the TFBSs are commonly used by the 
same or different TFs in the different serotonergic populations of 
the worm. In fact, UNC-86 is required for both NSM and HSN 
terminal differentiation (Sze et al. 2002) and we have identified 
POU TFBSs in the tph-1 and bas-1 CRMs that are functional both 
in HSN and NSM neurons. In addition, we also identified 
functional TFBSs (putative bHLH) that are shared between the 
HSN and the ADF neurons. In this case, we found partial ADF 
differentiation defects in hlh-3 null mutants, suggesting a 
possible role for this TF in the ADF neuron. In other cases, we 
found effects in the cis mutation but no ADF phenotype in the 
corresponding HSN TF mutant. Hence, a different member of the 
same TF family may be binding to the motif in the ADF. 
Redeployment of a cis-regulatory motif has already been shown 
for POU sites in distinct glutamatergic neurons; the same POU 
site is apparently recognised by UNC-86 in light touch receptor 
neurons and by CEH-6 in the AUA neurons (Duggan et al. 1998; 
Serrano-Saiz et al. 2013). Alternatively, the mutations introduced in 
the CRMs could be affecting alternative TFBSs that have not 
been considered in this work. 
Interestingly, we identified a case of two redundant CRMs for the 
ADF neuron. This redundancy in CRMs has been previously 
described in other systems as shadow enhancers and are usually 
associated to robustness in gene expression (Hong et al. 2008). 
Furthermore, although seldom, we also observed in our cis-
regulatory analysis events of ectopic GFP expression in neurons 
other than those that normally express the 5-HT pathway genes. 
This brings together the classical view of terminal selectors 
mainly acting as activators of specific gene batteries in distinct 
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neuronal types (Hobert 2008), with the increasing evidence that 
neuronal subtype diversity can be achieved, or at least 
modulated, through repressor elements (Esmaeili et al. 2002; 
Chang et al. 2003; Kerk et al. 2017; Miller et al. 1992). Following this 
idea, although not addressed in this work, we cannot discard the 
possibility that neuron subtype specificity in the serotonergic 
system is conferred by the presence of repressor elements in the 
set of differentially expressed genes between the three 
serotonergic neuron subtypes.
A complex code of six transcription factors is required and 
sufficient to induce serotonergic fate specifically in the 
serotonergic HSN subtype
Neuronal terminal differentiation programmes have been best 
characterised in C. elegans. So far, relatively simple TF codes, 
composed of two or three members, have been shown to be 
required, and in some contexts sufficient, to select specific 
neuronal types (van Buskirk & Sternberg 2010; Serrano-Saiz et al. 
2013; Doitsidou et al. 2008;  Zhang et al. 2014). Thus, previous work 
suggested a rather simple organisation of CRMs controlling 
expression of neuronal terminal features in C. elegans.  
Our results, however, demonstrate a more complex scenario in 
the regulation of the HSN transcriptome. In light of our findings, 
nematode neuronal terminal differentiation programmes are not 
necessarily significantly simpler than those found in vertebrates, 
as previously proposed (Holmberg & Perlmann 2012). Considering 
the technical advantages of C. elegans as a simple model system, 
our work is an example on how its study may help us to identify 
the general rules of terminal differentiation in eumetazoa.
In our characterisation of the regulatory mechanisms that control 
HSN terminal differentiation, we found a complex code of at least 
six terminal selectors belonging to different TF families, termed 
the HSN TF collective. This TF collective does not only control the 
serotonergic fate of the HSN, but also many additional effector 
genes of the neuron, supporting the principle of co-regulation of 
many distinct terminal identity features by terminal selector-type 
TFs (Hobert 2011) that has been shown for many other neuron 
types in C. elegans (Wenick & Hobert 2004; Flames & Hobert 2009; 
Doitsidou et al. 2013; Serrano-Saiz et al. 2013) → Table 1.1. In the 
absence of these six terminal selectors, HSN neurons appear to 
remain in an undifferentiated neuronal ground state, as the 
expression of certain neuronal genes remain. It would be 
interesting to assess if they additionally show a switch in identity, 
as occurs in the mouse dorsal spinal cord, where Tlx3 and Tlx1 
determine excitatory over inhibitory cell fates (Cheng et al. 2004). 
The mechanistic basis for this scenario could be that HSN 
terminal selector genes not only activate terminal differentiation 
genes, but also inhibit alternative fates by repressing the 
expression of other terminal selector genes. This has been 
elegantly demonstrated in C. elegans ALM and BDU neurons 
(Gordon & Hobert 2015). Although not included in the results, we 
observed ectopic expression of 5-HT pathway reporters in the 
PVT and an unidentified neuron in the posterior body of the 
worm, in sem-4 and unc-86 loss of function mutants, 
respectively. This suggests a direct or indirect role of these 
factors in the repression of the serotonergic phenotype in these 
unrelated neurons.
Moreover, the action of the six members of the HSN regulatory 
code seem to be exclusively required at the latest steps of HSN 
neuron differentiation and it must be maintained throughout the 
rest of the life of the animal in order to preserve the terminal 
differentiation programme unaltered, as described for many 
other terminal selectors (Deneris & Hobert 2014). Albeit meeting 
both conditions, egl-18 seems to have a dual role in the 
regulation of the HSN neuron: late, as demonstrated with the 
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CRM mutational analysis and specific in vitro binding to GATA 
sites, but also early, as revealed by a significant lineage defect 
observed in egl-18 mutants. Indeed, egl-18 expression in the HSN 
matches this idea, as our data suggests that its expression 
begins before the postmitotic HSN neuron is generated and is 
maintained throughout the life of the animal. Regarding hlh-3, 
however, our CRM mutagenesis analysis indicates direct binding 
to the 5-HT pathway genes, yet we have been unable to detect 
hlh-3::yfp signal in the HSN after the precursor HSN/PHB stage, 
before the 5-HT pathway genes are even expressed. This could 
be explained in two ways. On the one hand, it is well known that 
bHLH TFs act as proneural factors that activate target genes in 
proliferating and differentiating progenitors during neurogenesis 
(Bertrand et al. 2002). However, to explain our results, we could 
further envision HLH-3 as a pioneer TF, as has been recently 
shown for its mouse homologue Ascl1 (Raposo et al. 2015). These 
TFs are able to bind closed and open chromatin in proliferating 
cells, promoting accessibility and activation of differentiation 
specific genes (Zaret & Mango 2016). On the other hand, maybe 
we are not using the right tools to analyse hlh-3 expression in the 
cell. If hlh-3 expression in HSN were very low, then using 
standard fluorescent microscopy would not be enough to detect 
it. Alternatively, we have used a fosmid reporter strain and it is 
known that fosmids form episome-like structures that alter their 
accessibility to TF regulation and chromatin environment (Kelly 
et al. 1997). The use of CRISPR-Cas9 technology would help settle 
these doubts (Dickinson et al. 2015). 
The HSN TF collective is not only required to establish the 
serotonergic fate in the HSN neuron, but also sufficient, at least 
in some cellular contexts. Ectopic expression of all the members 
of the code, except egl-46, increases the number of 
serotonergic-like cells in the embryo and the effect seems to be 
stronger with some members of the code (ast-1, sem-4 and 
mainly unc-86). Ectopic expression of a combination of the six 
members of the HSN TF collective, a combination of the three 
‘highly responsive’ factors or unc-86 alone, induces the 
maximum response observed. Importantly, both combinations 
are statistically higher in terms of percentage of embryos that 
respond to the heat shock. Similar results were obtained with the 
dopaminergic TF code (Flames & Hobert 2009; Doitsidou et al. 
2013). When we analysed later developmental stages, the over-
expression response is much more modest and restricted to 
neuronal cells. Similarly to what happens in the embryo study, 
the combination of the six members of the HSN TF collective 
does not increase the number of ectopic cells and this lack of 
plasticity has been shown to be mediated by repressive chromatin 
marks deposited at the end of development (Patel & Hobert 2017). 
Nonetheless, as unc-86 regulates both HSN and NSM 
serotonergic fate (Sze et al. 2002; Zhang et al. 2014), we cannot 
distinguish between ectopic neurons generated by creating a 
‘HSN-like’ or an ‘NSM-like’ environment. The fact that the six TF 
combo further enhances the ectopic response of a larger 
number of embryos, suggests that the phenotype observed 
could be due to this ‘HSN-like’ environment. Furthermore, we 
have shown that the HSN TF collective is not only required and 
sufficient for the establishment of the HSN fate, but also for the 
maintenance of the serotonergic phenotype throughout the life 
of the worm, as has been claimed for many other regulators of 
terminal differentiation (Deneris & Hobert 2014).
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The HSN transcription factor collective acts through parallel 
pathways and shows synergistic relationships to regulate the 
terminal features of the HSN neuron
Our epistatic analysis indicates that the different members of the 
HSN TF collective tend to act mostly in an independent manner, 
reinforcing the results obtained from mutagenesis and EMSA 
analyses. Together, this evidence actively indicates that the six 
TFs act through parallel pathways to bind and directly regulate 
the terminal features of the HSN neuron. However, there are 
a few examples of cross-regulation between certain members 
of the HSN TF collective, suggesting the existence of a more 
complex serotonergic transcriptional regulatory network. 
While some TFs have no effect on the expression of the rest of 
the HSN TF collective, others seem to have key roles in the HSN 
transcriptional programme. Importantly, UNC-86 appears as 
master regulator of the HSN terminal differentiation as it is 
epistatic to ast-1, sem-4 and, to less extent, egl-46. Moreover, it 
is the single factor that, when ectopically expressed, induces the 
highest number of serotonergic cells in the embryo and, in 
combination with two of its probably direct targets sem-4 and/or 
ast-1, further increases the penetrance. Its relevance in 
serotonergic specification can be expanded to additional 
subtypes of the serotonergic system, as its requirement for NSM, 
AIM and RIH acquisition of the serotonergic fate is already known 
(Sze et al. 2002). UNC-86 is also expressed in many non-
serotonergic neurons, where it also acts as a terminal selector in 
combination with other TFs (Topalidou & Chalfie 2011; Gordon  
& Hobert 2015; Duggan et al. 1998). Another interesting 
observation is that several TFs (UNC-86, SEM-4, HLH-3 and, very 
subtly, EGL-46) control the expression of ast-1 and all of them, in 
turn, are required for the regulation of HSN terminal features. 
This type of regulation is known as feedforward loops and has 
been described to attain, stabilise and maintain the complete 
signature of a cell-specific programme of gene expression, 
increasing the robustness of the system (Davidson 2006; Altun-
Gultekin et al. 2001; Alon 2007). Remarkably, similar regulatory 
mechanisms are observed with ast-1 mouse homologue Pet1 
(Wyler et al. 2016; Deneris & Wyler 2012b).
Combinatorial TF binding enables cell type-specific enhancer 
expression and usually implies cooperativity between TFs.  
Our detailed phenotypic analysis of single and double TF mutants 
points to a synergistic and redundant control of the expression 
of the terminal features of the HSN. Firstly, co-regulation of 
terminal features by the HSN TF collective is not exactly 
equivalent in each target gene. AST-1, for example, is absolutely 
required for tph-1 and cat-1 expression, however it is 
dispensable for bas-1 expression. Considering the single mutant 
analysis in isolation, one would come to the erroneous conclusion 
that AST-1 does not play a role in bas-1 expression. However,  
we find functional ETS BSs in bas-1 minimal CRM and the role of 
AST-1 in bas-1 expression is revealed in double mutant analysis 
with other members of the HSN regulatory code (egl-46, sem-4 
or unc-86), showing an exacerbated phenotype or synergy 
between TFs. This is known to occur in over specified pathways, 
where organisms are buffered when redundant genes suffer  
a mutation that disrupts, but does not eliminate, the function  
of their respective proteins, increasing the robustness of the 
system. However, when both genes are deleted, there is not 
enough recruitment to the enhancer and no, or less, gene 
expression is achieved. A similar de-coupling of regulation of 
terminal identity features has been observed in the specification 
of the serotonergic neuron type NSM (Zhang et al. 2014) and in 
cholinergic command interneurons (Pereira et al. 2015). We also 
find other examples of synthetic enhancement and suppression 
between several pairs of HSN TF collective members. Similar to 
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ast-1, for any given TF pair, additive or synergic regulation varies 
between target genes. Although our analysis does not inform 
about the possible protein-DNA or protein-protein relationships 
between the members of the HSN TF collective, it is likely that 
the subtle differences in the regulation of each terminal feature 
are determined by the specific number and disposition of 
functional TFBSs found in the CRM of each gene as will be 
discussed next.
The HSN regulatory signature identifies HSN expressed genes
Co-binding of specific combinations of TFs to the same genomic 
region, assessed by chromatin immunoprecipitation sequencing 
(ChIP-seq), has been successfully used to identify, de novo, cell 
type-specific enhancers in Drosophila embryos (Busser et al. 
2015; Zinzen et al. 2009). However, this approach is based on 
experimental data and fails to address why some predicted 
TFBSs are actually bound by the TF while others are not. 
Following the terminal selector model, we hypothesised that the 
specific co-expression of the six members of the HSN TF 
collective in the HSN neuron could directly regulate its terminal 
transcriptome. 
In agreement with this idea, we find that known HSN expressed 
genes contain DNA elements enriched in clusters of 
bioinformatically-predicted TFBS for the six members of the HSN 
regulatory code, termed HSN signature. Taking advantage of this, 
we take a step further and demonstrate that the HSN regulatory 
signature is preferentially found in neuronal genes that show 
HSN-related functions, and can be used for the de novo 
identification of HSN active enhancers. Conceptually, this means 
that if the combinatorial code of TFs is complex enough (in our 
case six TFs), it is sufficient to impose a defining signature to the 
enhancers they regulate allowing for the discrimination of these 
HSN functional enhancers from the whole genome. The  
C. elegans genome is particularly compact compared to fruit flies 
and vertebrates, which could, in part, explain the success of our 
approach. Additionally, the number of TFs included in our analysis 
is higher than previous reports, which could help to confer 
sequence specificity to the HSN regulatory signature. 
Unfortunately, the use of C. elegans cis-regulatory bioinformatics 
analyses has been anecdotic to date (Beer & Tavazoie 2004).
Our results suggest that this approach might be transformative 
to decipher the rules underlying the regulatory genome. Of note, 
our analysis still shows a high rate of false positives, which 
suggests that additional features are present in HSN functional 
enhancers. It would be interesting to determine if this 
combination of six TFs is exclusively expressed in the HSN 
neuron. In fact, this seems to be the case based on our work 
using fluorescent reporters; we have determined that the HSN is 
the only serotonergic neuron where unc-86, sem-4, egl-46, ast-1 
and egl-18 are simultaneously expressed at the L4 and adult 
stage. hlh-3 expression in the worm, however, is restricted to 
embryonic stages, including the HSN. Future analyses based on 
more complex paradigms should facilitate the identification of 
HSN functional enhancers.
HSN regulatory signature contains syntactic rules
Three models have been proposed to explain enhancer function 
(Spitz & Furlong 2012). In the enhanceosome model, TFBSs show 
a rigid distribution in order, spacing and orientation. Conversely, 
the billboard model proposes a totally flexible distribution of 
TFBSs. Finally, the TF collective model shows flexibility in the 
arrangement of TFBSs or the requirement of all of them, but also 
considers some possible constraints in their disposition. These 
flexible constraints, which are important only in specific genomic 
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contexts, represent a challenge for the identification of general 
syntactic rules. In this work we show that the HSN regulatory 
programme matches best the TF collective model: the six TFs 
belonging to the HSN regulatory code act in a flexible manner, 
activating enhancers with variable TFBS order and distribution, 
as seen in the 5-HT pathway genes CRMs and functional 
enhancers of the HSN. Moreover, in agreement with the TF 
collective model, we observed that, in some genomic contexts, 
the presence of BSs for certain TFs is dispensable and can be 
compensated for by the rest of the TF code. Additionally, we 
determined that some TF pair orientations (ETS-GATA and ETS-
HLH) and distance bias between them are required for the 
activation of some HSN enhancers. This finding is further 
supported by the observation that ETS TFs physically interact 
with GATA or bHLH factors in other systems (Li et al. 2000; Shi 
et al. 2014).
Limited examples of TF pair orientation requirements have been 
reported so far. Synthetic enhancers have been used to show 
that a specific pMad-Tin orientation drives stronger expression 
in Drosophila mesoderm, although it is unclear whether similar 
constraints are also important in the context of endogenous 
enhancers (Erceg et al. 2014). More recently, Farley et al. showed 
that, in Ciona intestinalis, specific orientation constraints 
between an ETS site and a Zinc Finger site is required for 
notochord expression of a newly identified developmental 
enhancer of the Brachyury gene (Farley et al. 2016). Our results 
not only provide an additional example of endogenous enhancers 
with TF pair orientation restrictions, but also extend the 
importance of syntactic rules not only for developmental 
enhancers but also in the transcriptional regulation of terminal 
features. This suggests that orientation constraints might be 
widely present in regulatory modules.  
Deep homology, molecular homology and functional homology 
between Caenorhabditis elegans HSN and mouse serotonergic 
neurons
The diversity of C. elegans serotonergic neuronal classes 
contrasts with that of tetrapod vertebrates, in which 
serotonergic neurons are genetically and molecularly rather 
uniform and limited to the raphe system. In contrast, other 
chordates contain additional serotonergic populations. 
Serotonergic subclass diversity is also prevalent in other phyla 
such as arthropoda and mollusca, which suggests a loss of 
serotonergic diversity in the tetrapod branch. As in nematodes, 
serotonergic subclass specification in other organisms is likely 
to be independently regulated: in Drosophila, the TFs Islet, 
Hunchback and Engrailed are required for serotonergic 
specification of the ventral ganglion while dispensable for brain 
serotonergic specification, whereas in zebrafish, Pet1 regulates 
raphe serotonergic specification but not other serotonergic 
subclasses (reviewed in (Flames & Hobert 2011)).
Our results reveal that the regulatory programme of the HSN 
neuron, but not that of the NSM or ADF, strikingly resembles the 
serotonergic regulatory programme in mouse (Deneris & Wyler 
2012; Haugas et al. 2016; Scheuch et al. 2007; Nasu et al. 2014). This 
high similarity allowed for the identification of PHA-4, a new 
regulator of HSN serotonergic terminal identity in the worm, and 
the identification of SALL2 as a candidate regulator of 
serotonergic specification in mouse. In the light of these results, 
we propose that the HSN neuron shares deep homology with 
mouse raphe neurons and that this deep homology might be the 
result of a common ancestor cell type. However, as we do not 
have enough information about the serotonergic regulatory 
programmes in other animal groups, an alternative scenario is 
that they might have arisen independently in nematodes and 
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vertebrates. If HSN and mouse raphe serotonergic neurons were 
homologous cell types, we would predict that they are also 
functionally homologous. Serotonergic systems in all animal 
groups function as facilitators of motor output, often of repetitive 
nature, with 5-HT promoting a switch between states (Gillette 
2006). In mammals, serotonergic projections to spinal cord, 
which is the most ancient component of the serotonergic 
system, produce a long-lasting facilitation of spinal reflexes. 
In molluscs, for example, serotonergic activity accompanies 
motor activity and frequently precedes motor onset. 
Interestingly, C. elegans 5-HT signalling in HSN neurons also 
facilitates motor output. Egg-laying behaviour transitions from 
inactive to active states of egg-laying, and 5-HT signalling in HSN 
mediates the onset of the active phase (Waggoner et al. 1998). 
Thus, HSN and mouse serotonergic neurons share deep 
homology, as well as molecular and functional homology. 
Our data, together with previous reports of deep homology of 
other neuronal types (Nomaksteinsky et al. 2013; Strausfeld & Hirth 
2013; Tomer et al. 2010), suggest that deep homology might 
underlie the specification of a wide variety of neuron subtypes. 
The identification of homologous regulatory programmes using 
similar approaches to those described here will help identify 
homologous neuronal types in distant species.
In summary, we believe that our careful dissection of HSN 
regulatory enhancers, in the context of global serotonergic 
regulatory logic, has helped improve our understanding on the 
general laws of transcriptional regulation and supports that 
phylogenetically conserved mechanisms underlying these rules 
exist.  Beyond fundamental rules, our results also show, for the 
first time, that a regulatory signature based on a defined set of 
TFs is sufficient for enhancer identification merely based on 
primary DNA sequence without exclusively using experimental 
data. By defining the molecular logic underlying the function of 
DNA enhancer elements, it is starting to be possible to identify 
the regulatory genome based only on DNA sequence. This opens 
up the possibility of predicting the biological consequences of 
disease-associated mutations, which are generally located in 
non-coding regions of the genome. However, we are aware that 
our predictive model for the HSN still misses additional important 
elements (activator and/or repressor TFs) and possibly grammar 
rules (motif positioning and chromatin states) in order to build a 
proper enhancer language. Long-standing open questions and 
challenges still remain, mainly: how is regulatory information 
encoded in the four-letter ‘alphabet’ of enhancer sequences, 
how is the cross-talk between enhancer–target gene specified in 
a three dimension genome and if there are additional functions 
for the key player TFs. Hopefully these questions will be 
answered in the following years with the use of innovative 
approaches and state-of-the-art technology. Thus, these are 
exciting times to continue studying transcriptional regulation.
Conclusions
232 233
In this Thesis we have dissected the cis-regulatory 
logic underlying the specification of C. elegans 
serotonergic system and, focusing on the HSN neuron 
subtype, we have studied how the complement of 
cell type specific enhancers is selected.
The results obtained in this Thesis lead to the 
following conclusions:
1 Distinct cis-regulatory modules control 
serotonin pathway gene expression in the different 
subclasses of serotonergic neurons. This modular 
and independent subtype regulation is in agreement 
with the terminal selector model in which, for each 
cell type, a different combinatorial code of transcription 
factors directly activates the expression of its 
terminal features.
2 The serotonin pathway genes cis-regulatory 
modules active in different subclasses are 
sometimes partially overlapping suggesting that they 
can be regulated by common transcription factors, or 
members of the same transcription factor family.
3 Small cis-regulatory modules of the serotonin 
pathway genes occasionally show ectopic 
expression suggesting that repressor elements may 
contribute to restricted expression of these genes in 
the serotonergic neurons. 
4 A complex code of six transcription factors is 
required to induce the serotonergic fate specifically 
in the HSN neuron subtype. This code, that we have 
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termed the HSN transcription factor collective, is 
composed by UNC-86, SEM-4, HLH-3, EGL-46, AST-1 
and EGL-18 that belong to the POU, SPALT, HLH, 
INSM, ETS and GATA transcription factor families, 
respectively. These six transcription factors directly 
bind to the regulatory regions of the serotonin 
pathway genes in order to activate their expression 
in the HSN neuron.
5 The HSN transcription factor collective 
is expressed in the HSN neuron at larval stage L4 
and acts at the terminal steps of differentiation to 
establish the terminal fate of the neuron, except 
for HLH-3, whose expression is restricted to the 
HSN neuroblast. We propose that, similar to its 
mouse homologue ASCL1, HLH-3 has a dual role 
as a proneural and a pioneer factor, sequentially 
promoting neuronal specification and serotonergic 
differentiation of the HSN precursor cell, binding to 
the serotonin pathway genes in closed chromatin 
states. The expression of the HSN transcription 
factor collective, except for HLH-3, is required 
throughout the life of the animal in order to maintain 
the serotonergic identity of the HSN neuron. 
6 The HSN transcription factor collective acts 
through parallel pathways to activate the expression 
of the serotonin pathway genes in the HSN. 
Importantly, UNC-86 appears as a master-regulator, 
whereas the activity of AST-1 is highly regulated by 
other members of the code.
7 Ectopic expression of the HSN transcription 
factor collective is sufficient to induce serotonergic 
fate, in some cellular contexts.
8  The transcription factors that belong to the 
HSN collective act cooperatively and redundantly 
to regulate the expression of the serotonin pathway 
genes. The individual roles of each member of 
the HSN transcription factor collective and the 
synergistic relationships among them depend on the 
specific DNA regulatory context where they bind.
9 The HSN transcriptome contains a specific 
signature composed by the clustering of 
transcription factor binding sites for the six members 
of the HSN transcription factor collective, that is 
enriched in neuronal genes and allows for de novo 
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identification of HSN expressed genes. We show, 
for the first time, that a regulatory signature merely 
based on primary DNA sequence is sufficient for 
enhancer identification.
10 The HSN regulatory programme matches 
best the transcription factor collective model: the 
six transcription factors that belong to the HSN 
regulatory code act in a flexible manner, activating 
enhancers with variable transcription factor binding 
site order and distribution. Moreover, in agreement 
with this model, the presence of binding sites for 
certain transcription factors is dispensable in certain 
genomic contexts and can be compensated for 
by the rest of the transcription factor collective. 
Furthermore, syntactic rules such as transcription 
factor pair orientation are required for the activation 
of some HSN enhancers.
11 The regulatory programme of the HSN neuron, 
but not that of the NSM or ADF neurons, strikingly 
resembles the serotonergic regulatory programme 
in mouse: AST-1/PET1, HLH-3/ASCL1, EGL-18/
GATA2/3, EGL-46/INSM1 and UNC-86/BRN2 appear 
as orthologue transcription factors. This homology 
allows for the identification of the new regulatory 
candidates in the worm PHA-4 (FOXA2), and in the 
mouse SALL2 (SEM-4). 
12 C. elegans HSN neuron and mouse serotonergic 
raphe neurons share deep homology, as well as 
molecular and functional homology. We propose that 
this deep homology may have arisen from a common 
ancestor cell type.
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5-HT serotonin
5-HTP 5 hydroxytryptophan
AADC amino acid decarboxylase
ADF Amphid neuron Dual F
BAS-1 biogenic amine synthesis related 1
bHLH basic Helix-Loop-Helix
bp base pair
BS binding site
C. briggsae Caenorhabditis briggsae
C. brenneri Caenorhabditis brenneri
C. elegans Caenorhabditis elegans
CGC Caenorhabditis Genetic Center
C. japonica Caenorhabditis japonica
C. remanei Caenorhabditis japonica
CRISPR Clustered Regularly Interspaced Short 
Palindromic Repeats
CRM cis-regulatory module
DiD 1,1’-Dioctadecyl-3,3,3’,3’-
tetramethylindodicarbocyanine, 
4-chlorobenzenesulfonate salt
DiI 1,1’-Dioctadecyl-3,3,3’,3’-
tetramethylindocarbocyanine perchlorate
DiO 3,3’-Dioctadecyloxacarbocyanine perchlorate
dpy dumpy
egl egg-laying defective
DAPI 4’,6-diamidino-2-phenylindole
DNA Deoxyribonucleic acid
E. coli Escherichia coli
EMSA Electrophoretic Mobility Shift Assay
ETS E26 transformation-specific or E-twenty-six
FKH forkhead
Fwd forward
GCH1 GTP cyclohydrolase 1
GFP Green Fluorescent Protein
GWAS Genome-wide association study 
HD Homeo Domain
hs heat shock
hsp heat shock promoter
hpf hours post-fertilisation
HSN Hermaphrodite Specific Motorneuron
IPTG Isopropyl β-D-1-thiogalactopyranoside
kb kilo base
MOD-5 modulation of locomotion defective
NSM Neuro Secretory Motorneuron
nt nucleotide
PAM Protospacer Adjacent Motif
PBS Phosphate Buffered Saline
PCR Polymerase Chain Reaction
PHB Phasmid neuron B
PFA  paraformaldehyde
POU Pit-Oct-Unc
PPI protein-protein interaction
PWM position weight matrix
pV p value
Rev reverse
r n rhombomere
RNA Ribonucleic acid
RNAi RNA interference
RT room temperature
SD  standard deviation
SEC Self-Excising Cassette
SEM standard error of the mean
SERT serotonin transporter
sgRNA single guide RNA
SLC18A1/2 Solute Carrier Family 18 Member A1/A2
SLC6A4 Solute Carrier Family 6 Member A4.
SNP Single Nucleotide Polimorphism
TF transcription factor
TFBS transcription factor binding site
TPH-1 tryptophan hydroxylase
Trp tryptophan
TSS transcription starting site
UTR untranslated region
ZnF Zinc Finger
VMAT vesicular monoamine transporter
wt wild type
Abbreviations
and achronyms
Annexes Annex 3.1.1 Primary data of serotonin 
pathway gene cis-regulatory 
analysis
Apart from the serotonergic 
neurons (NSM, ADF, AIM, RIH 
and VC4/5), we included in 
the analysis all monoamin-
ergic neurons that share the 
expression of some 5-HT
pathway genes, including 
dopaminergic (CEPD, CEPV, 
ADE, PDE), octopaminergic 
(RIC) and tyraminergic (RIM) 
neurons. (–): not expected to 
be expressed. See Figure 3.1.3.
5-HT
Promoter % HSN % NSM %ADF % VC4/5 %AIM %RIH Other cells Lines
tph-1prom1 81,84,91 31, 76, 86 69,90,93 31, 69, 76 (–) (–) no 3
tph-1prom8 0,0,0 0,0,0 0,0,0 0,0,0 (–) (–) yes 3
tph-1prom2 41,53,61,
62,68,93
89,92,95,
98,98,98
90,03,04,
95,95,98
43,48,55,
58,81,90
(–) (–) yes 6
tph-1prom6 0,0 0,0 0,0 0,0 (–) (–) no 2
tph-1prom5 0,0,0 0,09,98 0,0,0 0,0,0 (–) (–) no 3
tph-1prom3 0,0,0,0 85,86,89,94 0,0,0,0 0,0,0,0 (–) (–) no 4
tph-1prom17 0,0,0 0,0,0 90,93,95 53,53,59 (–) (–) no 3
bas-1prom1 88,92 92,100 100,100 (–) 67,88 (–) yes 2
bas-1prom2 42,50 100,93 0,0 (–) 0,0 (–) yes 2
bas-1prom13 90,91 31,78 0,0 (–) 0,0 (–) yes 2
bas-1prom14 0 0 0 (–) 0 (–) no 1
bas-1prom15 0,0,0 0,0,0 0,0,0 (–) 0,0,0 (–) yes 3
bas-1prom16 75 45 12 (–) 0 (–) no 1
bas-1prom17 0,0 0,0 0,0 (–) 0,0 (–) no 2
bas1prom18 38,43,43,63 82,92,93,95 0,0,0,0 (–) 0,0,0,0 (–) yes 4
bas-1prom3 8,17 0,0 95,95 (–) 0,0 (–) no 2
bas-1prom4 0,0 0,0 0,0 (–) 0,0 (–) yes 2
bas-1prom5 0,0,0 0,0,0 67,85,87 (–) 0,0,0 (–) yes 3
bas-1prom6 0,0,0 0,0,0 0,0,0 (–) 0,0,0 (–) no 3
bas-1prom7 0,0,0 0,0,0 88,97,97 (–) 0,0,0 (–) no 3
cat-1prom1 0,70,87 93,93,100 2,83,93 3,82,97 (–) 0,70,83 no 3
cat-1prom2 0,0 0,0 0,0 0,0 (–) 0,0 yes 2
cat-1prom3 87,92,97 93,93,98 78,88,98 83,92,97 (–) 0,8,12 no 3
cat-1prom12 43,68 98,98 70,73 0,0 (–) 0,0 no 2
↳
256
cat-1prom11 0,0 0,0 92,97 92,95 (–) 0,13 no 2
cat-1prom35 0,0,0 0,0, 0,0,0 0,0,0 (–) 0,0,0 no 3
cat-1prom36 0,0 0,0 77,80 0,0 (–) 0,0 no 2
cat-1prom37 0,0,0 0,0,0 92,95,98 0,0,0 (–) 0,0,0 yes 3
cat-1prom13 0,0,0 0,0,0 0,0,0 0,0,0 (–) 0,0,0 no 3
cat-1prom14 20,43,50, 
55,67,73
82,82,88,
92,93,95
10,10,72,
80,82,87
0,0,0,
0,0,0
(–) 0,0,0,
0,0,0
no 6
cat-1prom26 0,0,0 0,0,0 0,0,0 0,0,0 (–) 0,0,0 no 3
cat-1prom27 7,8,30 90,95,98 0,2,12 0,0,0 (–) 0,0,0 yes 3
cat-4prom4 85,87,95 90,97,98 87,88,93 (–) 80,82,92 (–) no 3
cat-4prom5 0,0,0 0,0,0 0,0,0 (–) 0,0,0 (–) no 3
cat-4prom6 52,78,80 93,95,97 38,55,72 (–) 72,80,87 (–) yes 3
cat-4prom8 48,75 0,0 0,0 (–) 0,0 (–) no 2
cat-4prom58 0,0,0 0,0,0 0,0,0 (–) 0,0,0 (–) no 3
cat-4prom59 0,0,0 0,0,0 0,0,0 (–) 0,0,0 (–) no 3
cat-4prom9 0,0,0 87,88,93 0,0,0 (–) 0,0,0 (–) no 3
cat-4prom18 0,0,0 0,0,0 0,0,0 (–) 0,0,0 (–) yes 3
cat-4prom19 0,0 0,0 0,0 (–) 0,0 (–) yes 2
cat-4prom27 0,0,0 20,72,72 0,0,0 (–) 0,0,0 (–) no 3
mod-5prom1 0,0,0 0,0,0 0,0,0 (–) 0,0,0 (–) no 3
mod-5prom3 0,0,0 97,98 95,97 (–) 0,0,0 (–) yes 3
mod-5prom8 0,0,0 0,0,0 53,58,92 (–) 0,0,0 (–) yes 3
mod-5prom6 0,0,0 0,0,0 61,83,87 (–) 0,0,0 (–) yes 3
DA Tyr Oct
Promoter % CEPV % CEPD %ADE % PDE %RIM % RIC Other cells Lines
bas-1prom1 92,95 87,97 90,97 100,100 (–) (–) yes 2
bas-1prom2 0,0 0,0 0,0 0,0 (–) (–) yes 2
bas-1prom13 0,0 0,0 0,0 0,0 (–) (–) yes 2
bas-1prom14 0 0 0 0 (–) (–) no 1
bas-1prom15 0,0,0 0,0,0 0,0,0 0,0,0 (–) (–) yes 3
bas-1prom16 0 0 0 0 (–) (–) no 1
bas-1prom17 0,0 0,0 0,0 0,0 (–) (–) no 2
bas-1prom18 0,0,0,0 0,0,0,0 0,0,0,0 0,0,0,0 (–) (–) yes 4
bas-1prom3 82,93 92,93 82,90 90,90 (–) (–) no 2
bas-1prom4 0,2 7,8 0,3 0,0 (–) (–) yes 2
bas-1prom5 87,88,90 87,92,93 83,88,97 68,80,83 (–) (–) yes 3
bas-1prom6 0,0,0 0,0,3 8,10,18 32,40,73 (–) (–) no 3
bas-1prom7 0,0,0 0,0,0 0,0,0 0,0,0 (–) (–) no 3
cat-1prom1 0,70,87 93,93,100 2,83,93 42,93,95 0,93,97 0,92,97 no 3
cat-1prom2 0,0 0,0 0,0 87,88 0,0 0,0 yes 2
cat-1prom3 87,92,97 93,93,98 78,88,98 85,90,97 0,0,0 0,0,98 no 3
cat-1prom12 43,68 98,98 70,73 90,90 0,0 0,0 no 2
cat-1prom11 0,0 0,0 92,97 0,0 9,97 0,0 no 2
cat-1prom35 0,0,0 0,0, 0,0,0 0,0,0 0,0,0 0,0,0 no 3
cat-1prom36 0,0 0,0 77,80 0,0 0,0 0,0 no 2
cat-1prom37 0,0,0 0,0,0 92,95,98 0,0,0 0,0,0 0,0,0 yes 3
cat-1prom13 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 no 3
cat-1prom14 20,43,50,
55,67,73
82,82,88,
92,93,95
10,10,72,
80,82,87
20,30,55,
78,85,95
0,0,0,
0,0,0
0,0,0,
0,0,0
no 6
cat-1prom26 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 no 3
cat-1prom27 7,8,30 90,95,98 0,2,12 2,13,23 0,0,0 0,0,0 yes 3
cat-4prom4 85,87,97 87,88,98 63,72,77 (–) (–) (–) no 3
cat-4prom5 0,0,0 0,0,0 0,0,0 (–) (–) (–) no 3
↳
↲
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cat-4prom6 97,97,100 87,95,97 70,80,90 (–) (–) (–) yes 3
cat-4prom8 0,0 0,0 0,0 (–) (–) (–) no 2
cat-4prom58 0,0,0 0,0,0 0,0,0 (–) (–) (–) no 3
cat-4prom59 0,0,0 0,0,0 0,0,0 (–) (–) (–) no 3
cat-4prom9 100,100,100 100,100,100 45,52,72 (–) (–) (–) no 3
cat-4prom18 0,0,0 0,0,0 0,0,0 (–) (–) (–) yes 3
cat-4prom19 7,63 0,0 0,27 (–) (–) (–) yes 2
cat-4prom27 7,90,93 0,0,0 0,0,0 (–) (–) (–) no 3
cat-4prom8 48,75 0,0 0,0 (–) 0,0 (–) no 2
cat-4prom58 0,0,0 0,0,0 0,0,0 (–) 0,0,0 (–) no 3
cat-4prom59 0,0,0 0,0,0 0,0,0 (–) 0,0,0 (–) no 3
cat-4prom9 0,0,0 87,88,93 0,0,0 (–) 0,0,0 (–) no 3
cat-4prom18 0,0,0 0,0,0 0,0,0 (–) 0,0,0 (–) yes 3
cat-4prom19 0,0 0,0 0,0 (–) 0,0 (–) yes 2
cat-4prom27 0,0,0 20,72,72 0,0,0 (–) 0,0,0 (–) no 3
mod-5prom1 0,0,0 0,0,0 0,0,0 (–) 0,0,0 (–) no 3
mod-5prom3 0,0,0 97,98 95,97 (–) 0,0,0 (–) yes 3
mod-5prom8 0,0,0 0,0,0 53,58,92 (–) 0,0,0 (–) yes 3
mod-5prom6 0,0,0 0,0,0 61,83,87 (–) 0,0,0 (–) yes 3
Annex 3.2.1 
Primary data of serotonin 
pathway gene expression in 
loss of function mutants
Analysis of tph-1, bas-1, cat-1 
and cat-4 expression in the 
different mutant backgrounds 
for the six candidate
regulators of the HSN neuron. 
Expression in the NSM 
and ADF neurons was also 
considered.
See Figures 3.2.2, 3.2.3 and 
3.2.5.
Gene Genotype % HSN SEP pV % NSM SEP pV % ADF SEP pV
5-HT 
staining
N2 100 0 (–) 100 0 (–) 97 0 (–)
ast-1(ot417)II 0 0 0.0001 100 0 1.000 100 0 1.000
unc-86(n846)III 1 1 0.0001 95 2 0.059 98 1 1.000
sem-4(n1971)I 4 2 0.0001 100 0 1.000 100 0 1.000
hlh-3(tm1688)II 38 3 0.0001 100 0 1.000 97 2 1.000
egl-46(sy628)V 82 2 0.0001 96 2 0.121 89 3 0.0489
egl-18(ok290)IV 74 3 0.0001 97 2 0.246 90 3 0.0818
end-1&ric-7(ok558)V 92 2 0.0025 100 0 1.000 100 0 1.000
lin-11 (n389)I; ceh-14 (ch3) X 95 2 0.0594 99 1 1.000 99 1 1.000
tph-1 zdIs13(tph-1::gfp)IV 100 0 (–) 100 0 (–) 100 0 (–)
yzIs71[tph-1::gfp, rol-6(su1006)]V 96 2 (–) 99 1 (–) 99 1 (–)
ast-1(ot417)II; zdIs13(tph-1::gfp)IV 0 0 0.0001 100 0 1.000 100 0 1.000
unc-86(n846)III;  
zdIs13(tph-1::gfp)IV
0 0 0.0001 0 0 0.0001 100 0 1.000
sem-4(n1971)I; zdIs13(tph-1::gfp)IV 52 3 0.0001 99 1 0.560 99 1 1.000
hlh-3(tm1688)II;  
zdIs13(tph-1::gfp)IV
22 4 0.0001 100 0 1.000 99 1 1.000
egl-46(sy628)V;  
zdIs13(tph-1::gfp)IV
62 5 0.0001 98 1 1.000 90 3 0.001
egl-18(ok290)IV; yzIs71[tph-1::gfp, 
rol-6(su1006)]V
75 4 0.0001 99 1 1.000 100 0 1.000
end-1&ric-7(ok558)V; 
zdIs13(tph-1::gfp)IV
100 0 1.000 n.a. n.a. n.a. n.a. n.a. n.a.
cat-1 otIs221(cat-1::gfp)III 100 0 (–) 100 0 (–) 97 2 (–)
otIs224(cat-1::gfp)V 100 0 (–) 100 0 (–) 100 0 (–)
ast-1(ot417)II; otIs221(cat-1::gfp)III 0 0 0.0001 100 0 1.000 100 0 1.000
unc-86(n846)III;otIs224(cat-1::gfp)V 5 2 0.0001 90 3 0.002 100 0 1.000
sem-4(n1971)I;  
otIs221(cat-1::gfp)III
0 0 0.0001 100 0 1.000 100 0 1.000
hlh-3(tm1688)II;  
otIs221(cat-1::gfp)III
81 3 0.0001 99 1 1.000 100 0 1.000
egl-46(sy628)V;  
otIs221(cat-1::gfp)III
61 5 0.0001 100 0 1.000 100 0 1.000
egl-18(ok290)IV;  
otIs221(cat-1::gfp)III
97 2 0.130 99 1 1.000 96 2 0.687
↲
↳
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end-1&ric-7(ok558)V;  
otIs221[cat-1::gfp]III
100 0 1.000 n.a. n.a. n.a. n.a. n.a. n.a.
lin-11 (n389)I; ceh-14 (ch3) X; 
otIs221(cat-1::gfp)III;  
him-5 (e1467)V
93 2 0.006 n.a. n.a. n.a. n.a. n.a. n.a.
cat-4 otEx2470[cat-4::gfp(50ng/ul),  
rol-6(su1006)]
89 3 (–) 95 3 (–) 91 4 (–)
otIs225(cat-4::gfp)II 100 0 (–) 100 0 (–) 100 0 (–)
ast-1(ot417)II; otEx2470[cat-4::gfp 
(50ng/ul), rol-6(su1006)]
89 3 1.000 90 3 0.359 90 3 1.000
unc-86(n846)III;  
otIs225(cat-4::gfp)II
0 0 0.0001 86 3 0.0001 100 0 1.000
sem-4(n1971)I;  
otIs225(cat-4::gfp)II
1 1 0.0001 100 0 1.000 100 0 1.000
hlh-3(tm1688)II; otEx2470[cat-4::g-
fp (50ng/ul), rol-6(su1006)]
89 3 1.000 85 8 0.171 90 7 1.000
egl-46(sy628)V;  
otIs225(cat-4::gfp)II
100 0 1.000 100 0 1.000 98 1 0.498
egl-18(ok290)IV;  
otIs225(cat-4::gfp)II
99 3 1.000 100 0 1.000 100 0 0.567
end-1&ric-7(ok558)V;  
otIs225[cat-4::gfp]II
100 0 1.000 n.a. n.a. n.a. n.a. n.a. n.a.
bas-1 otIs226(bas-1::gfp)IV 100 0 (–) 100 0 (–) 100 0 (–)
otEx2435[bas-1::gfp(50ng/ul),  
rol-6(su1006)]
85 4 (–) 85 3 (–) 91 2 (–)
ast-1(ot417)II; otIs226(bas-1::gfp)IV 100 0 1.000 100 0 1.000 100 0 1.000
ast-1(hd92); vlcEx844[ast-1(+),  
cat-1::DsRed]; otIs226(bas-1::gfp)IV
100 0 1.000 n.a. n.a. n.a. n.a. n.a. n.a.
ast-1(hd92); vlcEx845[ast-1(+),  
cat-1::DsRed]; otIs226(bas-1::gfp)IV
100 0 1.000 n.a. n.a. n.a. n.a. n.a. n.a.
unc-86(n846)III;  
otIs226(bas-1::gfp)IV
0 0 0.0001 83 4 0.0001 99 1 1.000
sem-4(n1971)I;  
otIs226(bas-1::gfp)IV
0 0 0.0001 100 0 1.000 90 3 0.001
hlh-3(tm1688)II;  
otIs226(bas-1::gfp)IV
49 5 0.0001 100 0 1.000 86 3 0.0001
egl-46(sy628)V;  
otIs226(bas-1::gfp)IV
85 3 0.0001 98 1 0.500 97 1 0.251
egl-18(ok290)IV;  
otEx2435[bas-1::gfp (50ng/ul),  
rol-6(su1006]
79 1 0.162 97 1 0.001 90 3 0.836
end-1&ric-7(ok558)V; 
otIs226(bas-1::gfp)IV
100 0 1.000 n.a. n.a. n.a. n.a. n.a. n.a.
Gene Genotype % HSN SEP pV
kcc-2c vsEx580[kcc-2c::gfp, myo-2::gfp] 74 4 (–)
ast-1(ot417)II; vsEx580[kcc-2c::gfp, myo-2::gfp] 0 0 0 .0001
unc-86(n846)III; vsEx580[kcc-2c::gfp, myo-2::gfp] 0 0 0 .0001
sem-4(n1971)I; vsEx580[kcc-2c::gfp, myo-2::gfp] 6 2 0 .0001
hlh-3(tm1688)II; vsEx580[kcc-2c::gfp, myo-2::gfp] 0 0 0 .0001
egl-46(sy628)V; vsEx580[kcc-2c::gfp, myo-2::gfp] 52 5 0 .0016
egl-18(ok290)IV; vsEx580[kcc-2c::gfp, myo-2::gfp] 45 5 0 .0001
lgc-55 zfIs4(lgc-55::mCherry) 100 0 (–)
zfIs6(lgc-55::gfp)II 100 0 (–)
ast-1(ot417)II; zfIs4(lgc-55::mCherry) 0 0 0 .0001
unc-86(n846)III; zfIs6(lgc-55::gfp)II 12 3 0 .0001
sem-4(n1971)I; zfIs6(lgc-55::gfp)II 0 0 0 .0001
hlh-3(tm1688)II; zfIs4(lgc-55::mCherry) 8 3 0 .0001
egl-46(sy628)V; zfIs6(lgc-55::gfp)II 85 3 0 .0001
egl-18(ok290)IV; zfIs6(lgc-55::gfp)II 98 1 1
ida-1 inIs181(ida-1::gfp); inIs182(ida-1::gfp) 100 0 (–)
inIs179(ida-1::gfp)II 100 0 (–)
ast-1(ot417)II; inIs181(ida-1::gfp); inIs182(ida-1::gfp) 96 2 0 .449
unc-86(n846)III; inIs179(ida-1::gfp)II 0 0 0 .0001
sem-4(n1971)I; inIs179(ida-1::gfp)II 4 2 0 .0001
hlh-3(tm1688)II; inIs181(ida-1::gfp); inIs182(ida-1::gfp) 28 4 0 .0001
egl-46(sy628)V; inIs179(ida-1::gfp)II 77 4 0 .0001
egl-18(ok290)IV; inIs179(ida-1::gfp)II 92 2 0 .0019
flp-19 ynIs34(flp-19::gfp)IV 100 0 (–)
ast-1(ot417)II; ynIs34(flp-19::gfp)IV; him-5(e1490)V 100 0 1
unc-86(n846)III; ynIs34(flp-19::gfp) IV; him-5(e1490)V 0 0 0 .0001
sem-4(n1971)I; ynIs34(flp-19::gfp) IV; him-5(e1490)V 0 0 0 .0001
hlh-3(tm1688)II; ynIs34(flp-19::gfp) IV 43 5 0 .0001
egl-46(sy628)V; ynIs34(flp-19::gfp) IV 5 2 0 .0001
Annex 3.2.2  
Primary data of non-serotonin 
related gene expression in 
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Analysis of a battery of 
terminal features of the HSN 
that are independent of the 
5-HT biosynthetic pathway, 
in the different mutant 
backgrounds for the six 
candidate regulators of the 
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unc-17 otIs576(unc-17fosmid::GFP, lin-44::YFP) 79 3 (–)
ast-1(ot417)II; otIs576(unc-17fosmid::GFP, lin-44::YFP) 81 3 0 .86
unc-86(n846)III; otIs576(unc-17fosmid::GFP,  
lin-44::YFP); him-5(e1490)V
67 3 0 .0587
sem-4(n1971)I; otIs576(unc-17fosmid::GFP,  
lin-44::YFP); him-5(e1490)V
1 0 0 .0001
hlh-3(tm1688)II; otIs576(unc-17fosmid::GFP,  
lin-44::YFP); him-5(e1490)V
15 3 0 .0001
egl-46(sy628)V; otIs576(unc-17fosmid::GFP,  
lin-44::YFP)
34 3 0 .0001
egl-18(ok290)IV; otIs576(unc-17fosmid::GFP,  
lin-44::YFP)
82 3 0 .1922
unc-40 icIs132(unc-40::gfp) 92 2 (–)
ast-1(ot417)II; icIs132 (unc-40::gfp); him-8(e1489)IV 95 2 0 .3421
unc-86(n846)III; icIs132 (unc-40::gfp); him-8(e1489)IV 88 3 0 .24
sem-4(n1971)I; icIs132 (unc-40::gfp); him-8(e1489)IV 75 4 0 .0001
hlh-3(tm1688)II; icIs132 (unc-40::gfp); him-8(e1489)IV 35 5 0 .0001
egl-46(sy628)V; icIs132 (unc-40::gfp); him-8(e1489)IV 10 3 0 .0001
egl-18(ok290)IV; icIs132 (unc-40::gfp); him-8(e1489)IV 96 2 0 .2208
rab-3 otIs287[rab-3::yfp, rol-6(su1006)]IV 100 0 (–)
otIs291[rab-3::gfp, rol-6(su1006)] 100 0 (–)
ast-1(ot417)II; otIs287[rab-3::yfp, rol-6(su1006)]IV 100 0 1
unc-86(n846)III; otIs287[rab-3::yfp, rol-6(su1006)]IV 100 0 1
sem-4(n1971)I; otIs287[rab-3::yfp, rol-6(su1006)]IV 81 4 0 .0001
hlh-3(tm1688)II; otIs287[rab-3::yfp, rol-6(su1006)]IV 34 4 0 .0001
egl-46(sy628)V; otIs287[rab-3::yfp, rol-6(su1006)]IV 93 2 0 .0142
egl-18(ok290)IV; otIs291[rab-3::gfp, rol-6(su1006)] 94 2 0 .029
nlg-1 sIs13247(nlg-1::gfp) 69 3 (–)
ast-1(ot417)II; sIs13247(nlg-1::gfp) 46 5 0 .0001
unc-86(n846)III; sIs13247(nlg-1::gfp) 60 4 0 .0783
sem-4(n1971)I; sIs13247(nlg-1::gfp) 15 3 0 .0001
hlh-3(tm1688)II; sIs13247(nlg-1::gfp) 57 5 0 .0364
egl-46(sy628)V; sIs13247(nlg-1::gfp) 48 6 0 .0007
kal-1 otIs33(kal-1::gfp)IV 92 2 (–)
vlcEx453[kal-1::gfp, ttx-3::mCherry, rol-6(su1006)] 84 4 (–)
ast-1(ot417)II; otIs33(kal-1::gfp)IV 90 3 0 .8181
unc-86(n846)III; otIs33(kal-1::gfp)IV 85 4 0 .1432
sem-4(n1971)I; otIs33(kal-1::gfp)IV 82 3 0 .0161
hlh-3(tm1688)II; otIs33(kal-1::gfp)IV 100 0 0 .0014
egl-46(sy628)V; otIs33 (kal-1::gfp)IV 96 3 0 .4117
egl-18(ok290)IV; vlcEx453[kal-1::gfp, ttx-3::mCherry, 
rol-6(su1006)]
93 2 0 .8059
↲
TF Family Genotype Scoring % HSN SEP pV
GATA rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV + L4440 F1 100 0 (–)
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV + egl-18 RNAi F1 68 6 0.0001
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV + elt-3 RNAi F1 92 4 0.0573
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV + elt-6 RNAi F1 92 4 0.0573
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV + elt-7 RNAi F1 93 3 0.1187
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV + end-1 RNAi F1 88 4 0.013
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV + end-3 RNAi F1 96 3 0.4958
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV + med-1/med-2 RNAi F1 95 3 0.2437
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV + L4440 P0 100 0 (–)
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV + elt-1 RNAi P0 100 0 1
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV + elt-2 RNAi P0 100 0 1
rrf-3(pk1426)II; otIs221(cat-1::gfp)III+ L4440 F1 100 0 (–)
rrf-3(pk1426)II; otIs221(cat-1::gfp)III+ egl-18 RNAi F1 40 6 0.0001
rrf-3(pk1426)II; otIs221(cat-1::gfp)III+ elt-3 RNAi F1 80 5 0.0003
rrf-3(pk1426)II; otIs221(cat-1::gfp)III+ elt-6 RNAi F1 87 4 0.0061
rrf-3(pk1426)II; otIs221(cat-1::gfp)III+ elt-7 RNAi F1 93 3 0.1187
rrf-3(pk1426)II; otIs221(cat-1::gfp)III+ end-1 RNAi F1 63 6 0.0001
rrf-3(pk1426)II; otIs221(cat-1::gfp)III+ end-3 RNAi F1 93 3 0.1187
rrf-3(pk1426)II; otIs221(cat-1::gfp)III+ med-1/med-2  RNAi F1 100 0 1
rrf-3(pk1426)II; otIs221(cat-1::gfp)III+ L4440 P0 100 0 (–)
rrf-3(pk1426)II; otIs221(cat-1::gfp)III+ elt-1 RNAi P0 100 0 1
rrf-3(pk1426)II; otIs221(cat-1::gfp)III+ elt-2 RNAi P0 100 0 1
FKH rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV + L4440 F1 97 2 0.4958
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV + attf-4 RNAi F1 98 2 1
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV +  C34B4.2 RNAi F1 100 0 1
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV +  daf-16 RNAi F1 98 2 1
FKH rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV +  fkh-2 RNAi F1 100 0 1
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV +  fkh-3/4 RNAi F1 98 2 1
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV +  fkh-5 RNAi F1 98 2 1
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV +  fkh-6 RNAi F1 96 3 0.4958
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV +  fkh-7 RNAi F1 100 0 1
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV +  fkh-8 RNAi F1 98 2 1
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV +  fkh-9 RNAi F1 95 3 0.2437
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV +  fkh-10 RNAi F1 98 2 1
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV +  lin-31 RNAi F1 98 2 1
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV +  let-381 RNAi F1 98 2 1
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV + pha-4 RNAi F1 82 5 0.013
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV +  T27A8.2  RNAi F1 97 2 0.4958
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV + unc-130 RNAi F1 100 0 1
rrf-3(pk1426)II; otIs221(cat-1::gfp)III + L4440 F1 99 1 0.4958
rrf-3(pk1426)II;  otIs221(cat-1::gfp)III + attf-4 RNAi F1 100 0 1
rrf-3(pk1426)II; otIs221(cat-1::gfp)III +  C34B4.2 RNAi F1 100 0 1
rrf-3(pk1426)II; otIs221(cat-1::gfp)III +  daf-16 RNAi F1 100 0 1
rrf-3(pk1426)II; otIs221(cat-1::gfp)III +  fkh-2 RNAi F1 100 0 1
rrf-3(pk1426)II;  otIs221(cat-1::gfp)III +  fkh-3/4 RNAi F1 100 0 1
rrf-3(pk1426)II;  otIs221(cat-1::gfp)III +  fkh-5 RNAi F1 100 0 1
rrf-3(pk1426)II;  otIs221(cat-1::gfp)III +  fkh-6 RNAi F1 98 2 0.4958
rrf-3(pk1426)II;  otIs221(cat-1::gfp)III +  fkh-7 RNAi F1 100 0 1
rrf-3(pk1426)II;  otIs221(cat-1::gfp)III +  fkh-8 RNAi F1 100 0 1
rrf-3(pk1426)II;  otIs221(cat-1::gfp)III +  fkh-9 RNAi F1 100 0 1
rrf-3(pk1426)II;  otIs221(cat-1::gfp)III +  fkh-10 RNAi F1 100 0 1
rrf-3(pk1426)II;  otIs221(cat-1::gfp)III +  lin-31 RNAi F1 100 0 1
rrf-3(pk1426)II;  otIs221(cat-1::gfp)III +  let-381 RNAi F1 97 2 1
rrf-3(pk1426)II;  otIs221(cat-1::gfp)III + pha-4 RNAi F1 40 6 0.0001
rrf-3(pk1426)II;  otIs221(cat-1::gfp)III +  T27A8.2  RNAi F1 100 0 1
rrf-3(pk1426)II;  otIs221(cat-1::gfp)III + unc-130 RNAi F1 100 0 1
Annex 3.2.3 
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LIM-HD rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV + L4440 F1 100 0 1
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV + ceh-14 RNAi F1 91 4 0.0573
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV + lim-4 RNAi F1 98 2 1
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV + lim-6  RNAi F1 98 2 1
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV + lim-7 RNAi F1 97 2 0.4958
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV + lin-11 RNAi F1 92 4 0.0573
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV + mec-3 RNAi F1 96 3 0.4958
rrf-3(pk1426)II; zdIs13(tph-1::gfp)IV + ttx-3 RNAi F1 100 0 1
rrf-3(pk1426)II;  otIs221(cat-1::gfp)III + L4440 F1 100 0 1
rrf-3(pk1426)II;  otIs221(cat-1::gfp)III + ceh-14 RNAi F1 80 5 0.0003
rrf-3(pk1426)II;  otIs221(cat-1::gfp)III + lim-4 RNAi F1 100 0 1
rrf-3(pk1426)II;  otIs221(cat-1::gfp)III + lim-6  RNAi F1 91 4 0.0573
rrf-3(pk1426)II;  otIs221(cat-1::gfp)III + lim-7 RNAi F1 100 0 0.4958
rrf-3(pk1426)II;  otIs221(cat-1::gfp)III + lin-11 RNAi F1 70 6 0.0001
rrf-3(pk1426)II;  otIs221(cat-1::gfp)III + mec-3 RNAi F1 100 0 0.4958
rrf-3(pk1426)II;  otIs221(cat-1::gfp)III + ttx-3 RNAi F1 95 3 1
↲
Genotype % PHB SEP pV
N2 87 4 (–)
ast-1(ot417)II; otIs221(cat-1::gfp)III 90 4 1
unc-86(n846)III; otIs224(cat-1::gfp)V 79 5 0.7306
sem-4(n1971)I; otIs221(cat-1::gfp)III 70 6 0.2092
hlh-3(tm1688)II; otIs221(cat-1::gfp)III 86 4 1
egl-46(sy628)V; otIs221(cat-1::gfp)III 75 6 0.3354
egl-18(ok290)IV; otIs221(cat-1::gfp)III 61 6 0.0391
Annex 3.2.4  
Primary data of PHB neuron 
DiI staining analysis.  
 
Scoring of the phasmid 
PHB neuron (HSN sister) 
that is located in the tail.  
See Figure 3.2.7.
Promoter Genotype Target Binding 
Site
Mutation (wt BS > mutant BS)
tph-1prom2 N2 (–) (–)
tph-1prom14 N2 ETS CGGATA > CaGATA
tph-1prom26 N2 POU GCGCATAATAAAACAATCA >  
GtGtATAccAcAACAAgCg
tph-1prom31 N2 SPALT TTGTGT > TTagGT
tph-1prom44 N2 HLH CCAGAA > tttGAA
tph-1prom43 N2 INSM CCCCTCTC > tttCTCTC
tph-1prom54 N2 GATA GGATATCT > GtATATtT
tph-1prom55 N2 GATA GGATAT > GGAaAT
tph-1prom60 N2 GATA GGATATCT > GtATATtT; GGATAT > GGAaAT
tph-1prom52 N2 FKH ATAAATA > ATAggTA
cat-1prom14 N2 (–) (–)
cat-1prom63 N2 ETS TTTCCG > TTTCgG
cat-1prom61 N2 POU TTCATCAT > TTgggCAT
cat-1prom60 N2 SPALT TTGTCT > cTagCT
cat-1prom73 N2 HLH TTCTGG > TTtTtt
cat-1prom71 N2 INSM CCCCACCA > ttttACCA
cat-1prom74 N2 GATA AGATAA > AtATAA
cat-1prom75 N2 GATA TGATAG > TtATAG
cat-1prom76 N2 GATA AGATAA > AtATAA ; TGATAG > TtATAG
cat-1prom83 N2 FHK ATCAACA > ATCggCA
cat-1prom3 N2 (–) (–)
cat-1prom79 N2 INSM CCGCTAGA > ttGtTAGA; CCCCACCA >  
tttACCA'; CCCCTTGG > ttttTTGG
bas-1prom18 N2 (–) (–)
bas-1prom73 N2 ETS TATCCG > TATCgG
bas-1prom71 N2 POU TGCATTCA > TGgggTCA
bas-1prom65 N2 SPALT/MYT AAATTT > AAgggg
bas-1prom78 N2 GATA CTATCC > CTtTCC
bas-1prom13 N2 (–) (–)
bas-1prom77 N2 HLH CCAGAA > tttGAA
bas-1prom76 N2 INSM CCCCAACA > CtttAACA
bas-1prom83 N2 GATA ATATC > ATATa
bas-1prom84 N2 GATA TGATAT > TtATAT
bas-1prom86 N2 GATA ATATC > ATATa; TGATAT > TtATAT; TGATAT > 
TtATAT
bas-1prom78 ast-1(ot417) GATA CTATCC > CTtTCC
Annex 3.2.5  
Specific DNA modifications 
for mutagenesis cis-regulato-
ry analysis 
 
Uppercase letters indicate 
wild type nucleotides, while 
lowercase letters indicate 
mutated nucleotides that alter 
a specific BS motif.   
See Figures 3.2.8-3.2.10.
↳
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Gene  Embryo L1 L2 L3 L4 Young 
adult
unc-86 % 100.00 97.00 100.00 100.00 100.00 100.00
SEP 0.00 2.00 0.00 0.00 0.00 0.00
N 40.00 45.00 50.00 40.00 50.00 50.00
sem-4 % n.a. 45.00 100.00 100.00 100.00 92.00
SEP n.a. 5.00 0.00 0.00 0.00 4.00
N n.a. 45.00 13.00 15.00 14.00 24.00
egl-46 % n.a. 53.00 57.00 39.00 48.00 67.00
SEP n.a. 7.00 5.00 5.00 7.00 3.00
N n.a. 27.00 29.00 46.00 24.00 95.00
ast-1 % 0.00 0.00 0.00 40.00 94.00 99.00
SEP 0.00 0.00 0.00 11.00 3.00 1.00
N 10.00 20.00 20.00 10.00 44.00 71.00
egl-18 % n.a. 91.00 100.00 100.00 83.00 87.00
SEP n.a. 4.00 9.00 0.00 8.00 4.00
N n.a. 22.00 12.00 20.00 12.00 50.00
hlh-3 % 90.00 0.00 0.00 0.00 0.00 0.00
SEP 3.00 0.00 0.00 0.00 0.00 0.00
N 50.00 20.00 20.00 20.00 20.00 20.00
Annex 3.2.6  
Primary data of cross- 
regulation between the six 
members of the HSN  
regulatory code 
 
In the first table we include 
the expression pattern date 
for the six members of the 
HSN regulatory code over 
time. In the second table we 
resume the expression of 
reporters of the individual 
members of the HSN regula-
tory code in the six mutant 
backgrounds. See Figures 
3.2.14 and 3.2.15.
Gene Genotype Age % HSN SEP pV
unc-86 otIs337(unc-86fosmid::NLS::YFP::H2B; ttx-3::mCherry) Young 
adult
100 0 (–)
otIs337(unc-86fosmid::NLS::YFP::H2B; ttx-3::mCherry) L1 97 2 (–)
sem-4(n1971)I; otIs337(unc-86fosmid::NLS::YFP::H2B,  
ttx-3::mCherry)
Young 
adult
95 2 0.0595
hlh-3(tm1688)II; otIs337(unc-86fosmid::NLS::YFP::H2B,  
ttx-3::mCherry)
Young 
adult
99 1 0.4845
egl-46(sy628)V; otIs337(unc-86fosmid::NLS::YFP::H2B,  
ttx-3::mCherry)
Young 
adult
100 0 1
ast-1(ot417)II; otIs337(unc-86fosmid::NLS::YFP::H2B,  
ttx-3::mCherry)
Young 
adult
100 0 1
ast-1(hd92)II; otIs337(unc-86fosmid::NLS::YFP::H2B,  
ttx-3::mCherry)
L1 100 0 1
egl-18(ok290)IV;  
otIs337(unc-86fosmid::NLS::YFP::H2B, ttx-3::mCherry)
Young 
adult
98 1 0.254
sem-4 kuIs34(sem-4::gfp)IV Young 
adult
100 0 (–)
kuIs34(sem-4::gfp)IV L1 44 3 (–)
sem-4 kuIs35(sem-4::gfp) Young 
adult
100 0 (–)
unc-86(n846)III; kuIs34(sem-4::gfp)IV Young 
adult
19 3 0.0001
unc-86(n846)III; kuIs34(sem-4::gfp)IV L1 30 4 0.0087
hlh-3(tm1688)II; kuIs34(sem-4::gfp)IV Young 
adult
100 0 1
egl-46(sy628)V; kuIs34(sem-4::gfp)IV Young 
adult
96 2 0.0648
ast-1(ot417)II; kuIs34(sem-4::gfp)IV Young 
adult
100 0 1
ast-1(hd92)II; kuIs34(sem-4::gfp)IV L1 57 5 0.0392
egl-18(ok290)IV; kuIs35(sem-4::gfp) Young 
adult
95 2 0.0594
egl-46 vlcEx324[egl-46::DsRed; ttx-3::mCherry; rol-6(su1006)] Young 
adult
67 3 (–)
vlcEx324[egl-46::DsRed; ttx-3::mCherry; rol-6(su1006)] L1 53 7 (–)
unc-86(n846)III; vlcEx324[egl-46::DsRed; ttx-3::mCherry;  
rol-6(su1006)]
Young 
adult
22 4 0.0001
unc-86(n846)III; vlcEx324[egl-46::DsRed; ttx-3::mCherry;  
rol-6(su1006)]
L1 4 2 0.0001
sem-4(n1971)I; zdIs13(tph-1::gfp)IV; vlcEx324[egl-46::DsRed; 
ttx-3::mCherry; rol-6(su1006)]
Young 
adult
58 6 0.472
hlh-3(tm1688)II; vlcEx324[egl-46::DsRed; ttx-3::mCherry;  
rol-6(su1006)]
Young 
adult
28 4 0.0001
hlh-3(tm1688)II; vlcEx324[egl-46::DsRed; ttx-3::mCherry;  
rol-6(su1006)]
L1 52 5 1
ast-1(ot417)II;  vlcEx324[egl-46::DsRed; ttx-3::mCherry;  
rol-6(su1006)]
Young 
adult
67 5 1
ast-1(hd92)II; hdEx237[ast-1(+), rol-6(su1006)];  
vlcEx324[egl-46::DsRed; ttx-3::mCherry; rol-6(su1006)]
L1 96 2 0.449
ast-1(hd92)II; vlcEx324[egl-46::DsRed; ttx-3::mCherry;  
rol-6(su1006)]
L1 31 4 0.752
egl-18(ok290)IV; vlcEx324[egl-46::DsRed; ttx-3::mCherry;  
rol-6(su1006)]
Young 
adult
71 5 0.5985
↳
270
ast-1 ast-1(vlc19[ast-1::gfp])II Young 
adult
99 1 (–)
unc-86(n846)III; ast-1(vlc19[ast-1::gfp])II Young 
adult
1 1 0.0001
sem-4(n1971)I;  ast-1(vlc19[ast-1::gfp])II Young 
adult
6 2 0.0001
hlh-3(tm1688)II;  ast-1(vlc19[ast-1::gfp])II Young 
adult
64 4 0.0001
egl-46(sy628)V;  ast-1(vlc19[ast-1::gfp])II Young 
adult
94 2 0.0361
egl-18(ok290)IV;  ast-1(vlc19[ast-1::gfp])II Young 
adult
95 2 0.085
egl-18 unc-119(tm4063)III; stIs11606[egl-18a::H1-mCherry + unc-119(+)] Young 
adult
87 3 (–)
unc-86(n846)III;  stIs11606[egl-18a::H1-mCherry + unc-119(+)] Young 
adult
79 4 0.1807
sem-4(n1971)I; stIs11606[egl-18a::H1-mCherry + unc-119(+)] Young 
adult
77 4 0.0694
hlh-3(tm1688)II; stIs11606[egl-18a::H1-mCherry + unc-119(+)] Young 
adult
79 4 0.1743
egl-18 egl-46(sy628)V; stIs11606[egl-18a::H1-mCherry + unc-119(+)] Young 
adult
88 3 1
ast-1(ot417)II;  vlcEx324[egl-46::DsRed; ttx-3::mCherry;  
rol-6(su1006)]
Young 
adult
87 3 0.0002
ast-1(hd92)II; hdEx237[ast-1(+), rol-6(su1006)]; unc-119(tm4063)III; 
stIs11606[egl-18a::H1-mCherry + unc-119(+)]
L1 72 4 (–)
ast-1(hd92)II; vlcEx845[cat-1:.mCherry, ast-1(+)];  
stIs11606[egl-18a::H1- mCherry + unc-119(+)]
L1 65 5 0.752
hlh-3 otEx4140[hlh-3fosmid::YFP, rol-6(su1006)] Embryo 90 3 (–)
unc-86(n846)III; otEx4140[hlh-3fosmid::YFP, rol-6(su1006)] Embryo 84 4 0.29
sem-4(n1971)I; otEx4140[hlh-3fosmid::YFP, rol-6(su1006)] Embryo 81 4 0.0884
egl-46(sy628)V; otEx4140[hlh-3fosmid::YFP, rol-6(su1006)] Embryo 92 3 0.7934
ast-1(hd92)II; otEx4140[hlh-3fosmid::YFP, rol-6(su1006)] Embryo 93 3 0.5895
egl-18(ok290)IV; otEx4140[hlh-3fosmid::YFP, rol-6(su1006)] Embryo 67 6 0.0002
↲ Annex 3.2.7 
Primary data and statistics 
for overexpression of the HSN 
regulatory code experiments, 
at different developmental 
stages (embryonic and larval)
Comparison analysis of the 
number of tph-1::gfp positive 
cells in the different experi-
mental conditions of overex-
pression of factors (wt, single 
or combinations of factors).
Three independent experi-
ments were performed and all 
data has been pooled togeth-
er. Statistical relationships 
between all of the conditions 
tested are showed. Non-para
metric Kruskal-Wallis analysis 
with Dunn’s correction for 
multiple comparisons was 
performed. ns: non-signifi-
cant difference. See Figure 
3.2.18.
Figure 3.2.18-A Figure 3.2.18-B Figure 3.2.18-C Figure 3.2.18-D
Dunn’s multi-
ple compar-
ison
Significancy Dunn’s multi-
ple compar-
ison
Significancy Dunn’s multi-
ple compar-
ison
Significancy Dunn’s multi-
ple compar-
ison
Significancy
wt vs. ast-1 **** wt vs. ast-1 **** wt vs. ast-1 **** wt vs. ast-1 ****
wt vs. unc-86 **** wt vs. unc-86 **** wt vs. unc-86 **** wt vs. unc-86 ****
wt vs. sem-4 **** wt vs. sem-4 **** wt vs. sem-4 **** wt vs. sem-4 ****
wt vs. hlh-3 ns wt vs. hlh-3 L1 ns wt vs. hlh-3 ** wt vs. hlh-3 L1 ns
wt vs. egl-46 ns wt vs. hlh-3 L2 ns wt vs. egl-46 ns wt vs. hlh-3 L2 **
wt vs. egl-18 ns wt vs. egl-46 
L1
ns wt vs. egl-18 **** wt vs. egl-46 
L1
ns
wt vs. combo 
‘A+U+S’ 
**** wt vs. egl-46 
L2
ns wt vs. combo 
‘A+U+S’ 
**** wt vs. egl-46 
L2
ns
wt vs. combo 
6
**** wt vs. egl-18 
L1
ns wt vs. combo 
6
**** wt vs. egl-18 
L1
**
ast-1 vs. 
unc-86
* wt vs. egl-18 
L2
ns ast-1 vs. 
unc-86
*** wt vs. egl-18 
L2
ns
ast-1 vs. 
sem-4
ns wt vs. combo 
‘A+U+S’
**** ast-1 vs. 
sem-4
ns wt vs. combo 
‘A+U+S’
****
ast-1 vs. hlh-3 ** wt vs. combo 
6 L1
**** ast-1 vs. hlh-3 ns wt vs. combo 
6 L1
****
ast-1 vs. 
egl-46
** wt vs. combo 
6 L2
**** ast-1 vs. 
egl-46
ns wt vs. combo 
6 L2
****
ast-1 vs. 
egl-18
** ast-1 vs. 
unc-86
ns ast-1 vs. 
egl-18
ns ast-1 vs. 
unc-86
**
ast-1 vs. com-
bo ‘A+U+S’
**** ast-1 vs. 
sem-4
ns ast-1 vs. com-
bo ‘A+U+S’
**** ast-1 vs. 
sem-4
ns
ast-1 vs. 
combo 6
**** ast-1 vs. hlh-3 
L1
** ast-1 vs. 
combo 6
*** ast-1 vs. hlh-3 
L1
ns
unc-86 vs. 
sem-4
ns ast-1 vs. hlh-3 
L2
ns unc-86 vs. 
sem-4
ns ast-1 vs. hlh-3 
L2
ns
↳
unc-86 vs. 
hlh-3
**** ast-1 vs. egl-
46 L1
ns unc-86 vs. 
hlh-3
** ast-1 vs. egl-
46 L1
ns
unc-86 vs. 
egl-46
**** ast-1 vs. egl-
46 L2
* unc-86 vs. 
egl-46
* ast-1 vs. egl-
46 L2
ns
unc-86 vs. 
egl-18
**** ast-1 vs. egl-
18 L1
** unc-86 vs. 
egl-18
** ast-1 vs. egl-
18 L1
ns
unc-86 
vs. combo 
‘A+U+S’ 
ns ast-1 vs. egl-
18 L2
ns unc-86 
vs. combo 
‘A+U+S’ 
ns ast-1 vs. egl-
18 L2
ns
unc-86 vs. 
combo 6
ns ast-1 vs. com-
bo ‘A+U+S’
**** unc-86 vs. 
combo 6
ns ast-1 vs. com-
bo ‘A+U+S’
****
sem-4 vs. 
hlh-3
**** ast-1 vs. com-
bo 6 L1
**** sem-4 vs. 
hlh-3
ns ast-1 vs. com-
bo 6 L1
**
sem-4 vs. 
egl-46
**** ast-1 vs. com-
bo 6 L2
ns sem-4 vs. 
egl-46
ns ast-1 vs. com-
bo 6 L2
ns
sem-4 vs. 
egl-18
**** unc-86 vs. 
sem-4
ns sem-4 vs. 
egl-18
ns unc-86 vs. 
sem-4
ns
sem-4 vs. 
combo 
‘A+U+S’ 
* unc-86 vs. 
hlh-3 L1
**** sem-4 vs. 
combo 
‘A+U+S’ 
** unc-86 vs. 
hlh-3 L1
ns
sem-4 vs. 
combo 6
ns unc-86 vs. 
hlh-3 L2
** sem-4 vs. 
combo 6
ns unc-86 vs. 
hlh-3 L2
*
hlh-3 vs. 
egl-46
ns unc-86 vs. 
egl-46 L1
** hlh-3 vs. 
egl-46
ns unc-86 vs. 
egl-46 L1
ns
hlh-3 vs. 
egl-18
ns unc-86 vs. 
egl-46 L2
**** hlh-3 vs. 
egl-18
ns unc-86 vs. 
egl-46 L2
ns
hlh-3 vs. com-
bo ‘A+U+S’ 
**** unc-86 vs. 
egl-18 L1
**** hlh-3 vs. com-
bo ‘A+U+S’ 
*** unc-86 vs. 
egl-18 L1
*
hlh-3 vs. 
combo 6
**** unc-86 vs. 
egl-18 L2
ns hlh-3 vs. 
combo 6
** unc-86 vs. 
egl-18 L2
ns
egl-46 vs. 
egl-18
ns unc-86 
vs. combo 
‘A+U+S’
ns egl-46 vs. 
egl-18
ns unc-86 
vs. combo 
‘A+U+S’
ns
egl-46 vs. 
combo 
‘A+U+S’ 
**** unc-86 vs. 
combo 6 L1
ns egl-46 vs. 
combo 
‘A+U+S’ 
** unc-86 vs. 
combo 6 L1
ns
egl-46 vs. 
combo 6
**** unc-86 vs. 
combo 6 L2
ns egl-46 vs. 
combo 6
* unc-86 vs. 
combo 6 L2
ns
egl-18 vs. 
combo 
‘A+U+S’ 
**** sem-4 vs. hlh-
3 L1
**** egl-18 vs. 
combo 
‘A+U+S’ 
*** sem-4 vs. hlh-
3 L1
ns
egl-18 vs. 
combo 6
**** sem-4 vs. hlh-
3 L2
* egl-18 vs. 
combo 6
** sem-4 vs. hlh-
3 L2
ns
combo 
‘A+U+S’ vs. 
combo 6
ns sem-4 vs. egl-
46 L1
** combo 
‘A+U+S’ vs. 
combo 6
ns sem-4 vs. egl-
46 L1
ns
sem-4 vs. egl-
46 L2
**** sem-4 vs. egl-
46 L2
ns
↲ sem-4 vs. egl-
18 L1
**** sem-4 vs. egl-
18 L1
ns
sem-4 vs. egl-
18 L2
ns sem-4 vs. egl-
18 L2
ns
sem-4 vs. 
combo 
‘A+U+S’
ns sem-4 vs. 
combo 
‘A+U+S’
*
sem-4 vs. 
combo 6 L1
ns sem-4 vs. 
combo 6 L1
ns
sem-4 vs. 
combo 6 L2
ns sem-4 vs. 
combo 6 L2
ns
hlh-3 L1 vs. 
hlh-3 L2
ns hlh-3 L1 vs. 
hlh-3 L2
ns
hlh-3 L1 vs. 
egl-46 L1
ns hlh-3 L1 vs. 
egl-46 L1
ns
hlh-3 L1 vs. 
egl-46 L2
ns hlh-3 L1 vs. 
egl-46 L2
ns
hlh-3 L1 vs. 
egl-18 L1
ns hlh-3 L1 vs. 
egl-18 L1
ns
hlh-3 L1 vs. 
egl-18 L2
ns hlh-3 L1 vs. 
egl-18 L2
ns
hlh-3 L1 
vs. combo 
‘A+U+S’
**** hlh-3 L1 
vs. combo 
‘A+U+S’
ns
hlh-3 L1 vs. 
combo 6 L1
**** hlh-3 L1 vs. 
combo 6 L1
ns
hlh-3 L1 vs. 
combo 6 L2
**** hlh-3 L1 vs. 
combo 6 L2
ns
hlh-3 L2 vs. 
egl-46 L1
ns hlh-3 L2 vs. 
egl-46 L1
ns
hlh-3 L2 vs. 
egl-46 L2
ns hlh-3 L2 vs. 
egl-46 L2
ns
hlh-3 L2 vs. 
egl-18 L1
ns hlh-3 L2 vs. 
egl-18 L1
ns
hlh-3 L2 vs. 
egl-18 L2
ns hlh-3 L2 vs. 
egl-18 L2
ns
hlh-3 L2 
vs. combo 
‘A+U+S’
**** hlh-3 L2 
vs. combo 
‘A+U+S’
**
hlh-3 L2 vs. 
combo 6 L1
**** hlh-3 L2 vs. 
combo 6 L1
ns
hlh-3 L2 vs. 
combo 6 L2
** hlh-3 L2 vs. 
combo 6 L2
ns
egl-46 L1 vs. 
egl-46 L2
ns egl-46 L1 vs. 
egl-46 L2
ns
↳
egl-46 L1 vs. 
egl-18 L1
ns egl-46 L1 vs. 
egl-18 L1
ns
egl-46 L1 vs. 
egl-18 L2
ns egl-46 L1 vs. 
egl-18 L2
ns
egl-46 L1 
vs. combo 
‘A+U+S’
**** egl-46 L1 
vs. combo 
‘A+U+S’
ns
egl-46 L1 vs. 
combo 6 L1
**** egl-46 L1 vs. 
combo 6 L1
ns
egl-46 L1 vs. 
combo 6 L2
** egl-46 L1 vs. 
combo 6 L2
ns
egl-46 L2 vs. 
egl-18 L1
ns egl-46 L2 vs. 
egl-18 L1
ns
egl-46 L2 vs. 
egl-18 L2
ns egl-46 L2 vs. 
egl-18 L2
ns
egl-46 L2 
vs. combo 
‘A+U+S’
**** egl-46 L2 
vs. combo 
‘A+U+S’
ns
egl-46 L2 vs. 
combo 6 L1
**** egl-46 L2 vs. 
combo 6 L1
ns
egl-46 L2 vs. 
combo 6 L2
*** egl-46 L2 vs. 
combo 6 L2
ns
egl-18 L1 vs. 
egl 18 L2
ns egl-18 L1 vs. 
egl-18 L2
ns
egl-18 L1 
vs. combo 
‘A+U+S’
**** egl-18 L1 
vs. combo 
‘A+U+S’
*
egl-18 L1 vs. 
combo 6 L1
**** egl-18 L1 vs. 
combo 6 L1
ns
egl-18 L1 vs. 
combo 6 L2
**** egl-18 L1 vs. 
combo 6 L2
ns
egl-18 L2 
vs. combo 
‘A+U+S’
*** egl-18 L2 
vs. combo 
‘A+U+S’
ns
egl-18 L2 vs. 
combo 6 L1
* egl-18 L2 vs. 
combo 6 L1
ns
egl-18 L2 vs. 
combo 6 L2
ns egl-18 L2 vs. 
combo 6 L2
ns
combo 
‘A+U+S’ vs. 
combo 6 L1
ns combo 
‘A+U+S’ vs. 
combo 6 L1
ns
combo 
‘A+U+S’ vs. 
combo 6 L2
ns combo 
‘A+U+S’ vs. 
combo 6 L2
ns
combo 6 L1 
vs. combo 
6 L2
ns combo 6 L1 
vs. combo 
6 L2
ns
↲ Percentage of ‘positive 
embryos’
‘Positive embryos’ are those 
that express tph-1::gfp in 
more than four cells after 
ectopic expression of single 
factors, or combinations of 
them, via heat shock treatment.
Three independent experi-
ments were performed and all 
data has been pooled together. 
Statistical significance was 
calculated using two-tailed 
Fisher test; *:pV<0,05.
See Figure 3.2.18.
Overexpressed 
factor (hsp)
% tph(–)1::gfp + SEP N embryos pV (vs wt) pV (specified)
wt 3 1 196 <0.0001 (–)
ast-1 55 4 150 <0.0001 (–)
unc-86 63 6 70 <0.0001 (–)
sem-4 77 6 57 <0.0001 (–)
hlh-3 29 6 56 <0.0001 (–)
egl-46 21 6 43 0.0002 (–)
egl-18 33 6 67 <0.0001 (–)
combo 3 9 1 3 77 <0.0001 (–)
combo 6 87 5 54 <0.0001 (–)
unc-86 vs combo 
‘A+U+S’
(–) (–) (–) (–) <0.0001
unc-86 vs combo 6 (–) (–) (–) (–) 0.0037
sem-4 vs combo 
‘A+U+S’
(–) (–) (–) (–) 0.0477
sem-4 vs combo 6 (–) (–) (–) (–) 0.2204
Percentage of ectopic cells at 
larval stages
Scoring of ectopic tph-1::gfp 
expressing cells at larval 
stages L1 and L2, after 
overexpression of single 
factors, or combinations
of them, via heat shock 
treatment at L1 stage. Three 
independent experiments 
were performed and all data 
has been pooled together.
Statistical significance was 
calculated using two-tailed 
Fisher test; *:pV<0,05.  
See Figure 3.2.18.
Head neuron PVT Tail neurons (ALN + unknown)
Overexpressed 
factor
% SEP N pV % SEP N pV % SEP N pV
wt 0 0 58 (–) 3 2 58 (–) 0 0 58 (–)
hsp::ast-1 0 0 74 1 9 3 74 0.2975 27 5 74 0.0001
hsp::unc-86 91 3 108 0.0001 69 4 108 0.0001 0 0 108 1
hsp::sem-4 33 9 30 0.0001 17 7 30 0.0429 0 0 30 1
hsp::combo 6 47 6 70 0.001 71 5 70 0.0001 15 4 70 0.0001
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Genetic
relationship
Genotype % HSN SEP pV
Synergistic 
enhancement
egl-46(sy628)V; otIs226(bas-1::gfp)IV 84.5 3.4 (–)
hlh-3(tm1688)II; otIs226(bas-1::gfp)IV 49.0 5.0 (–)
hlh-3(tm1688)II; egl-46(sy628)V; otIs226(bas-1::gfp)IV 0.0 0.0 0.0001
ast-1(ot417)II; otIs226(bas-1::gfp)IV 100.0 0.0 (–)
egl-46(sy628)V; otIs226(bas-1::gfp)IV 84.5 3.4 (–)
ast-1(ot417)II; egl-46(sy628)V; otIs226(bas-1::gfp)IV 1.9 1.3 0.0001
ast-1(ot417)II; otIs226(bas-1::gfp)IV 100.0 0.0 (–)
sem-4(n2654)I; otIs226(bas-1::gfp)IV 66.0 4.7 (–)
sem-4(n2654)I; ast-1(ot417)II; otIs226(bas-1::gfp)IV 0.0 0.0 0.0001
ast-1(ot417)II; otIs226(bas-1::gfp)IV 100.0 0.0 (–)
unc-86(n848)III; otIs226[bas-1::gfp]IV 45.0 5.0 (–)
ast-1(ot417)II; unc-86(n848)III; otIs226[bas-1::gfp]IV 0.0 0.0 0.0001
egl-18(ok290)IV; otIs221(cat-1::gfp)III 96.8 1.6 (–)
hlh-3(tm1688)II; otIs221(cat-1::gfp)III 81.0 3.5 (–)
hlh-3(tm1688)II; egl-18(ok290)IV; otIs221(cat-1::gfp)III 28.7 4.4 0.0001
egl-18(ok290)IV; otIs221(cat-1::gfp)III 96.8 1.6 (–)
sem-4(n2654)I; otIs221(cat-1::gp)III 48.0 4.9 (–)
egl-18(ok290)IV; sem-4(n2654)I; otIs221(cat-1::gp)III 30.0 4.6 0.0405
egl-18(ok290)IV; zdIs13(tph-1::gp)IV 91.0 2.9 (–)
sem-4(n2654)I; zdIs13(tph-1::gp)IV 54.0 5.0 (–)
egl-18(ok290)IV; sem-4(n2654)I; zdIs13(tph-1::gp)IV 30.0 4.6 0.0405
Annex 3.2.8 
Primary data of serotonin 
pathway gene expression in 
double mutants
Analysis of tph-1, bas-1 and 
cat-1 in the different mutant 
backgrounds for the six candi- 
date regulators of the HSN 
neuron. See Figure 3.2.21.
Synergistic 
suppression
egl-18(ok290)IV; otIs221(cat-1::gfp)III 96.8 1.6 (–)
egl-46(sy628)V; otIs221(cat-1::gfp)III 61.3 4.7 (–)
egl-18(ok290)IV; egl-46(sy628)V; otIs221(cat-1::gfp)III 94.3 2.2 0.0001
hlh-3(tm1688)II; otIs221(cat-1::gfp)III 81.0 3.5 (–)
egl-46(sy628)V; otIs221(cat-1::gfp)III 61.3 4.7 (–)
hlh-3(tm1688)II; egl-46(sy628)V; otIs221(cat-1::gfp)III 72.0 4.5 0.0001
sem-4(n2654)I; zdIs13(tph-1::gfp)IV 54.0 5.0 (–)
ast-1(ot417)II; zdIs13(tph-1::gfp)IV 0.0 0.0 (–)
sem-4(n2654)I; ast-1(ot417)II; zdIs13(tph-1::gfp)IV 19.0 4.0 0.0001
Additivity unc-86(n848)III; otIs224(cat-1::gfp)V 60.0 4.5 (–)
sem-4(n2654)I; otIs224(cat-1::gfp)V 57.0 5.0 (–)
sem-4(n2654)I; unc-86(n848)III; otIs224(cat-1::gfp)V 9.0 2.9 1
hlh-3(tm1688)II; otIs224(cat-1::gfp)V 82.0 3.6 (–)
unc-86(n848)III; otIs224(cat-1::gfp)V 60.0 4.5 (–)
hlh-3(tm1688)II; unc-86(n848)III; otIs224(cat-1::gfp)V 30.0 4.5 0.1048
Epistasis egl-18(ok290)IV; otex2435 [bas1prom1 gfp (50ng/ul), rol6] 78.6 3.5 (–)
hlh-3(tm1688)II; otex2435 [bas1prom1 gfp (50ng/ul), rol6] 41.0 5.2 (–)
hlh-3(tm1688)II; egl-18(ok290)IV;  
otex2435 [bas1prom1 gfp (50ng/ul), rol6]
33.0 4.6 0.0355
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Gene name Functional category
aak-2 Terminal feature
abts-1 Neurotransmission
ags-3 Terminal feature
aho-3 Terminal feature
ari-1 Terminal feature
arr-1 Terminal feature
arrd-17 Terminal feature
bas-1 Neurotransmission
baz-2 Other
cam-1 Migration
cat-1 Neurotransmission
cat-4 Neurotransmission
cdh-3 Sinaptogenesis
ceh-20 TF
che-7 Terminal feature
clh-3 Neurotransmission
dhc-3 Terminal feature
dsh-1 Wnt pathway
eat-16 Terminal feature
ebax-1 Migration
egl-18 TF
egl-43 TF
egl-44 TF
egl-46 TF
egl-47 Terminal feature
egl-5 TF
egl-6 Neurotransmission
elpc-1 Terminal feature
elpc-3 Terminal feature
eor-2 Wnt pathway
flp-19 Neurotransmission
fmi-1 Axon guidance
gar-2 Neurotransmission
gei-8 TF
ggr-2 Neurotransmission
glr-5 Neurotransmission
goa-1 Terminal feature
grd-6 Terminal feature
gsa-1 Terminal feature
ham-2 Migration
hlh-14 TF
hlh-3 TF
ida-1 Neurotransmission
ife-4 TF
ins-18 Neurotransmission
inx-3 Neurotransmission
inx-7 Neurotransmission
irk-1 Neurotransmission
Gene name Functional category
kal-1 Migration
kcc-2 Neurotransmission
kin-20 Terminal feature
lgc-55 Neurotransmission
mab-23 TF
madd-2 Migration
mau-2 Migration
mec-6 Neurotransmission
mig-10 Migration
mig-2 Migration
mom-2 Wnt pathway
mpz-1 Neurotransmission
nck-1 Axon guidance
nhx-5 Neurotransmission
nid-1 Migration / NT
nlg-1 Neurotransmission
nlp-1 Neurotransmission
nlp-15 Neurotransmission
nlp-3 Neurotransmission
nra-4 Neurotransmission
plr-1 Wnt pathway
prkl-1 Wnt pathway
ptps-1 Neurotransmission
puf-9 Terminal feature
pxf-1 Terminal feature
rep-1 Terminal feature
rig-6 Terminal feature
rsbp-1 Terminal feature
rsy-1 Neurotransmission
sel-10 Notch pathway
sem-4 TF
syg-1 Neurotransmission
tba-6 Terminal feature
tbb-4 Terminal feature
ten-1 Terminal feature
top-1 Terminal feature
tph-1 Neurotransmission
unc-103 Neurotransmission
unc-14 Migration
unc-17 Neurotransmission
unc-2 Neurotransmission
unc-40 Migration
unc-51 Migration
unc-53 Migration
unc-77 Neurotransmission
unc-86 TF
unc-9 Neurotransmission
vang-1 Wnt pathway
Annex 3.3.1  
Gene expression profile of  
the HSN neuron 
 
96 genes are known to be 
expressed in the HSN neuron, 
excluding panneuronal 
features ((Hobert et al. 2016), 
(www.wormbase.org)).  
See Figure 3.3.1 and 3.3.2.
Gene name Gene name
aat-8 elo-5
abu-12 ent-4
acly-1 eri-12
alh-13 F09C8.2
B0403.6 F10E7.9
B0511.6 F26F12.8
bus-19 F26G1.1
C01B10.6 F28C1.3
C05G5.2 F39G3.2
C07A9.2 F52G3.5
C27F2.8 F53F8.7
C33D3.5 F59E12.8
C34B2.9 fut-6
C39D10.7 gcy-23
C43H6.6 gon-1
C44F1.1 H11E01.3
C49H3.16 H12D21.9
C54G6.2 hbl-1
cand-1 her-1
ceh-10 hlh-13
cutl-3 hum-1
D1086.17 inx-11
daf-16 ist-1
eef-1A.2 K08D12.8
egl-13 K09E4.1
Gene name Gene name
kvs-4 T21F4.1
lgc-25 T24B8.3
lgc-52 T25B9.3
M03D4.4 T28F3.5
M04C3.5 tag-273
mct-2 tbc-7
mua-6 tbx-33
mvk-1 tiam-1
nep-18 toca-1
nhr-45 tsp-3
perm-5 unc-44
prk-1 xol-1
R01B10.2 Y37A1A.4
R05G6.1 Y38H8A.1
rgs-4 Y39G10AR.11
set-23 Y47D3A.32
shl-1 Y48G1BL.7
sqv-5 Y55F3AM.21
srg-51 Y62H9A.13
srh-48 Y66C5A.2
sru-47 Y71H2B.1
T02G6.5 Y73B3A.16
T07G12.5 Y7A5A.7
T13H5.1 Y87G2A.2
T14G8.3 ZC84.1
Annex 3.3.2  
List of random genes used in 
the ‘sliding window analysis’ 
 
The selected genes have a 
similar upstream and intronic 
distribution to HSN expressed 
genes. See Figure 3.3.1.
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Annex 3.3.3  
Specific DNA modifications 
for motif orientation 
analysis of the HSN regulatory 
signature
Specific BSs were flipped in 
order to test functionality of 
the overrepresented TFBS 
pairs (ETS-HLH and ETS-
GATA). The two flanking 
nucleotides to the motif 
were also considered when 
flipping. Uppercase letters 
indicate wild type nucleo-
tides, while lowercase letters 
indicate mutated nucleotides 
that alter a specific BS motif. 
Whenever two motifs 
overlapped, as in the case 
of ETS-GATA pair, or were 
directly next to each other, 
as in one particular HLH-ETS 
pair, additional point 
mutations were introduced in 
the non-flipped binding site, 
or immediately next to it, in 
order to maintain a unique 
motif in each orientation, and 
are indicated in light grey.  
See Figure 3.3.7.
Promoter TF pair Modified binding site Mutation (wt BS> mutant BS)
tph-1prom2 (–) (–) (–)
tph-1prom58 GATA-ETS GATA TCCGGATATTA > taatatctccTCCGGAaATTA
tph-1prom59 HLH-ETS HLH TTCCAGAAGC > ttccagaag
bas-1prom13 (–) (–) (–)
bas-1prom87 HLH-ETS HLH CTTTCTGCCAGAATT > tggcagaaagTGCCAGAATT
bas-1prom89 GATA-ETS GATA TCTATCCGTT > tctatccgttacagataga
cat-1prom14 (–) (–) (–)
cat-1prom85 HLH-ETS HLH CATTCTGGTTTTCCG > aaccagaatggGTTTCCG
cat-1prom86 SPALT-ETS SPALT AATTGTCTTG > cagacaatt
cat-1prom87 HLH-ETS ETS GGTTTCCGTT > aacggaaacc
Annex 3.4.1  
Primary data of HSN rescue 
experiments using mouse 
factors
Analysis of tph-1::gfp expres-
sion in mutant animals for the 
HSN TF collective, carrying an 
extrachromosomal ‘rescue 
array’ that contains the worm 
or its orthologue mouse 
factor, under an HSN specific 
promoter. (See Figure 3.4.4).
Genotype % HSN SEP pV
zdIs13(tph-1::gfp)IV 100 0 (–)
ast-1(ot417)II; zdIs13(tph-1::gfp)IV 0 0 (–)
ast-1(ot417)II; zdIs13(tph-1::gfp)IV; 
vlcEx148[bas-1prom::ast-1, ttx-3::mCherry; rol-6(su1006)]
46 5 0.0001
ast-1(ot417)II; zdIs13(tph-1::gfp)IV;
vlcEx148[bas-1prom::Pet1, ttx-3::mCherry; rol-6(su1006)]
83 4 0.0001
zdIs13(tph-1::gfp)IV 100 0 (–)
unc-86(n846)III; zdIs13(tph-1::gfp)IV 0 0 (–)
unc-86(n846)III; zdIs13(tph-1::gfp)IV;vlcEx503[kal-1prom::unc.86 
genomic, ttx-3::mCherry, rol-6(su1006)]
0 0 1
zdIs13(tph-1::gfp)IV 100 0 (–)
sem-4(n1971)I; zdIs13(tph-1::gfp)IV 52 3 (–)
sem-4(n1971)I; zdIs13(tph-1::gfp)IV;
vlcEx511[kal-1prom::Sall2; ttx-3::mCherry, rol-6(su1006)]
87 4 0.0001
zdIs13(tph-1::gfp)IV 100 0 (–)
hlh-3(tm1688)II; zdIs13(tph-1::gfp)IV 22 4 (–)
hlh-3(tm1688)II; zdIs13(tph-1::gfp)IV;
vlcEx458[cat-4prom::hlh-3; ttx-3::mCherry, rol-6(su1006)]
66 4 0.0001
hlh-3(tm1688)II; zdIs13(tph-1::gfp)IV;
vlcEx479[cat-4prom::Ascl1, ttx-3::mCherry, rol-6(su1006)]
43 5 0.0024
hlh-3(tm1688)II; zdIs13(tph-1::gfp)IV;
vlcEx480[cat-4prom::Ascl1, ttx-3::mCherry, rol-6(su1006)]
57 5 0.0001
zdIs13(tph-1::gfp)IV 100 0 (–)
egl-46(sy628)V; zdIs13(tph-1::gfp)IV 62 5 (–)
egl-46(sy628)V; zdIs13(tph-1::gfp)IV; vlcEx471[cat-4prom::egl-46, 
ttx-3::mCherry, rol-6(su1006)]
90 2 0.0001
egl-46(sy628)V; zdIs13(tph-1::gfp)IV; vlcEx472[cat-4prom::egl-46, 
ttx-3::mCherry, rol-6(su1006)]
96 2 0.0001
egl-46(sy628)V; zdIs13(tph-1::gfp)IV; vlcEx481[cat-4prom::Inms1; 
ttx-3::mCherry, rol-6(su1006)]
97 2 0.0001
yzIs71[tph-1::gfp, rol-6(su(1006)]V 96 1 (–)
egl-18(ok290)IV; yzIs71[tph-1::gfp, rol-6(su1006)]V 75 4 (–)
egl-18(ok290)IV; yzIs71[tph-1::gfp, rol-6(su1006)]V;
vlcEx469[cat-4prom2::egl-18, ttx-3::mCherry, rol-6(su1006)]
86 5 0.1858
egl-18(ok290)IV; yzIs71[tph-1::gfp, rol-6(su1006)]V;
vlcEx470[cat-4prom2::egl-18, ttx-3::mCherry, rol-6(su1006)]
69 4 0.3594
egl-18(ok290)IV; yzIs71[tph-1::gfp, rol-6(su1006)]V;
vlcEx485[cat-4prom2::Gata3, ttx-3::mCherry, rol-6(su1006)]
79 4 0.5042
282
Neuron Number of genes
ADE 32
ADF 77
ADL 101
AFD 56
AIY 71
ALM 83
ALN 31
AQR 45
ASE 132
ASG 58
ASH 98
ASI 133
ASJ 79
ASK 99
AUA 30
AVA 53
AVM 64
AWA 45
AWB 74
AWC 102
BAG 41
BDU 32
CAN 65
CEPD 36
Neuron Number of genes
CEPV 32
DVA 36
DVC 30
FLP 37
HSN 98
NSM 44
OLL 38
OLQD 36
OLQV 36
PDE 39
PHA 90
PHB 89
PLM 84
PQR 52
PVC 43
PVD 49
PVM 54
PVQ 45
PVT 85
RIC 32
RMED 30
RMEV 30
SDQ 35
SMDD 32
URX 42
Annex 3.4.2  
Caenorhabditis elegans 
neuronal profiles 
 
Worm neurons used in the 
Principal Coordinate Analysis, 
which are known to express 
at least 30 genes. See Figures 
3.4.5 and 3.4.6.
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Summary — Spanish
Introducción
La generación de una clase neuronal concreta del 
sistema nervioso es un proceso que consta de va-
rias etapas de elección y compromiso de destino 
celular neuronal y que culmina con la activación de 
una batería de genes específica, que define las pro-
piedades únicas de la neurona madura y funcional 
(Hobert 2005). Este conjunto de genes específicos, 
llamados genes efectores, se expresan a lo largo 
de la vida de la neurona adulta (Hobert 2016b) y le 
confiere su identidad única; es decir, su identidad 
o huella molecular. La composición de estas bate-
rías de genes es combinatoria, en el sentido de que 
cada subtipo neuronal no expresa unos genes ex-
clusivos, sino una combinación exclusiva de genes 
que, a su vez, se pueden expresar de una manera 
más amplia (Wenick & Hobert 2004). Este mecanis-
mo puede dar lugar a la construcción de un núme-
ro casi infinito de diferentes patrones de expresión 
específicos de tipo neuronal y, por tanto, de tipos 
neuronales. Por tanto, la cuestión de la diferencia-
ción de los diferentes tipos neuronales se podría 
reformular a cómo se ejecutan los programas de 
expresión génica específicos de tipo neuronal.
Un modelo prevalente para explicar la adquisi-
ción de la identidad postmitótica de una neurona 
es el de los ‘selectores terminales’ (Hobert 2008). 
Selectores terminales son aquellos factores de 
transcripción (FT) que se activan entre el final de 
la mitosis y el estadio postmitótico, y que contro-
lan directamente la identidad terminal de los tipos 
neuronales en el sistema nervioso. Estos FT re-
conocen y se unen a regiones reguladoras del 
ADN que son comunes a todos los genes de dife-
renciación terminal de la neurona, generalmen-
te activando la expresión génica, aunque cada vez 
hay más evidencias del papel de genes represo-
res en la generación de diversidad neuronal (Kerk 
et al. 2017). El concepto de selector terminal impli-
ca que un tipo neuronal específico no necesitará, 
a priori, un gran número de FT para regular cada 
una de sus características terminales (transcrip-
toma celular), sino que todas estos genes efecto-
res, aunque no estén relacionados entre sí, serán 
co-regulados por uno o, más habitualmente, una 
combinación de selectores terminales (Xue et al. 
1993; Wenick & Hobert 2004; Doitsidou et al. 2013). 
El nematodo Caenorhabditis elegans ha sido am-
pliamente utilizado en el estudio de la lógica de la 
regulación transcripcional de muchos tipos neuro-
nales. Por ejemplo, el FT UNC-3, de la familia de los 
dedos de zinc, regula la diferenciación terminal de 
varios tipos de neuronas colinérgicas (Kratsios et 
al. 2011; Pereira et al. 2015), mientras que una combi-
nación específica de tres FT pertenecientes a dife-
rentes familias (AST-1 (FT ETS), CEH-43 (FT DLX) y 
CEH-20/CEH-40 (FT PBX)) regula de manera direc-
ta la identidad terminal de todas las neuronas do-
paminérgicas del gusano (Flames & Hobert 2011; 
Doitsidou et al. 2013). Aunque descrito por primera 
vez en C. elegans, este modelo se extiende a otros 
Lógica de la regulación
transcripcional de las neuronas 
serotonérgicas en Caenorhabditis 
elegans
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animales más complejos como los vertebrados. 
Por ejemplo, PET1 muestra características clave 
de selector terminal para las neuronas serotonér-
gicas del raphe en ratones (Hendricks et al. 1999; 
Hendricks et al. 2003), mientras que una combina-
ción de dos FT, NURR1 y PITX3, regula la diferen-
ciación terminal de las neuronas dopaminérgicas 
del mesencéfalo de ratón (Jacobs, van der Linden 
et al. 2009; Jacobs, van Erp, et al. 2009). Además, el 
conjunto de NGN2, ISL1 y LHX3 es suficiente para 
reprogramar células embrionarias de ratón a neu-
ronas motoras espinales (Mazzoni et al. 2013).
De acuerdo con la hipótesis de los selectores ter-
minales, combinaciones específicas de FT se 
encargan de la regulación total o parcial del trans-
criptoma, de un tipo neuronal concreto. Está bien 
establecido que los FT se unen de una manera 
combinatoria y cooperativa a secuencias de ADN 
presentes en los elementos de regulación en cis 
del genoma, llamados potenciadores (enhancers) 
(Reiter et al. 2017). Esto otorga a los FT un papel 
central en la regulación de la expresión génica. A lo 
largo de la última década, el desarrollo de tecnolo-
gía de alto rendimiento ha permitido la caracteriza-
ción, tanto in vitro como in vivo, de la presencia de 
sitios de unión de FT y potenciadores funcionales a 
nivel genómico. Métodos tales como la inmunopre-
cipitación de cromatina seguida de secuenciación 
han permitido identificar potenciadores activos aso-
ciados a marcas específicas de cromatina, medir el 
grado de ocupación de los sitios de unión a nivel 
genómico, trazar las preferencias de unión de nu-
merosos FT y asociar zonas reguladoras activas 
en el genoma (regulatory landscape) con su corres-
pondiente tipo celular (revisado en (Levo & Segal 
2014)). Por otro lado, se ha descrito que la llama-
da arquitectura de un potenciador puede contener 
ciertas propiedades restrictivas en cuanto al nú-
mero, localización, orientación y orden de los sitios 
de unión a FT, las cuales se conocen como ‘normas 
sintácticas o gramaticales’ de una secuencia regu-
ladora (Spitz & Furlong 2012). Por ejemplo, a mayor 
número de sitios de unión para un mismo FT (agru-
paciones homotípicas) y, sobro todo, a mayor nú-
mero de diferentes sitios de unión para diferentes 
FT (agrupaciones heterotípicas) mayor es la expre-
sión predicha para un mismo potenciador (Smith et 
al. 2013).
Sin embargo, experimentos masivos de caracte-
rización funcional de la actividad de los potencia-
dores en el genoma han desvelado que sólo una 
pequeña fracción de los potenciales sitios de unión 
de FT del genoma eucariota se encuentran real-
mente ocupados por FTs en cualquier tipo celular 
dado (Whitfield et al. 2012; Kheradpour et al. 2013; 
White et al. 2013; Kwasnieski et al. 2014). Además 
sólo una fracción de los FT que se unen a sitios de 
unión se corresponden con potenciadores activos 
(Kwasnieski et al. 2014; White et al. 2013; Fisher et al. 
2012). Todo ello pone de manifiesto que todavía no 
somos capaces de distinguir sitios de unión y po-
tenciadores funcionales de los no funcionales, así 
como que desconocemos los mecanismos por los 
que estas combinaciones de FT identifican y acti-
van sus secuencias diana. En este trabajo hemos 
utilizado las neuronas serotonérgicas como para-
digma de investigación de las leyes que regulan la 
selección y activación del transcriptoma de un tipo 
neuronal en concreto, las neuronas serotonérgi-
cas, durante la diferenciación terminal.
Las neuronas serotonérgicas se encuentran pre-
sentes en todos los grupos de eumetazoos y se 
definen por su habilidad de sintetizar y liberar se-
rotonina (5-HT), lo cual es posible gracias a la ex-
presión de los llamados ‘genes de la vía de la 5-HT’ 
→ Figura 1-A. Dada su relevancia clínica y el gran 
número de procesos en los que están implicadas 
(Deneris & Wyler 2012), estas neuronas han sido 
ampliamente estudiadas en los últimos años, tanto 
en mamíferos como en nematodos. 
El sistema serotonérgico de C. elegans cons-
ta de tres pares de neuronas con diferente fun-
ción: la neurona motora neurosecretora NSM, la 
neurona secretora ADF y la neurona motora HSN 
→ Figura 1-B. En cuanto la regulación de su dife-
renciación terminal, se sabe que la identidad ce-
lular de la neurona NSM viene determinada por la 
pareja de selectores terminales TTX-3 (FT LIM ho-
meodominio) y UNC-86 (FT POU homeodominio) 
(Zhang et al. 2014), mientras que en la regulación de 
la neurona ADF participa DAF-19 (FT RFX) (Xie et al. 
2013). Múltiples FT se han asociado al desarrollo de 
la neurona HSN (Desai et al. 1988; Basson & H Robert 
Horvitz 1996; Doonan et al. 2008; Sze et al. 2002), 
destacando UNC-86 como el mejor candidato a se-
lector terminal.
Aprovechando la elevada conservación filogenéti-
ca de las neuronas serotonérgicas, hemos utilizado 
el organismo modelo C. elegans para diseccionar 
su lógica de regulación transcripcional.
Objetivos
Los objetivos específicos de esta tesis son los 
siguientes:
1 Diseccionar in vivo la lógica de regulación en cis 
de los genes de la vía de la 5-HT en los diferentes sub-
tipos serotonérgicos de C. elegans, NSM, ADF y HSN.
2 Identificar y caracterizar en profundidad los FT 
que controlan el programa de diferenciación ter-
a
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d
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Figura 1 
Neuronas serotonérgicas 
y sistema serotonérgico en 
C. elegans
A) Ruta de biosíntesis 
de serotonina (5-HT). 
Abreviaturas: 5-HT: serotoni-
na; 5-HTP: 5 hidroxitriptófano; 
BAS-1: síntesis de aminas 
biógenas 1; AADC: aminoácido 
descarboxilasa; GCH1: GTP 
ciclohidrolasa 1; MOD-5: 
modulación de locomoción 
defectuosa; 
SERT: transportador 
de serotonina; TPH: 
triptófano hidroxilasa; Trp: 
triptófano; SLC18A1/2: familia 
de transportador de solutos 
18 miembro A1/A2 (también 
llamado VMAT: transportador 
vesicular de monoaminas); 
SLC6A4: familia de transpor-
tador de solutos 6 miembro 4.
B) Sistema serotonérgico 
del hermafrodita C. elegans. 
I/D: neuronas bilaterales 
(izquierda/derecha).
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minal del subtipo serotonérgico HSN (selectores 
terminales de la neurona HSN), siguiendo una apro-
ximación por genes candidatos.
3 Interrogar el transcriptoma de la neurona HSN 
para la presencia de una huella de identidad regu-
ladora, codificada en la secuencia primaria de ADN, 
que permita la identificación de potenciadores fun-
cionales en la neurona HSN a nivel genómico.
4 Determinar si el programa de regulación de las 
neuronas serotonérgicas está conservado filoge-
néticamente, en términos moleculares y funciona-
les, entre nematodos y mamíferos.
Resultados y metodología
1 Diferentes módulos de regulación en cis con-
trolan la expresión de los genes de la vía de la se-
rotonina en las diferentes subclases de neuronas 
serotonérgicas
Llevamos a cabo un análisis de las regiones re-
guladoras de los genes de la vía de la 5-HT (tph-1, 
cat-1, bas-1, cat-4 y mod-5) mediante la creación 
de reporteros transgénicos que expresan la pro-
teína fluorescente GFP bajo el control de estas re-
giones reguladoras, en diferentes longitudes. De 
este modo, aislamos la región reguladora mínima 
de cada gen que es capaz de activar la expresión 
de GFP en cada uno de los subtipos neuronales, a 
las que denominamos módulos de regulación en cis 
(MRC). Los resultados de este análisis revelan que 
MRC independientes son necesarios para activar la 
expresión de cada gen en cada subtipo serotonér-
gico, como se ha esquematizado en la → Figura 2. 
Esta organización modular concuerda con un mo-
delo de regulación donde diferentes selectores 
terminales regulan la expresión de los genes de 
la vía de la 5-HT en NSM, ADF y HSN. Teniendo en 
cuenta esta lógica de regulación serotonérgica de-
pendiente de subtipo celular, decidimos enfocar el 
resto de nuestro trabajo en el estudio en la neurona 
HSN, por ser la mejor caracterizada hasta la fecha.
2.1 FT pertenecientes a seis familias 
diferentes son necesarios para la diferenciación 
terminal de la neurona HSN
La neurona HSN regula los músculos de la vulva 
del gusano y, por tanto, su disfunción provoca un 
fenotipo muy evidente de defecto en la puesta de 
huevos. Siguiendo una aproximación por gen can-
didato, elegimos seis genes que codifican para FT 
y cuyos mutantes presentan este fenotipo y de-
fectos de tinción de 5-HT en la neurona HSN. De 
este modo seleccionamos como posibles selecto-
res terminales de la neurona HSN al FT UNC-86 de 
la familia POU, al FT SEM-4 de la familia SPALT, al 
FT HLH-3 de la familia bHLH, al FT EGL-46 de la fa-
milia INSM (Desai et al. 1988; Basson & Horvitz 1996; 
Doonan et al. 2008; Wu et al. 2001), al FT AST-1 de la 
familia ETS y al FT EGL-18 de la familia GATA (ambos 
por observaciones en nuestro laboratorio).
Cruzamos alelos de pérdida de función para los 
seis genes candidatos con reporteros transcrip-
cionales fluorescentes de los cuatro genes de la vía 
de la 5-HT que se expresan en la neurona HSN (tph-
1, cat-1, bas-1 y cat-4) y de nueve genes del trans-
criptoma de HSN que no están relacionados con la 
síntesis de 5-HT (kcc-2, lgc-55, ida-1, flp-19, unc-17, 
unc-40, nlg-1, rab-3 y kal-1). Observamos que la ex-
presión de estos reporteros se ve afectada a distin-
tos niveles en los distintos fondos mutantes, como 
se representa en el heatmap de la → Figura 3. Por 
ejemplo, en mutantes unc-86 y sem-4 la expre-
sión de casi todos los genes analizados se vio al-
tamente afectada, mientras que en mutantes para 
egl-18 observamos una pérdida de expresión géni-
ca más modesta y sólo en algunos genes. En cual-
quier caso, la expresión de los seis FT es necesaria 
para una correcta diferenciación terminal de HSN 
y, por motivos de brevedad, los llamamos conjunta-
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Resumen de la lógica de 
regulación de las neuronas 
serotonérgicas de C. elegans 
 
El análisis de las regiones 
reguladoras revela que 
módulos de regulación en 
cis (MRC) independientes 
controlan la expresión de los 
genes de la vía de la 5-HT 
en los distintos subtipos 
neuronales, y predice que 
estos MRC serán activas 
por diferentes factores de 
transcripción.
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mente ‘código regulador de HSN’. De acuerdo con 
los resultados del análisis de MRC, los defectos 
de expresión son principalmente específicos de la 
neurona HSN. Algunos genes como kal-1 no vieron 
su expresión prácticamente afectada, lo que nos 
permite saber que, en estos mutantes, la neurona 
HSN sí que se genera y adquiere un fenotipo neu-
ronal, pero no alcanza a completar su programa de 
diferenciación terminal y ve su transcriptoma alte-
rado. También es interesante la apreciación de que 
el patrón de expresión de cada mutante es ligera 
o radicalmente diferente, sugiriendo que cada FT 
actúa en rutas independientes.
2.2 Los seis FT del código regulador de la HSN 
actúan directamente sobre sus genes diana
Quisimos determinar si el fenotipo observado en 
los animales mutantes sobre el transcriptoma de 
la neurona HSN era debido a una activación directa 
por parte de los FT que componen el código regu-
lador de HSN o, por el contario, podría ser un efecto 
indirecto en el que alguno o todos los miembros del 
código actúan aguas arriba en la cascada trans-
cripcional. Con esta finalidad, llevamos a cabo un 
análisis de los MRC previamente aislados de los 
genes tph-1, cat-1 y bas-1, los que mayor fenotipo 
mutante tenían, donde buscamos sitios de unión 
predichos bioinformáticamente para los seis miem-
bros del código. En todos los MRC encontramos al 
menos un sitio para cada una de las seis familias de 
FT, los cuales truncamos mediante mutagénesis di-
rigida y analizamos su expresión resultante in vivo 
en la HSN. En los casos donde la señal de GFP dis-
minuyó o se perdió, inferimos que ese sitio de unión 
en concreto es funcional y el FT complementario se 
une de manera directa. De este modo encontramos 
sitios funcionales para los seis miembros del códi-
go y concluimos que regulan de manera directa la 
expresión de los genes de la vía de la 5-HT. En la 
→ Figura 4 se ha incluido, a modo de ejemplo, el 
MRC para tph-1. Curiosamente, observamos casos 
de redundancia entre sitios de unión de la misma 
familia de FT, como con los GATA, o incluso entre di-
ferentes familias, entre los GATA y ETS.
2.3 El ‘código regulador de HSN’ actúa 
mediante rutas paralelas
Los resultados obtenidos hasta el momento su-
gieren que los seis miembros del código regulador 
de HSN actúan de manera directa e independien-
te sobre los genes de la vía de la serotonina. Nos 
planteamos si, además, podrían mostrar rela-
ciones de regulación cruzada. Para comprobar-
lo, primero obtuvimos cepas reporteras para los 
seis miembros del código, tanto de otros labo-
ratorios y de la CGC (Caenorhabditis Genetics 
Center), como por métodos de clonación tradicio-
nal o CRISPR en nuestro laboratorio con aquellos 
que no estaban disponibles. Confirmamos que los 
seis FT se expresan en la HSN en el gusano adul-
to, a excepción de hlh-3, cuya expresión sólo se 
observa en la célula precursora de la HSN. A con-
tinuación, cruzamos estos reporteros con los di-
ferentes mutantes y analizamos su expresión en 
la neurona HSN. Descubrimos que la expresión de 
cada miembro es principalmente independiente 
del código en sí mismo, con algunas excepciones, 
indicando que los seis FT actúan de manera inde-
pendiente para regular la identidad de la neurona 
HSN. A destacar, UNC-86 aparece como regula-
dor principal del código (controlando la expresión 
de EGL-46, SEM-4 y/o AST-1), mientras que la acti-
vidad de AST-1 está regulada por otros miembros 
del código (HLH-3, SEM-4 y/o UNC-86) → Figura 5. 
2.4 El código regulador de HSN es necesario 
durante toda la vida del animal para el manteni-
miento de la identidad celular de la neurona HSN
También exploramos si el código regulador de HSN 
es prescindible una vez establecida la identidad 
serotonérgica de la neurona o si, en cambio, es ne-
cesario durante toda la vida del animal para man-
tener el estado correcto de diferenciación de la 
neurona HSN (Deneris & Wyler 2012). Para ello lle-
vamos a cabo experimentos de silenciamiento de 
la expresión génica mediante ARN de interferen-
cia, dónde alimentamos a los gusanos con clones 
complementarios a cinco de nuestros genes can-
didatos. Estos clones se administraron en la edad 
adulta, una vez los genes de la vía de la 5-HT se han 
expresado en la neurona HSN y ésta es funcional. 
Estos experimentos no se realizaron para hlh-3, 
puesto que no parece ser expresado en la neuro-
na HSN en la edad adulta. Nuestros resultados in-
dican que el silenciamiento de los cinco FT en la 
edad adulta provoca una pérdida de expresión de 
tph-1::yfp, uno de los genes de la vía de la 5-HT y 
principal marcador de las neuronas serotonérgi-
cas y , por tanto, que el código regulador de HSN no 
es sólo necesario para establecer el fenotipo sero-
tonérgico en la neurona, sino también para mante-
nerlo → Figura 6. 
3.1 La huella de identidad reguladora de la  
neurona HSN permite la identificación de novo 
de genes expresados en la neurona HSN
Existe un gran desconocimiento sobre por qué 
ciertas regiones del ADN tienen actividad regula-
dora y otras no. En la actualidad, no es posible pre-
decir qué potenciadores se encuentran unidos a FT 
y si son activos o no. En este trabajo, debido a que 
los miembros del código regulador de HSN perte-
necen a seis familias de FT diferentes que reco-
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Heatmap resumen de la 
caracterización de los seis 
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kcc-2: co-transportador de 
cloruro de potasio; lgc-55: 
canal de cloro dependiente de 
aminas, ida-1: receptor tirosi-
na fosfatasa; flp-19: péptido 
FMRF; unc-17: transportador 
vesicular de acetilcolina; 
unc-40: receptor de netrina; 
nlg-1: neuroligina; rab-3: ras 
GTPasa; kal-1: síndrome de 
Kallmann. Aquellos defectos 
de expresión en animales 
mutantes que son estadísti-
camente significativos con 
respecto a los animales 
silvestres, se indican con 
un cuadrado negro. n.a.: no 
analizado. La significación 
estadística fue calculada 
con el test exacto de Fisher, 
pV< 0,05. n > 50 animales por 
condición.
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nocen secuencias de unión al ADN muy diferentes 
entre sí, nos planteamos si la agrupación de estos 
seis sitios de unión en los genes expresados en la 
neurona HSN podría conferir suficiente especifici-
dad como para imponer una huella única de la neu-
rona HSN.
Llevamos a cabo análisis bioinformáticos utilizan-
do R (The R  Team 2016) y Bioconductor (Huber et al. 
2015) para analizar las secuencias reguladoras 
(aguas arriba e intrónicas) de los 96 genes que se 
expresan en la neurona HSN (Hobert et al. 2016) en 
busca de ventanas de ADN de hasta 700 pares de 
bases que contuviesen, por lo menos, un sitio de 
unión para cada FT del código regulador de HSN. A 
esto lo llamamos huella de identidad reguladora de 
HSN. Encontramos que los genes que se expresan 
en la HSN contienen esta huella de identidad regu-
ladora en mayor medida que un conjunto de genes 
control (ratio 1,3), y que la ratio aumenta si sólo con-
sideramos genes conservados en diferentes espe-
cies de Caenorhabditis (ratio 1,8) → Figura 7-A, lo 
que apoyaría la idea de que esta huella se haya se-
leccionado en la evolución para definir los poten-
ciadores de este tipo neuronal concreto. De ser así, 
pensamos que esta huella se debería correspon-
der con potenciadores funcionales de la neurona 
HSN y lo comprobamos fusionando 5 de estas ven-
tanas con gfp y corroborando su expresión en HSN 
en 4/5 líneas.
A continuación, examinamos la distribución de la 
huella de identidad reguladora de HSN en todo el 
genoma de C. elegans y la encontramos preferen-
temente en genes que se expresan en neuronas o 
tienen alguna función neuronal (genoma neuronal) 
→ Figura 7-B. Por tanto, decidimos utilizarla para
identificar genes nuevos que se expresen en la
neurona HSN. Escogimos al azar 35 de estos genes 
neuronales que contenían la huella de identidad
reguladora de HSN conservada en varias espe-
cies del nematodo y generamos reporteros trans-
génicos. 13 de estos genes se expresan en la HSN,
mientras que ninguno de los controles negativos
mostró GFP en la neurona. Nuestros resultados de-
muestran, por primera vez, que la la presencia de
una secuencia primaria de ADN (la huella de iden-
tidad reguladora de HSN) puede ser utilizada para
identificar genes de novo → Figura 7-C. Sin embar-
go, el alto número de falsos positivos indica que la
huella, por si misma, no es suficiente en todos los
casos para inducir expresión en la neurona HSN, y
que nos falta información relevante sobre el meca-
nismo de activación del transcriptoma de HSN.
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Análisis de regulación 
cruzada
El esquema resume las 
relaciones entre los seis 
miembros del código 
regulador de la neurona HSN, 
determinadas por el análisis 
de expresión de reporteros 
para los seis miembros en los 
diferentes fondos mutantes.
Las flechas negras indican 
defectos fuertes de 
expresión, las flechas grises 
indican defectos parciales de 
expresión, mientras que las 
flechas grises discontinuas 
indican defectos débiles. Las 
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indican que el efecto que 
ejerce UNC-86 sobre AST-1 
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por SEM-4. La significación 
estadística fue calculada 
con el test exacto de Fisher, 
pV< 0,05. n > 50 animales por 
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3.2 Los potenciadores de la HSN siguen el 
modelo del ‘colectivo de FT’ y contienen reglas 
sintácticas
La arquitectura reguladora hace referencia a la 
multiplicidad, identidad, afinidad y posición de los 
sitios de unión de los FT presentes en una secuen-
cia reguladora o potenciador. Arquitecturas espe-
cíficas pueden contener restricciones en relación 
a estas variables, lo que recibe el nombre de ‘re-
glas gramaticales o sintácticas’. Se han propuesto 
tres modelos para explicar la función de los poten-
ciadores basados en estas normas gramaticales 
(Spitz & Furlong 2012). En el primer modelo (enhan-
ceosome), los sitios de unión a FT muestran una 
distribución muy rígida en cuanto a orden, espacia-
do y orientación, lo que implica elevada coopera-
tividad entre los FT para unirse al ADN. En cambio, 
el segundo modelo (billboard o cartelera) propone 
una distribución y orientación mucho más laxa de 
los sitios de unión de los FT, donde no es necesario 
que todos los FT se unan al ADN ni que haya coo-
peratividad de unión al ADN. Finalmente, el tercer 
modelo (colectivo de FT) representa una situación 
intermedia entre los dos anteriores. Como el se-
gundo, muestra flexibilidad en el espaciado y orden 
de los sitios de unión e incluso en su composición; 
es decir, aunque se requiere la presencia de todo el 
colectivo de FT, no todos se unirán al ADN necesa-
riamente, sino que algunos podrán ejercer su fun-
ción mediante la interacción con otros FT del grupo. 
Además, este modelo predice la existencia de re-
glas gramaticales que podrán ser requeridas o no 
dependiendo del contexto de cada potenciador.
Los datos obtenidos del análisis de los MRC sostie-
nen que el código regulador de HSN podría seguir 
el segundo modelo. Sin embargo, decidimos inves-
tigar la posibilidad de que la huella reguladora de 
la HSN contuviese reglas gramaticales que ayuda-
sen a explicar la funcionalidad de los potenciado-
res de la neurona HSN. Descubrimos que cuando 
dos parejas de FT (ETS-GATA y ETS-HLH) se en-
contraban en una orientación particular en una 
secuencia de ADN con la huella reguladora, la pro-
babilidad de que se expresara en la HSN era mayor 
→ Figura 7-D, confirmando la existencia de nor-
mas sintácticas y, por tanto, concluyendo que los 
potenciadores de la HSN siguen el modelo del co-
lectivo de FT. A partir de entonces, decidimos lla-
mar más correctamente a los seis FT que regulan a 
la neurona HSN ‘colectivo de FT de la HSN’.
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A) Un 66% de los genes ex-
presados en la neurona HSN 
contienen la huella reguladora 
de HSN, en comparación con 
un 50% en los genes control 
(100 genes con un tamaño 
similar a los presentes en  
la HSN, elegidos al azar).  
La inclusión de los criterios 
de conservación de la huella 
reguladora de HSN aumenta 
las diferencias entre los 
genes expresados en la HSN y 
los genes control. *: pV<0,05. 
Test exacto de Fisher.  
 
B) El análisis de la distribución 
de la huella reguladora de la 
HSN en todo el genoma de  
C. elegans indica la existencia 
de un enriquecimiento de ésta 
en genes neuronales o con 
una función neuronal (genoma 
neuronal) en comparación con 
genes sin función neuronal 
asignada. La inclusión de los 
criterios de conservación 
de la huella reguladora de 
HSN aumenta las diferencias 
entre el genoma neuronal y 
no-neuronal. Chi cuadrado 
con corrección de Yates.  
***: pV<0,0001.  
 
C) La presencia de la huella 
reguladora de HSN permite 
identificar potenciadores 
asociados a genes neuronales 
expresados en la neurona 
HSN en un 37% de los casos 
(13/35 ventanas analizadas), 
mientras que ninguno de 
los controles (ventanas 
correspondientes a genes 
neuronales y de longitud 
comparable, pero sin huella 
reguladora de HSN) se 
expresa en la neurona. 
D) Ventanas con la huella 
reguladora de HSN muestran 
una preferencia de orien-
tación estadísticamente 
significativa entre sitios 
de unión de la familia 
ETS-GATA (3’3’) y ETS-HLH 
(5’5’). Aquellas ventanas 
que presentan ambas 
configuraciones gramaticales 
presentan mayor probabilidad 
de expresión en la HSN (50% 
en comparación con 20% en 
ventanas sin ninguna de las 
dos sintaxis).
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4.1 El programa serotonérgico de la neurona 
HSN y el de las neuronas del raphe de ratón 
muestran una elevada homología
El programa de diferenciación de las neuronas se-
rotonérgicas de ratón ha sido ampliamente estu-
diado, por lo que se sabe que está controlado por 
varios FT, entre los cuales se encuentran ortólo-
gos a los del nematodo: HLH-3/ASCL1, EGL-18/
GATA2/3, EGL-46/INSM1 y AST-1/PET1. Esta eleva-
da homología entre los FT del ratón y el colectivo 
de FT de la HSN nos hizo plantearnos si sería po-
sible que el resto de factores que intervienen en 
C. elegans también pudieran tener un papel en el 
ratón, y viceversa. Ensayos de silenciamiento gé-
nico y mutagénesis dirigida en gusano indican que 
PHA-4 (FT de la familia FKH y ortólogo del factor de 
ratón FOXA2) podría tener un papel en la diferen-
ciación de la neurona HSN. Además, exploramos si 
los FT murinos BRN2 (ortólogo de UNC-86) y SALL2 
(ortólogo de SEM-4) podrían tener un rol en la dife-
renciación serotonérgica. Descubrimos que ambos 
factores se expresan en las neuronas serotonérgi-
cas recién nacidas del raphe en ratón. Asimismo, 
demostramos mediante experimentos de resca-
te en gusanos mutantes que los ortólogos de ratón 
son capaces de sustituir funcionalmente a los FT 
equivalentes en gusano.
4.2 La neurona HSN y las neuronas 
serotonérgicas del raphe de ratón son 
molecularmente similares y comparten 
homología profunda
En biología evolutiva el término ‘homología profun-
da’ hace referencia a dos estructuras que com-
parten los mecanismos genéticos que regulan su 
diferenciación (Shubin et al. 1997). La gran homolo-
gía que comparten los programas genéticos de di-
ferenciación serotonérgica en C. elegans y en ratón 
sugiere que estos dos tipos neuronales podrían 
compartir una homología profunda y, por tanto, se-
rían estructuras homólogas. Para que esto fuese 
cierto, la neurona HSN y las neuronas del raphe de 
ratón no sólo deberían compartir la expresión de los 
genes de la vía de la 5-HT, que además también los 
expresan las neuronas serotonérgicas del gusa-
no NSM y ADF, sino que deberían ser ampliamente 
parecidas en términos moleculares. Para abordar 
esta cuestión, utilizamos la información disponible 
en www.wormbase.org y en (Hobert 2016a) sobre 
el perfil de expresión génica en HSN, para com-
pararla con los datos disponibles del transcripto-
ma de las neuronas serotonérgicas del raphe de 
ratón (Okaty et al. 2015). Realizamos un análisis de 
coordinadas principales que sugiere que, de entre 
todas las neuronas del gusano, el transcriptoma de 
la neurona HSN es el que más se asemeja a aquel 
de las neuronas serotonérgicas de ratón, apoyan-
do la teoría de que comparten homología profun-
da → Figura 8.
Conclusiones
En esta Tesis hemos diseccionado la lógica de re-
gulación transcripcional que subyace la especifi-
cación del sistema serotonérgico de C. elegans y, 
centrándonos en el subtipo neuronal HSN, hemos 
estudiado los mecanismos que seleccionan el 
complemento de potenciadores específicos de un 
tipo celular.
Los resultados obtenidos en esta Tesis han condu-
cido a las siguientes conclusiones:
1 Módulos de regulación en cis diferentes con-
trolan la expresión de los genes de la vía de la 
serotonina en los distintos tipos de neuronas sero-
tonérgicas de C. elegans. Esta regulación modular 
e independiente está de acuerdo con el modelo de 
los selectores terminales donde, para cada subtipo 
neuronal, una combinación de factores de trans-
cripción diferente activa la expresión de sus carac-
terísticas terminales.
2 Un complejo código de factores de transcrip-
ción es necesario para inducir el fenotipo sero-
tonérgico en la neurona HSN. Este código, al que 
hemos denominado colectivo de factores de trans-
cripción de HSN, está compuesto por UNC-86, 
SEM-4, HLH-3, EGL-46, AST-1 y EGL-18, que per-
tenecen a las familias POU, SPALT, HLH, INSM, ETS 
y GATA, respectivamente. Estos seis factores de 
transcripción se unen directamente a las regiones 
reguladoras de los genes de la vía de la serotonina 
con la finalidad de activar su expresión en la neu-
rona HSN.
3 El colectivo de factores de transcripción de 
HSN se expresa en la neurona a estadio larvario 
L4 y actúa específicamente en el paso de diferen-
ciación terminal de la célula, a excepción de HLH-
3, cuya expresión se limita al neuroblasto de HSN. 
Proponemos que, al igual que su homólogo en ratón 
ASCL1, HLH-3 muestra un rol dual como factor pro-
neural y pionero, promocionando secuencialmen-
te la especificación neuronal y la diferenciación 
terminal serotonérgica de la célula precursora de 
HSN, siendo capaz de unirse a los genes de la vía de 
la serotonina aún en estados de cromatina cerrada. 
El colectivo de factores de transcripción de HSN, a 
excepción de HLH-3, es necesario que se exprese 
durante toda la vida del animal para mantener la 
identidad serotonérgica de la neurona HSN.
4 El colectivo de factores de transcripción de 
HSN activa la expresión de los genes de la vía de la 
5-HT a través de rutas paralelas en la neurona HSN.
5 El colectivo de factores de transcripción de 
HSN regula la expresión de los genes de la vía de 
la serotonina de manera cooperativa y redundan-
te. El rol individual de cada miembro del colectivo 
y las relaciones sinergísticas entre ellos depende 
del gen en particular y del contexto donde se unen.
6 El colectivo de factores de transcripción de 
HSN contiene una huella de identidad reguladora 
compuesta por la agrupación de sitios de unión de 
los seis factores de transcripción del colectivo que 
está enriquecida en los genes neuronales y permi-
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Neuronas del gusano vs neuronas del raphe de ratón Figura 8 
Análisis de homología mole-
cular entre la neurona HSN y 
las neuronas serotonérgicas 
del raphe de ratón 
 
Comparación entre los 
perfiles de expresión de 
las neuronas del gusanos 
(construidos mediante la asig-
nación de ortólogos de ratón a 
los genes de C. elegans) y los 
perfiles de expresión de las 
neuronas serotonérgicas del
raphe de ratón (construidos 
a partir de datos de RNAseq), 
utilizando un análisis de 
coordinadas principales.  
El perfil molecular de la 
neurona HSN (verde) es el  
más cercano a las neuronas 
del raphe de ratón (azul).  
Este resultado no es debido a 
su naturaleza serotonérgica, 
puesto que los perfiles de 
NSM y ADF (rojo), también 
serotonérgicas del gusano, 
están más alejadas.
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te la identificación de novo de genes expresados 
en la neurona HSN. En este trabajo demostramos, 
por primera vez, que una huella de identidad re-
guladora meramente basada en secuencia prima-
ria de ADN es suficiente para la identificación de 
potenciadores.
7 El programa de regulación de la neurona HSN 
encaja con el modelo del colectivo de factores de 
transcripción: los seis factores de transcripción 
actúan de manera flexible, consiguiendo la acti-
vación de potenciadores con un orden y una dis-
tribución variable de sitios de unión. Además, de 
acuerdo con este modelo, la presencia de sitios de 
unión para ciertos factores de transcripción puede 
ser dispensable en determinados contextos genó-
micos al ser compensada por el resto de miembros 
del colectivo.
8 El programa de regulación serotonérgico de la 
neurona HSN, pero no el de las otras neuronas se-
rotonérgicas NSM y ADF, se asemeja al de las neu-
ronas serotonérgicas del raphe del ratón: AST-1/
PET1, HLH-3/ASCL1, EGL-18/GATA2/3, EGL-46/
INSM1 y UNC-86/BRN2 aparecen como factores de 
transcripción ortólogos. Esta homología permite la 
identificación de nuevos candidatos para la neu-
rona HSN del gusano PHA-4 (FOXA2), and para el 
ratón SALL2 (SEM-4). 
9 La neurona HSN de C. elegans y las neuronas 
serotonérgicas del raphe de ratón comparten ho-
mología profunda, además de homología funcional. 
Proponemos que esta homología profunda podría 
haber aparecido a partir de un tipo celular ances-
tral común.

